
<html lang="en"     class="pb-page"  data-request-id="b2ed0283-4b3f-444a-9e29-266a0b65230a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.7b00085;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-7"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The “Phenylalkylaminome” with a Focus on Selected Drugs of Abuse†" /></meta><meta name="dc.Creator" content="Richard A.  Glennon" /></meta><meta name="dc.Description" content="The phenylalkylamine, particularly the phenylethylamine, moiety is a common structural feature found embedded in many clinically approved agents. Greater still is its occurrence in drugs of abuse. ..." /></meta><meta name="Description" content="The phenylalkylamine, particularly the phenylethylamine, moiety is a common structural feature found embedded in many clinically approved agents. Greater still is its occurrence in drugs of abuse. ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00085" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00085" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00085" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00085" /></link>
        
    
    

<title>The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The “Phenylalkylaminome” with a Focus on Selected Drugs of Abuse | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00085" /></meta><meta property="og:title" content="The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The “Phenylalkylaminome” with a Focus on Selected Drugs of Abuse†" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0025.jpeg" /></meta><meta property="og:description" content="The phenylalkylamine, particularly the phenylethylamine, moiety is a common structural feature found embedded in many clinically approved agents. Greater still is its occurrence in drugs of abuse. The simplest phenylethylamine, 2-phenylethylamine itself, is without significant central action when administered at moderate doses, but fairly simple structural modifications profoundly impact its pharmacology and result in large numbers of useful pharmacological tools, agents with therapeutic potential, and in drugs of abuse (e.g., hallucinogens, central stimulants, empathogens), the latter of which are the primary focus here. In vivo drug discrimination techniques and in vitro receptor/transporter methods have been applied to understand the actions of these phenylalkylamines and their mechanisms of action. Thus far, depending upon pendent substituents, certain receptors (e.g., serotonin receptors) and monoamine transporters (i.e., serotonin, dopamine, and norepinephrine transporters) have been implicated as playing major roles in the actions of these abused agents in a complex and, at times, interwoven manner." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00085"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00085">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00085&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00085&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00085&amp;href=/doi/10.1021/acs.jmedchem.7b00085" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2605-2628</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.6b01065" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The “Phenylalkylaminome” with a Focus on Selected Drugs of Abuse<a class="ref internalNav" href="#lecture" aria-label="†">†</a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+A.++Glennon">Richard A. Glennon</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-3600-9045" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 804-828-8487. E-mail: <a href="/cdn-cgi/l/email-protection#90f7fcf5fefefffed0e6f3e5bef5f4e5"><span class="__cf_email__" data-cfemail="147378717a7a7b7a546277613a717061">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00085&amp;href=/doi/10.1021%2Facs.jmedchem.7b00085" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2605–2628</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 28, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 January 2017</li><li><span class="item_label"><b>Published</b> online</span>15 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00085</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2605%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRichard%2BA.%2BGlennon%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D7%26contentID%3Dacs.jmedchem.7b00085%26title%3DThe%2B2014%2BPhilip%2BS.%2BPortoghese%2BMedicinal%2BChemistry%2BLectureship%253A%2BThe%2B%25E2%2580%259CPhenylalkylaminome%25E2%2580%259D%2Bwith%2Ba%2BFocus%2Bon%2BSelected%2BDrugs%2Bof%2BAbuse%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2628%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00085"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1537</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00085" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The “Phenylalkylaminome” with a Focus on Selected Drugs of Abuse&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;A. Glennon&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2605-2628&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00085&quot;},&quot;abstract&quot;:&quot;The phenylalkylamine, particularly the phenylethylamine, moiety is a common structural feature found embedded in many clinically approved agents. Greater still is its occurrence in drugs of abuse. The simplest phenylethylamine, 2-phenylethylamine itself, is without significant central action when administered at moderate doses, but fairly simple structural modifications profoundly impact its pharmacology and result in large numbers of useful pharmacological tools, agents with therapeutic potential, and in drugs of abuse (e.g., hallucinogens, central stimulants, empathogens), the latter of which are the primary focus here. In vivo drug discrimination techniques and in vitro receptor/transporter methods have been applied to understand the actions of these phenylalkylamines and their mechanisms of action. Thus far, depending upon pendent substituents, certain receptors (e.g., serotonin receptors) and monoamine transporters (i.e., serotonin, dopamine, and norepinephrine transporters) have been implicated as playi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00085&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00085" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00085&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00085" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00085&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00085" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00085&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00085&amp;href=/doi/10.1021/acs.jmedchem.7b00085" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00085" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00085" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00085%26sid%3Dliteratum%253Aachs%26pmid%3D28244748%26genre%3Darticle%26aulast%3DGlennon%26date%3D2017%26atitle%3DThe%2B2014%2BPhilip%2BS.%2BPortoghese%2BMedicinal%2BChemistry%2BLectureship%253A%2BThe%2B%25E2%2580%259CPhenylalkylaminome%25E2%2580%259D%2Bwith%2Ba%2BFocus%2Bon%2BSelected%2BDrugs%2Bof%2BAbuse%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D7%26spage%3D2605%26epage%3D2628%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292214" title="Dissolved organic matter">Dissolved organic matter</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/jmcmar.2017.60.issue-7/20170413/jmcmar.2017.60.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The phenylalkylamine, particularly the phenylethylamine, moiety is a common structural feature found embedded in many clinically approved agents. Greater still is its occurrence in drugs of abuse. The simplest phenylethylamine, 2-phenylethylamine itself, is without significant central action when administered at moderate doses, but fairly simple structural modifications profoundly impact its pharmacology and result in large numbers of useful pharmacological tools, agents with therapeutic potential, and in drugs of abuse (e.g., hallucinogens, central stimulants, empathogens), the latter of which are the primary focus here. In vivo drug discrimination techniques and in vitro receptor/transporter methods have been applied to understand the actions of these phenylalkylamines and their mechanisms of action. Thus far, depending upon pendent substituents, certain receptors (e.g., serotonin receptors) and monoamine transporters (i.e., serotonin, dopamine, and norepinephrine transporters) have been implicated as playing major roles in the actions of these abused agents in a complex and, at times, interwoven manner.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Arylalkylamines</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Arylalkylamines (Ar–C<sub><i>n</i></sub>–N, where <i>n</i> is any whole number) represent one of the oldest and most frequently encountered structural scaffolds found among pharmacologically and physiologically active, naturally occurring or synthetic substances. The term arylalkylamine is quite general. The aryl (Ar) moiety includes substituted or unsubstituted, fused or unfused, aryl or heteroaryl rings distant from a nitrogen (N) atom by a branched or unbranched, saturated or unsaturated, substituted or unsubstituted alkyl chain of unspecified length (and the chain might be tethered back to the Ar group), and N is a primary, secondary, tertiary, or quaternary amine that might be cyclic in nature or where the N-substituent is incorporated into the alkyl chain or the Ar group to form a heterocycle (e.g., a piperidine or tetrahydroisoquinoline). A multitude of compounds have been investigated. But to many in medicinal chemistry, the term arylalkylamine conjures up something more restrictive (although there is probably no logical reason for this) and typically implies a chain length of two carbon atoms between the (hetero)aryl (Ar) and amine (N) moieties. Within the greater domain of arylalkylamines are the phenylalkylamines, compounds with some of the same structural attributes mentioned above regarding the “alkyl” and “amine” portions but where Ar is a phenyl (Ph) or substituted phenyl ring. Here, discussion will be restricted, for the most part, to relatively simple phenylalkylamines that possess the general structure Ph–C–C–N where Ph is an unsubstituted or substituted phenyl ring, and C–C is a simple ethyl or substituted ethyl chain (e.g., phenylethylamines and phenylisopropylamines).</div><div class="NLM_p">The intent of this article is to highlight the enormity, ubiquity, and pharmacological diversity of agents referred to as arylalkylamines and, more specifically, phenylalkylamines (and even more specifically, phenylethylamines). By analogy to the term genome, which consists of the entire known gene set, or receptorome, which represents the sum total of genes from which receptors are derived (or alternatively the sum total of all known receptors), we coined the term <i>phenyalkylaminome</i>.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> To indicate that this was done somewhat in jest, we also referred to this as the <i>phenylalkylaminegnome</i> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The term, as indicated by the latter, more whimsical sobriquet, was not meant to be “scientific” but was merely intended to underscore the enormity of this class of compounds.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The “phenylalkylaminegnome”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The DrugBank database is a cheminformatics resource that includes information on “approved” small-molecule marketed drugs.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> It includes data on 2198 unique agents, of which 1991 are classified as small molecules approved for use somewhere in the world. Of these, >1000 are U.S. FDA approved drugs. Using DrugBank (version 5.0.2, updated October 1, 2016; accessed November 1, 2016), a “substructure search” of agents with a molecular weight between 100 and 500 Da revealed that >10% of approved agents (i.e., 214) contain a phenylethylamine (i.e., Ph–C–C–N) substructure.</div><div class="NLM_p">It is fairly obvious that although the Ph–C–C–N motif represents a common structural scaffold, pendent substituents play a decisive role in its action(s). For example, the phenylethylamine (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) moiety is found embedded in the potent hallucinogenic agent lysergic acid diethylamide (LSD, <b>2</b>), not an “approved” agent (i.e., a U.S. schedule I controlled substance not found in DataBank), the analgesic agent morphine (<b>3</b>), the antidepressant venlafaxine (<b>4</b>), the atypical antipsychotic agent ziprasidone (<b>5</b>), and the appetite suppressant lorcaserin (<b>6</b>), just to mention a few. It is also found in the 5-HT<sub>1A</sub> serotonin receptor agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin (8-OH DPAT; <b>7</b>) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) and many other widely used research tools. This list easily can be extended to include >200 additional “approved agents” and grows manifold if regulated or unregulated drugs of abuse (i.e., “nonapproved” drugs, scheduled substances, and as yet unscheduled substances found on the clandestine market) are considered. As will be seen below, hundreds of drugs of abuse and other pharmacological tools are encompassed by the Ph–C–C–N skeleton; these, unless they have an approved use by happenstance (e.g., morphine), are not included in the DrugBank database.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of a few common agents containing an embedded phenylethylamine (<b>1</b>) moiety: lysergic acid diethylamide (<b>2</b>), morphine (<b>3</b>), venlafaxine (<b>4</b>), ziprasidone (<b>5</b>), lorcaserin (<b>6</b>), and the 5-HT<sub>1A</sub> serotonin receptor agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin (<b>7</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One might wonder why Ph–C–C–N (or, more generally, Ar–C–C–N) is such a common structural scaffold among drugs and pharmacologically active agents. It might be because this moiety is naturally occurring and commonly found within protein targets (e.g., the amino acids phenylalanine, tyrosine, tryptophan, histidine) or neurotransmitters (e.g., dopamine, norepinephrine, serotonin) and neurotransmitter precursors that interact with various receptor/transporter and enzyme targets that are composed of these amino acids. However, the Ph–C–C–N (and, more generally, the Ar–C–C–N) moiety might likely be a source of pharmacologically active agents because they mimic (e.g., as substrates, agonists) or interfere with (e.g., as blockers/inhibitors/antagonists) actions at those targets (e.g., receptors, transporters, enzymes) that include Ar–C–C–N or Ph–C–C–N moieties. In any event, the Ph–C–C–N moiety, perhaps initially because of synthetic accessibility or perhaps because so many derivatives were found early on to be of pharmacological value, has been of interest to medicinal chemists since the late 1800s and remains a current pursuit. As simple as the Ph–C–C–N motif might be, it continues to amaze how many simple Ph–C–C–N derivatives have not been pharmacologically evaluated or even synthesized!</div><div class="NLM_p">Our studies began in the early 1970s with the question “Why is it that certain phenylalkylamines (actually, arylalkylamines, in a broader sense) are central stimulants, some are hallucinogens, and yet others possess different actions or lack central actions altogether?” Evidently, although such agents possess a common arylalkylamine or phenylalkylamine backbone, the actions of these agents obviously rest upon their specific appurtenances (e.g., see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Particularly fascinating was the parent member of this family, phenylethylamine (PEA; <b>1</b>), an agent with minimal central action when administered systemically, and the central stimulant amphetamine (<b>8</b>; <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), the simple α-methyl analog of PEA, whose orally active central actions have been known for nearly a century. Here, the introduction of a one-carbon unit modified the pharmacology of PEA.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural relationships among several psychoactive arylalkylamines: the central stimulant amphetamine (<b>8</b>) and the classical hallucinogens mescaline (<b>9</b>), 5-methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine (5-OMe DMT, <b>10</b>), 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM, <b>11</b>), and its halogenated counterparts DOB (<b>12</b>) and DOI (<b>13</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It must be emphasized that our work was not conducted in a vacuum and that many investigators were working (and continue to work) in the same area. No attempt was made here to be comprehensive or all-inclusive. Our efforts in this area are highlighted. Some of what follows has been described by us (and others) in review articles over the years, and some of these reviews are cited here in order to reduce the number of references and to provide more overarching and detailed reading material. Contributions by others that directly impacted our work either will be cited here or, in certain instances, were prominently cited in the papers and reviews mentioned herein.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Phenylethylamine</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The simplest phenylethylamine, phenylethylamine itself, also known as 2-phenylethylamine, 2-phenylaminoethane, phenethylamine, or β-phenylethylamine (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), was first isolated and identified by the Polish chemist Marceli Nencki in 1876 (as reviewed by Grandy<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a>). More than 140 years later, PEA and its analogs remain a continuing and fascinating (and, perhaps, growing) topic of interest for medicinal chemists and, as witnessed by the number of new agents appearing on the illicit market, for clandestine chemists as well.</div><div class="NLM_p">Not only does PEA serve as scaffolding for various agents with therapeutic utility (e.g., <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> and associated text), it possesses activity in its own right. Although found in many plants and animals, as well as in humans,<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> PEA was initially thought to be a metabolic byproduct with no particular physiological relevance.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, it is now recognized that at very high doses, “several orders of magnitude above its normal physiological range”,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> PEA produces amphetamine-like effects in animals (reviewed;<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> see later).</div><div class="NLM_p last">Our early studies involved the use of a peripheral rat fundus tissue preparation to investigate centrally acting agents; the preparation was known to possess serotonin (5-hydroxytryptamine, 5-HT) receptors and was also reported to possess tryptamine receptors. This preparation was selected because several centrally acting indolealkylamines (i.e., tryptamines) were already known to act at fundus 5-HT receptors as agonists. Just prior to the discovery of multiple subtypes of brain 5-HT receptors (see below), it was found that [<sup>3</sup>H]tryptamine labeled a population of rat brain receptors distinct from any 5-HT receptor type then known (see Grandy<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> for a review). This provided us the first opportunity to examine the binding of centrally acting arylalkylamines at brain receptors rather than at peripheral fundus 5-HT receptors. We,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and others,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> showed that certain phenylalkylamines, including PEA, amphetamine, and 4-chloroamphetamine, displayed low μM affinity for [<sup>3</sup>H]tryptamine-labeled sites in rat brain frontal cortex homogenates. Other arylalkylamines, including certain tryptamines and conformationally constrained arylalkylamines such as β-carbolines, possessed even higher affinity.<a onclick="showRef(event, 'ref3 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref7">(3, 7)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">3 Trace Amine Receptors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Tryptamine and PEA had been referred to for some time as trace amines, the term trace amine being fully described by Usdin and Sandler<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> in 1976. Although found in human brain, trace amines were present at levels well below those found for common monoamine neurotransmitters and were thought to play a role as neuromodulators.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Other major endogenous trace amines include the phenylalkylamines <i>p</i>-tyramine and octopamine.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Over the years, trace amines (or their receptors) have been speculated to play a role in attention-deficit hyperactivity disorder (ADHD), schizophrenia, depression, Parkinson’s disease, substance abuse and in several other neuropsychiatric disorders (reviewed<a onclick="showRef(event, 'ref4 ref6 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref4 ref6 ref9 ref10">(4, 6, 9, 10)</a>). In 2001, the first trace amine receptor was cloned.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> These receptors are now realized to represent members of a receptor family that are termed trace amine-associated receptors (TAARs), and the first member was called TAAR1 (previously TR1 or TAR1). TAAR1 receptors are G-protein-coupled receptors associated with stimulation of cAMP (reviewed<a onclick="showRef(event, 'ref3 ref13'); return false;" href="javascript:void(0);" class="ref ref3 ref13">(3, 13)</a>). Various agents are known to activate TAAR1 including (followed by EC<sub>50</sub> value) <i>p</i>-tyramine (69 nM) > PEA (240 nM) > tryptamine (310 nM) > octopamine 1300 nM).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Other activating agents include the optical isomers of the phenylalkylamines amphetamine, 4-hydroxyamphetamine, methamphetamine, racemic 3-chloroamphetamine, and the indolealkylamine hallucinogen LSD.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In their study, Bunzow et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> found that the presence of a hydroxyl group at the 4-position of PEA-derived structures enhanced potency by several-fold; for example, 4-hydroxyamphetamine (EC<sub>50</sub> = 51 nM) was about 6 times more potent than amphetamine and the most potent activator then identified. However, many of these agents displayed higher affinity/potency at other receptors or targets. Once brain 5-HT receptors had been identified, we abandoned our work with tryptamine receptors in favor of 5-HT.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">4 Blood–Brain Barrier</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In retrospect, it is likely that [<sup>3</sup>H]tryptamine was labeling a TAAR. However, many TAAR1 ligands including PEA, tryptamine, and 4-hydroxyamphetamine have minimal central activity when administered by typical systemic routes of administration. Why are certain phenyl/arylalkylamines, such as these, centrally inactive, or nearly so, when administered systemically? One reason might be that they are unable to readily cross the blood–brain barrier. The concept of the blood–brain barrier (BBB) was proposed as early as 1900 by Lewandowsky<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (reviewed<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>) but was not fully appreciated for many decades to come. Basically, polar substances or substances of low lipophilicity cannot readily cross the BBB because tightly packed endothelial cells in cerebral blood vessels prevent their penetration (except in cases where active transport mechanisms are available, for example, for neurotransmitter precursors). This means that most polar agents (i.e., those that are not very lipophilic such as simple phenols, catechols, carboxylic acids, quaternary amines) typically fail (or display a reduced ability) to gain entry to the brain. Other agents, those possessing unprotected primary amines, such as PEA or tryptamine (agents of moderate lipophilicity) if they penetrate the BBB, are rapidly metabolized by enzymes such as monoamine oxidase (MAO). As a consequence, polar agents usually possess minimal, if any, central activity.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">5 Structurally Modified Phenylalkylamines: A Research Goal</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Certain arylalkylamines might not be centrally acting because of their inability to penetrate the BBB, whereas the actions of others are dictated by their specific substituents. Case in point: the α-methyl analog of PEA (i.e., amphetamine; <b>8</b>) is a central stimulant, whereas the 3,4,5-trimethoxy analog of PEA (i.e., mescaline; <b>9</b>; <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) is a weak hallucinogenic agent. It had been pretty much accepted at the time our studies began that amphetamine likely produces its stimulant actions via the dopamine transporter (a fairly new concept at the time), whereas mescaline had been hypothesized to act via interaction at a number of different receptors, including dopamine and norepinephrine receptors (adrenoceptors) whose natural substrates (i.e., dopamine and norepinephrine) bore a striking structural resemblance to mescaline.</div><div class="NLM_p last">One of our initial research goals was to elucidate the mechanism of action of hallucinogenic agents. In 1968, Hollister<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> defined the term “psychotomimetic”, which at the time was essentially synonymous with “hallucinogenic”, as “agents that, upon administration of a single dose, consistently produce changes in thought, mood, and perception without autonomic disturbance or addiction liability”. His definition was quite insightful but very broad and included agents already (and, certainly, later) recognized as producing different central actions in human subjects (e.g., LSD, phencyclidine, and tetrahydrocannabinol, the major active constituent of marihuana). Can these agents act via a common mechanism? So a second major goal of ours was to identify which psychoactive agents produced a common effect. We utilized a two-pronged approach. First, we used a behavioral technique (i.e., drug discrimination) to sort out which agents produced similar “stimulus” effects in animals; then, second, we examined those agents from a mechanistic perspective.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">6 The Drug Discrimination Paradigm</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the years, there have been many attempts to develop animal models of hallucinogenic drug action. None has been particularly successful.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This was likely due, in part, to the behavioral heterogeneity of the agents being examined.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Furthermore, many “hallucinogenic” agents profoundly alter an animal’s behavior, but this is also true of some nonhallucinogenic agents (e.g., central stimulants, analeptics, sedatives, muscle relaxants, anxiolytics, antipsychotics, antidepressants, anesthetics), and such studies were unlikely to afford useful information on mechanism(s) of action if they unknowingly included examples from these different classes of agents. Described below is a procedure we have found useful for our studies, but it is <u class="uu">not</u> an animal model of hallucinogenic drug action; rather, it is a model of stimulus similarity.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">6.a Training and Stimulus Generalization</h3><div class="NLM_p">The drug discrimination paradigm is a behavioral procedure whereby animals, typically rats, are trained to recognize the “stimulus” or “cueing” properties of a given dose of a training drug versus non-drug using a two-lever operant chamber. Training on drug and non-drug (i.e., typically vehicle) conditions, with (sweetened condensed milk or solid food pellet) re-enforcement, continues daily. (There are many variations of this paradigm including the use of other animal species, different apparati, various training and testing conditions, different routes of administration, various schedules of reinforcement, three-lever procedures, and so on; see Glennon and Young<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> for a comprehensive review of the drug discrimination paradigm.) Intermittently, generally once per week, and interspersed with continued daily training, reliably trained animals are administered lower doses of the training drug under nonreinforcement conditions; the animals engender fewer responses on the drug-appropriate lever such that a dose–response curve can be generated and an ED<sub>50</sub> dose calculated for the training drug (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. A typical dose–response plot for stimulus generalization studies. Animals trained to discriminate 1.0 mg/kg of a hypothetical training drug (uppermost solid square) from saline vehicle make >80% of their responses on the drug-appropriate lever following administration of this dose and <20 of their responses on this lever when administered vehicle (data not shown). Lower doses of the training drug result in decreased drug-appropriate responding (i.e., solid squares shown at <1.0 mg/kg) such that an ED<sub>50</sub> value can be calculated. When doses of challenge drugs A and B (open squares and open circles) are administered, stimulus generalization is said to have occurred if the animals produce >80% training-drug-appropriate responding at some dose. Here, drugs A and B substituted (implying a similarity of stimulus effects), and ED<sub>50</sub> doses can be calculated. Drug C (open triangles) produced vehicle-appropriate (i.e., <20 drug-appropriate) responding at the highest doses examined (this does not imply that the agents are pharmacologically inactive; i.e., they might be capable of producing a “different” stimulus effects). Some agents produce >20% but <80% drug-appropriate responding at the highest dose(s) examined; this is termed partial generalization. No reliable conclusions can be drawn from such data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequently, animals are intermittently (typically, once per week) administered doses of a nontraining drug (i.e., a challenge drug), under nonreinforcement conditions, and essentially the question is asked: “Does this drug produce, at some dose(s), a stimulus effect similar to that of the training drug?” That is, “Do you (i.e., the animal) recognize the challenge drug as producing a stimulus similar to the training drug?”. This is referred to as a test of <i>stimulus generalization</i>. Where stimulus generalization occurs, a dose–response curve can be constructed (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) and an ED<sub>50</sub> dose calculated; this process is diagramed in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. In this manner, the actions and potency of challenge drugs can be compared with that of the training drug. Again, this is <u class="uu">not</u> a model of hallucinogenic activity; it is a model of the stimulus similarity of drug action. For example, animals trained to discriminate the benzodiazepine anxiolytic agent diazepam will recognize (i.e., generalize to or substitute for, with the terms being used interchangeably) other benzodiazepine anxiolytic agents but not opioids, central stimulants, hallucinogens, and so on. It also might be noted that although agents that substitute for one another likely produce a common effect (i.e., some aspects of the stimulus properties or “cues” are shared), they need not produce identical effects. Furthermore, agents that substitute for one another seem to do so because they produce similar mechanism-based, not necessarily pharmacology/behavior-based, stimuli. For example, animals trained to discriminate the benzodiazepine anxiolytic agent diazepam do not recognize the arylpiperazine anxiolytic agent buspirone.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Whereas diazepam acts as a positive allosteric modulator of GABA<sub>A</sub> receptors, the anxiolytic actions of buspirone involve its (partial) agonist action at 5-HT<sub>1A</sub> serotonin receptors (see below). Thus, this paradigm, in addition to identifying agents that produce a common stimulus effect, is particularly well-suited to investigate mechanisms of drug action.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Stimulus generalization. A challenge drug might or might not substitute for (i.e., the challenge drug might or might not be recognized by) the trained animals. Stimulus generalization suggests a similarity of stimulus effects.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It should be appreciated that stimulus generalization (and antagonism) studies are labor-intensive. Normally, a few months are required to train the animals to recognize the training drug, and then, once trained, the animals are generally administered one dose of challenge drug once per week. Approximately three to four (or more) weeks are required to obtain full dose–response data. Hence, this is not a rapid method of obtaining pharmacological information. In contrast, the method provides a considerable amount of reliable data and is fairly consistent from laboratory to laboratory.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">6.b Stimulus Antagonism</h3><div class="NLM_p">Another common application of the drug discrimination procedure involves tests of stimulus antagonism (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Here, doses of various antagonists are administered in combination with the training dose of the training drug under nonreinforcement conditions. Typically, antagonists are first examined in tests of stimulus generalization, as control, to determine whether they might mimic the actions of a training drug (preferably, they should not) or whether they are disruptive to the animals’ lever-responding behavior (i.e., animals’ response rates are monitored). If a combination of training drug plus antagonist dose(s) results in the animals eventually making a decreased number of responses on the drug-appropriate lever (i.e., an increased number of responses on the nondrug lever until the combination elicits vehicle-appropriate responding), it is concluded that the training-drug stimulus has been effectively antagonized. It should be emphasized that the end-point of such studies is not inhibition of the animals’ lever-responding by administration of the antagonist (as determined by monitoring response rate) but a shift in the animals’ responding from the “drug lever” to the “non-drug (or vehicle) lever”. For example, D<sub>2</sub> dopamine receptor antagonists (e.g., haloperidol) block the stimulus effects of amphetamine and cocaine (agents that act via dopaminergic mechanisms) but not those of opioids, which act via an altogether different mechanism, when given in combination, such that the animals respond on the vehicle-appropriate (i.e., non-drug) lever. Furthermore, returning to the diazepam/buspirone mechanism-based claim made above, the benzodiazepine antagonist flumazenil blocked the stimulus actions of the anxiolytic agent diazepam but not those of the anxiolytic buspirone, whereas the 5-HT<sub>1A</sub> receptor antagonist 1-(2-methoxyphenyl)-4-(4-phthalimidobutyl)piperazine (an agent developed in our laboratories;<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> see below) blocked the stimulus effects of buspirone but not those of diazepam.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The technique is quite useful and of general applicability. If no known antagonist is available for a given agonist whose mechanism of action is understood, antagonists can be developed. This was the case in our development of 1-(2-methoxyphenyl)-4-(4-phthalimidobutyl)piperazine as an antagonist of the 5-HT<sub>1A</sub> receptor agonist 8-OH DPAT, an agent that served as a discriminative stimulus in rats but for which no antagonist was available. In contrast, antagonists with known receptor selectivity can be used to shed light on the mechanism of action of an agonist whose mechanism of action is unknown.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stimulus antagonism. Animals trained to a specific drug will respond on the “vehicle appropriate” lever if a combination of the training drug and the antagonist results in stimulus antagonism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">6.c Application</h3><div class="NLM_p">The drug discrimination paradigm now has been employed by numerous investigators to examine many hundreds of pharmacologically active agents in tests of stimulus generalization and stimulus antagonism.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The method is commonly used to, for example, (i) classify the actions of centrally acting agents, (ii) determine potencies of similar-acting agents, (iii) formulate in vivo structure–activity relationships, (iv) identify novel antagonists, (v) investigate mechanisms of action, (vi) examine time-course of action (i.e., time of onset, duration of action), and (vii) determine whether drug metabolites produce stimulus effects similar to their parent agent.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Because LSD was an established hallucinogen in humans, some of our first studies employed LSD as training drug. It was quickly realized that LSD produces stimulus effects that were training-dose dependent and that the effects might be mediated by different (or sometimes overlapping) mechanisms.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Also examined was the indolealkylamine hallucinogen 5-methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine (5-OMe DMT; <b>10</b>). Here too, stimulus effects were dose-dependent.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Eventually, we settled on the phenylalkylamine hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM; <b>11</b>) as training drug. Rats were trained to discriminate 1.0 mg/kg (ip) of DOM from saline vehicle (i.e., the non-drug condition), and tests of stimulus generalization and stimulus antagonism were conducted.</div><div class="NLM_p">(+)Amphetamine was already a well-documented training drug (reviewed<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>); hence, we used rats trained to discriminate 1.0 mg/kg (ip) of (+)amphetamine from vehicle and conducted tests of stimulus generalization and stimulus antagonism. It might be noted that DOM-trained animals do not recognize (+)amphetamine (i.e., the DOM-stimulus does not generalize to (+)amphetamine), and (+)amphetamine-trained animals do not recognize DOM.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The stimulus effects of the two agents are mutually exclusive.</div><div class="NLM_p last">Finally, the stage was set to examine various arylalkylamines and to classify them as being hallucinogens (actually, as being DOM-like) or stimulants (or being amphetamine-like). Furthermore, the drug discrimination paradigm, being centrally mediated, allowed us to identify (or eliminate) agents that did not readily penetrate the BBB barrier. For example, (+)amphetamine-trained animals did not recognize PEA or 4-hydroxyamphetamine, nor did DOM-trained animals recognize tryptamine.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Returning to the Hollister<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> definition, DOM-trained animals failed to recognize centrally acting agents such as phencyclidine, tetrahydrocannabinol, or certain other agents that were included in his original classification; these agents are now realized to produce altogether different stimulus effects, and animals trained to these agents failed to recognize arylalkylamines such as LSD, amphetamine, mescaline, or DOM.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> As a consequence, we were able to subclassify certain “hallucinogenic agents”, those that substituted for DOM, and termed them “classical hallucinogens”.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">7 Serotonin Receptor Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">7.a Peripheral 5-HT Receptors</h3><div class="NLM_p">At the time our studies began in the 1970s, there was evidence for the existence of two populations of peripheral 5-HT receptors: 5-HT-D and 5-HT-M receptors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The action of 5-HT at the former was antagonized by dibenzyline and at the latter by morphine. LSD was shown to act at the former, and its actions were blocked by dibenzyline.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> 5-HT-M receptors were eventually, decades later, found to be synonymous with 5-HT<sub>3</sub> serotonin receptors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A variety of isolated peripheral tissue preparations were being used to investigate serotonin receptors, and one of the most popular of these during the 1960s and 1970s was the rat fundus preparation.</div><div class="NLM_p last">Although rat fundus 5-HT receptors were never expressly identified as being 5-HT-D receptors, they bore the hallmarks of such on the basis of drug action. We examined a number of arylalkylamines (indolealkylamines and phenylalkylamines) at rat fundus 5-HT receptors and later demonstrated that for 14 such agents there was a significant correlation between their 5-HT receptor affinity and both their human hallucinogenic potency (note bene: reliable human hallucinogenic potency data were available only on a relatively limited number of agents at the time) and their stimulus generalization potency in DOM-trained rats (reviewed<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>).</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">7.b Central 5-HT Receptors</h3><div class="NLM_p">In 1979, using a newly developed rapid filtration technique, Peroutka and Snyder<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> identified two populations of brain 5-HT receptors: 5-HT<sub>1</sub> and 5-HT<sub>2</sub> receptors. Finally, there was a possibility of examining hallucinogens at brain 5-HT receptors rather than at peripheral 5-HT receptors or [<sup>3</sup>H]tryptamine-labeled brain binding sites.</div><div class="NLM_p">Before leaving the topic of fundus 5-HT receptors, it is worth mentioning that attempts were made to determine whether peripheral rat fundus 5-HT receptors bore any similarity to brain 5-HT<sub>1</sub> or 5-HT<sub>2</sub> receptors. The concept of tryptamine receptors had been around for a number of years, and it had been speculated that rat fundus might possess both 5-HT and tryptamine receptors. Cohen and Wittenaur<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> examined this in detail and concluded that both 5-HT and tryptamine contracted rat fundus by acting on the same population of 5-HT receptors but via receptors that were distinct from brain 5-HT<sub>1</sub> or 5-HT<sub>2</sub> receptors. This caused us to seriously question the relationships we had identified between peripheral fundus 5-HT receptor affinity and human hallucinogenic action or central DOM-like stimulus activity.</div><div class="NLM_p">Then, several interesting events occurred. In speaking with Drs. Norm Mason and Ray Fuller during a visit to Eli Lilly & Company, they agreed to examine several of our compounds at the recently identified rat brain 5-HT<sub>1</sub> and 5-HT<sub>2</sub> receptors; it should be noted that these were the only two populations of brain 5-HT receptors known at the time. Although our results were never published, they provided the first supporting evidence that several examples of classical hallucinogens, including DOM, displayed greater affinity for the latter than the former. As might have been expected, Pharma had no particular practical interest in pursuing investigations of hallucinogenic agents.</div><div class="NLM_p">Later, working with Dr. Milt Teitler (Albany Medical College), we found a significant correlation between the stimulus generalization potency of various agents in DOM-trained animals and rat-brain homogenate 5-HT<sub>2</sub> receptor affinity (see next section).</div><div class="NLM_p">Sometime later, two populations of brain 5-HT<sub>2</sub> receptors were identified: 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors. Years later, a team from Eli Lilly led by Dr. David Nelson cloned rat fundus 5-HT receptors and found them to be quite homologous to 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors; they termed these 5-HT<sub>2F</sub> (“F” for fundus) receptors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> These have since been renamed 5-HT<sub>2B</sub> receptors. Subsequently, in collaboration with Dr. Nelson, we demonstrated a significant correlation (<i>r</i> > 0.9) for the binding of 16 phenylalkylamines at rat and human 5-HT<sub>2B</sub> receptors.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> However, 5-HT<sub>2B</sub> receptors are not a major 5-HT<sub>2</sub> receptor population in human brain, and the 5-HT<sub>2B</sub> receptor affinities of the examined agents were significantly correlated (<i>r</i> > 0.9) with their brain 5-HT<sub>2A</sub> receptor affinities.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p last">Beginning in the early 1980s, we established a long-term relationship with Dr. Teitler who examined many of our compounds at 5-HT<sub>2</sub> receptors, first, at rat-brain homogenate 5-HT<sub>2</sub> and then human-brain homogenate 5-HT<sub>2</sub> receptors and, later, at cloned human 5-HT<sub>2A</sub> receptors. 5-HT<sub>2C</sub> (initially termed 5-HT<sub>1C</sub>) receptor binding data were also obtained. Over the years, many additional 5-HT receptors were identified: 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>1D</sub>, 5-HT<sub>1E</sub>, 5-HT<sub>1F</sub>, 5-HT<sub>3</sub>, 5-HT<sub>4</sub>, 5-HT<sub>5</sub>, 5-HT<sub>6</sub>, 5-HT<sub>7</sub>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Each time a new population of 5-HT receptors was identified, several representative classical hallucinogens were evaluated. Most of these studies were conducted in collaboration with Dr. Teitler, some early 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub> (initially at the University of Arizona, Tucson), and subsequent 5-HT<sub>2B</sub> receptor (Eli Lilly) studies were in collaboration with Dr. Nelson, and certain early 5-HT<sub>3</sub> receptor studies were conducted with Dr. Steve Peroutka (Stanford University) and later with Dr. Teitler. Although our primary focus always was on 5-HT<sub>2</sub> receptors, the latter investigations piqued our interest in other populations of 5-HT receptors which we went on to investigate. Such studies, with a few exceptions, will not be described here.</div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">8 Classical Hallucinogens and the 5-HT<sub>2</sub> Receptor Hypothesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Arylalkylamines we had termed classical hallucinogens included indolealkylamines (e.g., LSD, 5-OMe DMT) and phenylalkylamines (e.g., mescaline, DOM). On the basis of drug discrimination studies, we showed that they produced a common DOM-like stimulus effect in rats. This never implied that they produce an identical effect (in humans or animals); rather, they seemed capable of producing a common stimulus effect in animals (i.e., the “common component concept”), with certain agents producing additional effects via other mechanisms. That is, some of these agents, particularly indolealkylamines, also activated 5-HT<sub>1A</sub> receptors and/or some other receptor population/subpopulation. Notable among these agents was 5-OMe DMT (<b>10</b>) which displayed even higher affinity at 5-HT<sub>1A</sub> than at 5-HT<sub>2</sub> receptors (and note the earlier comment in <a class="ref internalNav" href="#sec6_3" aria-label="section 6.c">section 6.c</a> about 5-OMe DMT producing dose-dependent stimulus effects).<a onclick="showRef(event, 'ref18 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref20">(18, 20)</a> Other hallucinogenic agents, especially LSD, were particularly promiscuous and interacted at a variety of neurotransmitter receptors as agonists, partial agonists, or antagonists.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> But, these agents had the common ability to bind and activate 5-HT<sub>2</sub> receptors. For example, a dozen classical hallucinogens were compared and shown to stimulate 5-HT<sub>2A</sub>-mediated phosphatidylinositol hydrolysis involved in second messenger signaling.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Notable among these were DOM and its halogenated counterparts 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane (DOB) and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) (<b>12</b> and <b>13</b>, respectively; see <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> for structures).</div><div class="NLM_p">After examining the discriminative stimulus and 5-HT<sub>2</sub> binding properties of several dozen arylalkylamines, we found a significant correlation between (i) 5-HT<sub>2</sub> receptor binding affinity and stimulus generalization potency for substitution (stimulus generalization) in DOM-trained animals, (ii) 5-HT<sub>2</sub> receptor affinity and human hallucinogenic potency, and (iii) human hallucinogenic potency and drug discrimination potency using DOM-trained animals (reviewed<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a>). The 5-HT<sub>2</sub> hypothesis of hallucinogenic drug action (for the classical hallucinogens) was proposed. Once cloned, human 5-HT<sub>2A</sub> receptors were examined and the concept was modified to the “5-HT<sub>2A</sub> hypothesis” of classical hallucinogen drug action.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Drs. Jose Leysen and Francis Colpaert (the latter conducting drug discrimination studies using LSD-trained animals) at Janssen Pharmaceutica (Beerse, Belgium) developed the first useful 5-HT<sub>2</sub> receptor antagonists: ketanserin and pirenpirone.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> They kindly provided us, during a visit to their facilities, with samples of each agent, and we later found that both agents were potent antagonists of the DOM stimulus in tests of stimulus antagonism.<a onclick="showRef(event, 'ref30 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref33">(30, 33)</a> Results with these two antagonists supported our initial 5-HT<sub>2</sub> hypothesis of hallucinogenic drug action for classical hallucinogens. Subsequently, newer 5-HT<sub>2</sub> receptor antagonists were developed and provided by other investigators, examined, and found effective in blocking the DOM stimulus.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p last">More than a decade later, Vollenweider et al.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> demonstrated that “psilocybin-induced psychosis” (psilocybin being the phosphate ester of 4-hydroxy-<i>N</i>,<i>N</i>-dimethyltryptamine, an indolealkylamine classical hallucinogen) could be antagonized by ketanserin and risperidone (a mixed 5-HT<sub>2</sub>/D<sub>2</sub> receptor antagonist) but not by haloperidol (a D<sub>2</sub> dopamine receptor antagonist) in human volunteers. More recently, it was shown that the disrupting effects of psilocybin on sensorimotor gating in human volunteers were blocked by ketanserin,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> as were psilocybin-induced visual hallucinations.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Hence, human data, finally, became available to support our receptor- and rodent-based 5-HT<sub>2</sub> hypothesis of classical hallucinogen drug action.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">9 Utility of 5-HT<sub>2</sub> Agonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">9.a Development of Radioligands</h3><div class="NLM_p">For many years, the tritiated version of the 5-HT<sub>2</sub> receptor antagonist ketanserin, [<sup>3</sup>H]ketanserin, introduced by Janssen Pharmaceutica was employed as a radioligand for labeling 5-HT<sub>2</sub> receptors; it is still used today. As an aside, probably the two synthetic agents to make the greatest impact on early 5-HT receptor research since the discovery of 5-HT itself (in my opinion) were the 5-HT<sub>2</sub> receptor antagonist ketanserin and the 5-HT<sub>1A</sub> receptor agonist 8-OH DPAT.</div><div class="NLM_p">Although not as much a problem with today’s use of cloned and expressed receptors, the lack of ketanserin’s selectivity for 5-HT<sub>2</sub> receptors over some other receptors, notably histamine receptors and certain adrenoceptors, was a drawback when brain homogenates were being employed as the receptor source. Prior to the advent of [<sup>3</sup>H]ketanserin, [<sup>3</sup>H]spiperone was widely used to label 5-HT<sub>2</sub> receptors, but [<sup>3</sup>H]spiperone was already known to tag certain dopamine receptors and was later found to label 5-HT<sub>1A</sub> receptors as well, the latter finding resulting in the identification and subsequent subdivision of 5-HT<sub>1</sub> receptors into 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Because DOM represented an agent that lacked affinity for most receptors that [<sup>3</sup>H]ketanserin and [<sup>3</sup>H]spiperone labeled, we undertook a structure–activity study to identify novel entities that might be used as new agonist radioligands. Ultimately, we synthesized tritiated DOB and radioiodinated DOI. [<sup>3</sup>H]DOB was a very effective 5-HT<sub>2</sub> receptor radioligand but saw somewhat limited application, perhaps because DOB is a controlled (U.S. schedule I) substance and investigators were required to be licensed to use it. [<sup>125</sup>I]DOI, with higher specific activity and DOI not being a controlled substance, has seen wider application and is currently commercially available and fairly widely used in binding studies. 5-HT<sub>2A</sub> binding data are provided for several representative agents in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. h5-HT<sub>2A</sub> Receptor Binding Data for a Few Representative Examples of Phenylalkylamines Using [<sup>3</sup>H]Ketanserin ([<sup>3</sup>H]KET),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> [<sup>3</sup>H]DOB,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> or [<sup>125</sup>I]DOI<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> as Radioligand<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0020.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>K</i><sub>i</sub>, nM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]KET</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]DOB</th><th class="colsep0 rowsep0" align="center">[<sup>125</sup>I]DOI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5200</td><td class="colsep0 rowsep0" align="left">268</td><td class="colsep0 rowsep0" align="left">211</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1200</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="left">57.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">380</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">94.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">C<sub>3</sub>H<sub>7</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">88.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">0.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">See references for additional binding data.</p></div></div></div><div class="NLM_p">[<sup>125</sup>I]DOI has been used in autoradiographic studies with rat brain, and [<sup>123</sup>I]DOI as a single-photon emission computed tomography (SPECT) imaging agent in monkeys.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> As an aside, we also employed <i>R</i>(−)DOB, the higher affinity optical isomer of DOB, and (±)DOI as training drugs in drug discrimination studies for comparison with binding data being obtained using [<sup>3</sup>H]DOB and [<sup>125</sup>I]DOI as radioligands, but these novel training drugs offered no apparent advantage over DOM-trained animals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p last">An added bonus of [<sup>3</sup>H]DOB and [<sup>125</sup>I]DOI as 5-HT<sub>2</sub> receptor radioligands is that agonists generally bind with higher affinity (typically 10-fold or greater) at agonist-labeled receptors than at antagonist-labeled receptors. For example, 5-HT bound with 50-fold higher affinity at rat brain 5-HT<sub>2</sub> receptors labeled by [<sup>125</sup>I]DOI (<i>K</i><sub>i</sub> = 10.6 nM) versus receptors labeled by [<sup>3</sup>H]ketanserin (<i>K</i><sub>i</sub> = 600 nM), and DOI displayed nearly 30-fold higher affinity. In contrast, the 5-HT<sub>2</sub> receptor antagonist ketanserin bound with nearly comparable affinity at both (<i>K</i><sub>i</sub> of 2.4 and 1.2 nM, respectively, for [<sup>125</sup>I]DOI- and [<sup>3</sup>H]ketanserin-labeled sites).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> For some time, we employed both [<sup>3</sup>H]ketanserin and [<sup>125</sup>I]DOI in binding studies to obtain early clues as to whether novel agents might be potential 5-HT<sub>2</sub> receptor agonists or antagonists.</div></div><div id="sec9_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">9.b Development of 5-HT<sub>2</sub> Receptor Antagonists</h3><div class="NLM_p">A classical QSAR study was conducted to identify physicochemical properties that might underlie the binding of phenylalkylamines at 5-HT<sub>2</sub> receptors. For a series of greater than two dozen compounds (i.e., DOM-related analogs where the only structural change was replacement of the 4-position methyl group with a variety of substituents), it was found that affinity increased as substituent lipophilicity increased.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, some compounds with high 5-HT<sub>2</sub> receptor affinity failed to substitute in DOM-trained rats. For example, within a homologous series where the 4-position substituent ranged from methyl (i.e., DOM) to <i>n</i>-octyl, compounds with substituents larger (longer, bulkier?) than <i>n</i>-butyl failed to substitute. Being high-affinity 5-HT<sub>2</sub> serotonin receptor ligands, some were examined as potential antagonists and, indeed, were able to antagonize the DOM-stimulus when administered in combination with DOM.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Another informative lead eventually fueled the discovery of other phenylethylamine-based 5-HT<sub>2</sub> receptor antagonists. Neither PEA nor amphetamine (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) nor any of its monomethoxy analogs displayed significant affinity for 5-HT<sub>2</sub> receptors. Some dimethoxy analogs (e.g., <b>20</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) showed modest binding when unsubstituted at the 4-position, but affinity was substantially enhanced when certain substituents were present (e.g., DOB; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). It might be parenthetically mentioned that these studies led to the development of [<sup>3</sup>H]DOB and [<sup>125</sup>I]DOI. Interestingly, replacement of the 4-bromo group of DOB with a (3-phenyl)propyl group (i.e., <b>21</b>) had no effect on affinity and in an agent that did not substitute for DOM in stimulus generalization studies; furthermore, in the case of the latter, the 2,5-dimethoxy pattern, optimal for agonist action, was no longer required for high-affinity binding (e.g., <b>22</b> and <b>23</b>; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Ultimately, after further SAR studies were conducted, we developed several phenylalkylamines as 5-HT<sub>2</sub> receptor antagonists; for example, <b>24</b> and <b>25</b> (<i>K</i><sub>i</sub> of 20 and 13 nM, respectively) (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) were found to be inhibitors of 5-HT-induced phosphatidylinositol turnover.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Hence, a potent 5-HT<sub>2</sub> serotonin receptor agonist, DOB, was converted to several novel 5-HT<sub>2</sub> receptor antagonists. Both DOB and <b>25</b> can trace their structural ancestry to PEA, a compound that lacks affinity for 5-HT<sub>2</sub> receptors (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). It is evident that the agonist and antagonist phenylethylamines do not share a common SAR, and the SAR of the latter remains to be fully investigated. However, this supports the earlier contention that pendent substituents have a dramatic influence on the actions of phenylalkylamines.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. 5-HT<sub>2A</sub> Receptor Binding Data for Selected Phenylethylamines Using [<sup>3</sup>H]Ketanserin as Radioligand<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0021.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub>, nM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2820</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">4720</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr></tbody></table></div></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Examples of phenylalkylamine-derived 5-HT<sub>2A</sub> receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec9_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">9.c Development of 5-HT<sub>2</sub> Receptor Agonists with Therapeutic Potential</h3><div class="NLM_p">Glaucoma is a leading cause of blindness, and this has been related to increased intraocular pressure (IOP). Reduction of IOP is an effective treatment for glaucoma, but some patients are refractory to current therapies. A new direction in reducing IOP was desired. Investigators at Alcon Research identified 5-HT<sub>2A</sub> receptors in ocular tissue and demonstrated that topical administration of <i>R</i>(−)DOI, a potent 5-HT<sub>2</sub> receptor agonist identified by us, produced a significant decrease in IOP in cynomolgus monkeys. In a collaborative effort with Alcon, our goal was to identify a novel 5-HT<sub>2</sub> serotonin receptor agonist with reduced lipophilicity so that it would not readily penetrate the BBB to produce untoward (i.e., hallucinogenic) side effects. We selected a high-affinity/high-efficacy 5-HT<sub>2</sub> serotonin receptor agonist (i.e., DOB) and attempted to reduce its lipophilicity.</div><div class="NLM_p">How might this be accomplished? We already knew from prior studies<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> that replacement of the 4-bromo substituent of DOB with a carboxylic acid or conversion of DOB to an <i>N</i>,<i>N</i>,<i>N</i>-trimethyl quaternary amine<a onclick="showRef(event, 'ref27 ref42'); return false;" href="javascript:void(0);" class="ref ref27 ref42">(27, 42)</a> (both being effective strategies to limit BBB permeability<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a>) would not work because both of these compounds lacked affinity for the target receptor.<a onclick="showRef(event, 'ref37 ref42'); return false;" href="javascript:void(0);" class="ref ref37 ref42">(37, 42)</a></div><div class="NLM_p">Another strategy was to unmask one of the two methoxy groups of DOB to provide a polar phenolic group, phenolic groups being known to decrease BBB permeability. We had already examined the two <i>des</i>-methyl analogs of DOM: 2-<i>des</i>-methyl DOM (<b>26</b>) and 5-<i>des</i>-methyl DOM (<b>27</b>) (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Both compounds displayed affinity at 5-HT<sub>2A</sub> receptors, their affinities being approximately one-fifth and one-half, respectively, that of DOM. Furthermore, both compounds substituted in <i>R</i>(−)DOM-trained and LSD-trained animals, suggesting agonist action, and stimulus effects were antagonized by pretreatment of the animals with the selective phenylalkylamine-based 5-HT<sub>2A</sub> receptor antagonist volinanserin (earlier known as M100907 and MDL-100,907; <b>28</b>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. 5-HT<sub>2</sub> receptor agonists <b>26</b>, <b>27</b>, <b>29</b>-<b>31</b>, <b>40</b>, <b>41</b>, and the 5-HT<sub>2</sub> receptor antagonist volinanserin (<b>28</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Stimulus generalization was demonstrated to be time-dependent, with the phenolic compounds having a longer onset of action time (decreased ability of the agents to penetrate the BBB?). Both of these agents were potential candidates for further investigation. However, there was some concern that <b>26</b> and <b>27</b> might undergo further O-demethylation in vivo to a hydroquinone. It had been shown years earlier that DOM undergoes metabolic bis-demethylation to a hydroquinone and that the hydroquinone undergoes oxidation to a para-quinone (and/or a cyclic iminoquinone) that reacts irreversibly with various proteins.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> As a consequence, this approach was not pursued because of potential risk of neurotoxicity and/or off-target effects.</div><div class="NLM_p">Another approach at reducing lipophilicity would be to introduce a polar substituent on the alkyl chain. The first agent examined was morpholine <b>29</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> However, <b>29</b> displayed 100-fold lower affinity than <i>R</i>(−)DOB (<i>K</i><sub>i</sub> = 0.2 nM) for [<sup>125</sup>I]DOI-labeled 5-HT<sub>2A</sub> receptors (and note the radioligand being employed and implications with regard to agonist action). This might have been expected because N-methylation was already known to decrease the 5-HT<sub>2</sub> receptor affinity of DOB.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Next examined were phenylethylamines <b>30</b> and <b>31</b>, lacking an α-methyl group (to avoid problems of diastereomeric isomers); <b>30</b> and <b>31</b> showed improved affinity (<i>K</i><sub>i</sub> of 2.0 and 2.1 nM, respectively) relative to <b>29</b>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> What was learned was that introduction of small polar substituents at the β-position was tolerated by 5-HT<sub>2</sub> receptors; furthermore, one specific optical isomer of <b>30</b> and <b>31</b> might have been expected to display even higher affinity but was never prepared. Instead, we prepared optical isomers of β-methoxy and β-hydroxy DOB. All isomers displayed high affinity for 5-HT<sub>2A</sub> receptors (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). For both the β-methoxy and β-hydroxy analogs, the <i>R</i>,<i>R</i>-isomers (i.e., <b>35</b> and <b>39</b>, respectively) seemed optimal and their affinity approached the affinity of <i>R</i>(−)DOB. With <b>39</b> likely being the more polar and less likely to penetrate the BBB than <b>35</b>, due to the presence of the hydroxyl group, investigations continued with <b>39</b>. Compound <b>39</b> retained the efficacy of <i>R</i>(−)DOB in a calcium-mobilization assay and reduced IOP in cynomolgus monkeys upon topical application. Furthermore, in tests of stimulus generalization using DOM-trained animals, <b>39</b> was 17 times less potent than <i>R</i>(−)DOB.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> So even though <b>39</b> was not without central action, it was considered to possess minimal abuse liability considering its method of application (ocular instillation) and the intention of making available only very dilute ocular solutions of the agent. Then a turn of events.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. 5-HT<sub>2A</sub> Serotonin Receptor Affinity of β-Methoxy and Hydroxy DOB Analogs<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0022.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">stereochemistry</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">α</th><th class="colsep0 rowsep0" align="center">β</th><th class="colsep0 rowsep0" align="center" char=".">5-HT<sub>2A</sub><i>K</i><sub>i</sub>, nM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">–OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="char" char=".">17.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">–OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">–OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="char" char=".">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">–OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">–OH</td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="char" char=".">9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">–OH</td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">–OH</td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">–OH</td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i>(−)DOB</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr></tbody></table></div></div><div class="NLM_p last">In concert with our synthetic and behavioral efforts, Alcon developed <i>S</i>-2-(8,9-dihydro-7<i>H</i>-pyrano[2,3-<i>g</i>]indazol-1-yl)-1-methylethylamine (AL-38022A; <b>40</b>)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Compound <b>40</b> was a very high-affinity (<i>K</i><sub>i</sub> = 0.13 nM) 5-HT<sub>2A</sub> receptor agonist with efficacy comparable to <i>R</i>(−)DOI.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In stimulus generalization studies, <b>40</b> was more potent than <i>R</i>(−)DOI in DOM-trained rats (ED<sub>50</sub> of 0.05 mg/kg and 0.2 mg/kg, respectively, for <b>40</b> and <i>R</i>(−)DOI) and equipotent in DOM-trained rhesus monkeys (ED<sub>50</sub> = 0.04 mg/kg).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> As such, <b>40</b> rivaled the potency of LSD. Furthermore, its actions were blocked using the 5-HT<sub>2A</sub>-selective antagonist volinanserin. Obviously, compound <b>40</b> could not be further considered for therapeutic utility due to its high potential for abuse, although it might represent a useful pharmacological tool. In an attempt to decrease the lipophilicity of <b>40</b>, Alcon prepared several additional compounds and optical isomers; this ultimately led to compound <b>41</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), the 8-hydroxy counterpart of <b>40</b>.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Although <b>41</b> displayed 3-fold reduced affinity for 5-HT<sub>2A</sub> receptors relative to <b>40</b>, its experimentally determined distribution coefficient was >10-fold lower. Furthermore, in rats trained to discriminate DOM from vehicle, <b>41</b> produced saline-appropriate responding at 10 times the dose of <b>40</b> and effectively reduced IOP following topical application in monkey assays.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> From these and other studies, it was concluded that <b>41</b> had an overall profile favorable for consideration as a clinical candidate for continued evaluation.</div></div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">10 MDA, MDMA, and PMMA</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As described above, we employed DOM and (+)amphetamine as discriminative stimuli in rats in order to classify various arylalkylamines as acting as DOM-like or amphetamine-like substances. Very early on, we found one agent substituted in <u class="uu">both</u> groups of trained animals: 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA, <b>42</b>) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), a fairly popular drug of abuse during the 1960s (the “love drug”) that has resurfaced on the clandestine market in recent years. Because it was the first agent to do so, we subsequently examined MDA optical isomers and found that <i>R</i>(−)MDA, but not <i>S</i>(+)MDA, substituted in DOM-trained animals whereas the reverse was true in (+)amphetamine-trained animals. Furthermore, <i>S</i>(+)MDA, but not <i>R</i>(−)MDA, substituted in cocaine-trained animals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This probably represented the first time optical isomers of a given agent had been shown to produce different stimulus effects in drug discrimination studies with each isomer possessing a defined/different abuse potential.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of several MDA (<b>42</b>)-related compounds: MDMA (<b>43</b>), PMA (<b>44</b>), PMMA (<b>45</b>), 3,4-DMA (<b>46</b>), and MMA (<b>47</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further investigate this unique and very intriguing phenomenon, we trained rats to discriminate racemic MDA from saline vehicle. Typically, training rats to discriminate a centrally acting agent from vehicle (depending upon the particular agent) requires 60–90 days.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Training animals to discriminate racemic MDA from vehicle took well over one year, much, much longer than the typical training time of any agent we had previously used as a training drug.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> We were of the opinion that the animals were being required to recognize a complex stimulus, two different stimuli (?). This seemed to be borne out by subsequent stimulus generalization studies. But eventually the animals learned the task. Next, tests of stimulus generalization were conducted with a variety of agents, and (±)MDA-stimulus substitution occurred with classical hallucinogens such as DOM and LSD, as well as with central stimulants such as (+)amphetamine and cocaine<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (and it might be noted that amphetamine and cocaine substitute for one another regardless of which is used as training drug).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Substitution also occurred to both optical isomers of MDA.<a onclick="showRef(event, 'ref18 ref49'); return false;" href="javascript:void(0);" class="ref ref18 ref49">(18, 49)</a> Initially, it was thought that MDA-trained animals might supplant the use of DOM- and amphetamine-trained animals to quickly identify phenylalkylamines as being “active” in producing one of these two types of effects. We soon realized that (i) if substitution occurred, we would still need to examine the agents in DOM- and amphetamine-trained animals for further classification and (ii) the MDA-stimulus training period limited the time we could investigate new agents (i.e., training required 50–60% of a rat’s typical lifespan). Hence, we ventured a different approach.</div><div class="NLM_p">In a continuation of the above studies, another group of rats was trained to discriminate <i>R</i>(−)MDA from <i>S</i>(+)MDA from vehicle in a three-lever drug discrimination task.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Once the animals had been trained, and this took some time, administration of classical hallucinogens such as LSD, mescaline, and DOM engendered <i>R</i>(−)MDA-appropriate lever-responding, whereas following administration of central stimulants such as (+)amphetamine and cocaine, the animals responded on the <i>S</i>(+)MDA-appropriate lever.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Furthermore, the 5-HT<sub>2</sub> receptor antagonist pirenpirone blocked the <i>R</i>(−)MDA stimulus but not the <i>S</i>(+)MDA stimulus.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The results indicated that MDA optical isomers were capable of producing different and enantiospecific stimulus effects in animals. And this conclusion was supported by our being able to train the same group of animals to discriminate between two optical isomers of the same agent. However, technical difficulties precluded the use of this paradigm on a wide-scale basis. Nevertheless, the three-lever procedure provided “proof of concept” and was the first to show that animals could be trained to discriminate the stimulus effects of optical isomers of a given agent.</div><div class="NLM_p">In the 1980s, a new phenylalkylamine emerged on the clandestine market: the <i>N</i>-monomethyl homolog of MDA or methylenedioxymethamphetamine (MDMA, “ecstasy”, currently popular under the name of “Molly” and by several other names and acronyms; <b>43</b>). It is probably as popular today as it was then, if not more so. The agent has been termed an empathogen because it produces a sense of well-being and other prosocial effects.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> We first examined MDMA in the mid-1980s. On the basis of phenylalkylamine SAR we had established by then, it was our assumption that N-methylation would enhance the central stimulant character of MDA and, at the same time, detract from its hallucinogenic character. We found that <i>R</i>(−)MDMA displayed only modest affinity for 5-HT<sub>2</sub> receptors (<i>K</i><sub>i</sub> = 3310 nM) whereas the affinity of its <i>S</i>(+)-enantiomer was even lower (<i>K</i><sub>i</sub> = 15 800 nM).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This was not inconsistent with the concept that MDMA might be an amphetamine-like agent and with reports that <i>S</i>(+)MDMA was more potent than <i>R</i>(−)MDMA in humans.</div><div class="NLM_p">We and others (notably Dr. David Nichols and colleagues) examined MDMA and its isomers and various MDMA analogs in drug discrimination studies using animals trained to a variety of substances (see Nichols and Oberlender<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and Glennon<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> for early reviews and Glennon and Young<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> for a broader overview). MDMA did not substitute in “classical” hallucinogen-trained (i.e., LSD- or DOM-trained animals), but results in (+)amphetamine-trained animals were mixed. We found that both a (+)amphetamine stimulus and an MDA stimulus generalized to MDMA.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Clearly, MDMA, though neither a simple hallucinogen nor a simple central stimulant, seemed to possess some amphetamine-like qualities.</div><div class="NLM_p">MDMA has been used as a training drug,<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> and MDMA-stimulus generalization occurred to the central stimulant cocaine; however, cocaine-trained animals failed to recognize MDMA or either of its optical isomers.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Others also found that neither MDMA isomer substituted in cocaine-trained animals, whereas yet others showed that <i>R</i>(−)MDMA, but not <i>S</i>(+)MDMA,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> substituted (see Bondareva et al.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> for extended discussion). In one study, cocaine did not substitute either in <i>R</i>(−)MDMA- or in <i>S</i>(+)MDMA-trained rats,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> whereas in another study substitution occurred in <i>R</i>(−)MDMA- but not in <i>S</i>(+)MDMA-trained animals.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> It is generally concluded that the stimulus actions of MDMA are complex and might be (training) dose-related.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">In studying the SAR of MDMA as a discriminative stimulus, we found that the MDMA-stimulus generalized to <i>N</i>-methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA, <b>45</b>), a drug of abuse that has been sold on the clandestine market as representing MDMA (although our studies predated those reports). PMMA might be viewed as the simple 4-methoxy analog of methamphetamine (<b>52</b>; see later) or alternatively as the <i>N</i>-methyl analog of 4-methoxyamphetamine (PMA, <b>44</b>). Both methamphetamine and PMA substituted in (+)amphetamine-trained rats.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> What was puzzling was that PMMA, which combines both functional groups, did not substitute in (+)amphetamine-trained animals but did so in MDMA-trained animals. Furthermore, like (+)amphetamine, MDMA was a potent locomotor stimulant<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> whereas PMMA failed to increase mouse locomotor activity up to doses of 30 mg/kg (higher doses were not examined). Because MDA and both its optical isomers substituted in MDMA-trained rats,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> it seemed that aryl substituents, rather than the <i>N</i>-methyl group, were dictating the stimulus action of these agents.</div><div class="NLM_p">Subsequently, we trained rats to discriminate PMMA (1.25 mg/kg; ED<sub>50</sub> = 0.4 mg/kg) from saline vehicle. The PMMA-stimulus generalized to <i>S</i>(+)PMMA (ED<sub>50</sub> = 0.3 mg/kg), whereas administration of <i>R</i>(−)PMMA resulted only in partial substitution.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The PMMA-stimulus failed to generalize to the hallucinogen DOM or the stimulant (+)amphetamine (i.e., both produced vehicle-appropriate responding at the highest doses tested). PMMA seemed unique. However, the PMMA-stimulus generalized to (±)MDMA and <i>S</i>(+)MDMA (ED<sub>50</sub> of 1.32 and 0.48 mg/kg, respectively), but administration of <i>R</i>(−)MDMA resulted only in partial generalization. The PMMA-stimulus also generalized to (±)MDA, <i>S</i>(+)MDA, and <i>R</i>(−)MDA (ED<sub>50</sub> of 0.5, 0.7, and 1.5 mg/kg, respectively).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Despite some similarity between the actions of MDMA and PMMA, there was ever growing evidence that the two agents were acting differently. For example, the MDMA-stimulus, but not the PMMA-stimulus, generalized to cocaine.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This suggested that MDMA might possess more of a dopaminergic (i.e., amphetamine-like) stimulus component of action than PMMA.</div><div class="NLM_p">1-(3,4-Dimethoxyphenyl)-2-aminopropane (3,4-DMA; <b>46</b>) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>) can be viewed as a “ring opened” analog of MDA, and PMA and 1-(3-methoxyphenyl)-2-aminopropane (MMA; <b>47</b>) represent compound <b>46</b> minus one of the two methoxy groups. Although PMA and MMA substituted in (+)amphetamine-trained animals, 3,4-DMA curiously failed to do so. But, 3,4-DMA substituted in MDA-trained animals.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The optical isomers of 3,4-DMA substituted in both MDMA- and PMMA-trained animals with relatively little difference in potency (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Interestingly, although neither isomer of PMA substituted in MDMA-trained animals, <i>R</i>(−)PMA (but not <i>S</i>(+)PMA) substituted for PMMA and was equipotent with the training drug; in contrast, neither isomer of MMA substituted in PMMA-trained animals, but <i>R</i>(−)MMA (but not <i>S</i>(+)MMA) substituted for MDMA (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). This suggested that the 4-position oxygen atom is more important for PMMA-like action, whereas the 3-position oxygen atom favors MDMA-like actions. When both methoxy groups are present, such as in 3,4-DMA, the resulting compound displayed both types of actions and was relatively similar in potency.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Results of Stimulus Generalization Studies Using Rats Trained To Discriminate Either MDMA (1.5 mg/kg) or PMMA (1.25 mg/kg) from Saline Vehicle in a Two-Lever Procedure</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0023.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Where stimulus generalization (i.e., >80% training-drug appropriate responding occurred), an ED<sub>50</sub> value is provided. S = saline-like responding; no generalization (i.e., <20% drug-appropriate responding). PG = partial generalization (>20% but <80% drug-appropriate responding). PG cannot be reliably interpreted; it simply indicates differences in the stimulus effects of two agents.</p></div></div><div></div></div><div class="NLM_p">It was becoming increasingly apparent that MDA, in addition to binding with modest affinity at 5-HT<sub>2A</sub> receptors (<i>K</i><sub>i</sub> of 387 and 197 nM for (±)MDA and <i>R</i>(−)MDA), respectively),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> must be doing something else. Why else would there be cross-genralization (or lack thereof) between many of these structurally similar agents? Furthermore, (+)amphetamine and PMMA lacked affinity for 5-HT<sub>2A</sub> receptors. (+)Amphetamine had been shown to act at monoamine transporters as a substrate (i.e., as a releasing agent); hence, MDA, MDMA, and PMMA were examined at serotonin (SERT), dopamine (DAT), and norepinephrine (NET) transporters (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Action of MDMA, MDA, and PMMA as Releasing Agents at the Serotonin (SERT), Dopamine (DAT), and Norepinephrine (NET) Transporters<a onclick="showRef(event, 'ref18 ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref18 ref59 ref60">(18, 59, 60)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">EC<sub>50</sub>, nM<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">agent</th><th class="colsep0 rowsep0" align="center" char=".">SERT</th><th class="colsep0 rowsep0" align="center" char=".">DAT</th><th class="colsep0 rowsep0" align="center" char=".">NET</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)MDMA</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">278</td><td class="colsep0 rowsep0" align="char" char=".">110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(+)MDMA</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">142</td><td class="colsep0 rowsep0" align="char" char=".">136</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i>(−)MDMA</td><td class="colsep0 rowsep0" align="char" char=".">340</td><td class="colsep0 rowsep0" align="char" char=".">3700</td><td class="colsep0 rowsep0" align="char" char=".">560</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)MDA</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="char" char=".">190</td><td class="colsep0 rowsep0" align="char" char=".">108</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(+)MDA</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i>(−)MDA</td><td class="colsep0 rowsep0" align="char" char=".">310</td><td class="colsep0 rowsep0" align="char" char=".">900</td><td class="colsep0 rowsep0" align="char" char=".">290</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(+)PMMA</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">1000</td><td class="colsep0 rowsep0" align="char" char=".">147</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i>(−)PMMA</td><td class="colsep0 rowsep0" align="char" char=".">134</td><td class="colsep0 rowsep0" align="char" char=".">1600</td><td class="colsep0 rowsep0" align="char" char=".">>14000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(+)amphetamine</td><td class="colsep0 rowsep0" align="char" char=".">1765</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Data, although from different publications, were obtained from the same laboratory.</p></div></div></div><div class="NLM_p">The releasing actions of (+)amphetamine (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) and methamphetamine isomers (data not shown)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> are primarily at DAT and NET. In the case of methamphetamine, the potency of the <i>R</i>(−)-isomer is somewhat lower than its <i>S</i>(+)isomer by about 2-fold and 17-fold, respectively. For MDMA (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), although active at all three transporters, releasing potency follows the rank order SERT > NET > DAT. PMMA is also more of a serotonin releasing agent, SERT > DAT potency. Perhaps these subtle differences, coupled with the direct action of MDA at 5-HT<sub>2A</sub> receptors, account for the stimulus generalization profiles described above. Rothman and Baumann<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> found that increasing the SERT-releasing action of DAT releasing agents attenuates stimulant-related activity (e.g., self-administration, locomotor activity). It has been speculated that the same might be true for their discriminative stimulus effects.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> It would seem that further studies are needed to sort this out.</div><div class="NLM_p">Following an examination of >200 arylalkylamines (indolealkylamines and phenylalkylamines) in drug discrimination studies using animals (Sprague-Dawley rats) trained to discriminate the hallucinogen DOM, the central stimulant (+)amphetamine, or the agents MDA, MDMA, and PMMA from saline vehicle, we proposed that their stimulus actions might be classified on the basis of the Venn diagram shown in <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Most agents examined thus far fall into one of several categories. Agents (i) were “inactive” (e.g., PEA; that is, they produced none of these three stimulus effects perhaps because they did not readily penetrate the BBB at the doses examined or they produced an altogether different stimulus effect (e.g., morphine and diazepam)), (ii) produced a DOM-like (“<b>DOM</b>”) effect, (iii) produced an (+)amphetamine-like (“<b>AMPH</b>”) effect, or (iv) produced a PMMA-like (“<b>PMMA</b>”) effect. Certain agents or isomers produced a combination of effects: a DOM- and PMMA-like (D/P) effect or an (+)amphetamine- and PMMA-like (A/P) effect. That is, some agents produced more than one stimulus effect based on stimulus generalization studies. MDMA is best characterized as producing an A/P-like effect. (±)MDA produces all three stimulus effects; that is, (±)MDA produced stimulus effects best associated with the common (i.e., red) intersect of the Venn diagram (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). <i>R(</i>-)MDA is a D/P agent, and <i>S</i>(+)MDA is a A/P agent. Other agents have been similarly categorized.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> But it must be emphasized that as useful as this simple categorization was to initially explain the stimulus actions of certain agents, it was based on the specific training doses of the training drugs employed. And with the realization that certain of the examined agents have varying effects on SERT, DAT, and/or NET, which likely contribute to or temper their actions, a comprehensive understanding of these issues has become more complicated and requires further examination. More will be described below.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Stimulus properties of numerous arylalkylamines (indolealkylamines and phenylalkylamines) have been classified as being primarily of three types: DOM-like, amphetamine (AMPH)-like, or PMMA-like (reviewed<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>). Certain agents produce a combination of effects; for example, MDMA shares stimulus properties with amphetamine and PMMA and is best characterized as producing an A/P-like effect. (±)MDA produces all three stimulus effects and best associated with the common intersect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">11 Ephedrine and Related Phenylpropanolamines</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83415" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83415" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phenylpropanolamines are β-hydroxy (β-OH) analogs of phenylisopropylamines. Phenylisopropylamines (i.e., α-methyl analogs of phenylethylamines) are a class of phenylalkylamines that includes amphetamine and methamphetamine (<b>52</b>; <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). By introduction of the β-OH function, phenylpropanolamines now possess two chiral centers, and four optical isomers are possible (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Depending upon stereochemistry, norephedrine is the β-OH analog of amphetamine whereas ephedrine is the β-OH analog of methamphetamine; the other two optical isomers are referred to using the prefix “pseudo” (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). The naturally occurring (−)ephedrine (<b>53</b>), the most potent of the phenylpropanolamines as a central stimulant, is several times less potent than amphetamine or methamphetamine.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of <i>S</i>(+)amphetamine [<i>S</i>(+)AMPH], <i>S</i>(+)methamphetamine [<i>S</i>(+)METH], and their phenylpropanolamine counterparts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Phenylalkylamine central stimulants such as amphetamine, methamphetamine, and others readily serve as training drugs in drug discrimination studies and, typically, substitute for one another in tests of stimulus generalization regardless of which agent is used as training drug.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This is termed “cross generalization”.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> To investigate phenylpropanolamines more thoroughly, we trained animals to discriminate (−)ephedrine from vehicle, and (−)ephedrine-stimulus generalization occurred to (+)amphetamine; a (+)amphetamine-stimulus also generalized to (−)ephedrine (cross generalization).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> We next examined the other phenylpropanolamines shown in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>, and with the exception of (−)pseudonorephedrine (<b>51</b>) and (−)pseudoephedrine (<b>56</b>), each substituted in (−)ephedrine-trained animals. The same agents were also examined in (+)amphetamine-trained animals but stimulus generalization occurred only to (+)pseudonorephedrine (<b>49</b>) and (−)ephedrine.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Evidently, although (−)ephedrine and (+)amphetamine shared certain stimulus properties, their stimuli are not identical.</div><div class="NLM_p">As already mentioned, (−)ephedrine, although several-fold less potent than (+)amphetamine, was recognized by (+)amphetamine-trained animals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The reduced potency of the former agent might have been expected on the basis of its lower simulant potency in humans. However, using animals trained to discriminate (−)ephedrine from vehicle, stimulus generalization failed to occur upon administration of <i>S</i>(+)methamphetamine.<a onclick="showRef(event, 'ref18 ref62'); return false;" href="javascript:void(0);" class="ref ref18 ref62">(18, 62)</a> But <i>S</i>(+)methamphetamine-trained animals (1.0 mg/kg) recognized various phenylalkylamine stimulants including (−)ephedrine. An <i>S</i>(+)methamphetamine stimulus generalized to <i>R</i>(−)methamphetamine (ED<sub>50</sub> = 1.61 mg/kg), <i>S</i>(+)amphetamine (ED<sub>50</sub> = 0.28 mg/kg), cocaine (ED<sub>50</sub> = 3.68 mg/kg), and (−)ephedrine (ED<sub>50</sub> = 13.1 mg/kg). Note here that <i>S</i>(+)methamphetamine was 60-fold more potent than cocaine and >200-fold more potent than (−)ephedrine. Stimulus generalization between <i>S</i>(+)methamphetamine and (−)ephedrine was not bidirectional (termed “asymmetrical generalization” or “one-way generalization”).<a onclick="showRef(event, 'ref18 ref63'); return false;" href="javascript:void(0);" class="ref ref18 ref63">(18, 63)</a> This can be explained by the two agents producing somewhat similar effects but that (−)ephedrine-trained animals are “looking for something else” in addition to the common effect that is being produced and that this action seems to predominate in (−)ephedrine-trained animals.</div><div class="NLM_p">However, upon administration of <i>R</i>(−)methamphetamine (i.e., the less potent central stimulant of the two methamphetamine isomers) to (−)ephedrine-trained animals, substitution occurred and <i>R</i>(−)methamphetamine (ED<sub>50</sub> = 0.9 mg/kg) was nearly equipotent with (−)ephedrine (ED<sub>50</sub> = 0.8 mg/kg). It was hypothesized that although the exact basis for the observed results was unclear, they were likely related to the DAT versus NET releasing actions of the agent/isomers with the NET component being predominant.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">We subsequently undertook, in collaboration with Dr. Richard Rothman (NIDA), a thorough investigation of phenylpropanolamine optical isomers and several related agents.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (−)Ephedrine was examined at a large battery of cloned human receptors and at SERT, DAT, and NET. The most prominent action of ephedrine-type agents was as releasing agents (i.e., as substrates) at NET, followed by their releasing action at DAT.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Stimulus generalization potencies of the agents in (−)ephedrine-trained animals versus their potency as NET releasing agents were found to be significantly (<i>r</i> > 0.9) correlated. However, for a series of 11 agents, potencies as NET and DAT releasing agents were also significantly (<i>r</i> > 0.9) correlated.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The question remains as to which transporter, DAT or NET, is primarily responsible for this action or whether a combination of both is involved. It might be noted, however, that although phenylpropanolamines act as releasing agents at NET and DAT, they are generally more potent at the former. Interesting, though, was that the only two phenylpropanolamines that substituted in (+)amphetamine-trained animals were those with the highest potency at DAT (i.e., (+)pseudonorephedrine and (−)ephedrine).</div><div class="NLM_p">It might be asked where (−)ephedrine fits in the Venn diagram shown as <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>. This question remains unanswered. Perhaps an additional (A/E; amphetamine/ephedrine) domain needs to be added to encompass a noradrenergic (or NET) effect. It can be appreciated that the situation is complex.</div><div class="NLM_p">The complexity of the stimulus properties of phenylpropanolamines was further demonstrated in studies with caffeine. Methylxanthines such as caffeine are known to potentiate certain (e.g., thermogenic) effects of (−)ephedrine.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> As already mentioned, a (+)amphetamine stimulus generalized to (−)ephedrine but not to (+)ephedrine. Doses of caffeine that produced ≤1% drug-appropriate (i.e., vehicle-appropriate) responding when administered alone potentiated the stimulus effects of (−)ephedrine when administered in combination to (+)amphetamine-trained animals.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Furthermore, the (+)amphetamine stimulus, although it failed to generalize to (+)ephedrine, resulted in stimulus generalization when (+)ephedrine and a saline-like dose of caffeine were administered in combination. Two agents (at doses that failed to produce a specific stimulus effect) resulted in stimulus generalization when administered in combination. Hence, low doses of caffeine were shown to potentiate the stimulus effects of (−)ephedrine in (+)amphetamine-trained rats and <i>altered</i> the effect of (+)ephedrine such that generalization occurred.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p">Others had shown that rats trained to discriminate either amphetamine (0.5 mg/kg) or cocaine (10 mg/kg) from vehicle failed to generalize to caffeine but that stimulus generalization occurred when the animals were administered the “triple combination” of (−)ephedrine, phenylpropanolamine (i.e., a combination of norephedrine isomers), and caffeine.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> Caffeine also potentiated the discriminative stimulus actions of cocaine in cocaine-trained animals.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p">Nothing has been reported about the stimulus effects of PEA-caffeine combinations. But PEA has been used as a training drug in rats,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> and its training dose (30 mg/kg) was substantially (i.e., 30–60 times) higher than those typically employed for (+)amphetamine. The “level of discriminability was low” (with only about half of the animals reliably learning the task), and it was speculated that PEA was rapidly metabolized by MAO.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Limited tests of stimulus generalization were conducted (and neither amphetamine nor caffeine was examined).</div><div class="NLM_p">Nevertheless, there are anecdotal reports of PEA use/abuse. For example, the PEA forum Web site<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> suggests human intoxication requires total doses of 1–2 to as much as 4 g and indicates improved action of PEA when taken with a MAO inhibitor. It should be noted that (+)amphetamine produces a stimulant effect in humans at a total dose of 10–30 mg. Hence, the active human intoxication dose of PEA is probably >100 times that of (+)amphetamine.</div><div class="NLM_p">In addition to methylxanthines such as theobromine and caffeine, cocoa powder has been shown to contain PEA.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Cocoa powder snuffs are becoming popular for recreational use.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> But it is difficult to imagine that the achieved effect (whatever it might be) is due to the behavioral actions of PEA, caffeine, or a combination of the two at the doses administered. Nevertheless, PEA–caffeine combinations require investigation in documented scientific studies.</div><div class="NLM_p last">From the late 1980s into the early 2000s, herbal dietary preparations were very popular and legally available in tablet or capsule form for use in weight reduction (thermogenic agents advertised as “fat burners”) and as “energy boosters”. Many of them contained ephedra, a plant for which (−)ephedrine is a major constituent. Some also contained caffeine (or a caffeine-containing natural product). Because route of administration can influence drug action and/or potency, we questioned whether an orally administered ephedra-containing product could produce stimulus effects in animals similar to those of a parenterally administered stimulant. By use of rats trained to discriminate (+)amphetamine (ip) from vehicle, the (+)amphetamine stimulus generalized to (+)amphetamine administered via the intragastric route but was about 2.5-fold less potent than via the ip route.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Likewise, (−)ephedrine was also 2.5-fold less potent via the intragastric route compared to the ip route. The (+)amphetamine stimulus generalized to intragastric administration of a commercially available herbal preparation (purchased on the open market); its potency was roughly comparable to what might have been expected on the basis of its reported ephedrine content.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The results demonstrated that an orally administered ephedrine-containing herbal preparation could produce a (+)amphetamine-like stimulus effect in animals.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">12 Synthetic Cathinones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">(+)Pseudonorephedrine (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>), also known as (+)cathine (the two agents now realized as being identical), was long considered the active stimulant component of the shrub <i>Catha edulis</i>. The leaves of the plant (“khat”) have been used (chewed or brewed as a tea) for many hundreds of years in certain Middle Eastern countries. In the late 1970s the United Nations Narcotics Laboratory identified a phenylpropanonamine, an optical isomer of cathinone (<b>57</b>) (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>), <i>S</i>(−)cathinone, as a khat plant constituent with stimulant potency greater than (+)cathine (reviewed<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74, 75)</a>). Our initial work with cathinone was published in 1981, showing that cathinone produced hyperlocomotor effects in mice at relatively low doses (i.e., <i>S</i>(−)cathinone > (±) > <i>R</i>(+)cathinone).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Interestingly, our work with cathinone was wholly serendipitous and was begun prior to the discovery of this agent being identified as a constituent of khat. In the course of our studies on phenylalkylamine analogs, we had prepared certain phenylisopropylamines via Friedel–Crafts acylation of substituted benzene precursors followed by α-bromination and subsequent amination. The resultant phenylpropanonamines (or “β-ketoamphetamines”) were then catalytically reduced (i.e., hydrogenolyzed) to their corresponding phenylisopropylamines. In several instances, we evaluated the phenylpronanonamine synthetic intermediates (now termed cathinone analogs, one of which was ultimately termed “cathinone”) and found some of them active in mouse locomotor assays and, later, in drug discrimination assays using (+)amphetamine-trained animals. During an NIH site visit, the team leader, Dr. Robert Willette (NIDA), who had just returned from a U.N.-sponsored khat conference in Madagascar, informed us that what we had termed β-ketoamphetamine was identical to “cathinone”, the newly discovered active stimulant component of the khat plant. Once cathinone became a topic of interest, we found ourselves already in possession of substantial information on this substance and several of its aryl-substituted and other analogs.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Chemical structures of cathinone (originally termed β-ketoamphetamine), its optical isomers, and methcathinone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cathinone and both of its optical isomers substituted in (+)amphetamine-trained animals (ED<sub>50</sub> of 0.32, 0.72, and 4.41 mg/kg for <i>S</i>(−)- (±)-, and <i>R</i>(+)-cathinone, respectively, relative to 0.62 mg/kg for <i>S</i>(+)amphetamine) (reviewed<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a>). In collaboration with Dr. Marty Schechter (Northeast Ohio Medical University), using rats trained to discriminate racemic cathinone (ED<sub>50</sub> = 0.24 mg/kg) from vehicle, stimulus generalization occurred to (+)amphetamine (ED<sub>50</sub> = 0.20 mg/kg), <i>S</i>(−)cathinone (ED<sub>50</sub> = 0.22 mg/kg), <i>R</i>(+)cathinone (ED<sub>50</sub> = 0.72 mg/kg), and (+)cathine (ED<sub>50</sub> = 1.61 mg/kg).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">Cathinone (or what we had initially termed β-ketoamphetamine) was at least as potent as amphetamine as a discriminative stimulus. Some have referred to cathinone as “naturally occurring amphetamine”. By analogy to <i>N</i>-monomethylamphetamine (i.e., methamphetamine), we synthesized and examined the <i>N</i>-monomethyl analog of cathinone and termed it methcathinone (<b>58</b>).<a onclick="showRef(event, 'ref74 ref78'); return false;" href="javascript:void(0);" class="ref ref74 ref78">(74, 78)</a> Methcathinone was found to be more potent than cathinone as a locomotor stimulant and in animals trained to discriminate (+)amphetamine from vehicle (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Animals were subsequently trained to discriminate <i>S</i>(−)methcathinone from vehicle,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> and stimulus generalization occurred to a number of other phenylalkylamine stimulants (some data are provided in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). As was the (+)amphetamine stimulus, the <i>S</i>(−)methcathinone stimulus was potently antagonized by the dopamine D<sub>2</sub> receptor antagonist haloperidol.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a><i>S</i>(−)Methcathinone was also a potent synaptosomal releasing agent at DAT and NET (EC<sub>50</sub> of 14.8 and 13.1 nM, respectively) with much weaker action at SERT (EC<sub>50</sub> = 1772 nM)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and with a transporter profile similar to that of (+)amphetamine (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Comparison of Stimulus Generalization Potencies of Selected Agents in Rats Trained To Discriminate <i>S</i>(+)Amphetamine (AMPH), <i>S</i>(+)Methamphetamine (METH), or <i>S</i>(−)Methcathinone (MCAT) from Saline Vehicle<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">training drug: ED<sub>50</sub>, mg/kg</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">test agent</th><th class="colsep0 rowsep0" align="center"><i>S</i>(+)AMPH<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>S</i>(+)METH<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>S</i>(−)MCAT<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(+)amphetamine</td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(−)cathinone</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(+)methamphetamine</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(−)methcathinone</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cocaine</td><td class="colsep0 rowsep0" align="left">5.63</td><td class="colsep0 rowsep0" align="left">6.68</td><td class="colsep0 rowsep0" align="left">1.47</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Training doses were 1.0, 1.0, and 0.5 mg/kg for <i>S</i>(+)AMPH, <i>S</i>(+)METH, and <i>S</i>(−)MCAT, respectively.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Not evaluated.</p></div></div></div><div class="NLM_p">Following some additional SAR studies on cathinone analogs, relatively little was published on these agents for over a decade. Then, novel cathinone analogs began to appear on the European clandestine market;<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> these were termed synthetic cathinones.</div><div class="NLM_p">One of the early synthetic cathinones was referred to as “bath salts”. Bath salts were initially reported to be a combination of methylone (MDMC, <b>59</b>), the β-keto analog of MDMA, mephedrone (<b>60</b>), methylenedioxypyrovalerone (MDPV, <b>61</b>, <a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), or one or more of these agents in combination with other (known or novel) phenylisopropylamines (reviewed<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74, 75)</a>). Today, the term “bath salts” is often used rather generically to refer to almost any synthetic cathinone. Over the past 5 or 6 years, approximately 150 different synthetic cathinones have been confiscated from the clandestine market.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Examples of synthetic cathinones: methylone (<b>59</b>), mephedrone (<b>60</b>), methylenedioxypyrovalerone (<b>61</b>), and α-pyrrolidinovalerophenone (<b>62</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of studies we had conducted with amphetamine-related phenylisopropylamines, as well as with cathinone and methcathinone, we suspected that the synthetic cathinones would behave in a similar manner (i.e., acting primarily as releasing agents at DAT). Mephedrone was, indeed, found to be a DAT/NET releasing agent. However, MDPV was shown by several investigators to be a fairly selective DAT reuptake inhibitor, with a potency of about 35–50 times that of cocaine (reviewed<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a>).</div><div class="NLM_p">Several SAR and QSAR studies have been reported for the synthetic cathinones (reviewed<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a>). With regard to those that behaved as releasing agents, the 4-position substituent determined selectivity for DAT vesus SERT. Mephedrone is the 4-methyl counterpart of methcathinone. Whereas methcathinone displayed >200-fold selectivity for DAT over SERT (EC<sub>50</sub> of 12.5 and 3860 nM, respectively), mephedrone (EC<sub>50</sub> of 49.1 and 118 nM, respectively) displayed only about 2.5-fold selectivity. In contrast, 4-trifluoromethylmethcathinone (EC<sub>50</sub> of 2700 and 190 nM, respectively) was 14-fold selective for SERT. A QSAR study was conducted on a series of 4-substituted methcathinone analogs, and it was found that as substituent size increased, DAT potency decreased but SERT potency increased.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_p">Because MDPV was the first abused synthetic cathinone that behaved as a DAT reuptake inhibitor, it was of interest to determine which of its structural features might account for this action. We “deconstructed” the MDPV molecule by the systematic removal of one substituent at a time.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The presence of the carbonyl and methylenedioxy groups made a minimal (≤10-fold) contribution to potency but had no effect on action (i.e., the <i>des</i>-keto and <i>des</i>-methylenedioxy analogs of MDPV behaved as DAT reuptake inhibitors). More important contributors were the amine substituent and the extended α side chain. Either a tertiary amine (or a secondary amine bearing a bulky substituent) <u class="uu">or</u> an extended side chain was a necessary feature for the agents to act as DAT reuptake inhibitors. The presence of both features, although both were not required, seemed optimal.<a onclick="showRef(event, 'ref75 ref82'); return false;" href="javascript:void(0);" class="ref ref75 ref82">(75, 82)</a></div><div class="NLM_p">One of the compounds examined in the above SAR investigation was <b>62</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), MDPV minus the methylenedioxy group. While our manuscript describing the above SAR findings was in press,<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> this agent (α-pyrrolidinovalerophenone or α-PVP) appeared on the clandestine market as “flakka”<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and was popularized in the lay press as the “zombie drug”. A subsequent SAR and QSAR investigation of α-PVP analogs showed that the potency of the compounds as synaptosomal DAT reuptake inhibitors decreased as the length of the α side chain was decreased, that increasing the chain length by an additional methylene group resulted in retention of action and potency (i.e., another agent that appeared on the clandestine market just prior to the publication of our study, under the acronym “α-PHP”), that replacement of the <i>n</i>-propyl group of <b>62</b> with a cyclohexyl moiety doubled potency, and that replacement of the pyrrolidine with a piperidine ring decreased potency several-fold.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> For a series of eight analogs, potency as DAT reuptake inhibitors correlated with both α-substituent volume (<i>r</i> > 0.9) and lipophilicity (<i>r</i> > 0.9); however, for the substituents examined, substituent volume (Å<sup>3</sup>) and lipophilicity (π) were significantly intercorrelated (<i>r</i> > 0.9) and it is not known which of these two parameters is the more important.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> For a while, we felt we were always just a single step behind clandestine chemists who were making these agents available on the illicit market.</div><div class="NLM_p">With regard to cathinone analogs that acted as dopamine releasing agents, effects were generally enantioselective with the <i>S</i>(−)isomers being several-fold more potent than their <i>R</i>(+)enantiomers. Little was known about the stereochemistry of synthetic cathinones that acted as DAT reuptake inhibitors. After many unsuccessful attempts, the two optical isomers of MDPV were eventually prepared and examined and it was found that <i>S</i>(+)MDPV (IC<sub>50</sub> = 2.1 nM) was 180-fold more potent than <i>R</i>(−)MDPV and 100 times more potent than cocaine as a dopamine reuptake inhibitor.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Although less potent, the same rank order, <i>S</i>(+)MDPV > (±)MDPV > <i>R</i>(−)MDPV was observed for NET reuptake inhibition; both isomers were inactive at SERT as reuptake inhibitors or releasing agents.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p last">As already alluded to,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> synthetic cathinones do not represent a pharmacologically homogeneous group of agents. Depending upon terminal amine and aryl substituents, stereochemistry, and the nature of the α side chain, these agents can act as releasing agents or reuptake inhibitors at DAT, NET, and/or SERT. By “mixing and matching” the various substituents, certain cathinone analogs could possess “mixed” or “hybrid” actions.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> This, once again, underscores the concept that small structural alterations to the phenylalkylamine scaffold can have a significant impact on pharmacology.</div></div><div id="sec13" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">13 Conformationally Constrained Phenylalkylamines</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many of the agents described herein are drugs of abuse, and nearly all of these phenylalkylamines possess conformationally flexible side chains. Over the years we have examined various conformationally constrained analogs of these agents (e.g., amphetamine, DOM, DOB, MDMA, PMMA).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In general, there are two likely means of simple constraint: aminotetralins (i.e., <b>63</b>) and tetrahydroisoquinolines (<b>64</b>) (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>).</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Conformationally constrained phenylalkylamines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For example, the aminotetralin analog of PMMA was at least as potent as its parent in PMMA-trained animals, whereas its tetrahydroisoquinoline counterparts <b>66</b> and <b>67</b> resulted in vehicle-appropriate responding or incomplete substitution, respectively. Aminotetralin analogs of amphetamine and MDMA also seemed to better account for their actions than their tetrahydroisoquinoline counterparts.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, this does not imply that the latter compounds are without pharmacological action. A tetrahydroisoquinoline analog of MDMA (i.e., TDIQ, <b>68</b>) is a case in point.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a> TDIQ resulted in partial generalization when administered to MDMA- or (−)ephedrine-trained animals and in vehicle-appropriate responding in (+)amphetamine-, DOM-, and PMMA-trained trained animals. TDIQ also lacked locomotor stimulant actions in mice. To further investigate this agent, rats were trained and very rapidly learned (more rapidly than any agent we had previously used as a training drug in >20 years) to discriminate TDIQ from vehicle (ED<sub>50</sub> = 0.9 mg/kg).<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a> The TDIQ-stimulus failed to generalize to (+)amphetamine, methylphenidate, or PMMA (i.e., the animals responded on the vehicle-appropriate lever), and (−)ephedrine and MDMA administration resulted only in partial generalization. However, the TDIQ-stimulus fully generalized to cocaine (ED<sub>50</sub> = 1.5 mg/kg).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> These results were unexpected.</div><div class="NLM_p">(+)Amphetamine, cocaine, and the central stimulant methylphenidate cross-generalize to one another in tests of stimulus generalization.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Curiously, TDIQ-trained animals recognized cocaine but not other stimulants. Tests of stimulus generalization and stimulus antagonism were conducted with a variety of agents but shed little light on TDIQ’s mechanism of action. Additionally, antagonists capable of blocking a cocaine stimulus (e.g., haloperidol) failed to block the actions of TDIQ. A binding profile for TDIQ at 30 receptor populations, as well as at SERT, DAT, and NET, indicated affinity (<i>K</i><sub>i</sub> < 100 nM) only for α<sub>2A</sub>-, α<sub>2B</sub>-, and α<sub>2C</sub>-adrenoceptors, suggesting that TDIQ produces its stimulus effects primarily via a nonselective α<sub>2</sub>-adrenoceptor mechanism.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The partial generalization seen between TDIQ, MDMA, and (−)ephedrine might be related to their adrenergic effects and, perhaps, to the lack of a dopaminergic/stimulant component of action associated with the latter but absent with TDIQ. It was suggested that TDIQ be examined for the treatment of cocaine abuse.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><div class="NLM_p">Because the adrenergic system might be involved in certain forms of anxiety, TDIQ was examined in a mouse object-burying assay (an assay commonly used to evaluate potential anxiolytic agents) and was found to be active.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Compared with other anxiolytic agents (e.g., diazepam and buspirone, <b>69</b> and <b>70</b>, respectively, <a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>, which incidentally did not substitute in TDIQ-trained animals), TDIQ was effective in the object-burying assay (ED<sub>50</sub> of 0.20, 0.26, and 2.36 mg/kg, respectively, for TDIQ, diazepam, and buspirone) but without producing behaviorally disruptive side effects in a mouse inclined-plane or rotarod assay as seen with the other agents. TDIQ might represent a novel prototype for the development of a new generation of anxiolytic agents.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Chemical structures of diazepam (<b>69</b>), buspirone (<b>70</b>), and NAN-190 (<b>71</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, it was demonstrated that certain conformationally constrained phenylalkylamines lack many of the actions of their flexible counterparts and open new vistas for further research.</div></div><div id="sec14" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">14 5-HT<sub>1A</sub> Receptor Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17615" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17615" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Because the conformationally constrained phenylalkylamine 8-OH DPAT (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was identified as the first agent to display agonist action and selectivity for 5-HT<sub>1A</sub> serotonin receptors over all other 5-HT receptors known at the time, it quickly became a very popular pharmacological tool. We examined 8-OH DPAT in DOM-trained animals, before it was found to be a 5-HT<sub>1A</sub> receptor agonist, and observed a lack of stimulus generalization. We later trained animals to discriminate 8-OH DPAT from vehicle in order to investigate its SAR and mechanism of action and, subsequently, in an attempt to develop a 5-HT<sub>1A</sub> receptor antagonist, of which none was then available.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><div class="NLM_p">8-OH DPAT-trained animals did not recognize DOM which, by this time, had been shown to be a 5-HT<sub>2</sub> receptor agonist. The 8-OH DPAT stimulus generalized to its shorter <i>N</i>,<i>N</i>-diethyl counterpart <b>73</b> (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>) but not to its <i>N</i>,<i>N</i>-dimethyl analog <b>72</b> or longer <i>N</i>,<i>N</i>-di-<i>n</i>-butyl homolog <b>74</b>.<a onclick="showRef(event, 'ref18 ref89'); return false;" href="javascript:void(0);" class="ref ref18 ref89">(18, 89)</a> Results with the 8-OH DPAT analogs were consistent with 5-HT<sub>1A</sub> binding data: <i>K</i><sub>i</sub> of 4.84 nM, 9.65 nM, 75 nM, and 109 nM for <b>7</b>, <b>73</b>, <b>72</b>, and <b>74</b>, respectively (for their <i>R</i>-isomers).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> That is, only the highest affinity agent, <b>73</b>, substituted in the 8-OH DPAT-trained animals. [The <i>R</i>(+)-isomers displayed several-fold higher affinity than their <i>S</i> enantiomers except for <b>74</b> where the <i>S</i>-isomer possessed twice the affinity of the <i>R</i>.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a>] It was suspected that increased bulk on the terminal amine was not well tolerated by the receptor.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. 8-OH DPAT-related analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It was demonstrated (using radioligand binding and drug discrimination studies) that the hydroxyl group of 8-OH DPAT could be replaced by a methoxy group (5-HT<sub>1A</sub><i>K</i><sub>i</sub> of 1.2 and 1.3 nM, respectively, for 8-OH DPAT and <b>75</b>) (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> This was significant in that 8-methoxy analogs were more convenient to synthesize than their corresponding phenols and, in theory, should possess better BBB permeability than 8-OH DPAT itself (which, early on, was a consideration that later proved to be unfounded).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. 5-HT<sub>1A</sub> Receptor Affinities of Several 8-Methoxyaminotetralin Analogs<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0024.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">5-HT<sub>1A</sub><i>K</i><sub>i</sub>, nM<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>4</sub>-Ph</td><td class="colsep0 rowsep0" align="left">5.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">For comparison, the <i>K</i><sub>i</sub> for 8-OH DPAT is 1.2 nM.</p></div></div></div><div class="NLM_p">Using Ariens’ concept of accessory receptor areas<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> whereby introduction of a bulky terminal amine group often converts an agonist to an antagonist, we prepared several amine-substituted compounds (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). It was fairly evident that both <i>n</i>-propyl groups were not required for high-affinity binding. 3-(Phenyl)propyl compounds <b>79</b> and <b>80</b> displayed affinities nearly comparable to <b>75</b> and 8-OH DPAT. To determine if extended bulk was allowed here but not with, for example, <b>74</b>, because these compounds possessed a methoxy rather than 8-OH group, we examined the <i>O</i>-<i>des</i>-methyl counterpart of <b>80</b> and found it to bind (<i>K</i><sub>i</sub> = 1.9 nM) with similar affinity.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Unfortunately, the functional activities of these analogs (except for <b>75</b>) were never examined because we had just identified <b>71</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as a 5-HT<sub>1A</sub> receptor antagonist in a series of companion studies and turned our attention in that direction (see later). But it was learned that both 8-OH DPAT <i>n</i>-propyl substituents were not required for 5-HT<sub>1A</sub> receptor binding, that the primary amine binds with substantially reduced affinity compared to 8-OH DPAT and <b>75</b>, and that an <i>n</i>-propyl group could be replaced with a 3-(phenyl)propyl group without significant loss of affinity. These types of compounds remain to be further investigated and might yet yield novel 5-HT<sub>1A</sub> receptor antagonists.</div><div class="NLM_p">8-OH DPAT is a conformationally constrained phenylalkylamine. Interestingly, release of the conformational constraint resulted in a several-hundred-fold reduction in HT<sub>1A</sub> receptor affinity. For example, phenylethylamine <b>82</b> (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>), as well as its mono-<i>N</i>-<i>n</i>-propyl counterpart, binds at 5-HT<sub>1A</sub> receptors with <i>K</i><sub>i</sub> of 400 nM and >1000 nM, respectively.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> This dramatic decrease in affinity has never been explained.</div><div class="NLM_p last">There was literature evidence at the time that 8-OH DPAT produced an anxiolytic effect in rodents. Hence, we examined several anxiolytic agents (e.g., diazepam, <b>69</b>) and found that they failed to substitute in 8-OH DPAT trained animals.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> It might be noted that we had earlier examined diazepam as a training drug and were well acquainted with its stimulus actions and the SAR of benzodiazepines in this regard.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, buspirone (<b>70</b>) substituted in a dose-dependent fashion in 8-OH DPAT-trained animals, and this was the first indication that this novel (at that time) anxiolytic agent might be acting through a 5-HT<sub>1A</sub> receptor agonist mechanism. Currently, the anxiolytic action of buspirone is recognized as being attributable to a 5-HT<sub>1A</sub> partial agonist mechanism.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> As a side note, diazepam-trained animals did not recognize 8-OH DPAT, and buspirone-trained animals failed to recognize diazepam.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Continued investigations using 8-OH DPAT-trained animals ultimately resulted in <b>71</b>, one of the first useful 5-HT<sub>1A</sub> receptor antagonists (<b>71</b>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec15" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">15 “Candy Flipping”</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During the course of our investigations with DOM, we found that very low doses of the 5-HT<sub>1A</sub> receptor agonist 8-OH DPAT potentiated DOM stimulus effects and that administration of the ED<sub>50</sub> dose of DOM in combination with 8-OH DPAT doses resulted in complete stimulus generalization in DOM-trained animals. It should be noted that neither agent substituted for the other in tests of stimulus generalization and that DOM lacks affinity for 5-HT<sub>1A</sub> receptors and 8-OH DPAT lacks affinity for 5-HT<sub>2</sub> receptors. The mechanism underlying this potentiation is not yet fully understood.</div><div class="NLM_p">Administration of our 5-HT<sub>1A</sub> receptor antagonist <b>71</b> to MDMA-trained animals had no effect (i.e., no stimulus generalization); however, when administered in combination with the MDMA training dose, partial antagonism occurred. MDMA is known to release 5-HT, and the released 5-HT can interact with any of several populations of 5-HT receptors including 5-HT<sub>1A</sub> receptors. Subsequently and somewhat unexpectedly, in tests of stimulus generalization MDMA-trained animals generalized to 8-OH DPAT and both of its optical isomers.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> It has been demonstrated in various assays that <i>R</i>(+)8-OH DPAT is a full agonist at 5-HT<sub>1A</sub> receptors whereas <i>S</i>(−)8-OH DPAT is a partial agonist; in general, both isomers produce 8-OH DPAT-like effects, but the <i>R</i>(+)-isomer is several times more potent.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> In MDMA-trained animals, stimulus generalization occurred with the following rank order of potency: <i>R</i>(+)- > (±)- > <i>S</i>(−)8-OH DPAT.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Hence, the 5-HT releasing actions of MDMA, at least in drug discrimination studies, might be due, to a large extent, to activation of 5-HT<sub>1A</sub> receptors.</div><div class="NLM_p last">The phenomenon known as “flipping” or “candy flipping” refers to the combined use of a classical hallucinogen plus MDMA to achieve a heightened effect by drug users. That is, the combination seemingly results in a synergistic effect. Given that 8-OH DPAT potentiated the stimulus actions of DOM and that an MDMA-stimulus generalized to 8-OH DPAT, it was not unreasonable to hypothesize that MDMA might potentiate the stimulus actions of DOM and, as such, represent an animal counterpart of “candy flipping”. First, it was demonstrated that <i>R</i>(+)8-OH DPAT was twice as potent as (±)8-OH DPAT in potentiating the stimulus effects of DOM (i.e., both agents in combination with the DOM ED<sub>50</sub> dose resulted in stimulus generalization in DOM-trained animals). Next, it was shown that the 5-HT<sub>1A</sub> antagonist <b>71</b> was capable of blocking this effect (but not the effect of DOM when administered alone). And last, it was shown that low doses of MDMA potentiated the ED<sub>50</sub> dose of DOM to result in DOM-stimulus generalization.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> More recently, it has been reported that 8-OH DPAT is also a 5-HT<sub>7</sub> receptor agonist. However, <b>71</b> does not bind at 5-HT<sub>7</sub> receptors, and this latter population is unlikely to account for the potentiating effect that was described above.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec16" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">16 σ Receptor Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">σ receptor research got off to an arduous beginning, but even early efforts hinted at a relationship between σ receptors and stimulant abuse (reviewed<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96, 97)</a>). One of the first agents found to bind at σ receptors was <i>N</i>-allylnormetazocine (NANM; <b>83</b>) (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) (reviewed<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a>). It might be noted that <b>83</b> has embedded within its structure a phenylethylamine moiety and, more specifically, an amphetamine moiety. We deconstructed NANM to determine the various structural features important for σ receptor binding (reviewed<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98, 99)</a>). Using tritiated ditolylguanidine ([<sup>3</sup>H]DTG), various deconstructed analogs of NANM were examined. One of these, (+)amphetamine (<i>K</i><sub>i</sub> = 46 000 nM), displayed very low affinity relative to (±)NANM and its higher-affinity isomer (+)NANM (<i>K</i><sub>i</sub> of 430 and 150 nM, respectively).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> However, we eventually prepared several amine-substituted analogs of amphetamine that resulted in >2000-fold enhanced affinity (e.g., <b>84</b> and <b>85</b>; <i>K</i><sub>i</sub> of 22 and 6.3 nM, respectively for their <i>S</i>(+) isomers).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Aryl substitution and stereochemistry seemed to play little to no role in the binding of <b>84</b> and <b>85</b> analogs.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Examples of arylalkylamines examined at σ<sub>1</sub> receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In rats trained to discriminate (+)NANM from vehicle, <i>R</i>(−)<b>84</b> (σ <i>K</i><sub>i</sub> = 28 nM) and several related analogs behaved as effective NANM antagonists.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><div class="NLM_p">Shortly thereafter, two populations of σ receptors were identified: σ<sub>1</sub> and σ<sub>2</sub> receptors. Using [<sup>3</sup>H](+)pentazocine to label σ<sub>1</sub> receptors, <b>85</b> displayed higher affinity (<i>K</i><sub>i</sub> of 0.9 and 0.5 nM for <i>S</i>(+)- and <i>R</i>(−)<b>85</b>, respectively) than they did for the undifferentiated σ receptors. N-Methylation was found to have a small affinity-enhancing effect, and the affinity of <b>86</b> (<i>K</i><sub>i</sub> = 0.25 nM) was slightly higher than that of <b>85</b>. Interestingly, replacement of the phenylethylamine aryl ring of <b>86</b> with a methyl group had no effect on affinity (<b>87</b>; <i>K</i><sub>i</sub> = 0.29 nM), whereas a parallel replacement of the opposing aryl group decreased affinity by nearly 200-fold (<b>88</b>; <i>K</i><sub>i</sub> = 48 nM).<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Evidently, the presence of the 5-(phenyl)pentyl moiety, although still an arylalkylamine, was more consequential than the phenylethylamine portion. Phenylethylamine <b>89</b> (<i>K</i><sub>i</sub> = 0.14 nM) also displayed high affinity. Retention of a phenylethylamine structure, as in <b>90</b> (<i>K</i><sub>i</sub> = 0.08 nM), was tolerated but, here too, was unnecessary (<b>91</b> and <b>92</b>; <i>K</i><sub>i</sub> of 0.38 and 0.07 nM, respectively).<a onclick="showRef(event, 'ref99 ref101'); return false;" href="javascript:void(0);" class="ref ref99 ref101">(99, 101)</a></div><div class="NLM_p last">Eventually, we went on to examine other piperidine and piperazine analogs, identified a pharmacophore for σ<sub>1</sub> receptor binding, and turned our attention to σ<sub>1</sub> versus σ<sub>2</sub> selectivity.<a onclick="showRef(event, 'ref99 ref101'); return false;" href="javascript:void(0);" class="ref ref99 ref101">(99, 101)</a> A σ<sub>2</sub> receptor pharmacophore was later identified.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Nevertheless, this is a stunning example of how a phenylethylamine with mid-μM affinity for σ receptors (i.e., amphetamine) was structurally manipulated to result in a >100 000-fold increase in affinity.</div></div><div id="sec17" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">17 5-HT<sub>6</sub> Receptor Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16781" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16781" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We developed 5-methoxy-<i>N</i>,<i>N</i>-dimethyl-<i>N</i><sub>1</sub>-benzenesulfonyltryptamine (MS-245; <b>93</b>) (<a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>) as one of the first 5-HT<sub>6</sub> receptor antagonists (reviewed<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a>). Frantz et al.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> demonstrated that the 5-HT<sub>6</sub> receptor antagonist 5-chloro-<i>N</i>-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-3-methyl-1-benzothiophene-2-sulfonamide enhanced certain actions of amphetamine (e.g., rat locomotor activity, self-administration) but not those of cocaine. Likewise, we found that <b>93</b> was without effect when administered to rats trained to discriminate (+)amphetamine from vehicle in a drug discrimination task but potentiated the stimulus effects of the training drug such that when <b>93</b> was administered in combination with the ED<sub>50</sub> dose of (+)amphetamine, stimulus generalization occurred.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Similar studies were conducted using rats trained to discriminate cocaine from vehicle, but a combination of the ED<sub>50</sub> dose of cocaine together with doses of <b>93</b> resulted in no potentiation. Furthermore, although <b>93</b> neither substituted for nor antagonized the discriminative stimulus effects of (−)nicotine, it was shown to enhance the potency of (−)nicotine in animals trained to discriminate (−)nicotine from vehicle. That is, a combination of the ED<sub>50</sub> dose of (−)nicotine plus <b>93</b> resulted in stimulus generalization.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Compound <b>93</b> also potentiated the hypolocomotor actions, but not the antinociceptive effects, of (−)nicotine in mice.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Taken together, the data suggested that 5-HT<sub>6</sub> serotonin receptor agents might have potential clinical application in therapies that involve modulation of dopamine neurotransmission or in the treatment of certain aspects of drug abuse. It was findings such as these that contributed to our continued interest in this area.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. 5-HT<sub>6</sub> receptor ligands developed in our laboratory.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Benz[<i>c</i>,<i>d</i>]indole <b>94</b> (<i>K</i><sub>i</sub> = 1.6 nM) displayed an affinity similar to that of <b>93</b> (<i>K</i><sub>i</sub> = 2.1 nM). Conversion to aminotetralin <b>95</b> and phenylethylamine <b>96</b> (<i>K</i><sub>i</sub> of 49 and 21 nM, respectively) resulted in reduced affinity but identified novel chemotypes for exploitation. For example, <b>97</b>, the “reverse sulfonamide” of <b>96</b>, and sulfone <b>98</b> both displayed modest affinity (<i>K</i><sub>i</sub> of 70 and 50 nM). Transposition of these functionalities to the phenylethylamine 4-position also resulted in interesting compounds such as sulfonamide <b>99</b> (<i>K</i><sub>i</sub> = 38 nM) and “reverse sulfonamide” <b>100</b> (<i>K</i><sub>i</sub> = 2.5 nM),<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> again, examples of phenylethylamines with an unanticipated action.</div></div><div id="sec18" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">18 α-ET</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As an extension of some of the topics/concepts described above, this final section deals with several arylalkylamine (i.e., indolealkylamine or tryptamine) drugs of abuse. Although not phenylalkylamines, the behavioral effects of many indolealkylamines, such as 5-OMe DMT and numerous other <i>N</i>,<i>N</i>-dialkyltryptamines, were examined in our studies (reviewed<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>). As alluded to earlier regarding phenylalkylamines, indolealkylamines typically conjure tryptamine analogs where an indole nucleus is separated from a terminal amine by a 3-position two-atom carbon unit. Many such analogs were investigated using drug discrimination studies with animals trained to discriminate DOM.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> We also examined gramine analogs, homotryptamines, and isotryptamines. Here, we address several “α-alkyltryptamines”. Both α-methyltryptamine (α-MeT, AMT, “spirals”; <b>101</b>) and its homolog, α-ethyltrypamine (α-ET, AET, “ET”; <b>102</b>) (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>) have been found on the clandestine market since the 1960s as abused substances. Nearly 35 years ago<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> we showed that both of these agents, as their racemates (ED<sub>50</sub> of 3.1 and 6.6 mg/kg for <b>101</b> and <b>102</b>, respectively), substituted in tests of stimulus generalization using DOM-trained animals (for comparison: DOM ED<sub>50</sub> = 0.44 mg/kg). Furthermore, although <i>S</i>(+)α-MeT (ED<sub>50</sub> = 1.64 mg/kg), but not <i>R</i>(−)α-MeT, fully substituted for DOM, only the racemate was available on the clandestine market.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Chemical structures of indolealkylamines α-MeT (<b>101</b>) and α-ET (<b>102</b>) and the 5-HT releasing agent fenfluramine (<b>103</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">α-MeT displayed modest affinity for [<sup>3</sup>H]ketanserin-labeled 5-HT<sub>2</sub> receptors (<i>K</i><sub>i</sub> = 3100 nM), and <i>S</i>(+)α-MeT (<i>K</i><sub>i</sub> = 2500 nM) displayed slightly higher affinity than <i>R</i>(−)α-MeT (<i>K</i><sub>i</sub> = 5000 nM).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Hence, it was not unreasonable to assume that α-MeT might be acting as a classical hallucinogen but with modest potency.</div><div class="NLM_p">In humans, α-ET purportedly produces relatively weak hallucinogenic <i>and</i> central stimulant actions. DOM-trained animals recognized α-ET (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>); however, when administered to (+)amphetamine-trained animals, only partial generalization occurred.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Because α-ET possesses a chiral center, both optical isomers were prepared and individually examined (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Reminiscent of what was seen with MDA, one α-ET isomer, the <i>S</i>(+)isomer, substituted in DOM- but not in (+)amphetamine-trained animals whereas the other, the <i>R</i>(−)isomer, substituted in (+)amphetamine- but not DOM-trained animals (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> It appeared that the two optical isomers were capable of producing different stimulus actions. Given our prior experience with MDA, the results looked familiar.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Representative Results of Stimulus Generalization Studies Using Rats Trained To Discriminate Either DOM, (+)Amphetamine (AMPH), MDMA, PMMA, or α-ET from Vehicle<a onclick="showRef(event, 'ref109 ref110 ref111 ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref109 ref110 ref111 ref112 ref113">(109-113)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">training drug: ED<sub>50</sub>, mg/kg<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">test agent</th><th class="colsep0 rowsep0" align="center">DOM</th><th class="colsep0 rowsep0" align="center">AMPH</th><th class="colsep0 rowsep0" align="center">MDMA</th><th class="colsep0 rowsep0" align="center">PMMA</th><th class="colsep0 rowsep0" align="center">α-ET</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)α-ET</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">PG</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i>(−)α-ET</td><td class="colsep0 rowsep0" align="left">PG<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S</i>(+)α-ET</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">PG<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PMMA</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(+)amphetamine</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">PG</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">PG</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DOM</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">0.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Where stimulus generalization failed to occur: S = vehicle-appropriate responding; PG = partial generalization (i.e., >20% but <80% drug-appropriate responding).</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Not evaluated.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">33% DOM-appropriate responding.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">53% AMPH-appropriate responding.</p></div></div></div><div class="NLM_p">Subsequent studies showed that α-ET produced MDMA-like stimulus effects (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). It was looking more and more like α-ET was an indolealkylamine counterpart of MDA.</div><div class="NLM_p">Later, animals were trained to discriminate racemic α-ET from vehicle,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> and greater than one year of training was required to establish the stimulus cue (see comments in <a class="ref internalNav" href="#sec10" aria-label="section 10">section 10</a> on training animals to discriminate MDA from vehicle). α-ET stimulus generalization occurred to PMMA and DOM, and partial generalization was seen with (+)amphetamine (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Taken together, the results indicated that <i>S</i>(+)α-ET was primarily a DOM-like agent, <i>R</i>(−)α-ET was more of a (+)amphetamine-like agent, and both isomers produced a PMMA-like effect. The results are noteworthy because they showed that the stimulus effects of certain indolealkylamines, as well as phenylalkylamines, might be explained by the Venn diagram depicted in <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>.</div><div class="NLM_p">What underlies the stimulus actions of α-ET? Again in a collaborative effort with Dr. Rothman (NIDA), it was found that α-ET isomers behaved differently as releasing agents at SERT, DAT, and NET; EC<sub>50</sub> values for <i>S</i>(+)α-ET and <i>R</i>(−)α-ET were 20 and 68 nM at SERT and 64 and 900 nM at DAT, respectively, and >10 000 at NET.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Blough et al.,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> at nearly the same time, published similar findings: EC<sub>50</sub> values for <i>S</i>(+)α-ET and <i>R</i>(−)α-ET were 35 and 55 nM at SERT and 55 and 654 nM at DAT, but the compounds showed higher potency at NET (592 and 3670 nM, respectively) even though still reduced compared to potency at SERT and DAT. <i>S</i>(+)α-ET was also demonstrated to act as a weak 5-HT<sub>2A</sub> receptor partial agonist in a calcium mobilization assay, whereas <i>R</i>(−)α-ET was inactive.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div class="NLM_p">The results of the drug discrimination studies were, to some extent, counterintuitive. Curiously, the 5-HT releasing agent fenfluramine (<b>103</b>), an agent not generally considered to be hallucinogenic, has been shown to substitute in DOM-trained animals.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> This phenomenon has never been fully explained. Fenfluramine, in addition to being a weak 5-HT<sub>2A</sub> partial agonist, is a releasing agent at SERT (EC<sub>50</sub> = 108 nM) and NET (EC<sub>50</sub> = 740 nM) but inactive at DAT. Its actions are not unlike those of MDMA (EC<sub>50</sub> of 72, 110, and 278 nM for SERT, NET, and DAT, respectively; <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) except that MDMA is more potent than fenfluramine at DAT.<a onclick="showRef(event, 'ref59 ref115'); return false;" href="javascript:void(0);" class="ref ref59 ref115">(59, 115)</a> Hence, the actions of <i>S</i>(+)α-ET might be related to its weak agonist action at 5-HT<sub>2A</sub> receptors coupled with possible potentiation by release at SERT (see also <a class="ref internalNav" href="#sec15" aria-label="section 15">section 15</a> on “candy flipping”). The actions of <i>R</i>(−)α-ET are more of a conundrum; being a weaker releaser at DAT than its <i>S</i>(+)-enantiomer, it is difficult to explain why stimulus generalization occurred; nevertheless, it might be noted that it was approximately 20 times less potent than (+)amphetamine (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>).</div><div class="NLM_p last">Bottom line is that the actions of certain indolealkylamines, especially α-substituted tryptamines, (i) can be as complex as some phenylalkylamines already discussed and (ii) lend themselves to possible classification as described in <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>. Considerable effort has been devoted by many investigators to study the behavioral and mechanistic character of phenylalkylamine drugs of abuse (e.g., central stimulants, hallucinogens, empathogens). It would seem that more work now needs to be done with other arylalkylamines, such as indolealkylamines, specifically tryptamines and α-substituted tryptamines.</div></div><div id="sec19" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">19 Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The primary purpose of this review was to highlight the ubiquity and utility of the simple, chameleon-like, phenylalkylamine motif to provide examples of how relatively minor structural modifications immensely impact its pharmacology and to focus on some of our efforts in these areas with a particular emphasis on drugs of abuse. It was the latter studies that opened new avenues of pursuit to us (e.g., 5-HT<sub>1A</sub>, 5-HT<sub>6</sub>, σ, and other receptors).</div><div class="NLM_p">The phenyethylamine moiety has risen from humble beginnings as a presumed metabolic byproduct to serve as a noteworthy scaffold for therapeutically useful agents and for an even greater number of abused substances. PEA even has its own, although shared, receptor (TAAR1) and seems to play a role as a neuromodulator. TAARs are deserving of additional study. PEA is not centrally active via common routes of administration unless heroic doses are consumed/employed. However, introduction of substantive structural appendages to PEA can result in agents with a wide variety of actions (e.g., see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> and the related discussion). Of perhaps greater note is that even relatively minor structural changes to the PEA molecule have significant pharmacological impact. The introduction of phenolic/benzylic hydroxyl groups leads to the major neurotransmitters dopamine and norepinephrine. Introduction of other simple substituents enhances its lipohilicity to increase its BBB penetrability or alter its actions. For example, appending an α-methyl group to PEA leads to the phenylisopropylamine stimulant amphetamine. Then, alteration of the amphetamine structure leads to a host of other actions. Introduction of certain aryl substituents converts amphetamine to classical hallucinogens that act via a 5-HT<sub>2</sub> receptor agonist mechanism, whereas other substituents result in 5-HT<sub>2</sub> receptor antagonists. Different aryl, side chain, and amine substituents result in central stimulants, empathogens, 5-HT<sub>1A</sub> receptor agonists, and agents with therapeutic potential. Stereochemistry plays a role when the side chain bears substituents. Conformational aspects are also important.</div><div class="NLM_p">Many of the agents discussed here have been demonstrated to produce discriminative stimuli in animals that are helpful in their behavioral classification and characterization and that variously act at 5-HT<sub>2</sub> and 5-HT<sub>1A</sub> serotonin receptors, adrenoceptors, and monoamine transporters (SERT, DAT, NET) and, at the latter, as releasing agents and/or as reuptake inhibitors and occasionally with different selectivities. Many of the agents are abused substances; others possess mechanistic attributes that (internally, SERT vs DAT action of a given agent) temper or potentiate (i.e., 8-OH DPAT) these actions, and the actions of some agents probably involve multiple mechanisms. However, the potential for specific agents acting by a combination of these mechanisms represents nuances that require further investigation. Nevertheless, it is rather astounding how relatively minor structural changes on a very simple Ph–C–C–N molecule have such a profound influence on its actions, hence, the “phenylalkylaminegnome”.</div><div class="NLM_p last">The abuse of designer drugs is a terrible (and costly) societal scourge, and these agents are appearing in unprecedented numbers and faster than they can be pharmacologically evaluated or controlled (i.e., scheduled) or treatments identified. The term “designer drug” has not been used here so far. But many of the agents currently appearing on the clandestine market are “designer drugs”, and most of them possess an arylalkylamine or phenylalkylamine backbone. Recently, the term “novel psychoactive substances” (NPS) has been coined, and these NPS include, for the most part, novel phenylalkylamines, especially phenylalkylamine hallucinogens and phenylpropanonamines (i.e., synthetic cathinones). Studies such as those described here, as well as those of other investigators, attempt to unlock the mechanism(s) of action of these agents so that effective treatments might be identified for their abuse and to provide data that can be used in forecasting the actions of these agents and assist in controlling agents that have yet to appear on the clandestine market.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00085" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard A. Glennon</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
School of Pharmacy, Virginia Commonwealth
University, Richmond, Virginia 23298, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3600-9045" title="Orcid link">http://orcid.org/0000-0002-3600-9045</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3b5c575e555554557b4d584e155e5f4e"><span class="__cf_email__" data-cfemail="c4a3a8a1aaaaabaa84b2a7b1eaa1a0b1">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The author declares no competing financial interest.<br /></br><p class="inlineNote">This manuscript is based on an invited presentation provided by Dr. Glennon, recipient of the “Philip S. Portoghese Medicinal Chemistry Lectureship” award, at the annual American Chemical Society meeting in Denver, Colorado, March 2015.</p></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67401" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67401" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Richard A. Glennon</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=BIO-d39e4790-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Richard A. Glennon</b> is Professor, Chairman, and Alfred and Frances Burger Distinguished Professor of Medicinal Chemistry in the Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University. He has had a long-standing interest in the medicinal chemistry, mechanisms of action, and behavioral pharmacology of neuropsychiatric agents and selected drugs of abuse, has published >450 papers and book chapters on these topics, and pioneered the use of drug discrimination studies as applied to medicinal chemistry and drug development. He has mentored >50 graduate students and >50 postdoctoral fellows/visiting scientists. Some of his achievements include the American Pharmaceutical Association’s Research Achievement Award, the European Federation of Medicinal Chemistry’s Order of the Oak and Tulip Medal, and induction into the ACS Medicinal Chemistry Division’s Hall of Fame.</p></figure></div><div class="ack" id="ACK-d39e4795-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Most of the drug abuse-related studies from the author’s laboratory were supported by NIDA Grants DA-01642 (receptor binding and drug discrimination studies involving hallucinogens, central stimulants, and cathinone/methcathinone analogs) and DA-33930 (new “synthetic cathinones”). Some studies were supported by NIMH Grant MH-60599 (various serotonergic agents including development of NAN-190). Other studies mentioned here were supported, in part, by funding from Cambridge Neuroscience (σ receptors), Alcon (glaucoma studies), Allelix Biopharmaceticals (early 5-HT<sub>6</sub> and other studies), and the British Technology Group (later 5-HT<sub>6</sub> receptor and other studies). The author thanks his graduate students, postdoctoral fellows, laboratory assistants, and collaborators (who shared coauthorship of many of the papers cited here). In particular, collaborators Dr. Richard Young and Dr. Małgorzata Dukat deserve special recognition for their critical scientific input and involvement in many of these studies.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i39" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i39"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> Abbreviations Used</h2><tr><td class="NLM_term">α-ET</td><td class="NLM_def"><p class="first last">α-ethyltryptamine</p></td></tr><tr><td class="NLM_term">α-MeT</td><td class="NLM_def"><p class="first last">α-methyltryptamine</p></td></tr><tr><td class="NLM_term">ADHD</td><td class="NLM_def"><p class="first last">attention deficit hyperactivity disorder</p></td></tr><tr><td class="NLM_term">Ar</td><td class="NLM_def"><p class="first last">aryl</p></td></tr><tr><td class="NLM_term">Ar–C–C–N</td><td class="NLM_def"><p class="first last">arylalkylamine</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">3′,5′-adenosine monophosphate</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">DOB</td><td class="NLM_def"><p class="first last">1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane</p></td></tr><tr><td class="NLM_term">DOI</td><td class="NLM_def"><p class="first last">1-(2,5-dimethoxy-4-ioodophenyl)-2-aminopropane</p></td></tr><tr><td class="NLM_term">DOM</td><td class="NLM_def"><p class="first last">1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">IOP</td><td class="NLM_def"><p class="first last">intraocular pressure</p></td></tr><tr><td class="NLM_term">KET</td><td class="NLM_def"><p class="first last">ketanserin</p></td></tr><tr><td class="NLM_term">LSD</td><td class="NLM_def"><p class="first last">lysergic acid diethylamide</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">NE</td><td class="NLM_def"><p class="first last">norepinephrine</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporter</p></td></tr><tr><td class="NLM_term">PEA</td><td class="NLM_def"><p class="first last">phenylethylamine</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single-photon emission computed tomography</p></td></tr><tr><td class="NLM_term">TAAR</td><td class="NLM_def"><p class="first last">trace amine-associated receptor</p></td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">serotonin (5-hydroxytryptamine)</p></td></tr><tr><td class="NLM_term">5-OMe DMT</td><td class="NLM_def"><p class="first last">5-methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine</p></td></tr><tr><td class="NLM_term">8-OH DPAT</td><td class="NLM_def"><p class="first last">8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 115 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">The phenylalkylaminome: scaffolding for drugs of abuse, with a focus on synthetic cathinones</span>. Presented at the 249th National Meeting of the American Chemical Society, Denver, CO, March<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>MEDI 250.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+A.+Glennon&title=The+phenylalkylaminome%3A+scaffolding+for+drugs+of+abuse%2C+with+a+focus+on+synthetic+cathinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DThe%2520phenylalkylaminome%253A%2520scaffolding%2520for%2520drugs%2520of%2520abuse%252C%2520with%2520a%2520focus%2520on%2520synthetic%2520cathinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wishart, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassanali, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stothard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolsey, J.</span><span> </span><span class="NLM_article-title">DrugBank: A comprehensive resource for in silico drug discovery and exploration</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">Database issue</span><span class="NLM_x">) </span> <span class="NLM_fpage">D668</span><span class="NLM_x">–</span> <span class="NLM_lpage">D672</span><span class="refDoi"> DOI: 10.1093/nar/gkj067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1093%2Fnar%2Fgkj067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=16381955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=D668-D672&issue=Database+issue&author=D.+S.+Wishartauthor=C.+Knoxauthor=A.+C.+Guoauthor=S.+Shrivastavaauthor=M.+Hassanaliauthor=P.+Stothardauthor=Z.+Changauthor=J.+Woolsey&title=DrugBank%3A+A+comprehensive+resource+for+in+silico+drug+discovery+and+exploration&doi=10.1093%2Fnar%2Fgkj067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank: a comprehensive resource for in silico drug discovery and exploration</span></div><div class="casAuthors">Wishart, David S.; Knox, Craig; Guo, An Chi; Shrivastava, Savita; Hassanali, Murtaza; Stothard, Paul; Chang, Zhan; Woolsey, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">Database</span>),
    <span class="NLM_cas:pages">D668-D672</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank is a unique bioinformatics/cheminformatics resource that combines detailed drug (i.e. chem.) data with comprehensive drug target (i.e. protein) information.  The database contains >4100 drug entries including >800 FDA approved small mol. and biotech drugs as well as >3200 exptl. drugs.  Addnl., >14 000 protein or drug target sequences are linked to these drug entries.  Each DrugCard entry contains >80 data fields with half of the information being devoted to drug/chem. data and the other half devoted to drug target or protein data.  Many data fields are hyperlinked to other databases (KEGG, PubChem, ChEBI, PDB, Swiss-Prot and GenBank) and a variety of structure viewing applets.  The database is fully searchable supporting extensive text, sequence, chem. structure and relational query searches.  Potential applications of DrugBank include in silico drug target discovery, drug design, drug docking or screening, drug metab. prediction, drug interaction prediction and general pharmaceutical education.  DrugBank is available at http://redpoll.pharmacy.ualberta.ca/drugbank/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaNy9WiVtlu7Vg90H21EOLACvtfcHk0liwtxu2ur33tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFOrsw%253D%253D&md5=c3f4ad2fc489440be5b16f91bc9cf7db</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkj067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkj067%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DShrivastava%26aufirst%3DS.%26aulast%3DHassanali%26aufirst%3DM.%26aulast%3DStothard%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DWoolsey%26aufirst%3DJ.%26atitle%3DDrugBank%253A%2520A%2520comprehensive%2520resource%2520for%2520in%2520silico%2520drug%2520discovery%2520and%2520exploration%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26issue%3DDatabase%2520issue%26spage%3DD668%26epage%3DD672%26doi%3D10.1093%2Fnar%2Fgkj067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Trace amine-associated receptor 1 – Family archetype or iconoclast?</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2007.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pharmthera.2007.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=17888514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCrs7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=355-390&author=D.+K.+Grandy&title=Trace+amine-associated+receptor+1+%E2%80%93+Family+archetype+or+iconoclast%3F&doi=10.1016%2Fj.pharmthera.2007.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Trace amine-associated receptor 1-Family archetype or iconoclast?</span></div><div class="casAuthors">Grandy, David K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-390</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Interest has recently been rekindled in receptors that are activated by low-mol.-wt., noncatecholic, biogenic amines that are typically found as trace constituents of various vertebrate and invertebrate tissues and fluids.  The timing of this resurgent focus on receptors activated by the "trace amines" (TA) β-phenylethylamine (PEA), tyramine (TYR), octopamine (OCT), synephrine (SYN), and tryptamine (TRYP) is the direct result of 2 publications that appeared in 2001 describing the cloning of a novel G protein-coupled receptor (GPCR) referred to by their discoverers Borowsky et al. as TA1 and Bunzow et al. as TA receptor 1 (TAR1).  When heterologously expressed in Xenopus laevis oocytes and various eukaryotic cell lines, recombinant rodent and human TAR dose-dependently couple to the stimulation of adenosine 3',5'-monophosphate (cAMP) prodn.  Structure-activity profiling based on this functional response has revealed that in addn. to the TA, other biol. active compds. contg. a 2-carbon aliph. side chain linking an amino group to at least 1 benzene ring are potent and efficacious TA receptor agonists with amphetamine (AMPH), methamphetamine, 3-iodothyronamine, thyronamine, and dopamine (DA) among the most notable.  Almost 100 years after the search for TAR began, numerous TA1/TAR1-related sequences, now called TA-assocd. receptors (TAAR), have been identified in the genome of every species of vertebrate examd. to date.  Consequently, even though heterologously expressed TAAR1 fits the pharmacol. criteria established for a bona fide TAR, a major challenge for those working in the field is to discern the in vivo pharmacol. and physiol. of each purported member of this extended family of GPCR.  Only then will it be possible to establish whether TAAR1 is the family archetype or an iconoclast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8U1tCoTEP6bVg90H21EOLACvtfcHk0liwtxu2ur33tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCrs7bM&md5=9976ce0f7f07220a97144722505b22e6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DTrace%2520amine-associated%2520receptor%25201%2520%25E2%2580%2593%2520Family%2520archetype%2520or%2520iconoclast%253F%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D116%26spage%3D355%26epage%3D390%26doi%3D10.1016%2Fj.pharmthera.2007.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Irsfeld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spadafore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prüß, B. M.</span><span> </span><span class="NLM_article-title">β-Phenylethylamine, a small molecule with a large impact</span> <span class="citation_source-journal">WebmedCentral</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">4409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=4409&author=M.+Irsfeldauthor=M.+Spadaforeauthor=B.+M.+Pr%C3%BC%C3%9F&title=%CE%B2-Phenylethylamine%2C+a+small+molecule+with+a+large+impact"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIrsfeld%26aufirst%3DM.%26aulast%3DSpadafore%26aufirst%3DM.%26aulast%3DPr%25C3%25BC%25C3%259F%26aufirst%3DB.%2BM.%26atitle%3D%25CE%25B2-Phenylethylamine%252C%2520a%2520small%2520molecule%2520with%2520a%2520large%2520impact%26jtitle%3DWebmedCentral%26date%3D2013%26volume%3D4%26spage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Berry, M. D.</span><span> </span><span class="NLM_article-title">Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2004.02501.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1111%2Fj.1471-4159.2004.02501.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=15228583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVyrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=257-271&author=M.+D.+Berry&title=Mammalian+central+nervous+system+trace+amines.+Pharmacologic+amphetamines%2C+physiologic+neuromodulators&doi=10.1111%2Fj.1471-4159.2004.02501.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators</span></div><div class="casAuthors">Berry, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-271</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The presence of the so-called trace amines 2-phenylethylamine, m-tyramine, p-tyramine, m-octopamine, p-octopamine and tryptamine in the mammalian central nervous system has been known for several decades.  Despite much initial interest, these amines have largely been thought of as little more than metabolic byproducts.  The recent description of a family of mammalian trace amine receptors has, however, seen a resurgence of interest in the physiol. role of this class of compds.  Although the trace amines are well documented to cause amphetamine-like effects, such responses only occur at concns. multiple orders of magnitude above normal physiol. levels.  As such, it seems unlikely that these responses reflect the true physiol. role of the trace amines.  In this article previous studies showing responses to physiol. relevant concns. of trace amines are reviewed, along with those showing a reciprocal relationship between trace amine levels and fluctuations in basal monoaminergic tone.  On the basis of these studies it is hypothesized that the trace amines function as endogenous neuromodulators of classical monoamine neurotransmitters.  These effects are seen as an altered neuronal sensitivity to monoamine neurotransmitters, with no change in neuronal excitability in the absence of neurotransmitter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpooIbi2hZXPrVg90H21EOLACvtfcHk0lgvCFa9eXFXGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVyrsbk%253D&md5=445306d439de8f10c4a453988b080a04</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02501.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02501.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DM.%2BD.%26atitle%3DMammalian%2520central%2520nervous%2520system%2520trace%2520amines.%2520Pharmacologic%2520amphetamines%252C%2520physiologic%2520neuromodulators%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D90%26spage%3D257%26epage%3D271%26doi%3D10.1111%2Fj.1471-4159.2004.02501.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asif-Malik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canales, J. J.</span><span> </span><span class="NLM_article-title">Trace amines and the trace amine-associated receptor 1: Pharmacology, neurochemistry, and clinical implications</span> <span class="citation_source-journal">Front. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="refDoi"> DOI: 10.3389/fnins.2016.00148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.3389%2Ffnins.2016.00148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=27092049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A280%3ADC%252BC28bhsVSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=148&author=Y.+Peiauthor=A.+Asif-Malikauthor=J.+J.+Canales&title=Trace+amines+and+the+trace+amine-associated+receptor+1%3A+Pharmacology%2C+neurochemistry%2C+and+clinical+implications&doi=10.3389%2Ffnins.2016.00148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications</span></div><div class="casAuthors">Pei Yue; Asif-Malik Aman; Canales Juan J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148</span>
        ISSN:<span class="NLM_cas:issn">1662-4548</span>.
    </div><div class="casAbstract">Biogenic amines are a collection of endogenous molecules that play pivotal roles as neurotransmitters and hormones.  In addition to the "classical" biogenic amines resulting from decarboxylation of aromatic acids, including dopamine (DA), norepinephrine, epinephrine, serotonin (5-HT), and histamine, other biogenic amines, present at much lower concentrations in the central nervous system (CNS), and hence referred to as "trace" amines (TAs), are now recognized to play significant neurophysiological and behavioral functions.  At the turn of the century, the discovery of the trace amine-associated receptor 1 (TAAR1), a phylogenetically conserved G protein-coupled receptor that is responsive to both TAs, such as β-phenylethylamine, octopamine, and tyramine, and structurally-related amphetamines, unveiled mechanisms of action for TAs other than interference with aminergic pathways, laying the foundations for deciphering the functional significance of TAs and its mammalian CNS receptor, TAAR1.  Although, its molecular interactions and downstream targets have not been fully elucidated, TAAR1 activation triggers accumulation of intracellular cAMP, modulates PKA and PKC signaling and interferes with the β-arrestin2-dependent pathway via G protein-independent mechanisms.  TAAR1 is uniquely positioned to exert direct control over DA and 5-HT neuronal firing and release, which has profound implications for understanding the pathophysiology of, and therefore designing more efficacious therapeutic interventions for, a range of neuropsychiatric disorders that involve aminergic dysregulation, including Parkinson's disease, schizophrenia, mood disorders, and addiction.  Indeed, the recent development of novel pharmacological tools targeting TAAR1 has uncovered the remarkable potential of TAAR1-based medications as new generation pharmacotherapies in neuropsychiatry.  This review summarizes recent developments in the study of TAs and TAAR1, their intricate neurochemistry and pharmacology, and their relevance for neurodegenerative and neuropsychiatric disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF78JaKZBYZ6qcneEtCi92fW6udTcc2ebz4SiYq9emRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bhsVSisA%253D%253D&md5=1946ef222ab9fc87394df0efb72792b2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2016.00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2016.00148%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DY.%26aulast%3DAsif-Malik%26aufirst%3DA.%26aulast%3DCanales%26aufirst%3DJ.%2BJ.%26atitle%3DTrace%2520amines%2520and%2520the%2520trace%2520amine-associated%2520receptor%25201%253A%2520Pharmacology%252C%2520neurochemistry%252C%2520and%2520clinical%2520implications%26jtitle%3DFront.%2520Neurosci.%26date%3D2016%26volume%3D10%26spage%3D148%26doi%3D10.3389%2Ffnins.2016.00148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilapil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFaille, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Unique [<sup>3</sup>H]tryptamine binding sites in rat brain: Distribution and pharmacology</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=6732364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2cXktVWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1984&pages=194-200&author=P.+L.+Woodauthor=C.+Pilapilauthor=F.+LaFailleauthor=N.+P.+Nairauthor=R.+A.+Glennon&title=Unique+%5B3H%5Dtryptamine+binding+sites+in+rat+brain%3A+Distribution+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Unique [3H]tryptamine binding sites in rat brain:  distribution and pharmacology</span></div><div class="casAuthors">Wood, P. L.; Pilapil, C.; LaFaille, F.; Nair, N. P. V.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">194-201</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">3H-labeled tryptamine  [61-54-1] binding in rat brain is widely distributed, with highest densities in the cortex, striatum, and hippocampus.  This binding is stereospecific and is potently displaced by tryptamine analogs and β-carbolines.  Phenethylamines also possess a weaker activity in displacing [3H]tryptamine.  The strict structural requirements for binding to this site substantiate its unique character and suggest that it may represent a tryptamine receptor in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFU5Dbf77CtrVg90H21EOLACvtfcHk0lgvCFa9eXFXGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktVWguro%253D&md5=35bc9e4632fb40ba77401d6b29813c7e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BL.%26aulast%3DPilapil%26aufirst%3DC.%26aulast%3DLaFaille%26aufirst%3DF.%26aulast%3DNair%26aufirst%3DN.%2BP.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DUnique%2520%255B3H%255Dtryptamine%2520binding%2520sites%2520in%2520rat%2520brain%253A%2520Distribution%2520and%2520pharmacology%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1984%26volume%3D268%26spage%3D194%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Usdin, E.; Sandler, M.</span>, Eds.  <span class="citation_source-book">Trace Amines and the Brain</span>; <span class="NLM_publisher-name">M. Dekker</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1976</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1976&author=E.+Usdin&author=M.+Sandler&title=Trace+Amines+and+the+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DUsdin%26aufirst%3DE.%26btitle%3DTrace%2520Amines%2520and%2520the%2520Brain%26pub%3DM.%2520Dekker%26date%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Branchek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. P.</span><span> </span><span class="NLM_article-title">Trace amine receptors as targets for novel therapeutics: Legend, myth and fact</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1016/S1471-4892(02)00028-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS1471-4892%2802%2900028-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=12550748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=90-97&author=T.+A.+Branchekauthor=T.+P.+Blackburn&title=Trace+amine+receptors+as+targets+for+novel+therapeutics%3A+Legend%2C+myth+and+fact&doi=10.1016%2FS1471-4892%2802%2900028-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Trace amine receptors as targets for novel therapeutics: legend, myth and fact</span></div><div class="casAuthors">Branchek, Theresa A.; Blackburn, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-97</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Trace amines are attracting attention as neurotransmitters because they are believed to play a role in human disorders such as schizophrenia, depression, attention deficit disorder and Parkinson's disease.  Research to date is promising and confirms the need for continuing work to forge the way for new drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA33hMxXC1PrVg90H21EOLACvtfcHk0lgvLgZw8K2GhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVaqtQ%253D%253D&md5=4c72a2ca484b470a599c0a635b354bb0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2802%2900028-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252802%252900028-0%26sid%3Dliteratum%253Aachs%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DBlackburn%26aufirst%3DT.%2BP.%26atitle%3DTrace%2520amine%2520receptors%2520as%2520targets%2520for%2520novel%2520therapeutics%253A%2520Legend%252C%2520myth%2520and%2520fact%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D90%26epage%3D97%26doi%3D10.1016%2FS1471-4892%2802%2900028-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lindemann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoener, M. C.</span><span> </span><span class="NLM_article-title">A renaissance in trace amines inspired by a novel GPCR family</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1016/j.tips.2005.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.tips.2005.03.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=274-281&author=L.+Lindemannauthor=M.+C.+Hoener&title=A+renaissance+in+trace+amines+inspired+by+a+novel+GPCR+family&doi=10.1016%2Fj.tips.2005.03.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DLindemann%26aufirst%3DL.%26aulast%3DHoener%26aufirst%3DM.%2BC.%26atitle%3DA%2520renaissance%2520in%2520trace%2520amines%2520inspired%2520by%2520a%2520novel%2520GPCR%2520family%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D274%26epage%3D281%26doi%3D10.1016%2Fj.tips.2005.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Borowsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raddatz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artymyshyn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogozalek, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhlani, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathirana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouranova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtblau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochoa, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerald, C.</span><span> </span><span class="NLM_article-title">Trace amines: Identification of a family of mammalian G protein-coupled receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">8966</span><span class="NLM_x">–</span> <span class="NLM_lpage">8971</span><span class="refDoi"> DOI: 10.1073/pnas.151105198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1073%2Fpnas.151105198" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=8966-8971&author=B.+Borowskyauthor=N.+Adhamauthor=K.+A.+Jonesauthor=R.+Raddatzauthor=R.+Artymyshynauthor=K.+L.+Ogozalekauthor=M.+M.+Durkinauthor=P.+P.+Lakhlaniauthor=J.+A.+Boniniauthor=S.+Pathiranaauthor=N.+Boyleauthor=X.+Puauthor=E.+Kouranovaauthor=H.+Lichtblauauthor=F.+Y.+Ochoaauthor=T.+A.+Branchekauthor=C.+Gerald&title=Trace+amines%3A+Identification+of+a+family+of+mammalian+G+protein-coupled+receptors&doi=10.1073%2Fpnas.151105198"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.151105198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.151105198%26sid%3Dliteratum%253Aachs%26aulast%3DBorowsky%26aufirst%3DB.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DRaddatz%26aufirst%3DR.%26aulast%3DArtymyshyn%26aufirst%3DR.%26aulast%3DOgozalek%26aufirst%3DK.%2BL.%26aulast%3DDurkin%26aufirst%3DM.%2BM.%26aulast%3DLakhlani%26aufirst%3DP.%2BP.%26aulast%3DBonini%26aufirst%3DJ.%2BA.%26aulast%3DPathirana%26aufirst%3DS.%26aulast%3DBoyle%26aufirst%3DN.%26aulast%3DPu%26aufirst%3DX.%26aulast%3DKouranova%26aufirst%3DE.%26aulast%3DLichtblau%26aufirst%3DH.%26aulast%3DOchoa%26aufirst%3DF.%2BY.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DGerald%26aufirst%3DC.%26atitle%3DTrace%2520amines%253A%2520Identification%2520of%2520a%2520family%2520of%2520mammalian%2520G%2520protein-coupled%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D8966%26epage%3D8971%26doi%3D10.1073%2Fpnas.151105198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonders, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arttamangkul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchland, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasumamula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magenis, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1181</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1181-1188&author=J.+R.+Bunzowauthor=M.+S.+Sondersauthor=S.+Arttamangkulauthor=L.+M.+Harrisonauthor=G.+Zhangauthor=D.+I.+Quigleyauthor=T.+Darlandauthor=K.+L.+Suchlandauthor=S.+Pasumamulaauthor=J.+L.+Kennedyauthor=S.+B.+Olsonauthor=R.+E.+Magenisauthor=S.+G.+Amaraauthor=D.+K.+Grandy&title=Amphetamine%2C+3%2C4-methylenedioxymethamphetamine%2C+lysergic+acid+diethylamide%2C+and+metabolites+of+the+catecholamine+neurotransmitters+are+agonists+of+a+rat+trace+amine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DSonders%26aufirst%3DM.%2BS.%26aulast%3DArttamangkul%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DL.%2BM.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DQuigley%26aufirst%3DD.%2BI.%26aulast%3DDarland%26aufirst%3DT.%26aulast%3DSuchland%26aufirst%3DK.%2BL.%26aulast%3DPasumamula%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26aulast%3DOlson%26aufirst%3DS.%2BB.%26aulast%3DMagenis%26aufirst%3DR.%2BE.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DAmphetamine%252C%25203%252C4-methylenedioxymethamphetamine%252C%2520lysergic%2520acid%2520diethylamide%252C%2520and%2520metabolites%2520of%2520the%2520catecholamine%2520neurotransmitters%2520are%2520agonists%2520of%2520a%2520rat%2520trace%2520amine%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1181%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zucchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanlan, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Trace amine-associated receptors and their ligands</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1038%2Fsj.bjp.0706948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=17088868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12gsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=967-978&author=R.+Zucchiauthor=G.+Chielliniauthor=T.+S.+Scanlanauthor=D.+K.+Grandy&title=Trace+amine-associated+receptors+and+their+ligands&doi=10.1038%2Fsj.bjp.0706948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Trace amine-associated receptors and their ligands</span></div><div class="casAuthors">Zucchi, R.; Chiellini, G.; Scanlan, T. S.; Grandy, D. K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">967-978</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Classical biogenic amines (adrenaline, noradrenaline, dopamine, serotonin and histamine) interact with specific families of G protein-coupled receptors (GPCRs).  The term trace amines' is used when referring to p-tyramine, β-phenylethylamine, tryptamine and octopamine, compds. that are present in mammalian tissues at very low (nanomolar) concns.  The pharmacol. effects of trace amines are usually attributed to their interference with the aminergic pathways, but in 2001 a new gene was identified, that codes for a GPCR responding to p-tyramine and β-phenylethylamine but not to classical biogenic amines.  Several closely related genes were subsequently identified and designated as the trace amine-assocd. receptors (TAARs).  Pharmacol. investigations in vitro show that many TAAR subtypes may not respond to p-tyramine, β-phenylethylamine, tryptamine or octopamine, suggesting the existence of addnl. endogenous ligands.  A novel endogenous thyroid hormone deriv., 3-iodothyronamine, has been found to interact with TAAR1 and possibly other TAAR subtypes.  In vivo, micromolar concns. of 3-iodothyronamine det. functional effects which are opposite to those produced on a longer time scale by thyroid hormones, including redn. in body temp. and decrease in cardiac contractility.  Expression of all TAAR subtypes except TAAR1 has been reported in mouse olfactory epithelium, and several volatile amines were shown to interact with specific TAAR subtypes.  In addn., there is evidence that TAAR1 is targeted by amphetamines and other psychotropic agents, while genetic linkage studies show a significant assocn. between the TAAR gene family locus and susceptibility to schizophrenia or bipolar affective disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFznrJWTa4IbVg90H21EOLACvtfcHk0ljZNlXdqE391w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12gsLvL&md5=6aa4710192adc007ce00d9d07f45b38e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706948%26sid%3Dliteratum%253Aachs%26aulast%3DZucchi%26aufirst%3DR.%26aulast%3DChiellini%26aufirst%3DG.%26aulast%3DScanlan%26aufirst%3DT.%2BS.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DTrace%2520amine-associated%2520receptors%2520and%2520their%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26spage%3D967%26epage%3D978%26doi%3D10.1038%2Fsj.bjp.0706948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_contrib-group">Lewandowsky, M.</span><span> </span><span class="NLM_article-title">Zur lehre von der cerebrospinalflussigkeit</span> <span class="citation_source-journal">Z. Klin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1900</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1900&pages=480-494&author=M.+Lewandowsky&title=Zur+lehre+von+der+cerebrospinalflussigkeit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewandowsky%26aufirst%3DM.%26atitle%3DZur%2520lehre%2520von%2520der%2520cerebrospinalflussigkeit%26jtitle%3DZ.%2520Klin.%2520Med.%26date%3D1900%26volume%3D40%26spage%3D480%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">As cited in</p></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_contrib-group">Hawkins, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. P.</span><span> </span><span class="NLM_article-title">The blood-brain barrier</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1124/pr.57.2.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1124%2Fpr.57.2.4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=173-185&author=B.+T.+Hawkinsauthor=T.+P.+Davis&title=The+blood-brain+barrier&doi=10.1124%2Fpr.57.2.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1124%2Fpr.57.2.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.57.2.4%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DB.%2BT.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DThe%2520blood-brain%2520barrier%26jtitle%3DPharmacol.%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D173%26epage%3D185%26doi%3D10.1124%2Fpr.57.2.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">The blood-brain barrier: Bottleneck in brain drug development</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1602/neurorx.2.1.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1602%2Fneurorx.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=15717053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntVaqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=3-14&author=W.+M.+Pardridge&title=The+blood-brain+barrier%3A+Bottleneck+in+brain+drug+development&doi=10.1602%2Fneurorx.2.1.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The blood-brain barrier: bottleneck in brain drug development</span></div><div class="casAuthors">Pardridge William M</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">The blood-brain barrier (BBB) is formed by the brain capillary endothelium and excludes from the brain approximately 100% of large-molecule neurotherapeutics and more than 98% of all small-molecule drugs.  Despite the importance of the BBB to the neurotherapeutics mission, the BBB receives insufficient attention in either academic neuroscience or industry programs.  The combination of so little effort in developing solutions to the BBB problem, and the minimal BBB transport of the majority of all potential CNS drugs, leads predictably to the present situation in neurotherapeutics, which is that there are few effective treatments for the majority of CNS disorders.  This situation can be reversed by an accelerated effort to develop a knowledge base in the fundamental transport properties of the BBB, and the molecular and cellular biology of the brain capillary endothelium.  This provides the platform for CNS drug delivery programs, which should be developed in parallel with traditional CNS drug discovery efforts in the molecular neurosciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8zmuJRBq_D9y3lHz94U-GfW6udTcc2eaQJ63wD3cDPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntVaqtw%253D%253D&md5=88e326d840c4ab0f4e55da8a2ffd513c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DThe%2520blood-brain%2520barrier%253A%2520Bottleneck%2520in%2520brain%2520drug%2520development%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D3%26epage%3D14%26doi%3D10.1602%2Fneurorx.2.1.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hollister, L. E.</span> <span class="citation_source-book">Chemical Psychosis</span>; <span class="NLM_publisher-name">Charles C. Thomas</span>: <span class="NLM_publisher-loc">Springfield, IL</span>,<span class="NLM_x"> </span><span class="NLM_year">1968</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1968&author=L.+E.+Hollister&title=Chemical+Psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHollister%26aufirst%3DL.%2BE.%26btitle%3DChemical%2520Psychosis%26pub%3DCharles%2520C.%2520Thomas%26date%3D1968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Animal models for assessing hallucinogenic agents</span>. In  <span class="citation_source-book">Animal Models of Drug Addiction</span>; <span class="NLM_contrib-group">Boulton, A.; Baker, G.; Wu, P.</span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1385%2F0-89603-217-5%3A345" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=345-381&author=R.+A.+Glennonauthor=A.+Boulton&author=G.+Baker&author=P.+Wu&title=Animal+Models+of+Drug+Addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1385%2F0-89603-217-5%3A345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1385%252F0-89603-217-5%253A345%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DAnimal%2520models%2520for%2520assessing%2520hallucinogenic%2520agents%26btitle%3DAnimal%2520Models%2520of%2520Drug%2520Addiction%26aulast%3DBoulton%26aufirst%3DA.%26pub%3DHumana%2520Press%26date%3D1992%26spage%3D345%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Glennon, R. A.; Young, R.</span> <span class="citation_source-book">Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1002%2F9781118023150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+A.+Glennon&author=R.+Young&title=Drug+Discrimination%3A+Applications+to+Medicinal+Chemistry+and+Drug+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2F9781118023150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118023150%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26btitle%3DDrug%2520Discrimination%253A%2520Applications%2520to%2520Medicinal%2520Chemistry%2520and%2520Drug%2520Studies%26pub%3DWiley%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiman, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierson, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisberg, E.</span><span> </span><span class="NLM_article-title">NAN-190: An arylpiperazine analog that antagonizes the stimulus effects of the 5-HT<sub>1A</sub> agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin (8-OH-DPAT)</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1016/0014-2999(88)90212-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0014-2999%2888%2990212-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2976673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL1MXhvVertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1988&pages=339-341&author=R.+A.+Glennonauthor=N.+A.+Naimanauthor=M.+E.+Piersonauthor=M.+Titelerauthor=R.+A.+Lyonauthor=E.+Weisberg&title=NAN-190%3A+An+arylpiperazine+analog+that+antagonizes+the+stimulus+effects+of+the+5-HT1A+agonist+8-hydroxy-2-%28di-n-propylamino%29tetralin+%288-OH-DPAT%29&doi=10.1016%2F0014-2999%2888%2990212-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">NAN-190:  an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)</span></div><div class="casAuthors">Glennon, Richard A.; Naiman, Noreen A.; Pierson, M. Edward; Titeler, M.; Lyon, Robert A.; Weisberg, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">339-41</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">In order to det. whether NAN-190 (I) might serve as a 5-HT1A antagonist, it was evaluated in Sprague-Dawley rats trained to discriminate 8-OH-DPAT HBr (0.2 mg/kg i.p.) from saline in a 2-lever operant procedure using a VI-15 s schedule of reinforcement and a 15-min presession injection interval.  Doses of NAN-190 were administered (i.p.) in the absence or presence (45 min later) of 0.2 mg/kg of 8-OH-DPAT.  Results indicate that NAN-190 is a high-affinity ligand with selectivity for 5-HT1A and α1-adrenergic binding sites.  However, NAN-190, but not prazosin, antagonizes the stimulus effects of the 5-HT1A agonist 8-OH-DPAT, and yet, unlike propranolol and pindolol, NAN-190 does not product TFMPP-like stimulus effects.  Thus NAN-190 should be a useful 5-HT1A antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGSuq8QUo-jLVg90H21EOLACvtfcHk0lg9UOUxV7hTPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvVertg%253D%253D&md5=66d19532c54e5675f2bf05168959bd06</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990212-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990212-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DNaiman%26aufirst%3DN.%2BA.%26aulast%3DPierson%26aufirst%3DM.%2BE.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DWeisberg%26aufirst%3DE.%26atitle%3DNAN-190%253A%2520An%2520arylpiperazine%2520analog%2520that%2520antagonizes%2520the%2520stimulus%2520effects%2520of%2520the%25205-HT1A%2520agonist%25208-hydroxy-2-%2528di-n-propylamino%2529tetralin%2520%25288-OH-DPAT%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D154%26spage%3D339%26epage%3D341%26doi%3D10.1016%2F0014-2999%2888%2990212-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosecrans, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Behavioral effects of 5-methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine and dose-dependent antagonism by BC-105</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1007/BF00427960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FBF00427960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=6410445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL3sXksVOrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=156-160&author=R.+Youngauthor=J.+A.+Rosecransauthor=R.+A.+Glennon&title=Behavioral+effects+of+5-methoxy-N%2CN-dimethyltryptamine+and+dose-dependent+antagonism+by+BC-105&doi=10.1007%2FBF00427960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105</span></div><div class="casAuthors">Young, Richard; Rosecrans, John A.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-60</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The discriminative effects of 5-methoxy-N,N-dimethyltryptamine hydrogen oxalate salt (I)  [17286-40-7] were studied in rats trained to discriminate 1.5 mg/kg or 3.0 mg/kg I from saline.  A series of antagonist and generalization tests revealed that antagonism of the I stimulus response by the presumed serotonin antagonist BC-105  [15574-96-6] depended on the dose of I, the I stimulus generalized to LSD tartrate  [17676-08-3] and like I, antagonism of the LSD generalization response by BC-105 depended on the dose of LSD.  In another study, with rats responding under a variable-interval 15-s schedule of reinforcement doses of 1.0-3.0 mg/kg I significantly decreased response rate.  Furthermore, the decrease in responding produced by the administration of 1.5 mg/kg (but not by 3.0 mg/kg) I was blocked by BC-105.  This dose-dependent antagonism was of particular interest since the 1.5 mg/kg and 3.0 mg/kg dose of I had essentially the same effect on responding when given alone.  The results of both studies emphasize the importance of I dose in antagonism expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYoCCut6tJYrVg90H21EOLACvtfcHk0lg9UOUxV7hTPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksVOrs70%253D&md5=7440cad61e3881899e96551b8d3b0721</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2FBF00427960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00427960%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DRosecrans%26aufirst%3DJ.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBehavioral%2520effects%2520of%25205-methoxy-N%252CN-dimethyltryptamine%2520and%2520dose-dependent%2520antagonism%2520by%2520BC-105%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1983%26volume%3D80%26spage%3D156%26epage%3D160%26doi%3D10.1007%2FBF00427960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of amphetamine and structurally related phenalkylamines</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1002/med.2610060105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1002%2Fmed.2610060105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3512936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL28Xht1agu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1986&pages=99-130&author=R.+Youngauthor=R.+A.+Glennon&title=Discriminative+stimulus+properties+of+amphetamine+and+structurally+related+phenalkylamines&doi=10.1002%2Fmed.2610060105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus properties of amphetamine and structurally related phenalkylamines</span></div><div class="casAuthors">Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-130</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review, with 74 refs., of the discriminative stimulus properties of amphetamine  [300-62-9] and structurally related phenalkylamines.  In addn. to properties (dose and temporal parameters, nature of the stimulus, and locus and mechanism of action) of the drug stimulus, methodol. considerations and structure-activity relations are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGik3JXvrkmbVg90H21EOLACvtfcHk0lh3PTuwu_PoBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1agu7g%253D&md5=d93a9d1d8375021de478c7c1eba16559</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610060105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610060105%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520amphetamine%2520and%2520structurally%2520related%2520phenalkylamines%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1986%26volume%3D6%26spage%3D99%26epage%3D130%26doi%3D10.1002%2Fmed.2610060105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gaddum, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hameed, K. A.</span><span> </span><span class="NLM_article-title">Drugs which antagonize 5-hydroxytryptamine</span> <span class="citation_source-journal">Br. J. Pharmacol. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1954.tb00848.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1111%2Fj.1476-5381.1954.tb00848.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=13172437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaG2cXmsFGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1954&pages=240-248&author=J.+H.+Gaddumauthor=K.+A.+Hameed&title=Drugs+which+antagonize+5-hydroxytryptamine&doi=10.1111%2Fj.1476-5381.1954.tb00848.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs which antagonize 5-hydroxytryptamine</span></div><div class="casAuthors">Gaddum, J. H.; Hameed, Khan A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology and Chemotherapy</span>
        (<span class="NLM_cas:date">1954</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">240-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCAL</span>;
        ISSN:<span class="NLM_cas:issn">0366-0826</span>.
    </div><div class="casAbstract">With suitable concns. of mepyramine, piperoxan, and atropine it was possible to inhibit the effects of histamine, adrenaline, and acetylcholine without altering the effects of 5-hydroxytryptamine (I) on pharmacol. test prepns., supporting the view that I acts on a specific receptor.  One type of receptor to I was present in smooth muscle of the rat uterus and rabbit's perfused ear and was inhibited by low concns. of lysergic acid diethylamide (II).  The 2nd type, present in nervous tissue of guinea-pig ileum, was not inhibited by II.  The effect of I on ileum was inhibited by atropine or cocaine in the same way nicotine is inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz0Fm5NQMiSrVg90H21EOLACvtfcHk0lh3PTuwu_PoBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXmsFGmtQ%253D%253D&md5=ef08f60a262dfbeec028e743379f6de2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1954.tb00848.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1954.tb00848.x%26sid%3Dliteratum%253Aachs%26aulast%3DGaddum%26aufirst%3DJ.%2BH.%26aulast%3DHameed%26aufirst%3DK.%2BA.%26atitle%3DDrugs%2520which%2520antagonize%25205-hydroxytryptamine%26jtitle%3DBr.%2520J.%2520Pharmacol.%2520Chemother.%26date%3D1954%26volume%3D9%26spage%3D240%26epage%3D248%26doi%3D10.1111%2Fj.1476-5381.1954.tb00848.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">The role of serotonin in the mechanism of action of hallucinogenic agents</span>. In  <span class="citation_source-book">Neuropharmacology of Serotonin</span>; <span class="NLM_contrib-group">Green, A. R.</span>, Ed.; <span class="NLM_publisher-name">Oxford University Press</span>,<span class="NLM_x"> </span><span class="NLM_year">1985</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=253-280&author=R.+A.+Glennonauthor=A.+R.+Green&title=Neuropharmacology+of+Serotonin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DThe%2520role%2520of%2520serotonin%2520in%2520the%2520mechanism%2520of%2520action%2520of%2520hallucinogenic%2520agents%26btitle%3DNeuropharmacology%2520of%2520Serotonin%26aulast%3DGreen%26aufirst%3DA.%2BR.%26pub%3DOxford%2520University%2520Press%26date%3D1985%26spage%3D253%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Peroutka, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Multiple serotonin receptors: Differential binding of [<sup>3</sup>H]5-hydroxytryptamine, [<sup>3</sup>H]lysergic acid diethylamide and [<sup>3</sup>H]spiroperidol</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=687-699&author=S.+J.+Peroutkaauthor=S.+H.+Snyder&title=Multiple+serotonin+receptors%3A+Differential+binding+of+%5B3H%5D5-hydroxytryptamine%2C+%5B3H%5Dlysergic+acid+diethylamide+and+%5B3H%5Dspiroperidol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeroutka%26aufirst%3DS.%2BJ.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DMultiple%2520serotonin%2520receptors%253A%2520Differential%2520binding%2520of%2520%255B3H%255D5-hydroxytryptamine%252C%2520%255B3H%255Dlysergic%2520acid%2520diethylamide%2520and%2520%255B3H%255Dspiroperidol%26jtitle%3DMol.%2520Pharmacol.%26date%3D1979%26volume%3D16%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cohen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittenauer, L. A.</span><span> </span><span class="NLM_article-title">Relationship between serotonin and tryptamine receptors in the rat stomach fundus</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3981465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2MXitFGrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1985&pages=75-79&author=M.+L.+Cohenauthor=L.+A.+Wittenauer&title=Relationship+between+serotonin+and+tryptamine+receptors+in+the+rat+stomach+fundus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between serotonin and tryptamine receptors in the rat stomach fundus</span></div><div class="casAuthors">Cohen, Marlene L.; Wittenauer, Laura A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-9</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The fundus affinity of 5-HT  [50-67-9] receptor antagonists, ketanserin, metergoline, 1-(1-naphthyl)piperazine, LY154930, and LY175041 was similar when 5-HT or tryptamine  [61-54-1] was the agonist, indicating that 5-HT and tryptamine are interacting with the same receptor in the fundus.  Furthermore, max. contractile response to both 5-HT and tryptamine was reduced to the same extent by the Ca channel blocker, diltiazem, and by the calmodulin inhibitor, trifluoperazine.  Inasmuch as diltiazem and trifluoperazine did not similarly inhibit contraction to agents interacting with other receptors (i.e., carbamylcholine), these data are consistent with the idea that 5-HT and tryptamine are interacting with the same receptor in the fundus.  Consistent with this conclusion is the observation that affinity of the β-carbolines, harmaline and harmine, was also similar when tryptamine or 5-HT was used as the agonist.  However, affinity of the β-carbolines for the tryptamine/5-HT receptor in the fundus was dramatically lower than reported for [3H]tryptamine binding sites in brain membranes.  Thus, tryptamine and 5-HT contract the rat fundus by interaction with the same receptor which is distinct from the 5-HT, 5-HT2, or tryptaminergic receptors defined by radiolabeled ligand binding studies in rat brain membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTFHKuy3STibVg90H21EOLACvtfcHk0ljIRP6q7CO6rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitFGrsbc%253D&md5=89ec8c1c758b9d2c109828ac37cc69a0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DM.%2BL.%26aulast%3DWittenauer%26aufirst%3DL.%2BA.%26atitle%3DRelationship%2520between%2520serotonin%2520and%2520tryptamine%2520receptors%2520in%2520the%2520rat%2520stomach%2520fundus%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1985%26volume%3D233%26spage%3D75%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenck, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kursar, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucaites, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span> </span><span class="NLM_article-title">Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine<sub>2F</sub> receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=419-426&author=D.+B.+Wainscottauthor=M.+L.+Cohenauthor=K.+W.+Schenckauthor=J.+E.+Audiaauthor=J.+S.+Nissenauthor=M.+Baezauthor=J.+D.+Kursarauthor=V.+L.+Lucaitesauthor=D.+L.+Nelson&title=Pharmacological+characteristics+of+the+newly+cloned+rat+5-hydroxytryptamine2F+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DCohen%26aufirst%3DM.%2BL.%26aulast%3DSchenck%26aufirst%3DK.%2BW.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DNissen%26aufirst%3DJ.%2BS.%26aulast%3DBaez%26aufirst%3DM.%26aulast%3DKursar%26aufirst%3DJ.%2BD.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26atitle%3DPharmacological%2520characteristics%2520of%2520the%2520newly%2520cloned%2520rat%25205-hydroxytryptamine2F%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26spage%3D419%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucaites, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> receptors</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1007/PL00005315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FPL00005315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=9933142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFalu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1999&pages=1-6&author=D.+L.+Nelsonauthor=V.+L.+Lucaitesauthor=D.+B.+Wainscottauthor=R.+A.+Glennon&title=Comparisons+of+hallucinogenic+phenylisopropylamine+binding+affinities+at+cloned+human+5-HT2A%2C+5-HT2B+and+5-HT2C+receptors&doi=10.1007%2FPL00005315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors</span></div><div class="casAuthors">Nelson, D. L.; Lucaites, V. L.; Wainscott, D. B.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Since the classical hallucinogens were initially reported to produce their behavioral effects via a 5-HT2 agonist mechanism (i.e., the 5-HT2 hypothesis of hallucinogen action), 5-HT2 receptors have been demonstrated to represent a family of receptors that consists of three distinct subpopulations: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  Today, there is greater support for 5-HT2A than for 5-HT2C receptor involvement in the behavioral effects evoked by these agents.  However, with the recent discovery of 5-HT2B receptors, a new question arises: do classical hallucinogens bind at 5-HT2B receptors.  In the present study, the authors examd. and compared the binding of 17 phenylisopropylamines at human 5-HT2A, 5-HT2B, and 5-HT2C receptors.  Although there was a notable pos. correlation (r>0.9) between the affinities of the agents at all three populations of 5-HT2 receptors, structural modification resulted only in small differences in 5-HT2B receptor affinity such that the range of affinities was only about 50-fold.  As with 5-HT2A and 5-HT2C receptor affinity, there is a significant correlation (r>0.9) between 5-HT2B receptor affinity and human hallucinogenic potency.  Nevertheless, given that 5-HT2A and 5-HT2A/2C antagonists - antagonists with low affinity for 5-HT2B receptors - have been previously shown to block the stimulus effects of phenylisopropylamine hallucinogens, it is likely that 5-HT2A receptors play a more prominent role than 5-HT2B and 5-HT2C receptors in mediating such effects despite the affinity of these agents for all three 5-HT2 receptor subpopulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvcUJ72-JQ2LVg90H21EOLACvtfcHk0ljIRP6q7CO6rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFalu7k%253D&md5=0aa21959353f624601097271883a49de</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2FPL00005315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005315%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DComparisons%2520of%2520hallucinogenic%2520phenylisopropylamine%2520binding%2520affinities%2520at%2520cloned%2520human%25205-HT2A%252C%25205-HT2B%2520and%25205-HT2C%2520receptors%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1999%26volume%3D359%26spage%3D1%26epage%3D6%26doi%3D10.1007%2FPL00005315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Glennon, R. A.; Dukat, M.</span><span> </span><span class="NLM_article-title">Serotonin receptors and drugs affecting serotonergic neurotransmission</span>. In  <span class="citation_source-book">Foye’s Textbook of Medicinal Chemistry</span>; <span class="NLM_contrib-group">Lemke, T.; Williams, D. A.; Roche, V. F; Zito, S. W.</span>, Eds.; <span class="NLM_publisher-name">Wolters Kluwer/Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Baltimore, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=365-396&author=R.+A.+Glennon&author=M.+Dukatauthor=T.+Lemke&author=D.+A.+Williams&author=V.+F+Roche&author=S.+W.+Zito&title=Foye%E2%80%99s+Textbook+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DSerotonin%2520receptors%2520and%2520drugs%2520affecting%2520serotonergic%2520neurotransmission%26btitle%3DFoye%25E2%2580%2599s%2520Textbook%2520of%2520Medicinal%2520Chemistry%26aulast%3DLemke%26aufirst%3DT.%26pub%3DWolters%2520Kluwer%252FLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2013%26spage%3D365%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grella, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. V.</span><span> </span><span class="NLM_article-title">Binding of β-carbolines and related agents at serotonin (5-HT<sub>2</sub> and 5-HT<sub>1A</sub>), dopamine (D<sub>2</sub>) and benzodiazepine receptors</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1016/S0376-8716(99)00148-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0376-8716%2899%2900148-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10940539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFCis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=121-132&author=R.+A.+Glennonauthor=M.+Dukatauthor=B.+Grellaauthor=S.-S.+Hongauthor=L.+Costantinoauthor=M.+Teitlerauthor=C.+Smithauthor=C.+Eganauthor=K.+Davisauthor=M.+V.+Mattson&title=Binding+of+%CE%B2-carbolines+and+related+agents+at+serotonin+%285-HT2+and+5-HT1A%29%2C+dopamine+%28D2%29+and+benzodiazepine+receptors&doi=10.1016%2FS0376-8716%2899%2900148-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors</span></div><div class="casAuthors">Glennon, R. A.; Dukat, M.; Grella, B.; Hong, S.-S.; Costantino, L.; Teitler, M.; Smith, C.; Egan, C.; Davis, K.; Mattson, M. V.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-132</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A large series of β-carbolines was examd. for their ability to bind at [3H]agonist-labeled 5-HT2A serotonin receptors.  Selected β-carbolines were also examd. at 5-HT2C serotonin receptors, 5-HT1A serotonin receptors, dopamine D2 receptors, and benzodiazepine receptors.  Indolealkylamines and phenylisopropylamines were also evaluated in some of these binding assays.  The β-carbolines were found to bind with modest affinity at 5-HT2A receptors, and affinity was highly dependent upon the presence of ring substituents and ring satn.  The β-carbolines displayed little to no affinity for 5-HT1A serotonin receptors, dopamine D2 receptors and, with the exception of β-CCM, for benzodiazepine receptors.  Examples of β-carbolines, indolealkylamines (i.e. N,N-dimethyltryptamine analogs), and phenylisopropylamines have been previously shown to produce common stimulus effects in animals trained to discriminate the phenyliisopropylamine hallucinogen DOM 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane from vehicle.  Although the only common receptor population that might account for this action is 5-HT2A, on the basis of a lack of enhanced affinity for agonist-labeled 5-HT2A receptors, as well as on their lack of agonist action in the PI hydrolysis assay, it is difficult to conclude that the β-carbolines behave in a manner consistent with that of other classical hallucinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaypy9C8pdJrVg90H21EOLACvtfcHk0ljPnXkDu5w6Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFCis70%253D&md5=81e7b5842567ef2a43229f158112cec6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2899%2900148-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252899%252900148-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DGrella%26aufirst%3DB.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DEgan%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DK.%26aulast%3DMattson%26aufirst%3DM.%2BV.%26atitle%3DBinding%2520of%2520%25CE%25B2-carbolines%2520and%2520related%2520agents%2520at%2520serotonin%2520%25285-HT2%2520and%25205-HT1A%2529%252C%2520dopamine%2520%2528D2%2529%2520and%2520benzodiazepine%2520receptors%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2000%26volume%3D60%26spage%3D121%26epage%3D132%26doi%3D10.1016%2FS0376-8716%2899%2900148-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Classical Hallucinogens</span>. In  <span class="citation_source-book">Handbook of Experimental Pharmacology: Pharmacological Aspects of Drug Dependence</span>; <span class="NLM_contrib-group">Schuster, C. R.; Kuhar, M. J.</span>, Eds.; <span class="NLM_publisher-name">Springer Verlag</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2F978-3-642-60963-3_10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=343-371&author=R.+A.+Glennonauthor=C.+R.+Schuster&author=M.+J.+Kuhar&title=Handbook+of+Experimental+Pharmacology%3A+Pharmacological+Aspects+of+Drug+Dependence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-60963-3_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-60963-3_10%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DClassical%2520Hallucinogens%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%253A%2520Pharmacological%2520Aspects%2520of%2520Drug%2520Dependence%26aulast%3DSchuster%26aufirst%3DC.%2BR.%26pub%3DSpringer%2520Verlag%26date%3D1996%26spage%3D343%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Leysen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awouters, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laduron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A.</span><span> </span><span class="NLM_article-title">Receptor binding profile of R 41 468, a novel antagonist at 5-HT<sub>2</sub> receptors</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span><span class="refDoi"> DOI: 10.1016/0024-3205(81)90747-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0024-3205%2881%2990747-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1981&pages=1015-1022&author=J.+E.+Leysenauthor=F.+Awoutersauthor=L.+Kennisauthor=P.+M.+Laduronauthor=J.+Vandenberkauthor=P.+A.+Janssen&title=Receptor+binding+profile+of+R+41+468%2C+a+novel+antagonist+at+5-HT2+receptors&doi=10.1016%2F0024-3205%2881%2990747-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2881%2990747-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252881%252990747-5%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26aulast%3DAwouters%26aufirst%3DF.%26aulast%3DKennis%26aufirst%3DL.%26aulast%3DLaduron%26aufirst%3DP.%2BM.%26aulast%3DVandenberk%26aufirst%3DJ.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%26atitle%3DReceptor%2520binding%2520profile%2520of%2520R%252041%2520468%252C%2520a%2520novel%2520antagonist%2520at%25205-HT2%2520receptors%26jtitle%3DLife%2520Sci.%26date%3D1981%26volume%3D28%26spage%3D1015%26epage%3D1022%26doi%3D10.1016%2F0024-3205%2881%2990747-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Colpaert, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemegeers, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A.</span><span> </span><span class="NLM_article-title">A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=7062283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL38XitFSnt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1982&pages=206-214&author=F.+C.+Colpaertauthor=C.+J.+Niemegeersauthor=P.+A.+Janssen&title=A+drug+discrimination+analysis+of+lysergic+acid+diethylamide+%28LSD%29%3A+in+vivo+agonist+and+antagonist+effects+of+purported+5-hydroxytryptamine+antagonists+and+of+pirenperone%2C+a+LSD-antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A drug discrimination analysis of lysergic acid diethylamide (LSD):  in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist</span></div><div class="casAuthors">Colpaert, Francis C.; Niemegeers, Carlos J. E.; Janssen, Paul A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">206-14</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">An in vivo anal. was conducted of the pharmacol. interactions of the putative 5-HT receptor blocking agents metergoline  [17692-51-2], methysergide maleate  [129-49-7], 2-bromo-LSD  [478-84-2], mianserin  [24219-97-4], pizotifen maleate  [24359-22-6], cyproheptadine  [129-03-3], metitepine maleate  [19728-88-2], and cinanserine  [1166-34-3], with LSD (I)  [50-37-3].  Rats were trained to discriminate i.p. injections of 0.16 mg/kg of LSD from saline injections in a 2-lever procedure in which food served as the reinforcer.  Potential antagonists were given as a s.c. pretreatment before the injection of either LSD or saline to test for antagonist and LSD-like agonist activity, resp.  The 5-HT antagonists produced only a partial antagonism of LSD; their dose-response curve in antagonizing LSD was invariably curvilinear, reached a ceiling level at 29% (methysergide and metitepine) to 71% (pizotifen) of effect, and assumed a biphasic shape with methysergide, mianserin and cyproheptadine.  In addn., the 5-HT antagonists mimicked LSD; the max. LSD-like agonist effect ranged from 14 (cianserin) to 86% (methysergide and mianserin).  A dose of 40 mg/kg of methysergide or mianserin produced effects which were similar to those of 40 mg/kg of mescaline  [54-04-6] and the peak agonist activity of methysergide, mianserin, and cyproheptadine exceeded their peak antagonist effects.  Stimulus generalization of these agents with 0.16 mg/kg of LSD typically was a linear function of dose.  LSD-like agonist and antagonist effects of moderate intensity coexisted at the same dose of the same agent, but strong agonist activity was clearly incompatible with strong antagonist activity and vice versa.  Only pirenperone  [75444-65-4], a newly synthesized compd., effectively antagonized LSD.  This antagonism of LSD was unique in that it occurred at low (0.01-0.16 mg/kg) s.c. and oral doses, proceeded along a linear and steep gradient, reached the 100% level of effect and was not assocd. with any agonist activity.  Apparently, LSDs discriminative stimulus properties in the rat are contingent upon agonist effects at 5-HT receptor sites in the brain, the putative 5-HT antagonists mentioned above act complexly as partial and mixed agonists/antagonists at these sites and pirenperone is a pure antagonist of LSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromBL5XMo0ALVg90H21EOLACvtfcHk0ljHqdmeC_QUFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XitFSnt7o%253D&md5=439337a172560c4f2c5830909a5008e2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26aulast%3DNiemegeers%26aufirst%3DC.%2BJ.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%26atitle%3DA%2520drug%2520discrimination%2520analysis%2520of%2520lysergic%2520acid%2520diethylamide%2520%2528LSD%2529%253A%2520in%2520vivo%2520agonist%2520and%2520antagonist%2520effects%2520of%2520purported%25205-hydroxytryptamine%2520antagonists%2520and%2520of%2520pirenperone%252C%2520a%2520LSD-antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1982%26volume%3D221%26spage%3D206%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosecrans, J. A.</span><span> </span><span class="NLM_article-title">Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT<sub>2</sub> antagonists</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1016/0014-2999(83)90464-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0014-2999%2883%2990464-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=6617740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL3sXltlemt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1983&pages=189-196&author=R.+A.+Glennonauthor=R.+Youngauthor=J.+A.+Rosecrans&title=Antagonism+of+the+effects+of+the+hallucinogen+DOM+and+the+purported+5-HT+agonist+quipazine+by+5-HT2+antagonists&doi=10.1016%2F0014-2999%2883%2990464-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists</span></div><div class="casAuthors">Glennon, Richard A.; Young, Richard; Rosecrans, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">189-96</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats trained to discriminate 1.0 mg DOM  [15588-95-1]/kg from saline in a 2-lever operant choice task were administered doses of mescaline  [54-04-6], LSD  [50-37-3], 5-methoxy-N,N-dimethyltryptamine (5-OMe DMT)  [1019-45-0], quipazine  [4774-24-7], TFMPP, and RU-24969.  The DOM stimulus generalized to the 3 hallucinogenic agents and to quipazine, but not to the purported 5-HT (I)  [50-67-9] agonists TFMPP or RU-24969.  Pretreatment of the animals with the 5-HT2 antagonists ketanserin and pirenperone antagonized the effect produced by DOM.  Pirenperone also blocked DOM stimulus generalization to mescaline, LSD, 5-OMe DMT, and quipazine.  Thus, the discriminative stimulus effects of DOM, the 3 hallucinogenic agents to which DOM stimulus generalization occurred, and quipazine may involve those subpopulations of 5-HT receptors that are labeled by tritiated ketanserin (i.e., 5-HT2 sites).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-OJiL1dxlrVg90H21EOLACvtfcHk0ljHqdmeC_QUFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXltlemt7s%253D&md5=fc8829be27299647d45a81ecfd0c01a2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2883%2990464-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252883%252990464-8%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DRosecrans%26aufirst%3DJ.%2BA.%26atitle%3DAntagonism%2520of%2520the%2520effects%2520of%2520the%2520hallucinogen%2520DOM%2520and%2520the%2520purported%25205-HT%2520agonist%2520quipazine%2520by%25205-HT2%2520antagonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1983%26volume%3D91%26spage%3D189%26epage%3D196%26doi%3D10.1016%2F0014-2999%2883%2990464-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Vollenweider, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollenweider-Scherpenhuyzen, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bäbler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hell, D.</span><span> </span><span class="NLM_article-title">Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3897</span><span class="NLM_x">–</span> <span class="NLM_lpage">3902</span><span class="refDoi"> DOI: 10.1097/00001756-199812010-00024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1097%2F00001756-199812010-00024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=9875725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVCitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=3897-3902&author=F.+X.+Vollenweiderauthor=M.+F.+Vollenweider-Scherpenhuyzenauthor=A.+B%C3%A4blerauthor=H.+Vogelauthor=D.+Hell&title=Psilocybin+induces+schizophrenia-like+psychosis+in+humans+via+a+serotonin-2+agonist+action&doi=10.1097%2F00001756-199812010-00024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2A agonist action</span></div><div class="casAuthors">Vollenweider, Franz X.; Vollenweider-Scherpenhuyzen, Margreet F. I.; Babler, Andreas; Vogel, Helen; Hell, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3897-3902</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Psilocybin, an indoleamine hallucinogen, produces a psychosis-like syndrome in humans that resembles first episodes of schizophrenia.  In healthy human volunteers, the psychotomimetic effects of psilocybin were blocked dose-dependently by the serotonin-2A antagonist ketanserin or the atypical antipsychotic risperidone but were increased by the dopamine antagonist and typical antipsychotic haloperidol.  These data are consistent with animal studies and provide the first evidence in humans that psilocybin-induced psychosis is due to serotonin-2A receptor activation, independently of dopamine stimulation.  Thus, serotonin-2A overactivity may be involved in the pathophysiol. of schizophrenia and serotonin-2A antagonism may contribute to therapeutic effects of antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXARR5hR4eVrVg90H21EOLACvtfcHk0ljHqdmeC_QUFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVCitQ%253D%253D&md5=64c2f7fc49061f0df9fa0079d74e83b9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1097%2F00001756-199812010-00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199812010-00024%26sid%3Dliteratum%253Aachs%26aulast%3DVollenweider%26aufirst%3DF.%2BX.%26aulast%3DVollenweider-Scherpenhuyzen%26aufirst%3DM.%2BF.%26aulast%3DB%25C3%25A4bler%26aufirst%3DA.%26aulast%3DVogel%26aufirst%3DH.%26aulast%3DHell%26aufirst%3DD.%26atitle%3DPsilocybin%2520induces%2520schizophrenia-like%2520psychosis%2520in%2520humans%2520via%2520a%2520serotonin-2%2520agonist%2520action%26jtitle%3DNeuroReport%26date%3D1998%26volume%3D9%26spage%3D3897%26epage%3D3902%26doi%3D10.1097%2F00001756-199812010-00024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Quednow, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollenweider, F. X.</span><span> </span><span class="NLM_article-title">Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1038/npp.2011.228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1038%2Fnpp.2011.228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=21956447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=630-640&author=B.+B.+Quednowauthor=M.+Kometerauthor=M.+Geyerauthor=F.+X.+Vollenweider&title=Psilocybin-induced+deficits+in+automatic+and+controlled+inhibition+are+attenuated+by+ketanserin+in+healthy+human+volunteers&doi=10.1038%2Fnpp.2011.228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers</span></div><div class="casAuthors">Quednow, Boris B.; Kometer, Michael; Geyer, Mark A.; Vollenweider, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">630-640</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The serotonin-2A receptor (5-HT2AR) has been implicated in the pathogenesis of schizophrenia and related inhibitory gating and behavioral inhibition deficits of schizophrenia patients.  The hallucinogen psilocybin disrupts automatic forms of sensorimotor gating and response inhibition in humans, but it is unclear so far whether the 5-HT2AR or 5-HT1AR agonist properties of its bioactive metabolite psilocin account for these effects.  Thus, we investigated whether psilocybin-induced deficits in automatic and controlled inhibition in healthy humans could be attenuated by the 5-HT2A/2CR antagonist ketanserin.  A total of 16 healthy participants received placebo, ketanserin (40 mg p.o.), psilocybin (260 μg/kg p.o.), or psilocybin plus ketanserin in a double-blind, randomized, and counterbalanced order.  Sensorimotor gating was measured by prepulse inhibition (PPI) of the acoustic startle response.  The effects on psychopathol. core dimensions and behavioral inhibition were assessed by the altered states of consciousness questionnaire (5D-ASC), and the Color-Word Stroop Test.  Psilocybin decreased PPI at short lead intervals (30 ms), increased all 5D-ASC scores, and selectively increased errors in the interference condition of the Stroop Test.  Stroop interference and Stroop effect of the response latencies were increased under psilocybin as well.  Psilocybin-induced alterations were attenuated by ketanserin pretreatment, whereas ketanserin alone had no significant effects.  These findings suggest that the disrupting effects of psilocybin on automatic and controlled inhibition processes are attributable to 5-HT2AR stimulation.  Sensorimotor gating and attentional control deficits of schizophrenia patients might be due to changes within the 5-HT2AR system.  Neuropsychopharmacol. (2012) 37, 630-640; doi:10.1038/npp.2011.228; published online 28 Sept. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqef1LpbaT02bVg90H21EOLACvtfcHk0lhejKIWWCSCsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslOrsQ%253D%253D&md5=7325b4d05a587429c8c435edf645400d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.228%26sid%3Dliteratum%253Aachs%26aulast%3DQuednow%26aufirst%3DB.%2BB.%26aulast%3DKometer%26aufirst%3DM.%26aulast%3DGeyer%26aufirst%3DM.%26aulast%3DVollenweider%26aufirst%3DF.%2BX.%26atitle%3DPsilocybin-induced%2520deficits%2520in%2520automatic%2520and%2520controlled%2520inhibition%2520are%2520attenuated%2520by%2520ketanserin%2520in%2520healthy%2520human%2520volunteers%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D630%26epage%3D640%26doi%3D10.1038%2Fnpp.2011.228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kometer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jäncke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollenweider, F. X.</span><span> </span><span class="NLM_article-title">Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">10544</span><span class="NLM_x">–</span> <span class="NLM_lpage">10551</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3007-12.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1523%2FJNEUROSCI.3007-12.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=23785166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWmtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=10544-10551&author=M.+Kometerauthor=A.+Schmidtauthor=L.+J%C3%A4nckeauthor=F.+X.+Vollenweider&title=Activation+of+serotonin+2A+receptors+underlies+the+psilocybin-induced+effects+on+%CE%B1+oscillations%2C+N170+visual-evoked+potentials%2C+and+visual+hallucinations&doi=10.1523%2FJNEUROSCI.3007-12.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations</span></div><div class="casAuthors">Kometer, Michael; Schmidt, Andre; Jancke, Lutz; Vollenweider, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10544-10551</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Visual illusions and hallucinations are hallmarks of serotonergic hallucinogen-induced altered states of consciousness.  Although the serotonergic hallucinogen psilocybin activates multiple serotonin (5-HT) receptors, recent evidence suggests that activation of 5-HT2A receptors may lead to the formation of visual hallucinations by increasing cortical excitability and altering visual-evoked cortical responses.  To address this hypothesis, we assessed the effects of psilocybin (215 μg/kg vs. placebo) on both α oscillations that regulate cortical excitability and early visual-evoked P1 and N170 potentials in healthy human subjects.  To further disentangle the specific contributions of 5-HT2A receptors, subjects were addnl. pretreated with the preferential 5-HT2A receptor antagonist ketanserin (50 mg vs. placebo).  We found that psilocybin strongly decreased prestimulus parieto-occipital α power values, thus precluding a subsequent stimulus-induced α power decrease.  Furthermore, psilocybin strongly decreased N170 potentials assocd. with the appearance of visual perceptual alterations, including visual hallucinations.  All of these effects were blocked by pretreatment with the 5-HT2A antagonist ketanserin, indicating that activation of 5-HT2A receptors by psilocybin profoundly modulates the neurophysiol. and phenomenol. indexes of visual processing.  Specifically, activation of 5-HT2A receptors may induce a processing mode in which stimulus-driven cortical excitation is overwhelmed by spontaneous neuronal excitation through the modulation of α oscillations.  Furthermore, the obsd. redn. of N170 visual-evoked potentials may be a key mechanism underlying 5-HT2A receptor-mediated visual hallucinations.  This change in N170 potentials may be important not only for psilocybin-induced states but also for understanding acute hallucinatory states seen in psychiatric disorders, such as schizophrenia and Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnHwbbVhcjcLVg90H21EOLACvtfcHk0lhejKIWWCSCsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWmtr%252FJ&md5=d8e3b3b88bd19f1f7635d93719fd96a3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3007-12.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3007-12.2013%26sid%3Dliteratum%253Aachs%26aulast%3DKometer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DJ%25C3%25A4ncke%26aufirst%3DL.%26aulast%3DVollenweider%26aufirst%3DF.%2BX.%26atitle%3DActivation%2520of%2520serotonin%25202A%2520receptors%2520underlies%2520the%2520psilocybin-induced%2520effects%2520on%2520%25CE%25B1%2520oscillations%252C%2520N170%2520visual-evoked%2520potentials%252C%2520and%2520visual%2520hallucinations%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D10544%26epage%3D10551%26doi%3D10.1523%2FJNEUROSCI.3007-12.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Seggel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousif, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suba, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT<sub>2</sub> serotonin receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span><span class="refDoi"> DOI: 10.1021/jm00165a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00165a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1032-1036&author=M.+R.+Seggelauthor=M.+Y.+Yousifauthor=R.+A.+Lyonauthor=M.+Titelerauthor=B.+L.+Rothauthor=E.+A.+Subaauthor=R.+A.+Glennon&title=A+structure-affinity+study+of+the+binding+of+4-substituted+analogues+of+1-%282%2C5-dimethoxyphenyl%29-2-aminopropane+at+5-HT2+serotonin+receptors&doi=10.1021%2Fjm00165a023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00165a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00165a023%26sid%3Dliteratum%253Aachs%26aulast%3DSeggel%26aufirst%3DM.%2BR.%26aulast%3DYousif%26aufirst%3DM.%2BY.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSuba%26aufirst%3DE.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DA%2520structure-affinity%2520study%2520of%2520the%2520binding%2520of%25204-substituted%2520analogues%2520of%25201-%25282%252C5-dimethoxyphenyl%2529-2-aminopropane%2520at%25205-HT2%2520serotonin%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1032%26epage%3D1036%26doi%3D10.1021%2Fjm00165a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Radioligand binding evidence implicates the brain 5-HT<sub>2</sub> receptor as a site of action for LSD and phenylisopropylamine hallucinogens</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1007/BF00176847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FBF00176847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3127847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL1cXhs1Whtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1988&pages=213-216&author=M.+Titelerauthor=R.+A.+Lyonauthor=R.+A.+Glennon&title=Radioligand+binding+evidence+implicates+the+brain+5-HT2+receptor+as+a+site+of+action+for+LSD+and+phenylisopropylamine+hallucinogens&doi=10.1007%2FBF00176847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens</span></div><div class="casAuthors">Titeler, M.; Lyon, R. A.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-16</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The mechanism of action of LSD, mescaline, and other similarly acting hallucinogenic drugs of abuse such as DOM was studied.  To test the hypothesis that the mechanism of action of LSD and phenylisopropylamine hallucinogens is through stimulation of a specific brain serotonin receptor subtype, the affinities of these compds. for radiolabeled 5-HT2, 5-HT1A, 5-HT1B, and 5-HT1C receptors were detd. using a recently developed in vitro radioligand binding method.  The 5-HT2 receptor was labeled with the agonist/hallucinogen radioligand [3H]DOB.  The 5-HT1A, 5-HT1B, and 5-HT1C receptors were labeled with [3H]OH-DPAT, [3H]5-HT, and [3H]mesulergine, resp.  In general, the phenylisopropylamines displayed 10-100-fold higher affinities for the 5-HT2 receptor than for the 5-HT1C receptor and 100-1000-fold higher affinities for the 5-HT2 receptor than for the 5-HT1A or 5-HT1B receptor.  There was a strong correlation between hallucinogenic potencies and 5-HT2 receptor affinities of the phenylisopropylamines (r = 0.90); the correlation coeffs. for the 5-HT1A, 5-HT1B, and 5-HT1C were 0.73, 0.85, and 0.78, resp.  Because there is no evidence that 5-HT1A-selective or 5-HT1B-selective agonists are hallucinogenic and because the phenylisopropylamines are potent hallucinogens, a 5-HT2 receptor interaction is implicated and supports previous suggestions to this effect.  A secondary role for 5-HT1C receptors cannot be discounted at this time.  Thus, an important component of the mechanism of action of LSD and the phenylisopropylamine hallucinogens is through stimulation of brain 5-HT2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYMK5sDlN217Vg90H21EOLACvtfcHk0lhejKIWWCSCsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhs1Whtbs%253D&md5=8eaca0cc14d55dd8309911efa62497d6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF00176847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00176847%26sid%3Dliteratum%253Aachs%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DRadioligand%2520binding%2520evidence%2520implicates%2520the%2520brain%25205-HT2%2520receptor%2520as%2520a%2520site%2520of%2520action%2520for%2520LSD%2520and%2520phenylisopropylamine%2520hallucinogens%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1988%26volume%3D94%26spage%3D213%26epage%3D216%26doi%3D10.1007%2FBF00176847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seggel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soine, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span> </span><span class="NLM_article-title">[<sup>125</sup>I]-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane: An iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT<sub>2</sub> serotonin receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1021/jm00396a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00396a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=5-7&author=R.+A.+Glennonauthor=M.+R.+Seggelauthor=W.+H.+Soineauthor=K.+Herrick-Davisauthor=R.+A.+Lyonauthor=M.+Titeler&title=%5B125I%5D-1-%282%2C5-Dimethoxy-4-iodophenyl%29-2-aminopropane%3A+An+iodinated+radioligand+that+specifically+labels+the+agonist+high-affinity+state+of+5-HT2+serotonin+receptors&doi=10.1021%2Fjm00396a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm00396a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00396a003%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DSeggel%26aufirst%3DM.%2BR.%26aulast%3DSoine%26aufirst%3DW.%2BH.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26atitle%3D%255B125I%255D-1-%25282%252C5-Dimethoxy-4-iodophenyl%2529-2-aminopropane%253A%2520An%2520iodinated%2520radioligand%2520that%2520specifically%2520labels%2520the%2520agonist%2520high-affinity%2520state%2520of%25205-HT2%2520serotonin%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D5%26epage%3D7%26doi%3D10.1021%2Fjm00396a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Rangisetty, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowd, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuPre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharif, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">1-[2-Methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT<sub>2A</sub> serotonin receptor affinity and antagonist character</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3283</span><span class="NLM_x">–</span> <span class="NLM_lpage">3291</span><span class="refDoi"> DOI: 10.1021/jm0100739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3283-3291&author=J.+B.+Rangisettyauthor=M.+Dukatauthor=C.+S.+Dowdauthor=K.+Herrick-Davisauthor=A.+DuPreauthor=S.+Gadepalliauthor=M.+Teitlerauthor=C.+R.+Kelleyauthor=N.+A.+Sharifauthor=R.+A.+Glennon&title=1-%5B2-Methoxy-5-%283-phenylpropyl%29%5D-2-aminopropane+unexpectedly+shows+5-HT2A+serotonin+receptor+affinity+and+antagonist+character&doi=10.1021%2Fjm0100739"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0100739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100739%26sid%3Dliteratum%253Aachs%26aulast%3DRangisetty%26aufirst%3DJ.%2BB.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DDowd%26aufirst%3DC.%2BS.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DDuPre%26aufirst%3DA.%26aulast%3DGadepalli%26aufirst%3DS.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DKelley%26aufirst%3DC.%2BR.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D1-%255B2-Methoxy-5-%25283-phenylpropyl%2529%255D-2-aminopropane%2520unexpectedly%2520shows%25205-HT2A%2520serotonin%2520receptor%2520affinity%2520and%2520antagonist%2520character%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3283%26epage%3D3291%26doi%3D10.1021%2Fjm0100739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dowd, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuPre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT<sub>2A</sub> partial agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3074</span><span class="NLM_x">–</span> <span class="NLM_lpage">3084</span><span class="refDoi"> DOI: 10.1021/jm9906062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9906062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3074-3084&author=C.+S.+Dowdauthor=K.+Herrick-Davisauthor=C.+Eganauthor=A.+DuPreauthor=C.+Smithauthor=M.+Teitlerauthor=R.+A.+Glennon&title=1-%5B4-%283-Phenylalkyl%29phenyl%5D-2-aminopropanes+as+5-HT2A+partial+agonists&doi=10.1021%2Fjm9906062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm9906062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9906062%26sid%3Dliteratum%253Aachs%26aulast%3DDowd%26aufirst%3DC.%2BS.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DEgan%26aufirst%3DC.%26aulast%3DDuPre%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D1-%255B4-%25283-Phenylalkyl%2529phenyl%255D-2-aminopropanes%2520as%25205-HT2A%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3074%26epage%3D3084%26doi%3D10.1021%2Fjm9906062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seggel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span> </span><span class="NLM_article-title">N-Methyl derivatives of the 5-HT<sub>2</sub> agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1021/jm00388a032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00388a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2sXhsFGqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=930-932&author=R.+A.+Glennonauthor=M.+Titelerauthor=M.+R.+Seggelauthor=R.+A.+Lyon&title=N-Methyl+derivatives+of+the+5-HT2+agonist+1-%284-bromo-2%2C5-dimethoxyphenyl%29-2-aminopropane&doi=10.1021%2Fjm00388a032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane</span></div><div class="casAuthors">Glennon, Richard A.; Titeler, Milt; Seggel, Mark; Lyon, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">930-2</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">An enantiomeric potency comparison was made for the optical isomers of title compd. I (R = NH2), and the activities of I (R = NHMe, NMe2, N+Me3I-) were examd.  (R)-(-)-I (R = NH2) (Ki = 0.39 nM) had 6 times greater affinity than (S)-(+)-I (R = NH2) at tritiated I (R = NH2)-labeled (rat cortical homogenates) 5-HT2 sites; N-methylation of racemic I (R = NH2) decreased the affinity by at least 1 order of magnitude per Me group.  Similar results were obtained in an in vivo drug discrimination paradigm with rats as subjects and (R)-(-)-I (R = NH2) (0.2 mg/kg) as the training drug.  Thus, (R)-(-)-I (R = NH2) is more active than (S)-(+)-I (R = NH2) or any of the possible N-Me derivs. of I (R = NH2), both with respect to affinity at central 5-HT2 binding sites and with respect to potency in the behavioral (i.e., stimulus generalization) studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqno3zVIo2JSLVg90H21EOLACvtfcHk0lj0WxzspKUw5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsFGqtL8%253D&md5=1356b891209f5b155505ac8021157033</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00388a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00388a032%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DSeggel%26aufirst%3DM.%2BR.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26atitle%3DN-Methyl%2520derivatives%2520of%2520the%25205-HT2%2520agonist%25201-%25284-bromo-2%252C5-dimethoxyphenyl%2529-2-aminopropane%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D930%26epage%3D932%26doi%3D10.1021%2Fjm00388a032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Eckler, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang-Fong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J. C.</span><span> </span><span class="NLM_article-title">Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span><span class="refDoi"> DOI: 10.1016/S0091-3057(03)00159-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2803%2900159-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2003&pages=845-852&author=J.+R.+Ecklerauthor=J.+Chang-Fongauthor=R.+A.+Rabinauthor=C.+Smithauthor=M.+Teitlerauthor=R.+A.+Glennonauthor=J.+C.+Winter&title=Behavioral+characterization+of+2-O-desmethyl+and+5-O-desmethyl+metabolites+of+the+phenylethylamine+hallucinogen+DOM&doi=10.1016%2FS0091-3057%2803%2900159-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2803%2900159-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252803%252900159-X%26sid%3Dliteratum%253Aachs%26aulast%3DEckler%26aufirst%3DJ.%2BR.%26aulast%3DChang-Fong%26aufirst%3DJ.%26aulast%3DRabin%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DWinter%26aufirst%3DJ.%2BC.%26atitle%3DBehavioral%2520characterization%2520of%25202-O-desmethyl%2520and%25205-O-desmethyl%2520metabolites%2520of%2520the%2520phenylethylamine%2520hallucinogen%2520DOM%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2003%26volume%3D75%26spage%3D845%26epage%3D852%26doi%3D10.1016%2FS0091-3057%2803%2900159-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Jacob, P.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span> </span><span class="NLM_article-title">Chemical and biological studies of 1-(2,5-dihydroxy-4-methylphenyl)-2-aminopropane, an analogue of 6-hydroxydopamine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1021/jm00192a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00192a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=662-671&author=P.+Jacobauthor=T.+Klineauthor=N.+Castagnoli&title=Chemical+and+biological+studies+of+1-%282%2C5-dihydroxy-4-methylphenyl%29-2-aminopropane%2C+an+analogue+of+6-hydroxydopamine&doi=10.1021%2Fjm00192a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00192a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00192a011%26sid%3Dliteratum%253Aachs%26aulast%3DJacob%26aufirst%3DP.%26aulast%3DKline%26aufirst%3DT.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DChemical%2520and%2520biological%2520studies%2520of%25201-%25282%252C5-dihydroxy-4-methylphenyl%2529-2-aminopropane%252C%2520an%2520analogue%2520of%25206-hydroxydopamine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26spage%3D662%26epage%3D671%26doi%3D10.1021%2Fjm00192a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khorana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharif, N. A.</span><span> </span><span class="NLM_article-title">β-Oxygenated analogues of the 5-HT<sub>2A</sub> serotonin agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6034</span><span class="NLM_x">–</span> <span class="NLM_lpage">6041</span><span class="refDoi"> DOI: 10.1021/jm040082s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040082s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6034-6041&author=R.+A.+Glennonauthor=M.+L.+Bondarevauthor=N.+Khoranaauthor=R.+Youngauthor=J.+A.+Mayauthor=M.+R.+Hellbergauthor=M.+A.+McLaughlinauthor=N.+A.+Sharif&title=%CE%B2-Oxygenated+analogues+of+the+5-HT2A+serotonin+agonist+1-%284-bromo-2%2C5-dimethoxyphenyl%29-2-aminopropane&doi=10.1021%2Fjm040082s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm040082s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040082s%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DKhorana%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DMay%26aufirst%3DJ.%2BA.%26aulast%3DHellberg%26aufirst%3DM.%2BR.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BA.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26atitle%3D%25CE%25B2-Oxygenated%2520analogues%2520of%2520the%25205-HT2A%2520serotonin%2520agonist%25201-%25284-bromo-2%252C5-dimethoxyphenyl%2529-2-aminopropane%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6034%26epage%3D6041%26doi%3D10.1021%2Fjm040082s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">May, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharif, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, C. P.</span><span> </span><span class="NLM_article-title">Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT<sub>2</sub> receptor agonist AL-38022A [(<i>S</i>)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine]</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1016/j.pbb.2008.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2008.07.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2009&pages=307-314&author=J.+A.+Mayauthor=N.+A.+Sharifauthor=H.-H.+Chenauthor=J.+C.+Liaoauthor=C.+R.+Kellyauthor=R.+A.+Glennonauthor=R.+Youngauthor=J.-X.+Liauthor=K.+C.+Riceauthor=C.+P.+France&title=Pharmacological+properties+and+discriminative+stimulus+effects+of+a+novel+and+selective+5-HT2+receptor+agonist+AL-38022A+%5B%28S%29-2-%288%2C9-dihydro-7H-pyrano%5B2%2C3-g%5Dindazol-1-yl%29-1-methylethylamine%5D&doi=10.1016%2Fj.pbb.2008.07.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DJ.%2BA.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26aulast%3DChen%26aufirst%3DH.-H.%26aulast%3DLiao%26aufirst%3DJ.%2BC.%26aulast%3DKelly%26aufirst%3DC.%2BR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DJ.-X.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DFrance%26aufirst%3DC.%2BP.%26atitle%3DPharmacological%2520properties%2520and%2520discriminative%2520stimulus%2520effects%2520of%2520a%2520novel%2520and%2520selective%25205-HT2%2520receptor%2520agonist%2520AL-38022A%2520%255B%2528S%2529-2-%25288%252C9-dihydro-7H-pyrano%255B2%252C3-g%255Dindazol-1-yl%2529-1-methylethylamine%255D%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2009%26volume%3D91%26spage%3D307%26epage%3D314%26doi%3D10.1016%2Fj.pbb.2008.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">May, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharif, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severns, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T. R.</span><span> </span><span class="NLM_article-title">Ocular hypotensive response in nonhuman primates of (8<i>R</i>)-1-[(2<i>S</i>)-2-aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol, a selective 5-HT<sub>2</sub> receptor agonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8818</span><span class="NLM_x">–</span> <span class="NLM_lpage">8833</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8818-8833&author=J.+A.+Mayauthor=N.+A.+Sharifauthor=M.+A.+McLaughlinauthor=H.+H.+Chenauthor=B.+S.+Severnsauthor=C.+R.+Kellyauthor=W.+F.+Holtauthor=R.+Youngauthor=R.+A.+Glennonauthor=M.+R.+Hellbergauthor=T.+R.+Dean&title=Ocular+hypotensive+response+in+nonhuman+primates+of+%288R%29-1-%5B%282S%29-2-aminopropyl%5D-8%2C9-dihydro-7H-pyrano%5B2%2C3-g%5Dindazol-8-ol%2C+a+selective+5-HT2+receptor+agonist&doi=10.1021%2Facs.jmedchem.5b00857"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00857%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DJ.%2BA.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DH.%2BH.%26aulast%3DSeverns%26aufirst%3DB.%2BS.%26aulast%3DKelly%26aufirst%3DC.%2BR.%26aulast%3DHolt%26aufirst%3DW.%2BF.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DHellberg%26aufirst%3DM.%2BR.%26aulast%3DDean%26aufirst%3DT.%2BR.%26atitle%3DOcular%2520hypotensive%2520response%2520in%2520nonhuman%2520primates%2520of%2520%25288R%2529-1-%255B%25282S%2529-2-aminopropyl%255D-8%252C9-dihydro-7H-pyrano%255B2%252C3-g%255Dindazol-8-ol%252C%2520a%2520selective%25205-HT2%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8818%26epage%3D8833%26doi%3D10.1021%2Facs.jmedchem.5b00857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">Further investigation of the discriminative stimulus properties of MDA</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span><span class="refDoi"> DOI: 10.1016/0091-3057(84)90295-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2884%2990295-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1984&pages=501-505&author=R.+A.+Glennonauthor=R.+Young&title=Further+investigation+of+the+discriminative+stimulus+properties+of+MDA&doi=10.1016%2F0091-3057%2884%2990295-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2884%2990295-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252884%252990295-8%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DFurther%2520investigation%2520of%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520MDA%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1984%26volume%3D20%26spage%3D501%26epage%3D505%26doi%3D10.1016%2F0091-3057%2884%2990295-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">MDA: An agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1016/0014-2999(84)90250-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0014-2999%2884%2990250-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=6145599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2cXitVent7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1984&pages=249-250&author=R.+A.+Glennonauthor=R.+Young&title=MDA%3A+An+agent+that+produces+stimulus+effects+similar+to+those+of+3%2C4-DMA%2C+LSD+and+cocaine&doi=10.1016%2F0014-2999%2884%2990250-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">MDA:  an agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine</span></div><div class="casAuthors">Glennon, Richard A.; Young, Richard</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">249-50</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">In rats trained to discriminate 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA)(I)  [4764-17-4] from saline, generalization to I stimulus occurred with 1-(3,4-dimethoxyphenyl)-2-aminopropane (3,4-DMA)  [120-26-3], (+)-LSD tartrate  [15232-63-0] and cocaine  [50-36-2].  All the drugs were administered i.p. at various doses; generalization to I stimulus occurred in all doses tested.  The similarity between the stimulus effects of I and those of central stimulants (amphetamine, cocaine) and hallucinogens (LSD, DOM) may account for its abuse potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhvWGzEWxwxLVg90H21EOLACvtfcHk0lhQxV2KjZuqUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXitVent7g%253D&md5=7e511faf0913bd42dbd051387d82a075</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2884%2990250-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252884%252990250-4%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DMDA%253A%2520An%2520agent%2520that%2520produces%2520stimulus%2520effects%2520similar%2520to%2520those%2520of%25203%252C4-DMA%252C%2520LSD%2520and%2520cocaine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1984%26volume%3D99%26spage%3D249%26epage%3D250%26doi%3D10.1016%2F0014-2999%2884%2990250-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">A three-lever operant procedure differentiates the stimulus effects of <i>R</i>(−)-MDA from <i>S</i>(+)-MDA</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">594</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=8632326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK28XhtFaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1996&pages=594-601&author=R.+Youngauthor=R.+A.+Glennon&title=A+three-lever+operant+procedure+differentiates+the+stimulus+effects+of+R%28%E2%88%92%29-MDA+from+S%28%2B%29-MDA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A three-level operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA</span></div><div class="casAuthors">Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">594-601</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">1-(3,4-Methylenedioxyphenyl)-2-aminopropane (MDA) produces an effect in humans that is somewhat similar to both a hallucinogen and a central stimulant.  We have previously shown that R(-)-MDA but not S(+)-MDA produces a stimulus effect in animals similar to that of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), whereas S(+)-MDA but not R(-)-MDA produces a stimulus effect similar to that of the stimulant amphetamine.  Others have suggested that the stimulus effects of the two MDA isomers may be much more similar than our results would indicate.  To help clarify this issue, we have shown that rats can be trained to discriminate 1.25 mg/kg of R(-)-MDA (ED50 = 0.99 mg/kg) from 1.25 mg/kg of S(+)-MDA (ED50 = 0.80 mg/kg) vs. 0.9% saline with use of a three-level operant procedure.  To accomplish this task it was necessary to institute a sepn. of 4 days between injections of the isomers.  In tests of stimulus substitution, the administration of various doses of DOM (ED50 = 0.47 mg/kg), S(+)-DOM (Ed50 = 2.23 mg/kg) and mescaline (ED50 = 16.04 mg/kg) produced dose-related responding on the R(-)-MDA-appropriate lever.  In contrast, the injection of various doses of S(+)-amphetamine (ED50 = 0.46 mg/kg) and cocaine (ED50 = 6.40 mg/kg) produced dose-related responding on the S(+)-MDA-appropriate level.  The administration of racemic MDA, at twice the isomer training dose, resulted in the animals dividing their responses closely between the R(-)-MDA- and S(+)-MDA-designated levels.  In antagonism tests, the serotonin-2 antagonist pirenperone blocked the stimulus effect of 1.25 mg/kg of R(-)-MDA but had no effect on the stimulus effect of 1.25 mg/kg of S(+)-MDA.  Taken together these data support the contention that each optical isomer of MDA can produce a markedly different stimulus effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBr6Jl-Kp7JbVg90H21EOLACvtfcHk0lhQxV2KjZuqUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFaktrg%253D&md5=1aa3eb39bb6f3371c1cf77aa491c6ca4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DA%2520three-lever%2520operant%2520procedure%2520differentiates%2520the%2520stimulus%2520effects%2520of%2520R%2528%25E2%2588%2592%2529-MDA%2520from%2520S%2528%252B%2529-MDA%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D276%26spage%3D594%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kamilar-Britt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, G.</span><span> </span><span class="NLM_article-title">The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2015.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.neubiorev.2015.08.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2015&pages=433-446&author=P.+Kamilar-Brittauthor=G.+Bedi&title=The+prosocial+effects+of+3%2C4-methylenedioxymethamphetamine+%28MDMA%29%3A+Controlled+studies+in+humans+and+laboratory+animals&doi=10.1016%2Fj.neubiorev.2015.08.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2015.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2015.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DKamilar-Britt%26aufirst%3DP.%26aulast%3DBedi%26aufirst%3DG.%26atitle%3DThe%2520prosocial%2520effects%2520of%25203%252C4-methylenedioxymethamphetamine%2520%2528MDMA%2529%253A%2520Controlled%2520studies%2520in%2520humans%2520and%2520laboratory%2520animals%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2015%26volume%3D57%26spage%3D433%26epage%3D446%26doi%3D10.1016%2Fj.neubiorev.2015.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span> </span><span class="NLM_article-title">3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at brain 5-HT<sub>1</sub> and 5-HT<sub>2</sub> receptors</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span><span class="refDoi"> DOI: 10.1007/BF00178519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FBF00178519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2871581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL28XltVygs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1986&pages=525-526&author=R.+A.+Lyonauthor=R.+A.+Glennonauthor=M.+Titeler&title=3%2C4-Methylenedioxymethamphetamine+%28MDMA%29%3A+Stereoselective+interactions+at+brain+5-HT1+and+5-HT2+receptors&doi=10.1007%2FBF00178519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Methylenedioxymethamphetamine (MDMA):  stereoselective interactions at brain 5-HT1 and 5-HT2 receptors</span></div><div class="casAuthors">Lyon, Robert A.; Glennon, Richard A.; Titeler, Milt</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">525-6</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">(±)-3,4-Methylenedioxymethamphetamine (MDMA)  [42542-10-9], (±)-3,4-methylenedioxyamphetamine (MDA)  [4764-17-4], and their optical isomers, were assayed for their affinities at radiolabeled brain serotonin (5-HT1, 5-HT2) and dopamine (D2) binding sites.  R(-)-MDA  [61614-60-6] and R(-)-MDMA  [81262-70-6] displayed moderate affinities for [3H]ketanserin-labeled 5-HT2 sites (Ki = 3425 and 3310 nm, resp.) whereas the affinities for S(+)-MDA  [65620-66-8] and S(+)-MDMA  [66142-89-0] were lower (Ki = 13,000 and 15,800 nM, resp.).  Similar abs. and relative affinities were obtained at [3H]serotinin-labeled 5-HT1 sites; binding at D2 sites was very low (Ki > 25,000 nM in each case).  The (-) > (+) order of potency at 5-HT2 sites is consistent with the observation that R(-)-MDA is a more potent psychoactive agent than its S(+)-enantiomer, but contrasts with the reported finding that S(+)-MDMA is more potent than R(-)-MDMA in humans.  These results suggest that MDMA, unlike MDA and other hallucinogenic phenylisopropylamines, does not work primarily through a direct interaction at 5-HT sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJEljWTnnov7Vg90H21EOLACvtfcHk0liMmJf3CZRl0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XltVygs70%253D&md5=923e15de8d7014b48e377ddcbdf629cd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2FBF00178519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00178519%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26atitle%3D3%252C4-Methylenedioxymethamphetamine%2520%2528MDMA%2529%253A%2520Stereoselective%2520interactions%2520at%2520brain%25205-HT1%2520and%25205-HT2%2520receptors%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1986%26volume%3D88%26spage%3D525%26epage%3D526%26doi%3D10.1007%2FBF00178519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberlender, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of MDMA-like substances</span> <span class="citation_source-journal">NIDA Res. Monogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2575223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK3cXktlCht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1989&pages=1-29&author=D.+E.+Nicholsauthor=R.+Oberlender&title=Structure-activity+relationships+of+MDMA-like+substances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of MDMA-like substances</span></div><div class="casAuthors">Nichols, David E.; Oberlender, Robert</div><div class="citationInfo"><span class="NLM_cas:title">NIDA Research Monograph</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">Pharmacol. Toxicol. Amphetamine Relat. Des. Drugs</span>),
    <span class="NLM_cas:pages">1-29</span>CODEN:
                <span class="NLM_cas:coden">MIDAD4</span>;
        ISSN:<span class="NLM_cas:issn">0361-8595</span>.
    </div><div class="casAbstract">A review with 50 refs. discussing hallucinogenic effects of 3,4-methylenedioxymethamphetamine (MDMA)-like compds. in relation to their structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRtEc67nuxmLVg90H21EOLACvtfcHk0liMmJf3CZRl0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlCht7g%253D&md5=c9006717377d70b4b7d6f3f0f5800f07</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DOberlender%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationships%2520of%2520MDMA-like%2520substances%26jtitle%3DNIDA%2520Res.%2520Monogr.%26date%3D1989%26volume%3D94%26spage%3D1%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Stimulus properties of hallucinogenic phenylalkylamines and related designer drugs: Formulation of structure-activity relationships</span> <span class="citation_source-journal">NIDA Res. Monogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2575229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK3cXktFOgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1989&pages=43-67&author=R.+A.+Glennon&title=Stimulus+properties+of+hallucinogenic+phenylalkylamines+and+related+designer+drugs%3A+Formulation+of+structure-activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulus properties of hallucinogenic phenalkylamines and related designer drugs:  formulation of structure-activity relationships</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">NIDA Research Monograph</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">Pharmacol. Toxicol. Amphetamine Relat. Des. Drugs</span>),
    <span class="NLM_cas:pages">43-67</span>CODEN:
                <span class="NLM_cas:coden">MIDAD4</span>;
        ISSN:<span class="NLM_cas:issn">0361-8595</span>.
    </div><div class="casAbstract">A review with 32 refs. discussing drug discrimination studies in respect to structure-activity relationships of the title compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuHy8_VtPO-rVg90H21EOLACvtfcHk0liMmJf3CZRl0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktFOgtr4%253D&md5=194799f99707fc04e4bf463624dae663</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DStimulus%2520properties%2520of%2520hallucinogenic%2520phenylalkylamines%2520and%2520related%2520designer%2520drugs%253A%2520Formulation%2520of%2520structure-activity%2520relationships%26jtitle%3DNIDA%2520Res.%2520Monogr.%26date%3D1989%26volume%3D94%26spage%3D43%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Bondareva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title"><i>S</i>(+)- and <i>R</i>(−)<i>N</i>-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: Effect of cocaine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span><span class="refDoi"> DOI: 10.1016/j.pbb.2005.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2005.10.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2005&pages=531-538&author=T.+Bondarevaauthor=A.+Weso%C5%82owskaauthor=M.+Dukatauthor=M.+Leeauthor=R.+Youngauthor=R.+A.+Glennon&title=S%28%2B%29-+and+R%28%E2%88%92%29N-Methyl-1-%283%2C4-methylenedioxyphenyl%29-2-aminopropane+%28MDMA%29+as+discriminative+stimuli%3A+Effect+of+cocaine&doi=10.1016%2Fj.pbb.2005.10.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2005.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2005.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DBondareva%26aufirst%3DT.%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DS%2528%252B%2529-%2520and%2520R%2528%25E2%2588%2592%2529N-Methyl-1-%25283%252C4-methylenedioxyphenyl%2529-2-aminopropane%2520%2528MDMA%2529%2520as%2520discriminative%2520stimuli%253A%2520Effect%2520of%2520cocaine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2005%26volume%3D82%26spage%3D531%26epage%3D538%26doi%3D10.1016%2Fj.pbb.2005.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Broadbent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, J. B.</span><span> </span><span class="NLM_article-title">Generalization of cocaine to the isomers of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine: Effects of training dose</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1002/ddr.430160238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1002%2Fddr.430160238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1989&pages=443-450&author=J.+Broadbentauthor=E.+K.+Michaelauthor=J.+B.+Appel&title=Generalization+of+cocaine+to+the+isomers+of+3%2C4-methylenedioxyamphetamine+and+3%2C4-methylenedioxymethamphetamine%3A+Effects+of+training+dose&doi=10.1002%2Fddr.430160238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fddr.430160238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.430160238%26sid%3Dliteratum%253Aachs%26aulast%3DBroadbent%26aufirst%3DJ.%26aulast%3DMichael%26aufirst%3DE.%2BK.%26aulast%3DAppel%26aufirst%3DJ.%2BB.%26atitle%3DGeneralization%2520of%2520cocaine%2520to%2520the%2520isomers%2520of%25203%252C4-methylenedioxyamphetamine%2520and%25203%252C4-methylenedioxymethamphetamine%253A%2520Effects%2520of%2520training%2520dose%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1989%26volume%3D16%26spage%3D443%26epage%3D450%26doi%3D10.1002%2Fddr.430160238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Baker, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadbent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metosh, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, J. B.</span><span> </span><span class="NLM_article-title">Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxy-methamphetamine; MDMA)</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1097/00008877-199504000-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1097%2F00008877-199504000-00007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=263-275&author=L.+E.+Bakerauthor=J.+Broadbentauthor=E.+K.+Michaelauthor=P.+K.+Matthewsauthor=C.+A.+Metoshauthor=R.+B.+Saundersauthor=W.+B.+Westauthor=J.+B.+Appel&title=Assessment+of+the+discriminative+stimulus+effects+of+the+optical+isomers+of+ecstasy+%283%2C4-methylenedioxy-methamphetamine%3B+MDMA%29&doi=10.1097%2F00008877-199504000-00007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1097%2F00008877-199504000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008877-199504000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DL.%2BE.%26aulast%3DBroadbent%26aufirst%3DJ.%26aulast%3DMichael%26aufirst%3DE.%2BK.%26aulast%3DMatthews%26aufirst%3DP.%2BK.%26aulast%3DMetosh%26aufirst%3DC.%2BA.%26aulast%3DSaunders%26aufirst%3DR.%2BB.%26aulast%3DWest%26aufirst%3DW.%2BB.%26aulast%3DAppel%26aufirst%3DJ.%2BB.%26atitle%3DAssessment%2520of%2520the%2520discriminative%2520stimulus%2520effects%2520of%2520the%2520optical%2520isomers%2520of%2520ecstasy%2520%25283%252C4-methylenedioxy-methamphetamine%253B%2520MDMA%2529%26jtitle%3DBehav.%2520Pharmacol.%26date%3D1995%26volume%3D6%26spage%3D263%26epage%3D275%26doi%3D10.1097%2F00008877-199504000-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">MDMA (N-methyl-3,4-methylenedioxyamphetamine) and Its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span><span class="refDoi"> DOI: 10.1016/j.pbb.2007.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2007.09.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2008&pages=318-331&author=R.+Youngauthor=R.+A.+Glennon&title=MDMA+%28N-methyl-3%2C4-methylenedioxyamphetamine%29+and+Its+stereoisomers%3A+Similarities+and+differences+in+behavioral+effects+in+an+automated+activity+apparatus+in+mice&doi=10.1016%2Fj.pbb.2007.09.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2007.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2007.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DMDMA%2520%2528N-methyl-3%252C4-methylenedioxyamphetamine%2529%2520and%2520Its%2520stereoisomers%253A%2520Similarities%2520and%2520differences%2520in%2520behavioral%2520effects%2520in%2520an%2520automated%2520activity%2520apparatus%2520in%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2008%26volume%3D88%26spage%3D318%26epage%3D331%26doi%3D10.1016%2Fj.pbb.2007.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande-Allen, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesely, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1223</span><span class="NLM_x">–</span> <span class="NLM_lpage">1229</span><span class="refDoi"> DOI: 10.1124/mol.63.6.1223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1124%2Fmol.63.6.1223" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1223-1229&author=V.+Setolaauthor=S.+J.+Hufeisenauthor=K.+J.+Grande-Allenauthor=I.+Veselyauthor=R.+A.+Glennonauthor=B.+Bloughauthor=R.+B.+Rothmanauthor=B.+L.+Roth&title=3%2C4-Methylenedioxymethamphetamine+%28MDMA%2C+%22Ecstasy%22%29+induces+fenfluramine-like+proliferative+actions+on+human+cardiac+valvular+interstitial+cells+in+vitro&doi=10.1124%2Fmol.63.6.1223"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1223%26sid%3Dliteratum%253Aachs%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DGrande-Allen%26aufirst%3DK.%2BJ.%26aulast%3DVesely%26aufirst%3DI.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DBlough%26aufirst%3DB.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3D3%252C4-Methylenedioxymethamphetamine%2520%2528MDMA%252C%2520%2522Ecstasy%2522%2529%2520induces%2520fenfluramine-like%2520proliferative%2520actions%2520on%2520human%2520cardiac%2520valvular%2520interstitial%2520cells%2520in%2520vitro%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26spage%3D1223%26epage%3D1229%26doi%3D10.1124%2Fmol.63.6.1223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span> </span><span class="NLM_article-title">Therapeutic potential of monoamine transporter substrates</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1845</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span><span class="refDoi"> DOI: 10.2174/156802606778249766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.2174%2F156802606778249766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=17017961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVClurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1845-1859&author=R.+B.+Rothmanauthor=M.+H.+Baumann&title=Therapeutic+potential+of+monoamine+transporter+substrates&doi=10.2174%2F156802606778249766"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of monoamine transporter substrates</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1845-1859</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Monoamine transporter proteins are targets for many psychoactive compds., including therapeutic and abused stimulant drugs.  This paper reviews recent work from our lab. investigating the interaction of stimulants with transporters in brain tissue.  We illustrate how detg. the precise mechanism of stimulant drug action (uptake inhibitor vs. substrate) can provide unique opportunities for medication discovery.  An important lesson learned from this work is that drugs which display equipotent substrate activity at dopamine (DA) and serotonin (5-HT) transporters have minimal abuse liability and few stimulant side-effects, yet are able to suppress ongoing drug-seeking behavior.  As a specific example, we describe the development of PAL-287 (α-methylnaphthylethylamine), a dual DA/5-HT releasing agent that suppresses cocaine self-administration in rhesus monkeys, without the adverse effects assocd. with older phenylethylamine 5-HT releasers (e.g., fenfluramine) and DA releasers (e.g., amphetamine).  Our findings demonstrate the feasibility of developing non-amphetamine releasing agents as potential treatments for substance abuse disorders and other psychiatric conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE0sdYUhKT37Vg90H21EOLACvtfcHk0liHgzUUvQxkoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVClurjF&md5=a3d7c68c250eb00ad13ed00993f1db80</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F156802606778249766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778249766%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3DTherapeutic%2520potential%2520of%2520monoamine%2520transporter%2520substrates%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1845%26epage%3D1859%26doi%3D10.2174%2F156802606778249766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span> </span><span class="NLM_article-title">Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1074</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1196/annals.1369.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1196%2Fannals.1369.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1074&publication_year=2006&pages=245-260&author=R.+B.+Rothmanauthor=M.+H.+Baumann&title=Balance+between+dopamine+and+serotonin+release+modulates+behavioral+effects+of+amphetamine-type+drugs&doi=10.1196%2Fannals.1369.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1196%2Fannals.1369.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1369.064%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3DBalance%2520between%2520dopamine%2520and%2520serotonin%2520release%2520modulates%2520behavioral%2520effects%2520of%2520amphetamine-type%2520drugs%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1074%26spage%3D245%26epage%3D260%26doi%3D10.1196%2Fannals.1369.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">An examination of isomeric phenylpropanolamines in (−)ephedrine-trained rats</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1016/S0376-8716(99)00052-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0376-8716%2899%2900052-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10617308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVWlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=1-6&author=R.+Youngauthor=M.+Bondarevauthor=R.+A.+Glennon&title=An+examination+of+isomeric+phenylpropanolamines+in+%28%E2%88%92%29ephedrine-trained+rats&doi=10.1016%2FS0376-8716%2899%2900052-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">An examination of isomeric phenylpropanolamines in (-)ephedrine-trained rats</span></div><div class="casAuthors">Young, R.; Bondarev, M.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A total of eight isomeric phenylpropanolamines are possible when the terminal amine is either an N-monomethylamine or a primary amine: (-)ephedrine, (+)ephedrine, (+)pseudoephedrine, (-)pseudoephedrine, (-)norephedrine, (+)norephedrine, (+)cathine, and (-)cathine.  Few previous studies have examd. the individual optical isomers of these phenylpropanolamines and, with the exception of one report on locomotor effects, no comparative behavioral data have been published on this series of agents.  Using rats trained to discriminate 4 mg/kg of (-)ephedrine (i.p.) from saline vehicle using std. operant conditioning with a VI 15-s schedule of reinforcement, all eight agents were examd. in tests of stimulus generalization.  The (-)ephedrine stimulus (ED50=0.90 mg/kg) generalized to (+)ephedrine (ED50=2.64 mg/kg), (+)pseudoephedrine (ED50=6.58 mg/kg), (-)norephedrine (ED50=1.86 mg/kg), (+)norephedrine (ED50=5.75 mg/kg), and (+)cathine (ED50=4.87 mg/kg).  The (-)ephedrine stimulus failed to generalize to either (-)pseudoephedrine or (-)cathine; the latter agents produced a max. of 29 and 31% (-)ephedrine-appropriate responding, resp.  Thus, (a) six of the eight phenylpropanolamines produced ephedrine-like stimulus effects, (b) (-)ephedrine was the most potent of the examd. agents, and (c) where stimulus generalization occurred, ED50 values spanned less than a tenfold range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczQVGVd86DbVg90H21EOLACvtfcHk0lj6P3ijqGXH1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVWlsb8%253D&md5=bfe5c3a71b0397be3a93cab552ae15d8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2899%2900052-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252899%252900052-6%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DBondarev%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DAn%2520examination%2520of%2520isomeric%2520phenylpropanolamines%2520in%2520%2528%25E2%2588%2592%2529ephedrine-trained%2520rats%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D1999%26volume%3D57%26spage%3D1%26epage%3D6%26doi%3D10.1016%2FS0376-8716%2899%2900052-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Bondareva, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Central stimulants as discriminative stimuli. Asymmetric generalization between (−)ephedrine and <i>S</i>(+)methamphetamine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/S0091-3057(02)00963-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2802%2900963-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2002&pages=157-162&author=T.+S.+Bondarevaauthor=R.+Youngauthor=R.+A.+Glennon&title=Central+stimulants+as+discriminative+stimuli.+Asymmetric+generalization+between+%28%E2%88%92%29ephedrine+and+S%28%2B%29methamphetamine&doi=10.1016%2FS0091-3057%2802%2900963-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2802%2900963-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252802%252900963-2%26sid%3Dliteratum%253Aachs%26aulast%3DBondareva%26aufirst%3DT.%2BS.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DCentral%2520stimulants%2520as%2520discriminative%2520stimuli.%2520Asymmetric%2520generalization%2520between%2520%2528%25E2%2588%2592%2529ephedrine%2520and%2520S%2528%252B%2529methamphetamine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D74%26spage%3D157%26epage%3D162%26doi%3D10.1016%2FS0091-3057%2802%2900963-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton-Toth, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1124/jpet.103.053975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1124%2Fjpet.103.053975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=12954796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslGktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=138-145&author=R.+B.+Rothmanauthor=N.+Vuauthor=J.+S.+Partillaauthor=B.+L.+Rothauthor=S.+J.+Hufeisenauthor=B.+A.+Compton-Tothauthor=J.+Birkesauthor=R.+Youngauthor=R.+A.+Glennon&title=In+vitro+characterization+of+ephedrine-related+stereoisomers+at+biogenic+amine+transporters+and+the+receptorome+reveals+selective+actions+as+norepinephrine+transporter+substrates&doi=10.1124%2Fjpet.103.053975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates</span></div><div class="casAuthors">Rothman, Richard B.; Vu, Nga; Partilla, John S.; Roth, Bryan L.; Hufeisen, Sandra J.; Compton-Toth, Beth A.; Birkes, Jon; Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">138-145</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ephedrine is a long-studied stimulant available both as a prescription and over-the-counter medication, as well as an ingredient in widely marketed herbal prepns., and is also used as a precursor for the illicit synthesis of methamphetamine.  Ephedrine is related to phenylpropanolamine, a decongestant removed from the market place due to concerns that its use increased the risk of hemorrhagic stroke.  Std. pharmacol. texts emphasize that ephedrine is both a direct and indirect adrenergic agonist, activating adrenergic receptors both by direct agonist activity as well as by releasing norepinephrine via a carrier-mediated exchange mechanism.  Chem., ephedrine possesses two chiral centers.  In the present study, we characterized the stereoisomers of ephedrine and the closely related compds. pseudoephedrine, norephedrine, pseudonorephedrine (cathine), methcathinone, and cathinone at biogenic amine transporters and a large battery of cloned human receptors (e.g., "receptorome").  The most potent actions of ephedrine-type compds. were as substrates of the norepinephrine transporter (EC50 values of about 50 nM) followed by substrate activity at the dopamine transporter.  Screening the receptorome demonstrated weak affinity at α2-adrenergic and 5-hydroxytryptamine7 receptors (Ki values 1-10 μM) and no significant activity at β-adrenergic or α1-adrenergic receptors.  Viewed collectively, these data indicate that the pharmacol. effects of ephedrine-like phenylpropanolamines are likely mediated by norepinephrine release, and although sharing mechanistic similarities with, they differ in important respects from those of the phenylpropanonamines methcathinone and cathinone and the phenyisopropylamines methamphetamine and amphetamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3iuXuw5nBCrVg90H21EOLACvtfcHk0ljzzBgqgPoa5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslGktb0%253D&md5=fdc393937c271d2cba5da078f30315c0</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.053975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.053975%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DVu%26aufirst%3DN.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DCompton-Toth%26aufirst%3DB.%2BA.%26aulast%3DBirkes%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520ephedrine-related%2520stereoisomers%2520at%2520biogenic%2520amine%2520transporters%2520and%2520the%2520receptorome%2520reveals%2520selective%2520actions%2520as%2520norepinephrine%2520transporter%2520substrates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D307%26spage%3D138%26epage%3D145%26doi%3D10.1124%2Fjpet.103.053975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Dulloo, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seydoux, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girardier, L.</span><span> </span><span class="NLM_article-title">Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: Adenosine antagonism or phosphodiesterase inhibition?</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1233</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span><span class="refDoi"> DOI: 10.1016/0026-0495(92)90015-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0026-0495%2892%2990015-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1435297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A280%3ADyaK3s%252Fmt1Wnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1992&pages=1233-1241&author=A.+G.+Dullooauthor=J.+Seydouxauthor=L.+Girardier&title=Potentiation+of+the+thermogenic+antiobesity+effects+of+ephedrine+by+dietary+methylxanthines%3A+Adenosine+antagonism+or+phosphodiesterase+inhibition%3F&doi=10.1016%2F0026-0495%2892%2990015-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition?</span></div><div class="casAuthors">Dulloo A G; Seydoux J; Girardier L</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism: clinical and experimental</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1233-41</span>
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    </div><div class="casAbstract">Current concepts about the mechanisms underlying the therapeutic effects of dietary methylxanthines (caffeine, theophylline, and theobromine) favor their actions as antagonists of adenosine receptors, and attribute their other possible modes of action, namely those associated with translocation of intracellular calcium, inhibition of phosphodiesterase enzyme (PDE) activity, or the release of catecholamines, to high (near-toxic) doses.  From studies measuring the respiration rate of brown adipose tissue (BAT), evidence is provided here that at concentrations compatible with therapeutic doses, the ability of methylxanthines (25 to 50 mumol/L) to potentiate the thermogenic effect of the sympathomimetic drug, ephedrine (0.25 mumol/L), particularly under conditions of caloric restriction, involves a minor contribution of adenosine antagonism, but could mainly be explained by the inhibition of PDE activity.  In view of current interest in the pharmacological stimulation of metabolic rate to assist the management of obesity with low-calorie regimens, the targeting of PDE activity is therefore a rational approach in the search for drugs that could potentiate sympathomimetic stimulation of metabolic rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSI095mVM4Nz0SWnHPWbmmfW6udTcc2eZt98z9BjWdY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252Fmt1Wnsw%253D%253D&md5=57769406522028c061a05e0fe3376805</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0026-0495%2892%2990015-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0026-0495%252892%252990015-3%26sid%3Dliteratum%253Aachs%26aulast%3DDulloo%26aufirst%3DA.%2BG.%26aulast%3DSeydoux%26aufirst%3DJ.%26aulast%3DGirardier%26aufirst%3DL.%26atitle%3DPotentiation%2520of%2520the%2520thermogenic%2520antiobesity%2520effects%2520of%2520ephedrine%2520by%2520dietary%2520methylxanthines%253A%2520Adenosine%2520antagonism%2520or%2520phosphodiesterase%2520inhibition%253F%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D1992%26volume%3D41%26spage%3D1233%26epage%3D1241%26doi%3D10.1016%2F0026-0495%2892%2990015-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryszuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">-)Ephedrine and caffeine mutually potentiate one another’s amphetamine-like stimulus effects</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/S0091-3057(98)00044-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2898%2900044-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1998&pages=169-173&author=R.+Youngauthor=M.+Gabryszukauthor=R.+A.+Glennon&title=-%29Ephedrine+and+caffeine+mutually+potentiate+one+another%E2%80%99s+amphetamine-like+stimulus+effects&doi=10.1016%2FS0091-3057%2898%2900044-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2898%2900044-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252898%252900044-6%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGabryszuk%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D-%2529Ephedrine%2520and%2520caffeine%2520mutually%2520potentiate%2520one%2520another%25E2%2580%2599s%2520amphetamine-like%2520stimulus%2520effects%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1998%26volume%3D61%26spage%3D169%26epage%3D173%26doi%3D10.1016%2FS0091-3057%2898%2900044-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Holloway, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelis, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huerta, P. L.</span><span> </span><span class="NLM_article-title">Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1016/0024-3205(85)90191-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0024-3205%2885%2990191-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1985&pages=723-730&author=F.+A.+Hollowayauthor=R.+C.+Michaelisauthor=P.+L.+Huerta&title=Caffeine-phenylethylamine+combinations+mimic+the+amphetamine+discriminative+cue&doi=10.1016%2F0024-3205%2885%2990191-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2885%2990191-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252885%252990191-2%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DF.%2BA.%26aulast%3DMichaelis%26aufirst%3DR.%2BC.%26aulast%3DHuerta%26aufirst%3DP.%2BL.%26atitle%3DCaffeine-phenylethylamine%2520combinations%2520mimic%2520the%2520amphetamine%2520discriminative%2520cue%26jtitle%3DLife%2520Sci.%26date%3D1985%26volume%3D36%26spage%3D723%26epage%3D730%26doi%3D10.1016%2F0024-3205%2885%2990191-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Gauvin, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harland, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelis, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, F. A.</span><span> </span><span class="NLM_article-title">Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1016/0024-3205(89)90219-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0024-3205%2889%2990219-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1989&pages=67-73&author=D.+V.+Gauvinauthor=R.+D.+Harlandauthor=R.+C.+Michaelisauthor=F.+A.+Holloway&title=Caffeine-phenylethylamine+combinations+mimic+the+cocaine+discriminative+cue&doi=10.1016%2F0024-3205%2889%2990219-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2889%2990219-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252889%252990219-1%26sid%3Dliteratum%253Aachs%26aulast%3DGauvin%26aufirst%3DD.%2BV.%26aulast%3DHarland%26aufirst%3DR.%2BD.%26aulast%3DMichaelis%26aufirst%3DR.%2BC.%26aulast%3DHolloway%26aufirst%3DF.%2BA.%26atitle%3DCaffeine-phenylethylamine%2520combinations%2520mimic%2520the%2520cocaine%2520discriminative%2520cue%26jtitle%3DLife%2520Sci.%26date%3D1989%26volume%3D44%26spage%3D67%26epage%3D73%26doi%3D10.1016%2F0024-3205%2889%2990219-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Harland, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauvin, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelis, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seale, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, F. A.</span><span> </span><span class="NLM_article-title">Behavioral interaction between cocaine and caffeine: A drug discrimination analysis in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span><span class="refDoi"> DOI: 10.1016/0091-3057(89)90075-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2889%2990075-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1017-1023&author=R.+D.+Harlandauthor=D.+V.+Gauvinauthor=R.+C.+Michaelisauthor=J.+M.+Carneyauthor=T.+W.+Sealeauthor=F.+A.+Holloway&title=Behavioral+interaction+between+cocaine+and+caffeine%3A+A+drug+discrimination+analysis+in+rats&doi=10.1016%2F0091-3057%2889%2990075-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2889%2990075-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252889%252990075-0%26sid%3Dliteratum%253Aachs%26aulast%3DHarland%26aufirst%3DR.%2BD.%26aulast%3DGauvin%26aufirst%3DD.%2BV.%26aulast%3DMichaelis%26aufirst%3DR.%2BC.%26aulast%3DCarney%26aufirst%3DJ.%2BM.%26aulast%3DSeale%26aufirst%3DT.%2BW.%26aulast%3DHolloway%26aufirst%3DF.%2BA.%26atitle%3DBehavioral%2520interaction%2520between%2520cocaine%2520and%2520caffeine%253A%2520A%2520drug%2520discrimination%2520analysis%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1989%26volume%3D32%26spage%3D1017%26epage%3D1023%26doi%3D10.1016%2F0091-3057%2889%2990075-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Reid, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudie, A. J.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of β-phenylethylamine, deuterated β-phenylethylamine, phenylethanolamine and some metabolites of phenylethylamine in rodents</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1547</span><span class="NLM_x">–</span> <span class="NLM_lpage">1553</span><span class="refDoi"> DOI: 10.1016/0091-3057(86)90483-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2886%2990483-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1986&pages=1547-1553&author=D.+Reidauthor=A.+J.+Goudie&title=Discriminative+stimulus+properties+of+%CE%B2-phenylethylamine%2C+deuterated+%CE%B2-phenylethylamine%2C+phenylethanolamine+and+some+metabolites+of+phenylethylamine+in+rodents&doi=10.1016%2F0091-3057%2886%2990483-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2886%2990483-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252886%252990483-1%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DD.%26aulast%3DGoudie%26aufirst%3DA.%2BJ.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520%25CE%25B2-phenylethylamine%252C%2520deuterated%2520%25CE%25B2-phenylethylamine%252C%2520phenylethanolamine%2520and%2520some%2520metabolites%2520of%2520phenylethylamine%2520in%2520rodents%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1986%26volume%3D24%26spage%3D1547%26epage%3D1553%26doi%3D10.1016%2F0091-3057%2886%2990483-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span>PEA forum Web site. <a href="https://drugs-forum.com/forum/showthread.php?t=60910" class="extLink">https://drugs-forum.com/forum/showthread.php?t=60910</a> (accessed December 4,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PEA+forum+Web+site.+https%3A%2F%2Fdrugs-forum.com%2Fforum%2Fshowthread.php%3Ft%3D60910+%28accessed+December+4%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Ziegleder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojacic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpf, B.</span><span> </span><span class="NLM_article-title">Vorkommen von beta-phenylethylamin und seinen Derivaten in Kakao und Kakaoerzeugnissen</span> <span class="citation_source-journal">Z. Lebensm.-Unters. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span><span class="refDoi"> DOI: 10.1007/BF01202801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FBF01202801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1413998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK3sXjslyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=1992&pages=235-238&author=G.+Zieglederauthor=E.+Stojacicauthor=B.+Stumpf&title=Vorkommen+von+beta-phenylethylamin+und+seinen+Derivaten+in+Kakao+und+Kakaoerzeugnissen&doi=10.1007%2FBF01202801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Occurrence of 2-phenylethylamine and its derivatives in cocoas and chocolates</span></div><div class="casAuthors">Ziegleder, Gottfried; Stojacic, Eva; Stumpf, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Zeitschrift fuer Lebensmittel-Untersuchung und -Forschung</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-8</span>CODEN:
                <span class="NLM_cas:coden">ZLUFAR</span>;
        ISSN:<span class="NLM_cas:issn">0044-3026</span>.
    </div><div class="casAbstract">Studies of β-phenylethylamine (I) levels in cocoa beans and powder and in chocolate by gas chromatog.-mass spectroscopy revealed av. levels to increase from 0.5 mg/kg in lightly fermented, unroasted beans to 1.8 mg/kg following normal fermn., and to decrease to 1.4 mg/kg after roasting.  Alkalized cocoa powder and bitter chocolate had concns. of 1.4 and 1.1 mg/kg, resp.  Concns. in bitter chocolate depended on the content of nonfat cocoa powder.  Six aldimines were detected in cocoa powder, formed from the condensation of I with aldehydes.  The major compd., the N-benzylidene deriv., was present at ≤4 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe9VcVSNOo6LVg90H21EOLACvtfcHk0lg1PaYaG83CqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXjslyqsg%253D%253D&md5=2511b1a6ef018676d7eccc256906c699</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2FBF01202801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01202801%26sid%3Dliteratum%253Aachs%26aulast%3DZiegleder%26aufirst%3DG.%26aulast%3DStojacic%26aufirst%3DE.%26aulast%3DStumpf%26aufirst%3DB.%26atitle%3DVorkommen%2520von%2520beta-phenylethylamin%2520und%2520seinen%2520Derivaten%2520in%2520Kakao%2520und%2520Kakaoerzeugnissen%26jtitle%3DZ.%2520Lebensm.-Unters.%2520Forsch.%26date%3D1992%26volume%3D195%26spage%3D235%26epage%3D238%26doi%3D10.1007%2FBF01202801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">(+)Amphetamine-stimulus generalization to an herbal ephedrine product</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span><span class="refDoi"> DOI: 10.1016/S0091-3057(99)00238-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2899%2900238-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=655-658&author=R.+A.+Glennonauthor=R.+Young&title=%28%2B%29Amphetamine-stimulus+generalization+to+an+herbal+ephedrine+product&doi=10.1016%2FS0091-3057%2899%2900238-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2899%2900238-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252899%252900238-5%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3D%2528%252B%2529Amphetamine-stimulus%2520generalization%2520to%2520an%2520herbal%2520ephedrine%2520product%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2000%26volume%3D65%26spage%3D655%26epage%3D658%26doi%3D10.1016%2FS0091-3057%2899%2900238-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span><span class="refDoi"> DOI: 10.1016/B978-0-12-420118-7.00015-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FB978-0-12-420118-7.00015-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=24484988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFCitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=581-620&author=R.+A.+Glennon&title=Bath+salts%2C+mephedrone%2C+and+methylenedioxypyrovalerone+as+emerging+illicit+drugs+that+will+need+targeted+therapeutic+intervention&doi=10.1016%2FB978-0-12-420118-7.00015-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse</span>),
    <span class="NLM_cas:pages">581-620</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The term "synthetic cathinones" is fairly new, but, although the abuse of synthetic cathinones is a recent problem, research on cathinone analogs dates back >100 years.  One structural element cathinone analogs have in common is an α-aminophenone moiety.  Introduction of amine and/or aryl substituents affords a large no. of agents.  Today, >40 synthetic cathinones have been identified on the clandestine market and many have multiple "street names.  " Many cathinone analogs, although not referred to as such until the late 1970s, were initially prepd. as intermediates in the synthesis of ephedrine analogs.  The cathinones do not represent a pharmacol. or mechanistically homogeneous class of agents.  Currently abused synthetic cathinones are derived from earlier agents and seem to produce their actions primarily via the dopamine, norepinephrine, and/or serotonin transporter; i.e., they either release and/or inhibit the reuptake of one or more of these neurotransmitters.  The actions of these agents can resemble those of central stimulants such as methamphetamine, cocaine, and/or empathogens such as 1-(3,4-methylenedioxyphenyl)-2-aminopropane (Ecstasy) and/or produce other effects.  Side effects are primarily of a neurol. and/or cardiovascular nature.  The use of the "and/or" term is emphasized because synthetic cathinones represent a broad class of agents that produce a variety of actions; the agents cannot be viewed as being pharmacol. equiv.  Until valid structure-activity relationships are formulated for each behavioral/mechanistic action, individual synthetic cathinones remain to be evaluated on a case-by-case basis.  Treatment of synthetic cathinone intoxication requires more "basic science" research.  At this time, treatment is mostly palliative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZeLnZPeubvLVg90H21EOLACvtfcHk0lg1PaYaG83CqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFCitbc%253D&md5=a4f1c1877f906d352de4792d9598e971</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420118-7.00015-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420118-7.00015-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBath%2520salts%252C%2520mephedrone%252C%2520and%2520methylenedioxypyrovalerone%2520as%2520emerging%2520illicit%2520drugs%2520that%2520will%2520need%2520targeted%2520therapeutic%2520intervention%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D581%26epage%3D620%26doi%3D10.1016%2FB978-0-12-420118-7.00015-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Glennon, R. A.; Dukat, M.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of synthetic cathinones</span>. In  <span class="citation_source-book">New Psychoactive Substances</span>; <span class="NLM_contrib-group">Baumann, M. H.; Glennon, R. A.; Wiley, J.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>; in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glennon%2C+R.+A.%3B+Dukat%2C+M.+Structure-activity+relationships+of+synthetic+cathinones.+In+New+Psychoactive+Substances%3B+Baumann%2C+M.+H.%3B+Glennon%2C+R.+A.%3B+Wiley%2C+J.%2C+Eds.%3B+Springer%3B+in+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DStructure-activity%2520relationships%2520of%2520synthetic%2520cathinones%26btitle%3DNew%2520Psychoactive%2520Substances%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26pub%3DSpringer" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, D.</span><span> </span><span class="NLM_article-title">The effect of cathinone and several related derivatives on locomotor activity</span> <span class="citation_source-journal">Res. Commun. Subst. Abuse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL3MXktFyjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1981&pages=186-192&author=R.+A.+Glennonauthor=D.+Showalter&title=The+effect+of+cathinone+and+several+related+derivatives+on+locomotor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of cathinone and several related derivatives on locomotor activity</span></div><div class="casAuthors">Glennon, Richard A.; Showalter, Debra</div><div class="citationInfo"><span class="NLM_cas:title">Research Communications in Substances of Abuse</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-92</span>CODEN:
                <span class="NLM_cas:coden">RCSADO</span>;
        ISSN:<span class="NLM_cas:issn">0193-0818</span>.
    </div><div class="casAbstract">The effects of cathinone and several substituted derivs. on the locomotor activity of mice were compared with the effects produced by (+)-amphetamine.  (-)-Cathinone-HCl  [72739-14-1] was more active than its (+)-enantiomer  [76333-53-4], twice as active as (±)-cathinone-HCl  [16735-19-6], but only about one-seventh as active as (+)-amphetamine.  Removal of the α-Me group or substitution on the arom. ring abolished the stimulant effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg7LUPAayhGbVg90H21EOLACvtfcHk0lj5kat5QKsOpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXktFyjsrw%253D&md5=e5a463d8f7dae27eba6316dddc4086bb</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DShowalter%26aufirst%3DD.%26atitle%3DThe%2520effect%2520of%2520cathinone%2520and%2520several%2520related%2520derivatives%2520on%2520locomotor%2520activity%26jtitle%3DRes.%2520Commun.%2520Subst.%2520Abuse%26date%3D1981%26volume%3D2%26spage%3D186%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of phenylisopropylamine derivatives</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span><span class="refDoi"> DOI: 10.1016/0376-8716(86)90003-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0376-8716%2886%2990003-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2874967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL28XltVOktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1986&pages=119-134&author=R.+A.+Glennon&title=Discriminative+stimulus+properties+of+phenylisopropylamine+derivatives&doi=10.1016%2F0376-8716%2886%2990003-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus properties of phenylisopropylamine derivatives</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">119-34</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    </div><div class="casAbstract">A review with 16 refs. of drug discrimination studies by the author to det. whether substituted and (or) structurally-modified phenylisopropylamines produce effects similar to (+)-amphetamine  [51-64-9] or (±)-2,5-dimethoxy-4-methylamphetamine  [15588-95-1].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARg8vf5mMIbVg90H21EOLACvtfcHk0lj5kat5QKsOpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XltVOktrs%253D&md5=7683c36d59249156eb75c90711d233fe</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2F0376-8716%2886%2990003-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0376-8716%252886%252990003-7%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520phenylisopropylamine%2520derivatives%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D1986%26volume%3D17%26spage%3D119%26epage%3D134%26doi%3D10.1016%2F0376-8716%2886%2990003-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousif, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalix, P.</span><span> </span><span class="NLM_article-title">Methcathinone: A new and potent amphetamine-like agent</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1016/0091-3057(87)90164-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2887%2990164-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3575369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2sXktlaqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1987&pages=547-551&author=R.+A.+Glennonauthor=M.+Yousifauthor=N.+Naimanauthor=P.+Kalix&title=Methcathinone%3A+A+new+and+potent+amphetamine-like+agent&doi=10.1016%2F0091-3057%2887%2990164-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Methcathinone:  a new and potent amphetamine-like agent</span></div><div class="casAuthors">Glennon, Richard A.; Yousif, Mamoun; Naiman, Noreen; Kalix, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">547-51</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    </div><div class="casAbstract">The effect of N-monomethylation of phenylisopropylamine derivs. on amphetamine-like activity was examd.  With the exception of methcathinone, all of the new N-methyl derivs. were prepd. by acylation of the corresponding primary amine with ethyl chloroformate, followed by redn. of the resulting carbamate esters with lithium aluminum hydride.  In tests of stimulus generalization using rats trained to discriminate 1.0 mg/kg of (+)-amphetamine from saline, the N-monomethyl derivs. of 1-(X-phenyl)-2-aminopropane, where X = 2,4-dimethoxy-, 3,4-dimethoxy-, 2,4,5-trimethoxy-, and 2-methoxy-4,5-methylenedioxy-, did not produce amphetamine-appropriate responding at the doses evaluated.  However, the racemic N-monomethyl deriv. of cathinone (racemic methcathinone), like racemic cathinone, resulted in stimulus generalization.  Further studies with this agent revealed that (a) in the amphetamine-trained animals, methcathinone is more potent than racemic cathinone or racemic amphetamine; (b) methcathinone is capable of inducing release of radioactivity from 3H-labeled dopamine-prelabeled tissue of rat caudate nucleus in a manner similar to that obsd. with cathinone, amphetamine, and (+)-methamphetamine; and (c) methcathinone is more potent than cathinone as a locomotor stimulant in mice as detd. by their effect on spontaneous activity.  The results of the present study provide evidence for a structural analogy between the prototypic psychostimulants amphetamine/methamphetamine and cathinone/methcathinone, and lend further support to the concept that amphetamine and cathinone correspond in their pharmacol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMSeWNBePw87Vg90H21EOLACvtfcHk0lj5kat5QKsOpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktlaqurc%253D&md5=f1b2b1f805811dd496f6b8ca593cb29f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2887%2990164-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252887%252990164-X%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYousif%26aufirst%3DM.%26aulast%3DNaiman%26aufirst%3DN.%26aulast%3DKalix%26aufirst%3DP.%26atitle%3DMethcathinone%253A%2520A%2520new%2520and%2520potent%2520amphetamine-like%2520agent%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1987%26volume%3D26%26spage%3D547%26epage%3D551%26doi%3D10.1016%2F0091-3057%2887%2990164-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus effects of S(−)-methcathinone (MCAT): A potent stimulant drug of abuse</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1007/s002130050765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2Fs002130050765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=9877004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK1MXitVOksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1998&pages=250-256&author=R.+Youngauthor=R.+A.+Glennon&title=Discriminative+stimulus+effects+of+S%28%E2%88%92%29-methcathinone+%28MCAT%29%3A+A+potent+stimulant+drug+of+abuse&doi=10.1007%2Fs002130050765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse</span></div><div class="casAuthors">Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">250-256</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Methcathinone ("CAT") is a CNS stimulant that is a very significant drug of abuse in the former Soviet Union.  It has also appeared on the clandestine market in the United States and has been recently classified as a Schedule I substance.  In the present study, S(-)-methcathinone [S(-)-CAT, 0.50 mg/kg, i.p.] was employed as the training drug in a two-lever drug discrimination task in rats.  Once established, the S(-)-CAT stimulus was shown to have a rapid onset to action (within 5 min) and a duration of effect of approx. 60-90 min.  In tests of stimulus generalization (substitution), the S(-)-CAT (ED50 = 0.11 mg/kg) stimulus generalized to S(+)-methamphetamine (ED50 = 0.17 mg/kg), S(-)-cathinone (ED50 = 0.19 mg/kg), S(+)-amphetamine (ED50 = 0.23 mg/kg), aminorex (ED50 = 0.27 mg/kg), (±)-CAT (ED50 = 0.25 mg/kg), (±)-cathinone (ED50 = 0.41 mg/kg), R(+)-CAT (ED50 = 0.43 mg/kg), cis-4-methylaminorex (ED50 = 0.49 mg/kg), methylphenidate (ED50 = 0.83 mg/kg), and cocaine (ED50 = 1.47 mg/kg).  S(-)-CAT-stimulus generalization did not occur to fenfluramine, a structurally related nonstimulant anorectic.  Lastly, haloperidol (AD50 = 0.18 mg/kg), a dopamine receptor antagonist, potently antagonized the S(-)-CAT stimulus.  It is concluded that S(-)-methcathinone is a very potent CNS stimulant, which appears to produce its stimulus effect, at least in part, via a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_83iSDXoKyLVg90H21EOLACvtfcHk0lhMtFwo0aVxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitVOksQ%253D%253D&md5=f1cc8ea2d737d474b9a5092eb420d643</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2Fs002130050765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002130050765%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520effects%2520of%2520S%2528%25E2%2588%2592%2529-methcathinone%2520%2528MCAT%2529%253A%2520A%2520potent%2520stimulant%2520drug%2520of%2520abuse%26jtitle%3DPsychopharmacology%26date%3D1998%26volume%3D140%26spage%3D250%26epage%3D256%26doi%3D10.1007%2Fs002130050765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Iversen, L. E.</span><span> </span><span class="NLM_article-title">Consideration of the cathinones. Advisory Council on the Misuse of Drugs</span>. A report submitted to the Home Secretary of the U.K. (March 31,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+E.+Iversen&title=Consideration+of+the+cathinones.+Advisory+Council+on+the+Misuse+of+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DL.%2BE.%26atitle%3DConsideration%2520of%2520the%2520cathinones.%2520Advisory%2520Council%2520on%2520the%2520Misuse%2520of%2520Drugs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Sakloth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonano, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negus, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">2210</span><span class="NLM_x">–</span> <span class="NLM_lpage">2218</span><span class="refDoi"> DOI: 10.1111/bph.13043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1111%2Fbph.13043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=25522019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVentrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=2210-2218&author=F.+Saklothauthor=R.+Kolanosauthor=P.+D.+Mosierauthor=J.+S.+Bonanoauthor=M.+L.+Banksauthor=J.+S.+Partillaauthor=M.+H.+Baumannauthor=S.+S.+Negusauthor=R.+A.+Glennon&title=Steric+parameters%2C+molecular+modeling+and+hydropathic+interaction+analysis+of+the+pharmacology+of+para-substituted+methcathinone+analogues&doi=10.1111%2Fbph.13043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues</span></div><div class="casAuthors">Sakloth, F.; Kolanos, R.; Mosier, P. D.; Bonano, J. S.; Banks, M. L.; Partilla, J. S.; Baumann, M. H.; Negus, S. S.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2210-2218</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : There is growing concern over the abuse of certain psychostimulant methcathinone (MCAT) analogs.  This study extends an initial quant. structure-activity relationship (QSAR) investigation that demonstrated important steric considerations of seven 4- (or para-)substituted analogs of MCAT.  Specifically, the steric character (Taft's steric ES) of the 4-position substituent affected in vitro potency to induce monoamine release via dopamine and 5-HT transporters (DAT and SERT) and in vivo modulation of intracranial self-stimulation (ICSS).  Here, we have assessed the effects of other steric properties of the 4-position substituents.  Exptl. Approach : Definitive steric parameters that more explicitly focus on the vol., width and length of the MCAT 4-position substituents were assessed.  In addn., homol. models of human DAT and human SERT based upon the crystd. Drosophila DAT were constructed and docking studies were performed, followed by hydropathic interaction (HINT) anal. of the docking results.  Key Results : The potency of seven MCAT analogs at DAT was neg. correlated with the vol. and maximal width of their 4-position substituents, whereas potency at SERT increased as substituent vol. and length increased.  SERT/DAT selectivity, as well as abuse-related drug effects in the ICSS procedure, also correlated with the same parameters.  Docking solns. offered a means of visualizing these findings.  Conclusions and Implications : These results suggest that steric aspects of the 4-position substituents of MCAT analogs are key determinants of their action and selectivity, and that the hydrophobic nature of these substituents is involved in their potency at SERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre4XEAp6rxMbVg90H21EOLACvtfcHk0ljomWf7905-og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVentrbM&md5=8bcbd5708f72e4583518c29e28a59705</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1111%2Fbph.13043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13043%26sid%3Dliteratum%253Aachs%26aulast%3DSakloth%26aufirst%3DF.%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DBonano%26aufirst%3DJ.%2BS.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DSteric%2520parameters%252C%2520molecular%2520modeling%2520and%2520hydropathic%2520interaction%2520analysis%2520of%2520the%2520pharmacology%2520of%2520para-substituted%2520methcathinone%2520analogues%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D2210%26epage%3D2218%26doi%3D10.1111%2Fbph.13043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakloth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Felice, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">“Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1524</span><span class="NLM_x">–</span> <span class="NLM_lpage">1529</span><span class="refDoi"> DOI: 10.1021/cn4001236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn4001236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SgsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1524-1529&author=R.+Kolanosauthor=E.+Solisauthor=F.+Saklothauthor=L.+J.+De+Feliceauthor=R.+A.+Glennon&title=%E2%80%9CDeconstruction%22+of+the+abused+synthetic+cathinone+methylenedioxypyrovalerone+%28MDPV%29+and+an+examination+of+effects+at+the+human+dopamine+transporter&doi=10.1021%2Fcn4001236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Deconstruction of the Abused Synthetic Cathinone Methylenedioxypyrovalerone (MDPV) and an Examination of Effects at the Human Dopamine Transporter</span></div><div class="casAuthors">Kolanos, Renata; Solis, Ernesto; Sakloth, Farhana; De Felice, Louis J.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1524-1529</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthetic cathinones, β-keto analogs of amphetamine (or, more correctly, of phenylalkylamines), represent a new and growing class of abused substances.  Several such analogs have been demonstrated to act as dopamine (DA) releasing agents.  Methylenedioxypyrovalerone (MDPV) was the first synthetic cathinone shown to act as a cocaine-like DA reuptake inhibitor.  MDPV and seven deconstructed analogs were examd. to det. which of MDPV's structural features account(s) for uptake inhibition.  In voltage-clamped (-60 mV) Xenopus oocytes transfected with the human DA transporter (hDAT), all analogs elicited inhibitor-like behavior shown as hDAT-mediated outward currents.  Using hDAT-expressing mammalian cells the authors detd. the affinities of MDPV and its analogs to inhibit uptake of [3H]-DA by hDAT that varied over a broad range (IC50 values ∼135 to >25,000 nM).  The methylenedioxy group of MDPV made a minimal contribution to affinity, the carbonyl group and a tertiary amine are more important, and the extended α-alkyl group seems most important.  Either a tertiary amine, or the extended α-alkyl group (but not both), are required for the potent nature of MDPV as an hDAT inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfwvQn5iY92LVg90H21EOLACvtfcHk0ljomWf7905-og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SgsLjJ&md5=916dc6e16c83e9617a157b378f3f2f73</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fcn4001236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn4001236%26sid%3Dliteratum%253Aachs%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DSolis%26aufirst%3DE.%26aulast%3DSakloth%26aufirst%3DF.%26aulast%3DDe%2BFelice%26aufirst%3DL.%2BJ.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D%25E2%2580%259CDeconstruction%2522%2520of%2520the%2520abused%2520synthetic%2520cathinone%2520methylenedioxypyrovalerone%2520%2528MDPV%2529%2520and%2520an%2520examination%2520of%2520effects%2520at%2520the%2520human%2520dopamine%2520transporter%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1524%26epage%3D1529%26doi%3D10.1021%2Fcn4001236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP)</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.brainresbull.2016.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.brainresbull.2016.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=27142261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsV2ntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=111-126&author=R.+A.+Glennonauthor=R.+Young&title=Neurobiology+of+3%2C4-methylenedioxypyrovalerone+%28MDPV%29+and+%CE%B1-pyrrolidinovalerophenone+%28%CE%B1-PVP%29&doi=10.1016%2Fj.brainresbull.2016.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP)</span></div><div class="casAuthors">Glennon, Richard A.; Young, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">Part_1</span>),
    <span class="NLM_cas:pages">111-126</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Synthetic cathinones are analogs of cathinone or β-ketoamphetamine - the major psychostimulant component of the shrub Catha edulis or khat.  Cathinone analogs - though not termed as such - have been known for >100 years, but confusing chem. nomenclature often made the topic difficult to appreciate.  In addn., many of the early analogs were prepd. as synthetic precursors for the development of various other agents, and relatively few were pharmacol. evaluated.  Cathinone is a close structural relative of amphetamine.  Today, certain cathinone derivs., synthetic cathinones, are known to produce central stimulant actions and represent a "new" class of drugs of abuse.  Depending upon the nature of their terminal amine, α substituent, and aryl substituents, they seem to produce their effects via release or reuptake of various neurotansmitters including dopamine norepinephreine and/or serotonin.  Two of the newest and most prominent members of the class are MDPV and its parent α-PVP ("flakka").  Both have been encountered on their own and in what might be constituents of what has been termed by a variety of names including psychoactive "bath salts".  Here, we describe the nomenclature of synthetic cathinones, the mechanism(s) of action of MDPV and α-PVP, and their structure-activity relationships.  In order to assist in forensic studies, and to identify novel substances requiring future pharmacol. evaluation, the metab. of these agents is also described.  Finally, the preclin. behavioral actions of these two agents in a variety of behavioral assays, including rodent locomotor assays, self-administration studies, intracranial self-stimulation, conditioned place preference, and drug discrimination, is summarized.  The results of these studies with MDPV and α-PVP are consistent with their acting as potent cocaine-like central stimulants with abuse liability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAsLTRQFk2wrVg90H21EOLACvtfcHk0ljomWf7905-og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsV2ntLg%253D&md5=21eac8b7500d48fe780ff37f37391716</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2016.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2016.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DNeurobiology%2520of%25203%252C4-methylenedioxypyrovalerone%2520%2528MDPV%2529%2520and%2520%25CE%25B1-pyrrolidinovalerophenone%2520%2528%25CE%25B1-PVP%2529%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2016%26volume%3D126%26spage%3D111%26epage%3D126%26doi%3D10.1016%2Fj.brainresbull.2016.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakloth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Structural modification of the designer stimulant α-pyrrolidinovalerophenone (α-PVP) influences potency at dopamine transporters</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1726</span><span class="NLM_x">–</span> <span class="NLM_lpage">1731</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00160</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00160" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1CitL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1726-1731&author=R.+Kolanosauthor=F.+Saklothauthor=A.+D.+Jainauthor=J.+S.+Partillaauthor=M.+H.+Baumannauthor=R.+A.+Glennon&title=Structural+modification+of+the+designer+stimulant+%CE%B1-pyrrolidinovalerophenone+%28%CE%B1-PVP%29+influences+potency+at+dopamine+transporters&doi=10.1021%2Facschemneuro.5b00160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters</span></div><div class="casAuthors">Kolanos, R.; Sakloth, F.; Jain, A. D.; Partilla, J. S.; Baumann, M. H.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1726-1731</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Pyrrolidinovalerophenone (α-PVP, 7) is an illegal synthetic stimulant that is being sold on the clandestine market as "flakka" and "gravel".  The potent pharmacol. effects of α-PVP are presumably mediated by inhibition of dopamine uptake at the dopamine transporter (DAT).  However, little is known about how structural modification of α-PVP influences activity at DAT.  Eleven analogs of α-PVP were synthesized and examd. for their ability to inhibit uptake of [3H]dopamine and [3H]serotonin in rat brain synaptosomes.  None of the analogs significantly inhibited [3H]serotonin uptake when tested at 10 μM at the serotonin transporter (SERT).  All of the analogs behaved as DAT reuptake inhibitors, but potencies varied over a >1500-fold range.  Potency was primarily assocd. with the nature of the α-substituent, with the more bulky substituents imparting the highest potency.  Expansion of the pyrrolidine ring to a piperidine reduced potency up to 10-fold, whereas conformational constraint in the form of an aminotetralone resulted in the least potent compd.  Our study provides the first systematic and comparative structure-activity investigation on the ability of α-PVP analogs to act as inhibitors of DAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobeMNshDnZ-LVg90H21EOLACvtfcHk0ljomWf7905-og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1CitL7J&md5=e952abc13123688c8993bcb055c30554</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00160%26sid%3Dliteratum%253Aachs%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DSakloth%26aufirst%3DF.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DStructural%2520modification%2520of%2520the%2520designer%2520stimulant%2520%25CE%25B1-pyrrolidinovalerophenone%2520%2528%25CE%25B1-PVP%2529%2520influences%2520potency%2520at%2520dopamine%2520transporters%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1726%26epage%3D1731%26doi%3D10.1021%2Facschemneuro.5b00160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutsell, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negus, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Stereoselective actions of methylenedioxypyrovalerone (MDPV) to inhibit dopamine and norepinephrine transporters and facilitate intracranial self-stimulation in rats</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisl2nsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=771-777&author=R.+Kolanosauthor=J.+S.+Partillaauthor=M.+H.+Baumannauthor=B.+A.+Hutsellauthor=M.+L.+Banksauthor=S.+S.+Negusauthor=R.+A.+Glennon&title=Stereoselective+actions+of+methylenedioxypyrovalerone+%28MDPV%29+to+inhibit+dopamine+and+norepinephrine+transporters+and+facilitate+intracranial+self-stimulation+in+rats&doi=10.1021%2Facschemneuro.5b00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats</span></div><div class="casAuthors">Kolanos, R.; Partilla, J. S.; Baumann, M. H.; Hutsell, B. A.; Banks, M. L.; Negus, S. S.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">771-777</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The designer stimulant methylenedioxypyrovalerone (MDPV) is a potent reuptake inhibitor at transporters for dopamine (DAT) and norepinephrine (NET) that produces a constellation of abuse-related behavioral effects.  MDPV possesses a chiral center, and the abused formulation of the drug is a racemic mixt., but no data are available on the pharmacol. of its isomers.  Here, the individual optical isomers of MDPV were prepd. and examd. with respect to their neurochem. actions on neurotransmitter reuptake and behavioral effects in an assay of intracranial self-stimulation (ICSS) in rats.  In assays of DAT uptake inhibition, S(+)MDPV (EC50 = 2.13 nM) was more potent than either (±)MDPV (EC50 = 4.85 nM) or R(-)MDPV (EC50 = 382.80 nM); the three drugs were less potent at NET uptake inhibition, with the same rank order of potency.  Neither racemic MDPV nor its optical isomers inhibited the reuptake of serotonin at concns. up to 10 μM.  S(+)MDPV produced an abuse-related and dose-dependent facilitation of ICSS, and the potency of S(+)MDPV (significant facilitation at doses ≥ 0.1 mg/kg) was greater than that of the racemate (significant facilitation at doses ≥ 0.32 mg/kg).  R(-)MDPV failed to alter ICSS at doses up to 100 times greater than the lowest ED of S(+)MDPV.  The results indicate that abuse-related neurochem. and behavioral effects of racemic MDPV reside primarily with its S(+) isomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEYqB2-T_luLVg90H21EOLACvtfcHk0lhiN1GZdpeFqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisl2nsLs%253D&md5=1dc2fc5c94ce8e4f8a5e58fb0e676652</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00006%26sid%3Dliteratum%253Aachs%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DHutsell%26aufirst%3DB.%2BA.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DStereoselective%2520actions%2520of%2520methylenedioxypyrovalerone%2520%2528MDPV%2529%2520to%2520inhibit%2520dopamine%2520and%2520norepinephrine%2520transporters%2520and%2520facilitate%2520intracranial%2520self-stimulation%2520in%2520rats%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D771%26epage%3D777%26doi%3D10.1021%2Facschemneuro.5b00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1016/S0091-3057(01)00666-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2801%2900666-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=205-213&author=R.+Youngauthor=R.+A.+Glennon&title=The+stimulus+effect+of+5%2C6%2C7%2C8-tetrahydro-1%2C3-dioxolo%5B4%2C5-g%5Disoquinoline+is+similar+to+that+of+cocaine+but+different+from+that+of+amphetamine&doi=10.1016%2FS0091-3057%2801%2900666-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2801%2900666-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252801%252900666-9%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DThe%2520stimulus%2520effect%2520of%25205%252C6%252C7%252C8-tetrahydro-1%252C3-dioxolo%255B4%252C5-g%255Disoquinoline%2520is%2520similar%2520to%2520that%2520of%2520cocaine%2520but%2520different%2520from%2520that%2520of%2520amphetamine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D71%26spage%3D205%26epage%3D213%26doi%3D10.1016%2FS0091-3057%2801%2900666-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangisetty, J. B.</span><span> </span><span class="NLM_article-title">Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1016/S0091-3057(01)00768-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2801%2900768-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2002&pages=379-387&author=R.+A.+Glennonauthor=R.+Youngauthor=J.+B.+Rangisetty&title=Further+characterization+of+the+stimulus+properties+of+5%2C6%2C7%2C8-tetrahydro-1%2C3-dioxolo%5B4%2C5-g%5Disoquinoline&doi=10.1016%2FS0091-3057%2801%2900768-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2801%2900768-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252801%252900768-7%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DRangisetty%26aufirst%3DJ.%2BB.%26atitle%3DFurther%2520characterization%2520of%2520the%2520stimulus%2520properties%2520of%25205%252C6%252C7%252C8-tetrahydro-1%252C3-dioxolo%255B4%252C5-g%255Disoquinoline%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D72%26spage%3D379%26epage%3D387%26doi%3D10.1016%2FS0091-3057%2801%2900768-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1016/j.pbb.2006.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2006.04.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=62-73&author=R.+Youngauthor=S.+Batkaiauthor=M.+Dukatauthor=R.+A.+Glennon&title=TDIQ+%285%2C6%2C7%2C8-tetrahydro-1%2C3-dioxolo%5B4%2C5-g%5Disoquinoline%29+exhibits+anxiolytic-like+activity+in+a+marble-burying+assay+in+mice&doi=10.1016%2Fj.pbb.2006.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2006.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2006.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DBatkai%26aufirst%3DS.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DTDIQ%2520%25285%252C6%252C7%252C8-tetrahydro-1%252C3-dioxolo%255B4%252C5-g%255Disoquinoline%2529%2520exhibits%2520anxiolytic-like%2520activity%2520in%2520a%2520marble-burying%2520assay%2520in%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2006%26volume%3D84%26spage%3D62%26epage%3D73%26doi%3D10.1016%2Fj.pbb.2006.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of the 5-HT<sub>1A</sub> agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin (8-OH DPAT)</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1016/0091-3057(86)90243-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2886%2990243-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=135-139&author=R.+A.+Glennon&title=Discriminative+stimulus+properties+of+the+5-HT1A+agonist+8-hydroxy-2-%28di-n-propylamino%29tetralin+%288-OH+DPAT%29&doi=10.1016%2F0091-3057%2886%2990243-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2886%2990243-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252886%252990243-1%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520the%25205-HT1A%2520agonist%25208-hydroxy-2-%2528di-n-propylamino%2529tetralin%2520%25288-OH%2520DPAT%2529%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1986%26volume%3D25%26spage%3D135%26epage%3D139%26doi%3D10.1016%2F0091-3057%2886%2990243-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Björk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höök, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andén, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span> </span><span class="NLM_article-title">Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: Stereoselective interactions with 5-HT<sub>1A</sub> receptors in the brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1021/jm00124a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00124a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=779-783&author=L.+Bj%C3%B6rkauthor=B.+B.+H%C3%B6%C3%B6kauthor=D.+L.+Nelsonauthor=N.+E.+And%C3%A9nauthor=U.+Hacksell&title=Resolved+N%2CN-dialkylated+2-amino-8-hydroxytetralins%3A+Stereoselective+interactions+with+5-HT1A+receptors+in+the+brain&doi=10.1021%2Fjm00124a009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm00124a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00124a009%26sid%3Dliteratum%253Aachs%26aulast%3DBj%25C3%25B6rk%26aufirst%3DL.%26aulast%3DH%25C3%25B6%25C3%25B6k%26aufirst%3DB.%2BB.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DAnd%25C3%25A9n%26aufirst%3DN.%2BE.%26aulast%3DHacksell%26aufirst%3DU.%26atitle%3DResolved%2520N%252CN-dialkylated%25202-amino-8-hydroxytetralins%253A%2520Stereoselective%2520interactions%2520with%25205-HT1A%2520receptors%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D779%26epage%3D783%26doi%3D10.1021%2Fjm00124a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Naiman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydelek, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">2-(Alkylamino)tetralin derivatives: interaction with 5-HT<sub>1A</sub> serotonin binding sites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1021/jm00121a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00121a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=253-256&author=N.+Naimanauthor=R.+A.+Lyonauthor=A.+E.+Bullockauthor=L.+T.+Rydelekauthor=M.+Titelerauthor=R.+A.+Glennon&title=2-%28Alkylamino%29tetralin+derivatives%3A+interaction+with+5-HT1A+serotonin+binding+sites&doi=10.1021%2Fjm00121a045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm00121a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00121a045%26sid%3Dliteratum%253Aachs%26aulast%3DNaiman%26aufirst%3DN.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DBullock%26aufirst%3DA.%2BE.%26aulast%3DRydelek%26aufirst%3DL.%2BT.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D2-%2528Alkylamino%2529tetralin%2520derivatives%253A%2520interaction%2520with%25205-HT1A%2520serotonin%2520binding%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D253%26epage%3D256%26doi%3D10.1021%2Fjm00121a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Ariens, E. J.</span><span> </span><span class="NLM_article-title">Agonists and antagonists—Their structural relationship</span>. In  <span class="citation_source-book">Drug Design</span>; <span class="NLM_contrib-group">Ariens, E. J.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1971</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">I</span>, pp  <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1971&pages=162-193&author=E.+J.+Ariensauthor=E.+J.+Ariens&title=Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAriens%26aufirst%3DE.%2BJ.%26atitle%3DAgonists%2520and%2520antagonists%25E2%2580%2594Their%2520structural%2520relationship%26btitle%3DDrug%2520Design%26aulast%3DAriens%26aufirst%3DE.%2BJ.%26pub%3DAcademic%2520Press%26date%3D1971%26volume%3DI%26spage%3D162%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Hauck, A. E.</span><span> </span><span class="NLM_article-title">CNS stimulants and serotonergic properties of phenylalkylamines</span>. Doctoral Dissertation, Virginia Commonwealth University, Richmond, VA, May<span class="NLM_x"> </span><span class="NLM_year">1985</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&author=A.+E.+Hauck&title=CNS+stimulants+and+serotonergic+properties+of+phenylalkylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauck%26aufirst%3DA.%2BE.%26atitle%3DCNS%2520stimulants%2520and%2520serotonergic%2520properties%2520of%2520phenylalkylamines%26date%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">MDMA stimulus generalization to the 5-HT<sub>1A</sub> serotonin agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1016/S0091-3057(00)00174-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2800%2900174-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2000&pages=483-488&author=R.+A.+Glennonauthor=R.+Young&title=MDMA+stimulus+generalization+to+the+5-HT1A+serotonin+agonist+8-hydroxy-2-%28di-n-propylamino%29tetralin&doi=10.1016%2FS0091-3057%2800%2900174-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2800%2900174-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252800%252900174-X%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DMDMA%2520stimulus%2520generalization%2520to%2520the%25205-HT1A%2520serotonin%2520agonist%25208-hydroxy-2-%2528di-n-propylamino%2529tetralin%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2000%26volume%3D66%26spage%3D483%26epage%3D488%26doi%3D10.1016%2FS0091-3057%2800%2900174-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Khorana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Effect of 8-hydroxy-2-(N,N-di-<i>n</i>-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1016/j.pbb.2008.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2008.08.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2009&pages=385-392&author=N.+Khoranaauthor=R.+Youngauthor=R.+A.+Glennon&title=Effect+of+8-hydroxy-2-%28N%2CN-di-n-propylamino%29tetralin+and+MDMA+on+the+discriminative+stimulus+effects+of+the+classical+hallucinogen+DOM+in+rats&doi=10.1016%2Fj.pbb.2008.08.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DKhorana%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DEffect%2520of%25208-hydroxy-2-%2528N%252CN-di-n-propylamino%2529tetralin%2520and%2520MDMA%2520on%2520the%2520discriminative%2520stimulus%2520effects%2520of%2520the%2520classical%2520hallucinogen%2520DOM%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2009%26volume%3D91%26spage%3D385%26epage%3D392%26doi%3D10.1016%2Fj.pbb.2008.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Walker, J. M.; Martin, W. J.; Hohmann, A. G.; Hemstreet, M. K.; Roth, J. S.; Leitner, M. L.; Weiser, S. D.; Patrick, S. L.; Patrick, R. L.; Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">Role of sigma receptors in brain mechanisms of movement</span>. In  <span class="citation_source-book">Sigma Receptors</span>; <span class="NLM_contrib-group">Itzhak, Y.</span> Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">1994</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=205-224&author=J.+M.+Walker&author=W.+J.+Martin&author=A.+G.+Hohmann&author=M.+K.+Hemstreet&author=J.+S.+Roth&author=M.+L.+Leitner&author=S.+D.+Weiser&author=S.+L.+Patrick&author=R.+L.+Patrick&author=R.+R.+Matsumotoauthor=Y.+Itzhak&title=Sigma+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520sigma%2520receptors%2520in%2520brain%2520mechanisms%2520of%2520movement%26btitle%3DSigma%2520Receptors%26aulast%3DItzhak%26aufirst%3DY.%26pub%3DAcademic%2520Press%26date%3D1994%26spage%3D205%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Liu, Y.; Yu, Y.; Shaikh, J.; Pouw, B.; Daniels, A.; Chen, Q.-D.; Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">σ receptors and drug abuse</span>. In  <span class="citation_source-book">Sigma Receptors, Chemistry, Cell Biology and Clinical Implications</span>; <span class="NLM_contrib-group">Matsumoto, R. R.; Bowen, W. D.; Su, T.-P.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2F978-0-387-36514-5_15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=315-336&author=Y.+Liu&author=Y.+Yu&author=J.+Shaikh&author=B.+Pouw&author=A.+Daniels&author=Q.-D.+Chen&author=R.+R.+Matsumotoauthor=R.+R.+Matsumoto&author=W.+D.+Bowen&author=T.-P.+Su&title=Sigma+Receptors%2C+Chemistry%2C+Cell+Biology+and+Clinical+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-36514-5_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-36514-5_15%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26atitle%3D%25CF%2583%2520receptors%2520and%2520drug%2520abuse%26btitle%3DSigma%2520Receptors%252C%2520Chemistry%252C%2520Cell%2520Biology%2520and%2520Clinical%2520Implications%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26pub%3DSpringer%26date%3D2007%26spage%3D315%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Ablordeppey, S. Y.; Glennon, R. A.</span><span> </span><span class="NLM_article-title">Pharmacophore models for sigma1 receptor binding</span>. In  <span class="citation_source-book">Sigma Receptors, Chemistry, Cell Biology and Clinical Implications</span>; <span class="NLM_contrib-group">Matsumoto, R. R.; Bowen, W. D.; Su, T.-P.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=71-98&author=S.+Y.+Ablordeppey&author=R.+A.+Glennonauthor=R.+R.+Matsumoto&author=W.+D.+Bowen&author=T.-P.+Su&title=Sigma+Receptors%2C+Chemistry%2C+Cell+Biology+and+Clinical+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26atitle%3DPharmacophore%2520models%2520for%2520sigma1%2520receptor%2520binding%26btitle%3DSigma%2520Receptors%252C%2520Chemistry%252C%2520Cell%2520Biology%2520and%2520Clinical%2520Implications%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26pub%3DSpringer%26date%3D2007%26spage%3D71%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Pharmacophore identification for sigma-1 (σ<sub>1</sub>) receptor binding: Application of the “Deconstruction-Reconstruction-Elaboration” approach</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.2174/138955705774329519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.2174%2F138955705774329519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=16250835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=927-940&author=R.+A.+Glennon&title=Pharmacophore+identification+for+sigma-1+%28%CF%831%29+receptor+binding%3A+Application+of+the+%E2%80%9CDeconstruction-Reconstruction-Elaboration%E2%80%9D+approach&doi=10.2174%2F138955705774329519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore identification for sigma-1 (σ1) receptor binding: Application of the deconstruction - reconstruction - elaboration approach</span></div><div class="casAuthors">Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">927-940</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  At least two different types of sigma σ (σ1 and σ2) receptors have been identified.  A structural feature common to high-affinity (Ki <10 nM) σ1 ligands is: C-N(R)-X-Ph; both C and Ph are assocd. with regions of bulk tolerance.  Numerous other ligands bind, but typically do so with lower affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot_9JlDBLhrbVg90H21EOLACvtfcHk0likU8mss5foEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWku7rM&md5=66ae2e51d57fa97cd3954ae90e7e3167</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.2174%2F138955705774329519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955705774329519%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DPharmacophore%2520identification%2520for%2520sigma-1%2520%2528%25CF%25831%2529%2520receptor%2520binding%253A%2520Application%2520of%2520the%2520%25E2%2580%259CDeconstruction-Reconstruction-Elaboration%25E2%2580%259D%2520approach%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D927%26epage%3D940%26doi%3D10.2174%2F138955705774329519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J. L.</span><span> </span><span class="NLM_article-title">Antagonism of a (+)<i>N</i>-allylnormetazocine stimulus by (−)PPAP and several structurally related analogs</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span><span class="refDoi"> DOI: 10.1016/0091-3057(93)90133-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2893%2990133-E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=865-869&author=R.+A.+Glennonauthor=R.+Youngauthor=J.+L.+Herndon&title=Antagonism+of+a+%28%2B%29N-allylnormetazocine+stimulus+by+%28%E2%88%92%29PPAP+and+several+structurally+related+analogs&doi=10.1016%2F0091-3057%2893%2990133-E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2893%2990133-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252893%252990133-E%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DHerndon%26aufirst%3DJ.%2BL.%26atitle%3DAntagonism%2520of%2520a%2520%2528%252B%2529N-allylnormetazocine%2520stimulus%2520by%2520%2528%25E2%2588%2592%2529PPAP%2520and%2520several%2520structurally%2520related%2520analogs%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1993%26volume%3D45%26spage%3D865%26epage%3D869%26doi%3D10.1016%2F0091-3057%2893%2990133-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Ablordeppey, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Probing the proposed phenyl-A region of the sigma-1 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2765</span><span class="refDoi"> DOI: 10.1016/S0968-0896(02)00096-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0968-0896%2802%2900096-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2759-2765&author=S.+Y.+Ablordeppeyauthor=J.+B.+Fischerauthor=H.+Lawauthor=R.+A.+Glennon&title=Probing+the+proposed+phenyl-A+region+of+the+sigma-1+receptor&doi=10.1016%2FS0968-0896%2802%2900096-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900096-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900096-2%26sid%3Dliteratum%253Aachs%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DLaw%26aufirst%3DH.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DProbing%2520the%2520proposed%2520phenyl-A%2520region%2520of%2520the%2520sigma-1%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2759%26epage%3D2765%26doi%3D10.1016%2FS0968-0896%2802%2900096-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Binding characteristics of σ<sub>2</sub> receptor ligands</span> <span class="citation_source-journal">Brazil. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1590/S1516-93322005000100002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1590%2FS1516-93322005000100002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFCksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=1-12&author=R.+A.+Glennon&title=Binding+characteristics+of+%CF%832+receptor+ligands&doi=10.1590%2FS1516-93322005000100002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102aR"><div class="casContent"><span class="casTitleNuber">102a</span><div class="casTitle"><span class="NLM_cas:atitle">Binding characteristics of σ2 receptor ligands</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Revista Brasileira de Ciencias Farmaceuticas</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">RBCFFM</span>;
        ISSN:<span class="NLM_cas:issn">1516-9332</span>.
    
            (<span class="NLM_cas:orgname">Universidade de Sao Paulo, Faculdade de Ciencias Farmaceuticas</span>)
        </div><div class="casAbstract">A review.  Sigma (σ) receptors, once considered a type of opioid receptor are now recognized as representing a unique receptive entity and at least two different types of σ receptors have been identified σ1 and σ2 receptors.  Evidence suggests that these receptors might be targeted and exploited for the development of agents potentially useful for the treatment of several central disorders.  This review primarily describes some of our efforts to understand those structural features that contribute to σ2 receptor binding, and some recent work by other investigators is also included.  Despite an inability to formulate a unified pharmacophore model for α2 binding due to the diversity of structure-types that bind at the receptor, and to the conformational flexibility of these ligands, significant progress has been made to ward the development od some very high affinity agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQAG2gQdALrVg90H21EOLACvtfcHk0lj_D2vhaB0Hjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFCksLg%253D&md5=863bf7ddc28bafbe45a21d852d85954f</span></div><a href="/servlet/linkout?suffix=cit102a&amp;dbid=16384&amp;doi=10.1590%2FS1516-93322005000100002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS1516-93322005000100002%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520characteristics%2520of%2520%25CF%25832%2520receptor%2520ligands%26jtitle%3DBrazil.%2520J.%2520Pharm.%2520Sci.%26date%3D2005%26volume%3D41%26spage%3D1%26epage%3D12%26doi%3D10.1590%2FS1516-93322005000100002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit102b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Abate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">A structure-affinity and comparative molecular field analysis of sigma-2 (σ<sub>2</sub>) receptor ligands</span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.2174/1871524910909030246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.2174%2F1871524910909030246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=20021358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=246-257&author=C.+Abateauthor=P.+Mosierauthor=F.+Berardiauthor=R.+A.+Glennon&title=A+structure-affinity+and+comparative+molecular+field+analysis+of+sigma-2+%28%CF%832%29+receptor+ligands&doi=10.2174%2F1871524910909030246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102bR"><div class="casContent"><span class="casTitleNuber">102b</span><div class="casTitle"><span class="NLM_cas:atitle">A structure-affinity and comparative molecular field analysis of sigma-2 (σ2) receptor ligands</span></div><div class="casAuthors">Abate, Carmen; Mosier, Philip Daniel; Berardi, Francesco; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">246-257</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Several σ1 receptor ligands with sub-nanomolar affinity and excellent selectivity have been reported, but relatively few σ2-selective ligands are known.  1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl] piperazine (PB28; 1) has been reported by us as a high-affinity σ2 receptor ligand with significant σ2 selectivity, and several analogs of (1) now have been developed.  Among these are the class of cyclohexylpiperazines that display a good compromise between affinity/activity and selectivity for σ2 receptors.  Very little is currently known about the nature of σ2 receptors.  In the absence of structure-based receptor information, we applied a comparative mol. field anal. (CoMFA) - a three-dimensional structure-activity relationship (3D-QSAR) method - to a set of cyclohexylpiperazine σ2 ligands to develop a predictive model that might provide information about the stereoelectronic nature of the receptor binding site.  Two CoMFA models were generated from two different alignments: the first used an automated FlexS algorithm, and the second used a rationally-driven manual alignment.  Significantly better predictivity was obtained with the manual alignment (TSET: q2 = 0.73, r2 = 0.95; PSET: r2 = 0.55/0.73) than from the automated alignment (TSET: q2 = 0.69, r2 = 0.98; PSET: r2 = 0.13/0.16).  The resulting CoMFA maps account for obsd. structure-affinity relationships and suggest a possible anatomy for the σ2 receptor/cyclohexylpiperazine binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNSRDXO2Ws7bVg90H21EOLACvtfcHk0lj_D2vhaB0Hjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rK&md5=b1203a3a8343205b4439481c0ece5a8e</span></div><a href="/servlet/linkout?suffix=cit102b&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030246%26sid%3Dliteratum%253Aachs%26aulast%3DAbate%26aufirst%3DC.%26aulast%3DMosier%26aufirst%3DP.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DA%2520structure-affinity%2520and%2520comparative%2520molecular%2520field%2520analysis%2520of%2520sigma-2%2520%2528%25CF%25832%2529%2520receptor%2520ligands%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D246%26epage%3D257%26doi%3D10.2174%2F1871524910909030246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siripurapu, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikazwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span> </span><span class="NLM_article-title">The medicinal chemistry of 5-HT<sub>6</sub> receptor ligands with a focus on arylsulfonyltryptamine analogs</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span><span class="refDoi"> DOI: 10.2174/156802610791111542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.2174%2F156802610791111542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=20166945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFKnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=579-595&author=R.+A.+Glennonauthor=U.+Siripurapuauthor=B.+L.+Rothauthor=R.+Kolanosauthor=M.+L.+Bondarevauthor=D.+Sikazweauthor=M.+Leeauthor=M.+Dukat&title=The+medicinal+chemistry+of+5-HT6+receptor+ligands+with+a+focus+on+arylsulfonyltryptamine+analogs&doi=10.2174%2F156802610791111542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs</span></div><div class="casAuthors">Glennon, Richard A.; Siripurapu, Uma; Roth, Bryan L.; Kolanos, Renata; Bondarev, Mikhail L.; Sikazwe, Donald; Lee, Mase; Dukat, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Arylsulfonyl analogs of aminopyrimidines (e.g. Ro 04-6790; 2), aminopyridines (e.g. Ro 63-0563; 3), 1-phenylpiperazines (e.g. SB-271046; 4), and tryptamines (e.g. MS-245; 5) were described as the first examples of selective 5-HT6 receptor antagonists only ten years ago.  Today, hundreds of compds. of seemingly diverse structure have been reported.  The early antagonists featured an arylsulfonyl group leading to the widespread assumption that an arylsulfonyl moiety might be crit. for binding and antagonist action.  With respect to the arylsulfonyltryptamines, it seems that neither the "arylsulfonyl" nor the "tryptamine" portion of these compds. is essential for binding or for antagonist action, and some such derivs. even display agonist action.  The present review describes many of the currently available 5-HT6 receptor ligands and, unlike prior reviews, provides a narrative of the thinking (where possible) that led to their design, synthesis, and evaluation.  The arylsulfonyltryptamines are also used as the structural basis of attempts to relate various structure-types to one another to afford a better understanding of the overall structural requirements for 5-HT6 receptor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlcIaCOtbRK7Vg90H21EOLACvtfcHk0ljTtCWHjCIcZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFKnur8%253D&md5=c9aac49fd24a4bc84f478db4217073d4</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.2174%2F156802610791111542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791111542%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DSiripurapu%26aufirst%3DU.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DSikazwe%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3DThe%2520medicinal%2520chemistry%2520of%25205-HT6%2520receptor%2520ligands%2520with%2520a%2520focus%2520on%2520arylsulfonyltryptamine%2520analogs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D579%26epage%3D595%26doi%3D10.2174%2F156802610791111542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Frantz, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouffer, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span><span class="refDoi"> DOI: 10.1016/S0028-3908(01)00165-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0028-3908%2801%2900165-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=170-180&author=K.+J.+Frantzauthor=D.+G.+Hanssonauthor=L.+H.+Stoufferauthor=A.+Parsons&title=5-HT6+receptor+antagonism+potentiates+the+behavioral+and+neurochemical+effects+of+amphetamine+but+not+cocaine&doi=10.1016%2FS0028-3908%2801%2900165-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2801%2900165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252801%252900165-4%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DK.%2BJ.%26aulast%3DHansson%26aufirst%3DD.%2BG.%26aulast%3DStouffer%26aufirst%3DL.%2BH.%26aulast%3DParsons%26aufirst%3DA.%26atitle%3D5-HT6%2520receptor%2520antagonism%2520potentiates%2520the%2520behavioral%2520and%2520neurochemical%2520effects%2520of%2520amphetamine%2520but%2520not%2520cocaine%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D42%26spage%3D170%26epage%3D180%26doi%3D10.1016%2FS0028-3908%2801%2900165-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Pullagurla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondareva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Modulation of the stimulus effects of (+)amphetamine by the 5-HT<sub>6</sub> antagonist MS-245</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span><span class="refDoi"> DOI: 10.1016/j.pbb.2004.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2004.03.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2004&pages=263-268&author=M.+Pullagurlaauthor=T.+Bondarevaauthor=R.+Youngauthor=R.+A.+Glennon&title=Modulation+of+the+stimulus+effects+of+%28%2B%29amphetamine+by+the+5-HT6+antagonist+MS-245&doi=10.1016%2Fj.pbb.2004.03.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2004.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2004.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DPullagurla%26aufirst%3DM.%26aulast%3DBondareva%26aufirst%3DT.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DModulation%2520of%2520the%2520stimulus%2520effects%2520of%2520%2528%252B%2529amphetamine%2520by%2520the%25205-HT6%2520antagonist%2520MS-245%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2004%26volume%3D78%26spage%3D263%26epage%3D268%26doi%3D10.1016%2Fj.pbb.2004.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondareva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Effect of the 5-HT<sub>6</sub> serotonin antagonist MS-245 on the actions of (−)nicotine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1016/j.pbb.2006.07.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2006.07.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=170-177&author=R.+Youngauthor=T.+Bondarevaauthor=A.+Wesolowskaauthor=S.+Youngauthor=R.+A.+Glennon&title=Effect+of+the+5-HT6+serotonin+antagonist+MS-245+on+the+actions+of+%28%E2%88%92%29nicotine&doi=10.1016%2Fj.pbb.2006.07.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2006.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2006.07.029%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DBondareva%26aufirst%3DT.%26aulast%3DWesolowska%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DEffect%2520of%2520the%25205-HT6%2520serotonin%2520antagonist%2520MS-245%2520on%2520the%2520actions%2520of%2520%2528%25E2%2588%2592%2529nicotine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2006%26volume%3D85%26spage%3D170%26epage%3D177%26doi%3D10.1016%2Fj.pbb.2006.07.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacyno, J. M.</span><span> </span><span class="NLM_article-title">Indolealkylamine and phenalkylamine hallucinogens: Effect of α-methyl and N-methyl substituents on behavioral activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1267</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span><span class="refDoi"> DOI: 10.1016/0006-2952(83)90281-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0006-2952%2883%2990281-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1983&pages=1267-1273&author=R.+A.+Glennonauthor=R.+Youngauthor=J.+M.+Jacyno&title=Indolealkylamine+and+phenalkylamine+hallucinogens%3A+Effect+of+%CE%B1-methyl+and+N-methyl+substituents+on+behavioral+activity&doi=10.1016%2F0006-2952%2883%2990281-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2883%2990281-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252883%252990281-2%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DJacyno%26aufirst%3DJ.%2BM.%26atitle%3DIndolealkylamine%2520and%2520phenalkylamine%2520hallucinogens%253A%2520Effect%2520of%2520%25CE%25B1-methyl%2520and%2520N-methyl%2520substituents%2520on%2520behavioral%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1983%26volume%3D32%26spage%3D1267%26epage%3D1273%26doi%3D10.1016%2F0006-2952%2883%2990281-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seggel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Indolealkylamine analogs share 5-HT<sub>2</sub> binding characteristics with phenalkylamine hallucinogens</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1016/0014-2999(88)90432-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0014-2999%2888%2990432-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3350047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL1cXksVOrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1988&pages=291-297&author=R.+A.+Lyonauthor=M.+Titelerauthor=M.+R.+Seggelauthor=R.+A.+Glennon&title=Indolealkylamine+analogs+share+5-HT2+binding+characteristics+with+phenalkylamine+hallucinogens&doi=10.1016%2F0014-2999%2888%2990432-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens</span></div><div class="casAuthors">Lyon, Robert A.; Titeler, Milt; Seggel, Mark R.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-7</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">A group of 25 substituted indolealkylamines I; R = H, Me, Et; R2, R3 = H, Me; R4 = H, OMe; R5 = H, OH, OMe, benzyloxy; R6 = H, Me, OMe; R7 = H, OH, Me, OMe, Br) and related compds. some of which are known to be psychoactive in man, were examd. for their binding interactions with rat brain cortical 5-HT2 receptors labeled with the antagonist radioligand [3H]ketanserin in order to develop structure-activity relationships for binding at these sites.  Features investigated included arom., α-Me, and terminal amine substituents.  4-Methoxy and 5-methoxy substitution impart a higher affinity than 6- or 7-methoxy substitution; a 7-hydroxyl group essentially abolishes affinity whereas a 7-Me or 7-bromo group enhances affinity.  α-Methylation has little effect on affinity and, in the one case examd., the S(+) isomer of α-methyltryptamine was essentially equipotent with its racemate and twice as potent as its R(-) enantiomer.  Terminal amine methylation results in a small but progressive decrease in affinity in the order: primary amine > dimethylamine > diethylamine.  Similarities were noted between these structural requirements for binding and those of the phenalkylamines.  Selected compds. (5-methoxytryptamine, N,N-dimethyltryptamine, 5-methoxy-N,N-diethyltryptamine and 5-methoxy-N,N-dimethyltryptamine) were further examd. by 2-site anal. of displacement studies for [3H]ketanserin specific binding.  Hill coeffs. were less than 1 and computer-assisted anal. indicated that a 2-site model better fit the data than a 1-site model.  In displacement studies using the putative agonist radioligand [3H]DOB to label 5-HT2 receptors affinities were 10-100-fold higher than those using [3H]ketanserin.  These results are also consistent with earlier findings using psychoactive phenalkylamines in competition studies for radiolabeled 5-HT2 receptors.  The interactions of indolealkylamines and phenalkylamines with 5-HT2 receptors have many characteristics in common, supporting the hypothesis that 5-HT2 receptors may mediate the psychoactive properties of indolealkylamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRNq0psu7f-rVg90H21EOLACvtfcHk0lgjDUSBrDPuig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXksVOrtr0%253D&md5=1085e511e975b40cb19036a2240036e4</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990432-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990432-3%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DSeggel%26aufirst%3DM.%2BR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DIndolealkylamine%2520analogs%2520share%25205-HT2%2520binding%2520characteristics%2520with%2520phenalkylamine%2520hallucinogens%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D145%26spage%3D291%26epage%3D297%26doi%3D10.1016%2F0014-2999%2888%2990432-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of site-selective serotonin agonists</span>. In  <span class="citation_source-book">Transduction Mechanisms of Drug Stimuli</span>; <span class="NLM_contrib-group">Colpaert, F. C.; Balster, R. L.</span>, Eds.; <span class="NLM_publisher-name">Springer Verlag</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2F978-3-642-73223-2_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=15-31&author=R.+A.+Glennonauthor=F.+C.+Colpaert&author=R.+L.+Balster&title=Transduction+Mechanisms+of+Drug+Stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-73223-2_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-73223-2_2%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520site-selective%2520serotonin%2520agonists%26btitle%3DTransduction%2520Mechanisms%2520of%2520Drug%2520Stimuli%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26pub%3DSpringer%2520Verlag%26date%3D1988%26spage%3D15%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Hong, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of α-ethyltryptamine optical isomers</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span><span class="refDoi"> DOI: 10.1016/S0091-3057(01)00605-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2801%2900605-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=311-316&author=S.-S.+Hongauthor=R.+Youngauthor=R.+A.+Glennon&title=Discriminative+stimulus+properties+of+%CE%B1-ethyltryptamine+optical+isomers&doi=10.1016%2FS0091-3057%2801%2900605-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2801%2900605-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252801%252900605-0%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520%25CE%25B1-ethyltryptamine%2520optical%2520isomers%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2001%26volume%3D70%26spage%3D311%26epage%3D316%26doi%3D10.1016%2FS0091-3057%2801%2900605-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misenheimer, B. R.</span><span> </span><span class="NLM_article-title">Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span><span class="refDoi"> DOI: 10.1016/0091-3057(89)90491-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2889%2990491-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1989&pages=909-912&author=R.+A.+Glennonauthor=B.+R.+Misenheimer&title=Stimulus+effects+of+N-monoethyl-1-%283%2C4-methylenedioxyphenyl%29-2-aminopropane+%28MDE%29+and+N-hydroxy-1-%283%2C4-methylenedioxyphenyl%29-2-aminopropane+%28N-OH+MDA%29+in+rats+trained+to+discriminate+MDMA+from+saline&doi=10.1016%2F0091-3057%2889%2990491-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2889%2990491-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252889%252990491-7%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DMisenheimer%26aufirst%3DB.%2BR.%26atitle%3DStimulus%2520effects%2520of%2520N-monoethyl-1-%25283%252C4-methylenedioxyphenyl%2529-2-aminopropane%2520%2528MDE%2529%2520and%2520N-hydroxy-1-%25283%252C4-methylenedioxyphenyl%2529-2-aminopropane%2520%2528N-OH%2520MDA%2529%2520in%2520rats%2520trained%2520to%2520discriminate%2520MDMA%2520from%2520saline%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1989%26volume%3D33%26spage%3D909%26epage%3D912%26doi%3D10.1016%2F0091-3057%2889%2990491-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">MDMA-Like stimulus effects of α-ethyltryptamine and the α-ethyl homolog of DOM</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span><span class="refDoi"> DOI: 10.1016/0091-3057(93)90379-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2893%2990379-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=459-462&author=R.+A.+Glennon&title=MDMA-Like+stimulus+effects+of+%CE%B1-ethyltryptamine+and+the+%CE%B1-ethyl+homolog+of+DOM&doi=10.1016%2F0091-3057%2893%2990379-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2893%2990379-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252893%252990379-8%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DMDMA-Like%2520stimulus%2520effects%2520of%2520%25CE%25B1-ethyltryptamine%2520and%2520the%2520%25CE%25B1-ethyl%2520homolog%2520of%2520DOM%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1993%26volume%3D46%26spage%3D459%26epage%3D462%26doi%3D10.1016%2F0091-3057%2893%2990379-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondareva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">α-Ethyltryptamine (α-ET) as a discriminative stimulus in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span><span class="refDoi"> DOI: 10.1016/j.pbb.2006.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2006.09.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=448-453&author=R.+A.+Glennonauthor=T.+Bondarevaauthor=R.+Young&title=%CE%B1-Ethyltryptamine+%28%CE%B1-ET%29+as+a+discriminative+stimulus+in+rats&doi=10.1016%2Fj.pbb.2006.09.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2006.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2006.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DBondareva%26aufirst%3DT.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3D%25CE%25B1-Ethyltryptamine%2520%2528%25CE%25B1-ET%2529%2520as%2520a%2520discriminative%2520stimulus%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2006%26volume%3D85%26spage%3D448%26epage%3D453%26doi%3D10.1016%2Fj.pbb.2006.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landavazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span> </span><span class="NLM_article-title">α-Ethyltryptamines as dual dopamine-serotonin releasers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4754</span><span class="NLM_x">–</span> <span class="NLM_lpage">4758</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.07.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.bmcl.2014.07.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4754-4758&author=B.+E.+Bloughauthor=A.+Landavazoauthor=J.+S.+Partillaauthor=A.+M.+Deckerauthor=K.+M.+Pageauthor=M.+H.+Baumannauthor=R.+B.+Rothman&title=%CE%B1-Ethyltryptamines+as+dual+dopamine-serotonin+releasers&doi=10.1016%2Fj.bmcl.2014.07.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.07.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.07.062%26sid%3Dliteratum%253Aachs%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DLandavazo%26aufirst%3DA.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DPage%26aufirst%3DK.%2BM.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26atitle%3D%25CE%25B1-Ethyltryptamines%2520as%2520dual%2520dopamine-serotonin%2520releasers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4754%26epage%3D4758%26doi%3D10.1016%2Fj.bmcl.2014.07.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Evidence for possible involvement of 5-HT<sub>2B</sub> receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2836</span><span class="NLM_x">–</span> <span class="NLM_lpage">2841</span><span class="refDoi"> DOI: 10.1161/01.CIR.102.23.2836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1161%2F01.CIR.102.23.2836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=11104741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=2836-2841&author=R.+B.+Rothmanauthor=M.+H.+Baumannauthor=J.+E.+Savageauthor=L.+Rauserauthor=A.+McBrideauthor=S.+J.+Hufeisenauthor=B.+L.+Roth&title=Evidence+for+possible+involvement+of+5-HT2B+receptors+in+the+cardiac+valvulopathy+associated+with+fenfluramine+and+other+serotonergic+medications&doi=10.1161%2F01.CIR.102.23.2836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.; Savage, Jason E.; Rauser, Laura; McBride, Ace; Hufeisen, Sandra J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2836-2841</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Serotonergic medications with various mechanisms of action are used to treat psychiatric disorders and are being investigated as treatments for drug dependence.  The occurrence of fenfluramine-assocd. valvular heart disease (VHD) has raised concerns that other serotonergic medications might also increase the risk of developing VHD.  We hypothesized that fenfluramine or its metabolite norfenfluramine and other medications known to produce VHD have preferentially high affinities for a particular serotonin receptor subtype capable of stimulating mitogenesis.  Medications known or suspected to cause VHD (pos. controls) and medications not assocd. with VHD (neg. controls) were screened for activity at 11 cloned serotonin receptor subtypes by use of ligand-binding methods and functional assays.  The pos. control drugs were (±)-fenfluramine; (+)-fenfluramine; (-)-fenfluramine; its metabolites (±)-norfenfluramine, (+)-norfenfluramine, and (-)-norfenfluramine; ergotamine; and methysergide and its metabolite methylergonovine.  The neg. control drugs were phentermine, fluoxetine, its metabolite norfluoxetine, and trazodone and its active metabolite m-chlorophenylpiperazine.  (±)-, (+)-, And (-)-Norfenfluramine, ergotamine, and methylergonovine all had preferentially high affinities for the cloned human serotonin 5-HT2B receptor and were partial to full agonists at the 5-HT2B receptor.  Our data imply that activation of 5-HT2B receptors is necessary to produce VHD and that serotonergic medications that do not activate 5-HT2B receptors are unlikely to produce VHD.  We suggest that all clin. available medications with serotonergic activity and their active metabolites be screened for agonist activity at 5-HT2B receptors and that clinicians should consider suspending their use of medications with significant activity at 5-HT2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6spUXOCLtLrVg90H21EOLACvtfcHk0limanfzkonXeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D&md5=6b8c6059885dd9b058859089914c61b3</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.102.23.2836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.102.23.2836%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DSavage%26aufirst%3DJ.%2BE.%26aulast%3DRauser%26aufirst%3DL.%26aulast%3DMcBride%26aufirst%3DA.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DEvidence%2520for%2520possible%2520involvement%2520of%25205-HT2B%2520receptors%2520in%2520the%2520cardiac%2520valvulopathy%2520associated%2520with%2520fenfluramine%2520and%2520other%2520serotonergic%2520medications%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D2836%26epage%3D2841%26doi%3D10.1161%2F01.CIR.102.23.2836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102a','cit102b'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xuan Chen, <span class="NLM_string-name hlFld-ContribAuthor">Samir Z. Zard</span>. </span><span class="cited-content_cbyCitation_article-title">Convergent Route to β-Amino Acids and to β-Heteroarylethylamines: An Unexpected Vinylation Reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (9)
                                     , 3628-3632. <a href="https://doi.org/10.1021/acs.orglett.0c01087" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01087%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DConvergent%252BRoute%252Bto%252B%2525CE%2525B2-Amino%252BAcids%252Band%252Bto%252B%2525CE%2525B2-Heteroarylethylamines%25253A%252BAn%252BUnexpected%252BVinylation%252BReaction%26aulast%3DChen%26aufirst%3DXuan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25032020%26date%3D21042020%26volume%3D22%26issue%3D9%26spage%3D3628%26epage%3D3632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elisa Uliassi, Luis Emiliano Peña-Altamira, Aixa V. Morales, Francesca Massenzio, Sabrina Petralla, Michele Rossi, Marinella Roberti, Loreto Martinez Gonzalez, Ana Martinez, Barbara Monti, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 279-294. <a href="https://doi.org/10.1021/acschemneuro.8b00242" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00242%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BFocused%252BLibrary%252Bof%252BPsychotropic%252BAnalogues%252Bwith%252BNeuroprotective%252Band%252BNeuroregenerative%252BPotential%26aulast%3DUliassi%26aufirst%3DElisa%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20052018%26date%3D25092018%26date%3D09102018%26date%3D25092018%26volume%3D10%26issue%3D1%26spage%3D279%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuan-Hui Ouyang, Yang Li, Ren-Jie Song, <span class="NLM_string-name hlFld-ContribAuthor">Jin-Heng Li</span>. </span><span class="cited-content_cbyCitation_article-title">Alkylamination of Styrenes with Alkyl N-Hydroxyphthalimide Esters and Amines by B(C6H5)3-Facilitated Photoredox Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (21)
                                     , 6659-6662. <a href="https://doi.org/10.1021/acs.orglett.8b02670" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02670%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAlkylamination%252Bof%252BStyrenes%252Bwith%252BAlkyl%252BN-Hydroxyphthalimide%252BEsters%252Band%252BAmines%252Bby%252BB%252528C6H5%2525293-Facilitated%252BPhotoredox%252BCatalysis%26aulast%3DOuyang%26aufirst%3DXuan-Hui%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21082018%26date%3D22102018%26volume%3D20%26issue%3D21%26spage%3D6659%26epage%3D6662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ann M.  Decker</span>, <span class="hlFld-ContribAuthor ">Kelly M.  Mathews</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">Brian P.  Gilmour</span>. </span><span class="cited-content_cbyCitation_article-title">Validation of a High-Throughput Calcium Mobilization Assay for the Human Trace Amine-Associated Receptor 1. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2021,</strong> <em>26 </em>
                                    (1)
                                     , 140-150. <a href="https://doi.org/10.1177/2472555220945279" title="DOI URL">https://doi.org/10.1177/2472555220945279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555220945279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555220945279%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DValidation%252Bof%252Ba%252BHigh-Throughput%252BCalcium%252BMobilization%252BAssay%252Bfor%252Bthe%252BHuman%252BTrace%252BAmine-Associated%252BReceptor%252B1%26aulast%3DDecker%26aufirst%3DAnn%2BM.%26date%3D2021%26date%3D2020%26volume%3D26%26issue%3D1%26spage%3D140%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Xu</span>, <span class="hlFld-ContribAuthor ">Chun  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Three-component difluoroalkylamination of alkenes mediated by photoredox and iron cooperative catalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (37)
                                     , 8541-8545. <a href="https://doi.org/10.1039/C9OB01815H" title="DOI URL">https://doi.org/10.1039/C9OB01815H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01815H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01815H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThree-component%252Bdifluoroalkylamination%252Bof%252Balkenes%252Bmediated%252Bby%252Bphotoredox%252Band%252Biron%252Bcooperative%252Bcatalysis%26aulast%3DXu%26aufirst%3DRui%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D37%26spage%3D8541%26epage%3D8545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia N.  Calderon</span>, <span class="hlFld-ContribAuthor ">Joshua  Hunt</span>, <span class="hlFld-ContribAuthor ">Michael  Klein</span>. </span><span class="cited-content_cbyCitation_article-title">A regulatory perspective on the evaluation of hallucinogen drugs for human use. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>142 </em>, 135-142. <a href="https://doi.org/10.1016/j.neuropharm.2017.11.028" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.11.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.11.028%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DA%252Bregulatory%252Bperspective%252Bon%252Bthe%252Bevaluation%252Bof%252Bhallucinogen%252Bdrugs%252Bfor%252Bhuman%252Buse%26aulast%3DCalderon%26aufirst%3DSilvia%2BN.%26date%3D2018%26volume%3D142%26spage%3D135%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton E.  Canal</span>. </span><span class="cited-content_cbyCitation_article-title">Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 227-260. <a href="https://doi.org/10.1007/164_2018_107" title="DOI URL">https://doi.org/10.1007/164_2018_107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2018_107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2018_107%26sid%3Dliteratum%253Aachs%26atitle%3DSerotonergic%252BPsychedelics%25253A%252BExperimental%252BApproaches%252Bfor%252BAssessing%252BMechanisms%252Bof%252BAction%26aulast%3DCanal%26aufirst%3DClinton%2BE.%26date%3D2018%26date%3D2018%26spage%3D227%26epage%3D260%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNew%252BPsychoactive%252BSubstances%26aulast%3DMaurer%26aufirst%3DHans%2BH.%26date%3D2018%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The “phenylalkylaminegnome”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of a few common agents containing an embedded phenylethylamine (<b>1</b>) moiety: lysergic acid diethylamide (<b>2</b>), morphine (<b>3</b>), venlafaxine (<b>4</b>), ziprasidone (<b>5</b>), lorcaserin (<b>6</b>), and the 5-HT<sub>1A</sub> serotonin receptor agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin (<b>7</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural relationships among several psychoactive arylalkylamines: the central stimulant amphetamine (<b>8</b>) and the classical hallucinogens mescaline (<b>9</b>), 5-methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine (5-OMe DMT, <b>10</b>), 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM, <b>11</b>), and its halogenated counterparts DOB (<b>12</b>) and DOI (<b>13</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. A typical dose–response plot for stimulus generalization studies. Animals trained to discriminate 1.0 mg/kg of a hypothetical training drug (uppermost solid square) from saline vehicle make >80% of their responses on the drug-appropriate lever following administration of this dose and <20 of their responses on this lever when administered vehicle (data not shown). Lower doses of the training drug result in decreased drug-appropriate responding (i.e., solid squares shown at <1.0 mg/kg) such that an ED<sub>50</sub> value can be calculated. When doses of challenge drugs A and B (open squares and open circles) are administered, stimulus generalization is said to have occurred if the animals produce >80% training-drug-appropriate responding at some dose. Here, drugs A and B substituted (implying a similarity of stimulus effects), and ED<sub>50</sub> doses can be calculated. Drug C (open triangles) produced vehicle-appropriate (i.e., <20 drug-appropriate) responding at the highest doses examined (this does not imply that the agents are pharmacologically inactive; i.e., they might be capable of producing a “different” stimulus effects). Some agents produce >20% but <80% drug-appropriate responding at the highest dose(s) examined; this is termed partial generalization. No reliable conclusions can be drawn from such data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Stimulus generalization. A challenge drug might or might not substitute for (i.e., the challenge drug might or might not be recognized by) the trained animals. Stimulus generalization suggests a similarity of stimulus effects.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stimulus antagonism. Animals trained to a specific drug will respond on the “vehicle appropriate” lever if a combination of the training drug and the antagonist results in stimulus antagonism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Examples of phenylalkylamine-derived 5-HT<sub>2A</sub> receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. 5-HT<sub>2</sub> receptor agonists <b>26</b>, <b>27</b>, <b>29</b>-<b>31</b>, <b>40</b>, <b>41</b>, and the 5-HT<sub>2</sub> receptor antagonist volinanserin (<b>28</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of several MDA (<b>42</b>)-related compounds: MDMA (<b>43</b>), PMA (<b>44</b>), PMMA (<b>45</b>), 3,4-DMA (<b>46</b>), and MMA (<b>47</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Stimulus properties of numerous arylalkylamines (indolealkylamines and phenylalkylamines) have been classified as being primarily of three types: DOM-like, amphetamine (AMPH)-like, or PMMA-like (reviewed<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>). Certain agents produce a combination of effects; for example, MDMA shares stimulus properties with amphetamine and PMMA and is best characterized as producing an A/P-like effect. (±)MDA produces all three stimulus effects and best associated with the common intersect.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of <i>S</i>(+)amphetamine [<i>S</i>(+)AMPH], <i>S</i>(+)methamphetamine [<i>S</i>(+)METH], and their phenylpropanolamine counterparts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Chemical structures of cathinone (originally termed β-ketoamphetamine), its optical isomers, and methcathinone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Examples of synthetic cathinones: methylone (<b>59</b>), mephedrone (<b>60</b>), methylenedioxypyrovalerone (<b>61</b>), and α-pyrrolidinovalerophenone (<b>62</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Conformationally constrained phenylalkylamines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Chemical structures of diazepam (<b>69</b>), buspirone (<b>70</b>), and NAN-190 (<b>71</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. 8-OH DPAT-related analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Examples of arylalkylamines examined at σ<sub>1</sub> receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. 5-HT<sub>6</sub> receptor ligands developed in our laboratory.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/medium/jm-2017-00085x_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Chemical structures of indolealkylamines α-MeT (<b>101</b>) and α-ET (<b>102</b>) and the 5-HT releasing agent fenfluramine (<b>103</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00085/20170407/images/large/jm-2017-00085x_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00085&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 115 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">The phenylalkylaminome: scaffolding for drugs of abuse, with a focus on synthetic cathinones</span>. Presented at the 249th National Meeting of the American Chemical Society, Denver, CO, March<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>MEDI 250.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+A.+Glennon&title=The+phenylalkylaminome%3A+scaffolding+for+drugs+of+abuse%2C+with+a+focus+on+synthetic+cathinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DThe%2520phenylalkylaminome%253A%2520scaffolding%2520for%2520drugs%2520of%2520abuse%252C%2520with%2520a%2520focus%2520on%2520synthetic%2520cathinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wishart, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassanali, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stothard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolsey, J.</span><span> </span><span class="NLM_article-title">DrugBank: A comprehensive resource for in silico drug discovery and exploration</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">Database issue</span><span class="NLM_x">) </span> <span class="NLM_fpage">D668</span><span class="NLM_x">–</span> <span class="NLM_lpage">D672</span><span class="refDoi"> DOI: 10.1093/nar/gkj067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1093%2Fnar%2Fgkj067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=16381955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=D668-D672&issue=Database+issue&author=D.+S.+Wishartauthor=C.+Knoxauthor=A.+C.+Guoauthor=S.+Shrivastavaauthor=M.+Hassanaliauthor=P.+Stothardauthor=Z.+Changauthor=J.+Woolsey&title=DrugBank%3A+A+comprehensive+resource+for+in+silico+drug+discovery+and+exploration&doi=10.1093%2Fnar%2Fgkj067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank: a comprehensive resource for in silico drug discovery and exploration</span></div><div class="casAuthors">Wishart, David S.; Knox, Craig; Guo, An Chi; Shrivastava, Savita; Hassanali, Murtaza; Stothard, Paul; Chang, Zhan; Woolsey, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">Database</span>),
    <span class="NLM_cas:pages">D668-D672</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank is a unique bioinformatics/cheminformatics resource that combines detailed drug (i.e. chem.) data with comprehensive drug target (i.e. protein) information.  The database contains >4100 drug entries including >800 FDA approved small mol. and biotech drugs as well as >3200 exptl. drugs.  Addnl., >14 000 protein or drug target sequences are linked to these drug entries.  Each DrugCard entry contains >80 data fields with half of the information being devoted to drug/chem. data and the other half devoted to drug target or protein data.  Many data fields are hyperlinked to other databases (KEGG, PubChem, ChEBI, PDB, Swiss-Prot and GenBank) and a variety of structure viewing applets.  The database is fully searchable supporting extensive text, sequence, chem. structure and relational query searches.  Potential applications of DrugBank include in silico drug target discovery, drug design, drug docking or screening, drug metab. prediction, drug interaction prediction and general pharmaceutical education.  DrugBank is available at http://redpoll.pharmacy.ualberta.ca/drugbank/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaNy9WiVtlu7Vg90H21EOLACvtfcHk0lhCRelAOXgweg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFOrsw%253D%253D&md5=c3f4ad2fc489440be5b16f91bc9cf7db</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkj067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkj067%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DShrivastava%26aufirst%3DS.%26aulast%3DHassanali%26aufirst%3DM.%26aulast%3DStothard%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DWoolsey%26aufirst%3DJ.%26atitle%3DDrugBank%253A%2520A%2520comprehensive%2520resource%2520for%2520in%2520silico%2520drug%2520discovery%2520and%2520exploration%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26issue%3DDatabase%2520issue%26spage%3DD668%26epage%3DD672%26doi%3D10.1093%2Fnar%2Fgkj067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Trace amine-associated receptor 1 – Family archetype or iconoclast?</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2007.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pharmthera.2007.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=17888514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCrs7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=355-390&author=D.+K.+Grandy&title=Trace+amine-associated+receptor+1+%E2%80%93+Family+archetype+or+iconoclast%3F&doi=10.1016%2Fj.pharmthera.2007.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Trace amine-associated receptor 1-Family archetype or iconoclast?</span></div><div class="casAuthors">Grandy, David K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-390</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Interest has recently been rekindled in receptors that are activated by low-mol.-wt., noncatecholic, biogenic amines that are typically found as trace constituents of various vertebrate and invertebrate tissues and fluids.  The timing of this resurgent focus on receptors activated by the "trace amines" (TA) β-phenylethylamine (PEA), tyramine (TYR), octopamine (OCT), synephrine (SYN), and tryptamine (TRYP) is the direct result of 2 publications that appeared in 2001 describing the cloning of a novel G protein-coupled receptor (GPCR) referred to by their discoverers Borowsky et al. as TA1 and Bunzow et al. as TA receptor 1 (TAR1).  When heterologously expressed in Xenopus laevis oocytes and various eukaryotic cell lines, recombinant rodent and human TAR dose-dependently couple to the stimulation of adenosine 3',5'-monophosphate (cAMP) prodn.  Structure-activity profiling based on this functional response has revealed that in addn. to the TA, other biol. active compds. contg. a 2-carbon aliph. side chain linking an amino group to at least 1 benzene ring are potent and efficacious TA receptor agonists with amphetamine (AMPH), methamphetamine, 3-iodothyronamine, thyronamine, and dopamine (DA) among the most notable.  Almost 100 years after the search for TAR began, numerous TA1/TAR1-related sequences, now called TA-assocd. receptors (TAAR), have been identified in the genome of every species of vertebrate examd. to date.  Consequently, even though heterologously expressed TAAR1 fits the pharmacol. criteria established for a bona fide TAR, a major challenge for those working in the field is to discern the in vivo pharmacol. and physiol. of each purported member of this extended family of GPCR.  Only then will it be possible to establish whether TAAR1 is the family archetype or an iconoclast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8U1tCoTEP6bVg90H21EOLACvtfcHk0ljrvSGiUfXGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCrs7bM&md5=9976ce0f7f07220a97144722505b22e6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DTrace%2520amine-associated%2520receptor%25201%2520%25E2%2580%2593%2520Family%2520archetype%2520or%2520iconoclast%253F%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D116%26spage%3D355%26epage%3D390%26doi%3D10.1016%2Fj.pharmthera.2007.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Irsfeld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spadafore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prüß, B. M.</span><span> </span><span class="NLM_article-title">β-Phenylethylamine, a small molecule with a large impact</span> <span class="citation_source-journal">WebmedCentral</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">4409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=4409&author=M.+Irsfeldauthor=M.+Spadaforeauthor=B.+M.+Pr%C3%BC%C3%9F&title=%CE%B2-Phenylethylamine%2C+a+small+molecule+with+a+large+impact"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIrsfeld%26aufirst%3DM.%26aulast%3DSpadafore%26aufirst%3DM.%26aulast%3DPr%25C3%25BC%25C3%259F%26aufirst%3DB.%2BM.%26atitle%3D%25CE%25B2-Phenylethylamine%252C%2520a%2520small%2520molecule%2520with%2520a%2520large%2520impact%26jtitle%3DWebmedCentral%26date%3D2013%26volume%3D4%26spage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Berry, M. D.</span><span> </span><span class="NLM_article-title">Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2004.02501.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1111%2Fj.1471-4159.2004.02501.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=15228583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVyrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=257-271&author=M.+D.+Berry&title=Mammalian+central+nervous+system+trace+amines.+Pharmacologic+amphetamines%2C+physiologic+neuromodulators&doi=10.1111%2Fj.1471-4159.2004.02501.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators</span></div><div class="casAuthors">Berry, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-271</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The presence of the so-called trace amines 2-phenylethylamine, m-tyramine, p-tyramine, m-octopamine, p-octopamine and tryptamine in the mammalian central nervous system has been known for several decades.  Despite much initial interest, these amines have largely been thought of as little more than metabolic byproducts.  The recent description of a family of mammalian trace amine receptors has, however, seen a resurgence of interest in the physiol. role of this class of compds.  Although the trace amines are well documented to cause amphetamine-like effects, such responses only occur at concns. multiple orders of magnitude above normal physiol. levels.  As such, it seems unlikely that these responses reflect the true physiol. role of the trace amines.  In this article previous studies showing responses to physiol. relevant concns. of trace amines are reviewed, along with those showing a reciprocal relationship between trace amine levels and fluctuations in basal monoaminergic tone.  On the basis of these studies it is hypothesized that the trace amines function as endogenous neuromodulators of classical monoamine neurotransmitters.  These effects are seen as an altered neuronal sensitivity to monoamine neurotransmitters, with no change in neuronal excitability in the absence of neurotransmitter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpooIbi2hZXPrVg90H21EOLACvtfcHk0ljrvSGiUfXGOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVyrsbk%253D&md5=445306d439de8f10c4a453988b080a04</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02501.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02501.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DM.%2BD.%26atitle%3DMammalian%2520central%2520nervous%2520system%2520trace%2520amines.%2520Pharmacologic%2520amphetamines%252C%2520physiologic%2520neuromodulators%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D90%26spage%3D257%26epage%3D271%26doi%3D10.1111%2Fj.1471-4159.2004.02501.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asif-Malik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canales, J. J.</span><span> </span><span class="NLM_article-title">Trace amines and the trace amine-associated receptor 1: Pharmacology, neurochemistry, and clinical implications</span> <span class="citation_source-journal">Front. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="refDoi"> DOI: 10.3389/fnins.2016.00148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.3389%2Ffnins.2016.00148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=27092049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A280%3ADC%252BC28bhsVSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=148&author=Y.+Peiauthor=A.+Asif-Malikauthor=J.+J.+Canales&title=Trace+amines+and+the+trace+amine-associated+receptor+1%3A+Pharmacology%2C+neurochemistry%2C+and+clinical+implications&doi=10.3389%2Ffnins.2016.00148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications</span></div><div class="casAuthors">Pei Yue; Asif-Malik Aman; Canales Juan J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148</span>
        ISSN:<span class="NLM_cas:issn">1662-4548</span>.
    </div><div class="casAbstract">Biogenic amines are a collection of endogenous molecules that play pivotal roles as neurotransmitters and hormones.  In addition to the "classical" biogenic amines resulting from decarboxylation of aromatic acids, including dopamine (DA), norepinephrine, epinephrine, serotonin (5-HT), and histamine, other biogenic amines, present at much lower concentrations in the central nervous system (CNS), and hence referred to as "trace" amines (TAs), are now recognized to play significant neurophysiological and behavioral functions.  At the turn of the century, the discovery of the trace amine-associated receptor 1 (TAAR1), a phylogenetically conserved G protein-coupled receptor that is responsive to both TAs, such as β-phenylethylamine, octopamine, and tyramine, and structurally-related amphetamines, unveiled mechanisms of action for TAs other than interference with aminergic pathways, laying the foundations for deciphering the functional significance of TAs and its mammalian CNS receptor, TAAR1.  Although, its molecular interactions and downstream targets have not been fully elucidated, TAAR1 activation triggers accumulation of intracellular cAMP, modulates PKA and PKC signaling and interferes with the β-arrestin2-dependent pathway via G protein-independent mechanisms.  TAAR1 is uniquely positioned to exert direct control over DA and 5-HT neuronal firing and release, which has profound implications for understanding the pathophysiology of, and therefore designing more efficacious therapeutic interventions for, a range of neuropsychiatric disorders that involve aminergic dysregulation, including Parkinson's disease, schizophrenia, mood disorders, and addiction.  Indeed, the recent development of novel pharmacological tools targeting TAAR1 has uncovered the remarkable potential of TAAR1-based medications as new generation pharmacotherapies in neuropsychiatry.  This review summarizes recent developments in the study of TAs and TAAR1, their intricate neurochemistry and pharmacology, and their relevance for neurodegenerative and neuropsychiatric disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF78JaKZBYZ6qcneEtCi92fW6udTcc2eY-oID9c2_bu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bhsVSisA%253D%253D&md5=1946ef222ab9fc87394df0efb72792b2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2016.00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2016.00148%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DY.%26aulast%3DAsif-Malik%26aufirst%3DA.%26aulast%3DCanales%26aufirst%3DJ.%2BJ.%26atitle%3DTrace%2520amines%2520and%2520the%2520trace%2520amine-associated%2520receptor%25201%253A%2520Pharmacology%252C%2520neurochemistry%252C%2520and%2520clinical%2520implications%26jtitle%3DFront.%2520Neurosci.%26date%3D2016%26volume%3D10%26spage%3D148%26doi%3D10.3389%2Ffnins.2016.00148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilapil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFaille, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Unique [<sup>3</sup>H]tryptamine binding sites in rat brain: Distribution and pharmacology</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=6732364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2cXktVWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1984&pages=194-200&author=P.+L.+Woodauthor=C.+Pilapilauthor=F.+LaFailleauthor=N.+P.+Nairauthor=R.+A.+Glennon&title=Unique+%5B3H%5Dtryptamine+binding+sites+in+rat+brain%3A+Distribution+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Unique [3H]tryptamine binding sites in rat brain:  distribution and pharmacology</span></div><div class="casAuthors">Wood, P. L.; Pilapil, C.; LaFaille, F.; Nair, N. P. V.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">194-201</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">3H-labeled tryptamine  [61-54-1] binding in rat brain is widely distributed, with highest densities in the cortex, striatum, and hippocampus.  This binding is stereospecific and is potently displaced by tryptamine analogs and β-carbolines.  Phenethylamines also possess a weaker activity in displacing [3H]tryptamine.  The strict structural requirements for binding to this site substantiate its unique character and suggest that it may represent a tryptamine receptor in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFU5Dbf77CtrVg90H21EOLACvtfcHk0lj8kPbKXjNO8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktVWguro%253D&md5=35bc9e4632fb40ba77401d6b29813c7e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BL.%26aulast%3DPilapil%26aufirst%3DC.%26aulast%3DLaFaille%26aufirst%3DF.%26aulast%3DNair%26aufirst%3DN.%2BP.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DUnique%2520%255B3H%255Dtryptamine%2520binding%2520sites%2520in%2520rat%2520brain%253A%2520Distribution%2520and%2520pharmacology%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1984%26volume%3D268%26spage%3D194%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Usdin, E.; Sandler, M.</span>, Eds.  <span class="citation_source-book">Trace Amines and the Brain</span>; <span class="NLM_publisher-name">M. Dekker</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1976</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1976&author=E.+Usdin&author=M.+Sandler&title=Trace+Amines+and+the+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DUsdin%26aufirst%3DE.%26btitle%3DTrace%2520Amines%2520and%2520the%2520Brain%26pub%3DM.%2520Dekker%26date%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Branchek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. P.</span><span> </span><span class="NLM_article-title">Trace amine receptors as targets for novel therapeutics: Legend, myth and fact</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1016/S1471-4892(02)00028-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS1471-4892%2802%2900028-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=12550748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=90-97&author=T.+A.+Branchekauthor=T.+P.+Blackburn&title=Trace+amine+receptors+as+targets+for+novel+therapeutics%3A+Legend%2C+myth+and+fact&doi=10.1016%2FS1471-4892%2802%2900028-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Trace amine receptors as targets for novel therapeutics: legend, myth and fact</span></div><div class="casAuthors">Branchek, Theresa A.; Blackburn, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-97</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Trace amines are attracting attention as neurotransmitters because they are believed to play a role in human disorders such as schizophrenia, depression, attention deficit disorder and Parkinson's disease.  Research to date is promising and confirms the need for continuing work to forge the way for new drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA33hMxXC1PrVg90H21EOLACvtfcHk0li96ELQyGI-Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVaqtQ%253D%253D&md5=4c72a2ca484b470a599c0a635b354bb0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2802%2900028-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252802%252900028-0%26sid%3Dliteratum%253Aachs%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DBlackburn%26aufirst%3DT.%2BP.%26atitle%3DTrace%2520amine%2520receptors%2520as%2520targets%2520for%2520novel%2520therapeutics%253A%2520Legend%252C%2520myth%2520and%2520fact%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D90%26epage%3D97%26doi%3D10.1016%2FS1471-4892%2802%2900028-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lindemann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoener, M. C.</span><span> </span><span class="NLM_article-title">A renaissance in trace amines inspired by a novel GPCR family</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1016/j.tips.2005.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.tips.2005.03.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=274-281&author=L.+Lindemannauthor=M.+C.+Hoener&title=A+renaissance+in+trace+amines+inspired+by+a+novel+GPCR+family&doi=10.1016%2Fj.tips.2005.03.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DLindemann%26aufirst%3DL.%26aulast%3DHoener%26aufirst%3DM.%2BC.%26atitle%3DA%2520renaissance%2520in%2520trace%2520amines%2520inspired%2520by%2520a%2520novel%2520GPCR%2520family%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D274%26epage%3D281%26doi%3D10.1016%2Fj.tips.2005.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Borowsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raddatz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artymyshyn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogozalek, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhlani, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathirana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouranova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtblau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochoa, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerald, C.</span><span> </span><span class="NLM_article-title">Trace amines: Identification of a family of mammalian G protein-coupled receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">8966</span><span class="NLM_x">–</span> <span class="NLM_lpage">8971</span><span class="refDoi"> DOI: 10.1073/pnas.151105198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1073%2Fpnas.151105198" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=8966-8971&author=B.+Borowskyauthor=N.+Adhamauthor=K.+A.+Jonesauthor=R.+Raddatzauthor=R.+Artymyshynauthor=K.+L.+Ogozalekauthor=M.+M.+Durkinauthor=P.+P.+Lakhlaniauthor=J.+A.+Boniniauthor=S.+Pathiranaauthor=N.+Boyleauthor=X.+Puauthor=E.+Kouranovaauthor=H.+Lichtblauauthor=F.+Y.+Ochoaauthor=T.+A.+Branchekauthor=C.+Gerald&title=Trace+amines%3A+Identification+of+a+family+of+mammalian+G+protein-coupled+receptors&doi=10.1073%2Fpnas.151105198"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.151105198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.151105198%26sid%3Dliteratum%253Aachs%26aulast%3DBorowsky%26aufirst%3DB.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DRaddatz%26aufirst%3DR.%26aulast%3DArtymyshyn%26aufirst%3DR.%26aulast%3DOgozalek%26aufirst%3DK.%2BL.%26aulast%3DDurkin%26aufirst%3DM.%2BM.%26aulast%3DLakhlani%26aufirst%3DP.%2BP.%26aulast%3DBonini%26aufirst%3DJ.%2BA.%26aulast%3DPathirana%26aufirst%3DS.%26aulast%3DBoyle%26aufirst%3DN.%26aulast%3DPu%26aufirst%3DX.%26aulast%3DKouranova%26aufirst%3DE.%26aulast%3DLichtblau%26aufirst%3DH.%26aulast%3DOchoa%26aufirst%3DF.%2BY.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DGerald%26aufirst%3DC.%26atitle%3DTrace%2520amines%253A%2520Identification%2520of%2520a%2520family%2520of%2520mammalian%2520G%2520protein-coupled%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D8966%26epage%3D8971%26doi%3D10.1073%2Fpnas.151105198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonders, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arttamangkul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchland, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasumamula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magenis, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1181</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1181-1188&author=J.+R.+Bunzowauthor=M.+S.+Sondersauthor=S.+Arttamangkulauthor=L.+M.+Harrisonauthor=G.+Zhangauthor=D.+I.+Quigleyauthor=T.+Darlandauthor=K.+L.+Suchlandauthor=S.+Pasumamulaauthor=J.+L.+Kennedyauthor=S.+B.+Olsonauthor=R.+E.+Magenisauthor=S.+G.+Amaraauthor=D.+K.+Grandy&title=Amphetamine%2C+3%2C4-methylenedioxymethamphetamine%2C+lysergic+acid+diethylamide%2C+and+metabolites+of+the+catecholamine+neurotransmitters+are+agonists+of+a+rat+trace+amine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DSonders%26aufirst%3DM.%2BS.%26aulast%3DArttamangkul%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DL.%2BM.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DQuigley%26aufirst%3DD.%2BI.%26aulast%3DDarland%26aufirst%3DT.%26aulast%3DSuchland%26aufirst%3DK.%2BL.%26aulast%3DPasumamula%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26aulast%3DOlson%26aufirst%3DS.%2BB.%26aulast%3DMagenis%26aufirst%3DR.%2BE.%26aulast%3DAmara%26aufirst%3DS.%2BG.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DAmphetamine%252C%25203%252C4-methylenedioxymethamphetamine%252C%2520lysergic%2520acid%2520diethylamide%252C%2520and%2520metabolites%2520of%2520the%2520catecholamine%2520neurotransmitters%2520are%2520agonists%2520of%2520a%2520rat%2520trace%2520amine%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1181%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zucchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanlan, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Trace amine-associated receptors and their ligands</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1038%2Fsj.bjp.0706948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=17088868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12gsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=967-978&author=R.+Zucchiauthor=G.+Chielliniauthor=T.+S.+Scanlanauthor=D.+K.+Grandy&title=Trace+amine-associated+receptors+and+their+ligands&doi=10.1038%2Fsj.bjp.0706948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Trace amine-associated receptors and their ligands</span></div><div class="casAuthors">Zucchi, R.; Chiellini, G.; Scanlan, T. S.; Grandy, D. K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">967-978</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Classical biogenic amines (adrenaline, noradrenaline, dopamine, serotonin and histamine) interact with specific families of G protein-coupled receptors (GPCRs).  The term trace amines' is used when referring to p-tyramine, β-phenylethylamine, tryptamine and octopamine, compds. that are present in mammalian tissues at very low (nanomolar) concns.  The pharmacol. effects of trace amines are usually attributed to their interference with the aminergic pathways, but in 2001 a new gene was identified, that codes for a GPCR responding to p-tyramine and β-phenylethylamine but not to classical biogenic amines.  Several closely related genes were subsequently identified and designated as the trace amine-assocd. receptors (TAARs).  Pharmacol. investigations in vitro show that many TAAR subtypes may not respond to p-tyramine, β-phenylethylamine, tryptamine or octopamine, suggesting the existence of addnl. endogenous ligands.  A novel endogenous thyroid hormone deriv., 3-iodothyronamine, has been found to interact with TAAR1 and possibly other TAAR subtypes.  In vivo, micromolar concns. of 3-iodothyronamine det. functional effects which are opposite to those produced on a longer time scale by thyroid hormones, including redn. in body temp. and decrease in cardiac contractility.  Expression of all TAAR subtypes except TAAR1 has been reported in mouse olfactory epithelium, and several volatile amines were shown to interact with specific TAAR subtypes.  In addn., there is evidence that TAAR1 is targeted by amphetamines and other psychotropic agents, while genetic linkage studies show a significant assocn. between the TAAR gene family locus and susceptibility to schizophrenia or bipolar affective disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFznrJWTa4IbVg90H21EOLACvtfcHk0liY2vkfUEj9pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12gsLvL&md5=6aa4710192adc007ce00d9d07f45b38e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706948%26sid%3Dliteratum%253Aachs%26aulast%3DZucchi%26aufirst%3DR.%26aulast%3DChiellini%26aufirst%3DG.%26aulast%3DScanlan%26aufirst%3DT.%2BS.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DTrace%2520amine-associated%2520receptors%2520and%2520their%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26spage%3D967%26epage%3D978%26doi%3D10.1038%2Fsj.bjp.0706948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_contrib-group">Lewandowsky, M.</span><span> </span><span class="NLM_article-title">Zur lehre von der cerebrospinalflussigkeit</span> <span class="citation_source-journal">Z. Klin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1900</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1900&pages=480-494&author=M.+Lewandowsky&title=Zur+lehre+von+der+cerebrospinalflussigkeit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewandowsky%26aufirst%3DM.%26atitle%3DZur%2520lehre%2520von%2520der%2520cerebrospinalflussigkeit%26jtitle%3DZ.%2520Klin.%2520Med.%26date%3D1900%26volume%3D40%26spage%3D480%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">As cited in</p></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_contrib-group">Hawkins, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. P.</span><span> </span><span class="NLM_article-title">The blood-brain barrier</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1124/pr.57.2.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1124%2Fpr.57.2.4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=173-185&author=B.+T.+Hawkinsauthor=T.+P.+Davis&title=The+blood-brain+barrier&doi=10.1124%2Fpr.57.2.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1124%2Fpr.57.2.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.57.2.4%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DB.%2BT.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DThe%2520blood-brain%2520barrier%26jtitle%3DPharmacol.%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D173%26epage%3D185%26doi%3D10.1124%2Fpr.57.2.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">The blood-brain barrier: Bottleneck in brain drug development</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1602/neurorx.2.1.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1602%2Fneurorx.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=15717053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntVaqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=3-14&author=W.+M.+Pardridge&title=The+blood-brain+barrier%3A+Bottleneck+in+brain+drug+development&doi=10.1602%2Fneurorx.2.1.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The blood-brain barrier: bottleneck in brain drug development</span></div><div class="casAuthors">Pardridge William M</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">The blood-brain barrier (BBB) is formed by the brain capillary endothelium and excludes from the brain approximately 100% of large-molecule neurotherapeutics and more than 98% of all small-molecule drugs.  Despite the importance of the BBB to the neurotherapeutics mission, the BBB receives insufficient attention in either academic neuroscience or industry programs.  The combination of so little effort in developing solutions to the BBB problem, and the minimal BBB transport of the majority of all potential CNS drugs, leads predictably to the present situation in neurotherapeutics, which is that there are few effective treatments for the majority of CNS disorders.  This situation can be reversed by an accelerated effort to develop a knowledge base in the fundamental transport properties of the BBB, and the molecular and cellular biology of the brain capillary endothelium.  This provides the platform for CNS drug delivery programs, which should be developed in parallel with traditional CNS drug discovery efforts in the molecular neurosciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8zmuJRBq_D9y3lHz94U-GfW6udTcc2eaB_q8O5xNgyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntVaqtw%253D%253D&md5=88e326d840c4ab0f4e55da8a2ffd513c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DThe%2520blood-brain%2520barrier%253A%2520Bottleneck%2520in%2520brain%2520drug%2520development%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D3%26epage%3D14%26doi%3D10.1602%2Fneurorx.2.1.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hollister, L. E.</span> <span class="citation_source-book">Chemical Psychosis</span>; <span class="NLM_publisher-name">Charles C. Thomas</span>: <span class="NLM_publisher-loc">Springfield, IL</span>,<span class="NLM_x"> </span><span class="NLM_year">1968</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1968&author=L.+E.+Hollister&title=Chemical+Psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHollister%26aufirst%3DL.%2BE.%26btitle%3DChemical%2520Psychosis%26pub%3DCharles%2520C.%2520Thomas%26date%3D1968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Animal models for assessing hallucinogenic agents</span>. In  <span class="citation_source-book">Animal Models of Drug Addiction</span>; <span class="NLM_contrib-group">Boulton, A.; Baker, G.; Wu, P.</span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1385%2F0-89603-217-5%3A345" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=345-381&author=R.+A.+Glennonauthor=A.+Boulton&author=G.+Baker&author=P.+Wu&title=Animal+Models+of+Drug+Addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1385%2F0-89603-217-5%3A345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1385%252F0-89603-217-5%253A345%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DAnimal%2520models%2520for%2520assessing%2520hallucinogenic%2520agents%26btitle%3DAnimal%2520Models%2520of%2520Drug%2520Addiction%26aulast%3DBoulton%26aufirst%3DA.%26pub%3DHumana%2520Press%26date%3D1992%26spage%3D345%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Glennon, R. A.; Young, R.</span> <span class="citation_source-book">Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1002%2F9781118023150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+A.+Glennon&author=R.+Young&title=Drug+Discrimination%3A+Applications+to+Medicinal+Chemistry+and+Drug+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2F9781118023150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118023150%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26btitle%3DDrug%2520Discrimination%253A%2520Applications%2520to%2520Medicinal%2520Chemistry%2520and%2520Drug%2520Studies%26pub%3DWiley%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiman, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierson, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisberg, E.</span><span> </span><span class="NLM_article-title">NAN-190: An arylpiperazine analog that antagonizes the stimulus effects of the 5-HT<sub>1A</sub> agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin (8-OH-DPAT)</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1016/0014-2999(88)90212-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0014-2999%2888%2990212-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2976673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL1MXhvVertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1988&pages=339-341&author=R.+A.+Glennonauthor=N.+A.+Naimanauthor=M.+E.+Piersonauthor=M.+Titelerauthor=R.+A.+Lyonauthor=E.+Weisberg&title=NAN-190%3A+An+arylpiperazine+analog+that+antagonizes+the+stimulus+effects+of+the+5-HT1A+agonist+8-hydroxy-2-%28di-n-propylamino%29tetralin+%288-OH-DPAT%29&doi=10.1016%2F0014-2999%2888%2990212-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">NAN-190:  an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)</span></div><div class="casAuthors">Glennon, Richard A.; Naiman, Noreen A.; Pierson, M. Edward; Titeler, M.; Lyon, Robert A.; Weisberg, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">339-41</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">In order to det. whether NAN-190 (I) might serve as a 5-HT1A antagonist, it was evaluated in Sprague-Dawley rats trained to discriminate 8-OH-DPAT HBr (0.2 mg/kg i.p.) from saline in a 2-lever operant procedure using a VI-15 s schedule of reinforcement and a 15-min presession injection interval.  Doses of NAN-190 were administered (i.p.) in the absence or presence (45 min later) of 0.2 mg/kg of 8-OH-DPAT.  Results indicate that NAN-190 is a high-affinity ligand with selectivity for 5-HT1A and α1-adrenergic binding sites.  However, NAN-190, but not prazosin, antagonizes the stimulus effects of the 5-HT1A agonist 8-OH-DPAT, and yet, unlike propranolol and pindolol, NAN-190 does not product TFMPP-like stimulus effects.  Thus NAN-190 should be a useful 5-HT1A antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGSuq8QUo-jLVg90H21EOLACvtfcHk0ljjhBa06rGkcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvVertg%253D%253D&md5=66d19532c54e5675f2bf05168959bd06</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990212-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990212-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DNaiman%26aufirst%3DN.%2BA.%26aulast%3DPierson%26aufirst%3DM.%2BE.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DWeisberg%26aufirst%3DE.%26atitle%3DNAN-190%253A%2520An%2520arylpiperazine%2520analog%2520that%2520antagonizes%2520the%2520stimulus%2520effects%2520of%2520the%25205-HT1A%2520agonist%25208-hydroxy-2-%2528di-n-propylamino%2529tetralin%2520%25288-OH-DPAT%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D154%26spage%3D339%26epage%3D341%26doi%3D10.1016%2F0014-2999%2888%2990212-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosecrans, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Behavioral effects of 5-methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine and dose-dependent antagonism by BC-105</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1007/BF00427960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FBF00427960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=6410445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL3sXksVOrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1983&pages=156-160&author=R.+Youngauthor=J.+A.+Rosecransauthor=R.+A.+Glennon&title=Behavioral+effects+of+5-methoxy-N%2CN-dimethyltryptamine+and+dose-dependent+antagonism+by+BC-105&doi=10.1007%2FBF00427960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105</span></div><div class="casAuthors">Young, Richard; Rosecrans, John A.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-60</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The discriminative effects of 5-methoxy-N,N-dimethyltryptamine hydrogen oxalate salt (I)  [17286-40-7] were studied in rats trained to discriminate 1.5 mg/kg or 3.0 mg/kg I from saline.  A series of antagonist and generalization tests revealed that antagonism of the I stimulus response by the presumed serotonin antagonist BC-105  [15574-96-6] depended on the dose of I, the I stimulus generalized to LSD tartrate  [17676-08-3] and like I, antagonism of the LSD generalization response by BC-105 depended on the dose of LSD.  In another study, with rats responding under a variable-interval 15-s schedule of reinforcement doses of 1.0-3.0 mg/kg I significantly decreased response rate.  Furthermore, the decrease in responding produced by the administration of 1.5 mg/kg (but not by 3.0 mg/kg) I was blocked by BC-105.  This dose-dependent antagonism was of particular interest since the 1.5 mg/kg and 3.0 mg/kg dose of I had essentially the same effect on responding when given alone.  The results of both studies emphasize the importance of I dose in antagonism expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYoCCut6tJYrVg90H21EOLACvtfcHk0liUgV6E2ox5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksVOrs70%253D&md5=7440cad61e3881899e96551b8d3b0721</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2FBF00427960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00427960%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DRosecrans%26aufirst%3DJ.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBehavioral%2520effects%2520of%25205-methoxy-N%252CN-dimethyltryptamine%2520and%2520dose-dependent%2520antagonism%2520by%2520BC-105%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1983%26volume%3D80%26spage%3D156%26epage%3D160%26doi%3D10.1007%2FBF00427960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of amphetamine and structurally related phenalkylamines</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1002/med.2610060105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1002%2Fmed.2610060105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3512936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL28Xht1agu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1986&pages=99-130&author=R.+Youngauthor=R.+A.+Glennon&title=Discriminative+stimulus+properties+of+amphetamine+and+structurally+related+phenalkylamines&doi=10.1002%2Fmed.2610060105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus properties of amphetamine and structurally related phenalkylamines</span></div><div class="casAuthors">Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-130</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review, with 74 refs., of the discriminative stimulus properties of amphetamine  [300-62-9] and structurally related phenalkylamines.  In addn. to properties (dose and temporal parameters, nature of the stimulus, and locus and mechanism of action) of the drug stimulus, methodol. considerations and structure-activity relations are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGik3JXvrkmbVg90H21EOLACvtfcHk0liUgV6E2ox5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1agu7g%253D&md5=d93a9d1d8375021de478c7c1eba16559</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610060105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610060105%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520amphetamine%2520and%2520structurally%2520related%2520phenalkylamines%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1986%26volume%3D6%26spage%3D99%26epage%3D130%26doi%3D10.1002%2Fmed.2610060105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gaddum, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hameed, K. A.</span><span> </span><span class="NLM_article-title">Drugs which antagonize 5-hydroxytryptamine</span> <span class="citation_source-journal">Br. J. Pharmacol. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1954.tb00848.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1111%2Fj.1476-5381.1954.tb00848.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=13172437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaG2cXmsFGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1954&pages=240-248&author=J.+H.+Gaddumauthor=K.+A.+Hameed&title=Drugs+which+antagonize+5-hydroxytryptamine&doi=10.1111%2Fj.1476-5381.1954.tb00848.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs which antagonize 5-hydroxytryptamine</span></div><div class="casAuthors">Gaddum, J. H.; Hameed, Khan A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology and Chemotherapy</span>
        (<span class="NLM_cas:date">1954</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">240-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCAL</span>;
        ISSN:<span class="NLM_cas:issn">0366-0826</span>.
    </div><div class="casAbstract">With suitable concns. of mepyramine, piperoxan, and atropine it was possible to inhibit the effects of histamine, adrenaline, and acetylcholine without altering the effects of 5-hydroxytryptamine (I) on pharmacol. test prepns., supporting the view that I acts on a specific receptor.  One type of receptor to I was present in smooth muscle of the rat uterus and rabbit's perfused ear and was inhibited by low concns. of lysergic acid diethylamide (II).  The 2nd type, present in nervous tissue of guinea-pig ileum, was not inhibited by II.  The effect of I on ileum was inhibited by atropine or cocaine in the same way nicotine is inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz0Fm5NQMiSrVg90H21EOLACvtfcHk0lilG2b3Nxyqcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXmsFGmtQ%253D%253D&md5=ef08f60a262dfbeec028e743379f6de2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1954.tb00848.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1954.tb00848.x%26sid%3Dliteratum%253Aachs%26aulast%3DGaddum%26aufirst%3DJ.%2BH.%26aulast%3DHameed%26aufirst%3DK.%2BA.%26atitle%3DDrugs%2520which%2520antagonize%25205-hydroxytryptamine%26jtitle%3DBr.%2520J.%2520Pharmacol.%2520Chemother.%26date%3D1954%26volume%3D9%26spage%3D240%26epage%3D248%26doi%3D10.1111%2Fj.1476-5381.1954.tb00848.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">The role of serotonin in the mechanism of action of hallucinogenic agents</span>. In  <span class="citation_source-book">Neuropharmacology of Serotonin</span>; <span class="NLM_contrib-group">Green, A. R.</span>, Ed.; <span class="NLM_publisher-name">Oxford University Press</span>,<span class="NLM_x"> </span><span class="NLM_year">1985</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=253-280&author=R.+A.+Glennonauthor=A.+R.+Green&title=Neuropharmacology+of+Serotonin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DThe%2520role%2520of%2520serotonin%2520in%2520the%2520mechanism%2520of%2520action%2520of%2520hallucinogenic%2520agents%26btitle%3DNeuropharmacology%2520of%2520Serotonin%26aulast%3DGreen%26aufirst%3DA.%2BR.%26pub%3DOxford%2520University%2520Press%26date%3D1985%26spage%3D253%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Peroutka, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Multiple serotonin receptors: Differential binding of [<sup>3</sup>H]5-hydroxytryptamine, [<sup>3</sup>H]lysergic acid diethylamide and [<sup>3</sup>H]spiroperidol</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=687-699&author=S.+J.+Peroutkaauthor=S.+H.+Snyder&title=Multiple+serotonin+receptors%3A+Differential+binding+of+%5B3H%5D5-hydroxytryptamine%2C+%5B3H%5Dlysergic+acid+diethylamide+and+%5B3H%5Dspiroperidol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeroutka%26aufirst%3DS.%2BJ.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DMultiple%2520serotonin%2520receptors%253A%2520Differential%2520binding%2520of%2520%255B3H%255D5-hydroxytryptamine%252C%2520%255B3H%255Dlysergic%2520acid%2520diethylamide%2520and%2520%255B3H%255Dspiroperidol%26jtitle%3DMol.%2520Pharmacol.%26date%3D1979%26volume%3D16%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cohen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittenauer, L. A.</span><span> </span><span class="NLM_article-title">Relationship between serotonin and tryptamine receptors in the rat stomach fundus</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3981465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2MXitFGrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1985&pages=75-79&author=M.+L.+Cohenauthor=L.+A.+Wittenauer&title=Relationship+between+serotonin+and+tryptamine+receptors+in+the+rat+stomach+fundus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between serotonin and tryptamine receptors in the rat stomach fundus</span></div><div class="casAuthors">Cohen, Marlene L.; Wittenauer, Laura A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-9</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The fundus affinity of 5-HT  [50-67-9] receptor antagonists, ketanserin, metergoline, 1-(1-naphthyl)piperazine, LY154930, and LY175041 was similar when 5-HT or tryptamine  [61-54-1] was the agonist, indicating that 5-HT and tryptamine are interacting with the same receptor in the fundus.  Furthermore, max. contractile response to both 5-HT and tryptamine was reduced to the same extent by the Ca channel blocker, diltiazem, and by the calmodulin inhibitor, trifluoperazine.  Inasmuch as diltiazem and trifluoperazine did not similarly inhibit contraction to agents interacting with other receptors (i.e., carbamylcholine), these data are consistent with the idea that 5-HT and tryptamine are interacting with the same receptor in the fundus.  Consistent with this conclusion is the observation that affinity of the β-carbolines, harmaline and harmine, was also similar when tryptamine or 5-HT was used as the agonist.  However, affinity of the β-carbolines for the tryptamine/5-HT receptor in the fundus was dramatically lower than reported for [3H]tryptamine binding sites in brain membranes.  Thus, tryptamine and 5-HT contract the rat fundus by interaction with the same receptor which is distinct from the 5-HT, 5-HT2, or tryptaminergic receptors defined by radiolabeled ligand binding studies in rat brain membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTFHKuy3STibVg90H21EOLACvtfcHk0ljz8sOHJG1mMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitFGrsbc%253D&md5=89ec8c1c758b9d2c109828ac37cc69a0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DM.%2BL.%26aulast%3DWittenauer%26aufirst%3DL.%2BA.%26atitle%3DRelationship%2520between%2520serotonin%2520and%2520tryptamine%2520receptors%2520in%2520the%2520rat%2520stomach%2520fundus%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1985%26volume%3D233%26spage%3D75%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenck, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kursar, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucaites, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span> </span><span class="NLM_article-title">Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine<sub>2F</sub> receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=419-426&author=D.+B.+Wainscottauthor=M.+L.+Cohenauthor=K.+W.+Schenckauthor=J.+E.+Audiaauthor=J.+S.+Nissenauthor=M.+Baezauthor=J.+D.+Kursarauthor=V.+L.+Lucaitesauthor=D.+L.+Nelson&title=Pharmacological+characteristics+of+the+newly+cloned+rat+5-hydroxytryptamine2F+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DCohen%26aufirst%3DM.%2BL.%26aulast%3DSchenck%26aufirst%3DK.%2BW.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DNissen%26aufirst%3DJ.%2BS.%26aulast%3DBaez%26aufirst%3DM.%26aulast%3DKursar%26aufirst%3DJ.%2BD.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26atitle%3DPharmacological%2520characteristics%2520of%2520the%2520newly%2520cloned%2520rat%25205-hydroxytryptamine2F%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26spage%3D419%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucaites, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> receptors</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1007/PL00005315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FPL00005315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=9933142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFalu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1999&pages=1-6&author=D.+L.+Nelsonauthor=V.+L.+Lucaitesauthor=D.+B.+Wainscottauthor=R.+A.+Glennon&title=Comparisons+of+hallucinogenic+phenylisopropylamine+binding+affinities+at+cloned+human+5-HT2A%2C+5-HT2B+and+5-HT2C+receptors&doi=10.1007%2FPL00005315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors</span></div><div class="casAuthors">Nelson, D. L.; Lucaites, V. L.; Wainscott, D. B.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Since the classical hallucinogens were initially reported to produce their behavioral effects via a 5-HT2 agonist mechanism (i.e., the 5-HT2 hypothesis of hallucinogen action), 5-HT2 receptors have been demonstrated to represent a family of receptors that consists of three distinct subpopulations: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  Today, there is greater support for 5-HT2A than for 5-HT2C receptor involvement in the behavioral effects evoked by these agents.  However, with the recent discovery of 5-HT2B receptors, a new question arises: do classical hallucinogens bind at 5-HT2B receptors.  In the present study, the authors examd. and compared the binding of 17 phenylisopropylamines at human 5-HT2A, 5-HT2B, and 5-HT2C receptors.  Although there was a notable pos. correlation (r>0.9) between the affinities of the agents at all three populations of 5-HT2 receptors, structural modification resulted only in small differences in 5-HT2B receptor affinity such that the range of affinities was only about 50-fold.  As with 5-HT2A and 5-HT2C receptor affinity, there is a significant correlation (r>0.9) between 5-HT2B receptor affinity and human hallucinogenic potency.  Nevertheless, given that 5-HT2A and 5-HT2A/2C antagonists - antagonists with low affinity for 5-HT2B receptors - have been previously shown to block the stimulus effects of phenylisopropylamine hallucinogens, it is likely that 5-HT2A receptors play a more prominent role than 5-HT2B and 5-HT2C receptors in mediating such effects despite the affinity of these agents for all three 5-HT2 receptor subpopulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvcUJ72-JQ2LVg90H21EOLACvtfcHk0ljz8sOHJG1mMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFalu7k%253D&md5=0aa21959353f624601097271883a49de</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2FPL00005315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005315%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DComparisons%2520of%2520hallucinogenic%2520phenylisopropylamine%2520binding%2520affinities%2520at%2520cloned%2520human%25205-HT2A%252C%25205-HT2B%2520and%25205-HT2C%2520receptors%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1999%26volume%3D359%26spage%3D1%26epage%3D6%26doi%3D10.1007%2FPL00005315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Glennon, R. A.; Dukat, M.</span><span> </span><span class="NLM_article-title">Serotonin receptors and drugs affecting serotonergic neurotransmission</span>. In  <span class="citation_source-book">Foye’s Textbook of Medicinal Chemistry</span>; <span class="NLM_contrib-group">Lemke, T.; Williams, D. A.; Roche, V. F; Zito, S. W.</span>, Eds.; <span class="NLM_publisher-name">Wolters Kluwer/Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Baltimore, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=365-396&author=R.+A.+Glennon&author=M.+Dukatauthor=T.+Lemke&author=D.+A.+Williams&author=V.+F+Roche&author=S.+W.+Zito&title=Foye%E2%80%99s+Textbook+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DSerotonin%2520receptors%2520and%2520drugs%2520affecting%2520serotonergic%2520neurotransmission%26btitle%3DFoye%25E2%2580%2599s%2520Textbook%2520of%2520Medicinal%2520Chemistry%26aulast%3DLemke%26aufirst%3DT.%26pub%3DWolters%2520Kluwer%252FLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2013%26spage%3D365%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grella, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. V.</span><span> </span><span class="NLM_article-title">Binding of β-carbolines and related agents at serotonin (5-HT<sub>2</sub> and 5-HT<sub>1A</sub>), dopamine (D<sub>2</sub>) and benzodiazepine receptors</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1016/S0376-8716(99)00148-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0376-8716%2899%2900148-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10940539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFCis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=121-132&author=R.+A.+Glennonauthor=M.+Dukatauthor=B.+Grellaauthor=S.-S.+Hongauthor=L.+Costantinoauthor=M.+Teitlerauthor=C.+Smithauthor=C.+Eganauthor=K.+Davisauthor=M.+V.+Mattson&title=Binding+of+%CE%B2-carbolines+and+related+agents+at+serotonin+%285-HT2+and+5-HT1A%29%2C+dopamine+%28D2%29+and+benzodiazepine+receptors&doi=10.1016%2FS0376-8716%2899%2900148-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors</span></div><div class="casAuthors">Glennon, R. A.; Dukat, M.; Grella, B.; Hong, S.-S.; Costantino, L.; Teitler, M.; Smith, C.; Egan, C.; Davis, K.; Mattson, M. V.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-132</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A large series of β-carbolines was examd. for their ability to bind at [3H]agonist-labeled 5-HT2A serotonin receptors.  Selected β-carbolines were also examd. at 5-HT2C serotonin receptors, 5-HT1A serotonin receptors, dopamine D2 receptors, and benzodiazepine receptors.  Indolealkylamines and phenylisopropylamines were also evaluated in some of these binding assays.  The β-carbolines were found to bind with modest affinity at 5-HT2A receptors, and affinity was highly dependent upon the presence of ring substituents and ring satn.  The β-carbolines displayed little to no affinity for 5-HT1A serotonin receptors, dopamine D2 receptors and, with the exception of β-CCM, for benzodiazepine receptors.  Examples of β-carbolines, indolealkylamines (i.e. N,N-dimethyltryptamine analogs), and phenylisopropylamines have been previously shown to produce common stimulus effects in animals trained to discriminate the phenyliisopropylamine hallucinogen DOM 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane from vehicle.  Although the only common receptor population that might account for this action is 5-HT2A, on the basis of a lack of enhanced affinity for agonist-labeled 5-HT2A receptors, as well as on their lack of agonist action in the PI hydrolysis assay, it is difficult to conclude that the β-carbolines behave in a manner consistent with that of other classical hallucinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaypy9C8pdJrVg90H21EOLACvtfcHk0ljz8sOHJG1mMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFCis70%253D&md5=81e7b5842567ef2a43229f158112cec6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2899%2900148-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252899%252900148-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DGrella%26aufirst%3DB.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DEgan%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DK.%26aulast%3DMattson%26aufirst%3DM.%2BV.%26atitle%3DBinding%2520of%2520%25CE%25B2-carbolines%2520and%2520related%2520agents%2520at%2520serotonin%2520%25285-HT2%2520and%25205-HT1A%2529%252C%2520dopamine%2520%2528D2%2529%2520and%2520benzodiazepine%2520receptors%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2000%26volume%3D60%26spage%3D121%26epage%3D132%26doi%3D10.1016%2FS0376-8716%2899%2900148-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Classical Hallucinogens</span>. In  <span class="citation_source-book">Handbook of Experimental Pharmacology: Pharmacological Aspects of Drug Dependence</span>; <span class="NLM_contrib-group">Schuster, C. R.; Kuhar, M. J.</span>, Eds.; <span class="NLM_publisher-name">Springer Verlag</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2F978-3-642-60963-3_10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=343-371&author=R.+A.+Glennonauthor=C.+R.+Schuster&author=M.+J.+Kuhar&title=Handbook+of+Experimental+Pharmacology%3A+Pharmacological+Aspects+of+Drug+Dependence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-60963-3_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-60963-3_10%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DClassical%2520Hallucinogens%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%253A%2520Pharmacological%2520Aspects%2520of%2520Drug%2520Dependence%26aulast%3DSchuster%26aufirst%3DC.%2BR.%26pub%3DSpringer%2520Verlag%26date%3D1996%26spage%3D343%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Leysen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awouters, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laduron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A.</span><span> </span><span class="NLM_article-title">Receptor binding profile of R 41 468, a novel antagonist at 5-HT<sub>2</sub> receptors</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span><span class="refDoi"> DOI: 10.1016/0024-3205(81)90747-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0024-3205%2881%2990747-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1981&pages=1015-1022&author=J.+E.+Leysenauthor=F.+Awoutersauthor=L.+Kennisauthor=P.+M.+Laduronauthor=J.+Vandenberkauthor=P.+A.+Janssen&title=Receptor+binding+profile+of+R+41+468%2C+a+novel+antagonist+at+5-HT2+receptors&doi=10.1016%2F0024-3205%2881%2990747-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2881%2990747-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252881%252990747-5%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26aulast%3DAwouters%26aufirst%3DF.%26aulast%3DKennis%26aufirst%3DL.%26aulast%3DLaduron%26aufirst%3DP.%2BM.%26aulast%3DVandenberk%26aufirst%3DJ.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%26atitle%3DReceptor%2520binding%2520profile%2520of%2520R%252041%2520468%252C%2520a%2520novel%2520antagonist%2520at%25205-HT2%2520receptors%26jtitle%3DLife%2520Sci.%26date%3D1981%26volume%3D28%26spage%3D1015%26epage%3D1022%26doi%3D10.1016%2F0024-3205%2881%2990747-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Colpaert, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemegeers, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A.</span><span> </span><span class="NLM_article-title">A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=7062283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL38XitFSnt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1982&pages=206-214&author=F.+C.+Colpaertauthor=C.+J.+Niemegeersauthor=P.+A.+Janssen&title=A+drug+discrimination+analysis+of+lysergic+acid+diethylamide+%28LSD%29%3A+in+vivo+agonist+and+antagonist+effects+of+purported+5-hydroxytryptamine+antagonists+and+of+pirenperone%2C+a+LSD-antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A drug discrimination analysis of lysergic acid diethylamide (LSD):  in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist</span></div><div class="casAuthors">Colpaert, Francis C.; Niemegeers, Carlos J. E.; Janssen, Paul A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">206-14</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">An in vivo anal. was conducted of the pharmacol. interactions of the putative 5-HT receptor blocking agents metergoline  [17692-51-2], methysergide maleate  [129-49-7], 2-bromo-LSD  [478-84-2], mianserin  [24219-97-4], pizotifen maleate  [24359-22-6], cyproheptadine  [129-03-3], metitepine maleate  [19728-88-2], and cinanserine  [1166-34-3], with LSD (I)  [50-37-3].  Rats were trained to discriminate i.p. injections of 0.16 mg/kg of LSD from saline injections in a 2-lever procedure in which food served as the reinforcer.  Potential antagonists were given as a s.c. pretreatment before the injection of either LSD or saline to test for antagonist and LSD-like agonist activity, resp.  The 5-HT antagonists produced only a partial antagonism of LSD; their dose-response curve in antagonizing LSD was invariably curvilinear, reached a ceiling level at 29% (methysergide and metitepine) to 71% (pizotifen) of effect, and assumed a biphasic shape with methysergide, mianserin and cyproheptadine.  In addn., the 5-HT antagonists mimicked LSD; the max. LSD-like agonist effect ranged from 14 (cianserin) to 86% (methysergide and mianserin).  A dose of 40 mg/kg of methysergide or mianserin produced effects which were similar to those of 40 mg/kg of mescaline  [54-04-6] and the peak agonist activity of methysergide, mianserin, and cyproheptadine exceeded their peak antagonist effects.  Stimulus generalization of these agents with 0.16 mg/kg of LSD typically was a linear function of dose.  LSD-like agonist and antagonist effects of moderate intensity coexisted at the same dose of the same agent, but strong agonist activity was clearly incompatible with strong antagonist activity and vice versa.  Only pirenperone  [75444-65-4], a newly synthesized compd., effectively antagonized LSD.  This antagonism of LSD was unique in that it occurred at low (0.01-0.16 mg/kg) s.c. and oral doses, proceeded along a linear and steep gradient, reached the 100% level of effect and was not assocd. with any agonist activity.  Apparently, LSDs discriminative stimulus properties in the rat are contingent upon agonist effects at 5-HT receptor sites in the brain, the putative 5-HT antagonists mentioned above act complexly as partial and mixed agonists/antagonists at these sites and pirenperone is a pure antagonist of LSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromBL5XMo0ALVg90H21EOLACvtfcHk0lj_jURS43Qaaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XitFSnt7o%253D&md5=439337a172560c4f2c5830909a5008e2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26aulast%3DNiemegeers%26aufirst%3DC.%2BJ.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%26atitle%3DA%2520drug%2520discrimination%2520analysis%2520of%2520lysergic%2520acid%2520diethylamide%2520%2528LSD%2529%253A%2520in%2520vivo%2520agonist%2520and%2520antagonist%2520effects%2520of%2520purported%25205-hydroxytryptamine%2520antagonists%2520and%2520of%2520pirenperone%252C%2520a%2520LSD-antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1982%26volume%3D221%26spage%3D206%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosecrans, J. A.</span><span> </span><span class="NLM_article-title">Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT<sub>2</sub> antagonists</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1016/0014-2999(83)90464-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0014-2999%2883%2990464-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=6617740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL3sXltlemt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1983&pages=189-196&author=R.+A.+Glennonauthor=R.+Youngauthor=J.+A.+Rosecrans&title=Antagonism+of+the+effects+of+the+hallucinogen+DOM+and+the+purported+5-HT+agonist+quipazine+by+5-HT2+antagonists&doi=10.1016%2F0014-2999%2883%2990464-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists</span></div><div class="casAuthors">Glennon, Richard A.; Young, Richard; Rosecrans, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">189-96</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats trained to discriminate 1.0 mg DOM  [15588-95-1]/kg from saline in a 2-lever operant choice task were administered doses of mescaline  [54-04-6], LSD  [50-37-3], 5-methoxy-N,N-dimethyltryptamine (5-OMe DMT)  [1019-45-0], quipazine  [4774-24-7], TFMPP, and RU-24969.  The DOM stimulus generalized to the 3 hallucinogenic agents and to quipazine, but not to the purported 5-HT (I)  [50-67-9] agonists TFMPP or RU-24969.  Pretreatment of the animals with the 5-HT2 antagonists ketanserin and pirenperone antagonized the effect produced by DOM.  Pirenperone also blocked DOM stimulus generalization to mescaline, LSD, 5-OMe DMT, and quipazine.  Thus, the discriminative stimulus effects of DOM, the 3 hallucinogenic agents to which DOM stimulus generalization occurred, and quipazine may involve those subpopulations of 5-HT receptors that are labeled by tritiated ketanserin (i.e., 5-HT2 sites).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-OJiL1dxlrVg90H21EOLACvtfcHk0lj_jURS43Qaaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXltlemt7s%253D&md5=fc8829be27299647d45a81ecfd0c01a2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2883%2990464-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252883%252990464-8%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DRosecrans%26aufirst%3DJ.%2BA.%26atitle%3DAntagonism%2520of%2520the%2520effects%2520of%2520the%2520hallucinogen%2520DOM%2520and%2520the%2520purported%25205-HT%2520agonist%2520quipazine%2520by%25205-HT2%2520antagonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1983%26volume%3D91%26spage%3D189%26epage%3D196%26doi%3D10.1016%2F0014-2999%2883%2990464-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Vollenweider, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollenweider-Scherpenhuyzen, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bäbler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hell, D.</span><span> </span><span class="NLM_article-title">Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3897</span><span class="NLM_x">–</span> <span class="NLM_lpage">3902</span><span class="refDoi"> DOI: 10.1097/00001756-199812010-00024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1097%2F00001756-199812010-00024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=9875725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVCitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=3897-3902&author=F.+X.+Vollenweiderauthor=M.+F.+Vollenweider-Scherpenhuyzenauthor=A.+B%C3%A4blerauthor=H.+Vogelauthor=D.+Hell&title=Psilocybin+induces+schizophrenia-like+psychosis+in+humans+via+a+serotonin-2+agonist+action&doi=10.1097%2F00001756-199812010-00024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2A agonist action</span></div><div class="casAuthors">Vollenweider, Franz X.; Vollenweider-Scherpenhuyzen, Margreet F. I.; Babler, Andreas; Vogel, Helen; Hell, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3897-3902</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Psilocybin, an indoleamine hallucinogen, produces a psychosis-like syndrome in humans that resembles first episodes of schizophrenia.  In healthy human volunteers, the psychotomimetic effects of psilocybin were blocked dose-dependently by the serotonin-2A antagonist ketanserin or the atypical antipsychotic risperidone but were increased by the dopamine antagonist and typical antipsychotic haloperidol.  These data are consistent with animal studies and provide the first evidence in humans that psilocybin-induced psychosis is due to serotonin-2A receptor activation, independently of dopamine stimulation.  Thus, serotonin-2A overactivity may be involved in the pathophysiol. of schizophrenia and serotonin-2A antagonism may contribute to therapeutic effects of antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXARR5hR4eVrVg90H21EOLACvtfcHk0lj5koJYQdVjHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVCitQ%253D%253D&md5=64c2f7fc49061f0df9fa0079d74e83b9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1097%2F00001756-199812010-00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199812010-00024%26sid%3Dliteratum%253Aachs%26aulast%3DVollenweider%26aufirst%3DF.%2BX.%26aulast%3DVollenweider-Scherpenhuyzen%26aufirst%3DM.%2BF.%26aulast%3DB%25C3%25A4bler%26aufirst%3DA.%26aulast%3DVogel%26aufirst%3DH.%26aulast%3DHell%26aufirst%3DD.%26atitle%3DPsilocybin%2520induces%2520schizophrenia-like%2520psychosis%2520in%2520humans%2520via%2520a%2520serotonin-2%2520agonist%2520action%26jtitle%3DNeuroReport%26date%3D1998%26volume%3D9%26spage%3D3897%26epage%3D3902%26doi%3D10.1097%2F00001756-199812010-00024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Quednow, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollenweider, F. X.</span><span> </span><span class="NLM_article-title">Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1038/npp.2011.228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1038%2Fnpp.2011.228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=21956447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=630-640&author=B.+B.+Quednowauthor=M.+Kometerauthor=M.+Geyerauthor=F.+X.+Vollenweider&title=Psilocybin-induced+deficits+in+automatic+and+controlled+inhibition+are+attenuated+by+ketanserin+in+healthy+human+volunteers&doi=10.1038%2Fnpp.2011.228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers</span></div><div class="casAuthors">Quednow, Boris B.; Kometer, Michael; Geyer, Mark A.; Vollenweider, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">630-640</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The serotonin-2A receptor (5-HT2AR) has been implicated in the pathogenesis of schizophrenia and related inhibitory gating and behavioral inhibition deficits of schizophrenia patients.  The hallucinogen psilocybin disrupts automatic forms of sensorimotor gating and response inhibition in humans, but it is unclear so far whether the 5-HT2AR or 5-HT1AR agonist properties of its bioactive metabolite psilocin account for these effects.  Thus, we investigated whether psilocybin-induced deficits in automatic and controlled inhibition in healthy humans could be attenuated by the 5-HT2A/2CR antagonist ketanserin.  A total of 16 healthy participants received placebo, ketanserin (40 mg p.o.), psilocybin (260 μg/kg p.o.), or psilocybin plus ketanserin in a double-blind, randomized, and counterbalanced order.  Sensorimotor gating was measured by prepulse inhibition (PPI) of the acoustic startle response.  The effects on psychopathol. core dimensions and behavioral inhibition were assessed by the altered states of consciousness questionnaire (5D-ASC), and the Color-Word Stroop Test.  Psilocybin decreased PPI at short lead intervals (30 ms), increased all 5D-ASC scores, and selectively increased errors in the interference condition of the Stroop Test.  Stroop interference and Stroop effect of the response latencies were increased under psilocybin as well.  Psilocybin-induced alterations were attenuated by ketanserin pretreatment, whereas ketanserin alone had no significant effects.  These findings suggest that the disrupting effects of psilocybin on automatic and controlled inhibition processes are attributable to 5-HT2AR stimulation.  Sensorimotor gating and attentional control deficits of schizophrenia patients might be due to changes within the 5-HT2AR system.  Neuropsychopharmacol. (2012) 37, 630-640; doi:10.1038/npp.2011.228; published online 28 Sept. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqef1LpbaT02bVg90H21EOLACvtfcHk0lj5koJYQdVjHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslOrsQ%253D%253D&md5=7325b4d05a587429c8c435edf645400d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.228%26sid%3Dliteratum%253Aachs%26aulast%3DQuednow%26aufirst%3DB.%2BB.%26aulast%3DKometer%26aufirst%3DM.%26aulast%3DGeyer%26aufirst%3DM.%26aulast%3DVollenweider%26aufirst%3DF.%2BX.%26atitle%3DPsilocybin-induced%2520deficits%2520in%2520automatic%2520and%2520controlled%2520inhibition%2520are%2520attenuated%2520by%2520ketanserin%2520in%2520healthy%2520human%2520volunteers%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D630%26epage%3D640%26doi%3D10.1038%2Fnpp.2011.228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kometer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jäncke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollenweider, F. X.</span><span> </span><span class="NLM_article-title">Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">10544</span><span class="NLM_x">–</span> <span class="NLM_lpage">10551</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3007-12.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1523%2FJNEUROSCI.3007-12.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=23785166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWmtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=10544-10551&author=M.+Kometerauthor=A.+Schmidtauthor=L.+J%C3%A4nckeauthor=F.+X.+Vollenweider&title=Activation+of+serotonin+2A+receptors+underlies+the+psilocybin-induced+effects+on+%CE%B1+oscillations%2C+N170+visual-evoked+potentials%2C+and+visual+hallucinations&doi=10.1523%2FJNEUROSCI.3007-12.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations</span></div><div class="casAuthors">Kometer, Michael; Schmidt, Andre; Jancke, Lutz; Vollenweider, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10544-10551</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Visual illusions and hallucinations are hallmarks of serotonergic hallucinogen-induced altered states of consciousness.  Although the serotonergic hallucinogen psilocybin activates multiple serotonin (5-HT) receptors, recent evidence suggests that activation of 5-HT2A receptors may lead to the formation of visual hallucinations by increasing cortical excitability and altering visual-evoked cortical responses.  To address this hypothesis, we assessed the effects of psilocybin (215 μg/kg vs. placebo) on both α oscillations that regulate cortical excitability and early visual-evoked P1 and N170 potentials in healthy human subjects.  To further disentangle the specific contributions of 5-HT2A receptors, subjects were addnl. pretreated with the preferential 5-HT2A receptor antagonist ketanserin (50 mg vs. placebo).  We found that psilocybin strongly decreased prestimulus parieto-occipital α power values, thus precluding a subsequent stimulus-induced α power decrease.  Furthermore, psilocybin strongly decreased N170 potentials assocd. with the appearance of visual perceptual alterations, including visual hallucinations.  All of these effects were blocked by pretreatment with the 5-HT2A antagonist ketanserin, indicating that activation of 5-HT2A receptors by psilocybin profoundly modulates the neurophysiol. and phenomenol. indexes of visual processing.  Specifically, activation of 5-HT2A receptors may induce a processing mode in which stimulus-driven cortical excitation is overwhelmed by spontaneous neuronal excitation through the modulation of α oscillations.  Furthermore, the obsd. redn. of N170 visual-evoked potentials may be a key mechanism underlying 5-HT2A receptor-mediated visual hallucinations.  This change in N170 potentials may be important not only for psilocybin-induced states but also for understanding acute hallucinatory states seen in psychiatric disorders, such as schizophrenia and Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnHwbbVhcjcLVg90H21EOLACvtfcHk0lj5koJYQdVjHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWmtr%252FJ&md5=d8e3b3b88bd19f1f7635d93719fd96a3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3007-12.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3007-12.2013%26sid%3Dliteratum%253Aachs%26aulast%3DKometer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DJ%25C3%25A4ncke%26aufirst%3DL.%26aulast%3DVollenweider%26aufirst%3DF.%2BX.%26atitle%3DActivation%2520of%2520serotonin%25202A%2520receptors%2520underlies%2520the%2520psilocybin-induced%2520effects%2520on%2520%25CE%25B1%2520oscillations%252C%2520N170%2520visual-evoked%2520potentials%252C%2520and%2520visual%2520hallucinations%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D10544%26epage%3D10551%26doi%3D10.1523%2FJNEUROSCI.3007-12.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Seggel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousif, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suba, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT<sub>2</sub> serotonin receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span><span class="refDoi"> DOI: 10.1021/jm00165a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00165a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1032-1036&author=M.+R.+Seggelauthor=M.+Y.+Yousifauthor=R.+A.+Lyonauthor=M.+Titelerauthor=B.+L.+Rothauthor=E.+A.+Subaauthor=R.+A.+Glennon&title=A+structure-affinity+study+of+the+binding+of+4-substituted+analogues+of+1-%282%2C5-dimethoxyphenyl%29-2-aminopropane+at+5-HT2+serotonin+receptors&doi=10.1021%2Fjm00165a023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm00165a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00165a023%26sid%3Dliteratum%253Aachs%26aulast%3DSeggel%26aufirst%3DM.%2BR.%26aulast%3DYousif%26aufirst%3DM.%2BY.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSuba%26aufirst%3DE.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DA%2520structure-affinity%2520study%2520of%2520the%2520binding%2520of%25204-substituted%2520analogues%2520of%25201-%25282%252C5-dimethoxyphenyl%2529-2-aminopropane%2520at%25205-HT2%2520serotonin%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1032%26epage%3D1036%26doi%3D10.1021%2Fjm00165a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Radioligand binding evidence implicates the brain 5-HT<sub>2</sub> receptor as a site of action for LSD and phenylisopropylamine hallucinogens</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1007/BF00176847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FBF00176847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3127847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL1cXhs1Whtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1988&pages=213-216&author=M.+Titelerauthor=R.+A.+Lyonauthor=R.+A.+Glennon&title=Radioligand+binding+evidence+implicates+the+brain+5-HT2+receptor+as+a+site+of+action+for+LSD+and+phenylisopropylamine+hallucinogens&doi=10.1007%2FBF00176847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens</span></div><div class="casAuthors">Titeler, M.; Lyon, R. A.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-16</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The mechanism of action of LSD, mescaline, and other similarly acting hallucinogenic drugs of abuse such as DOM was studied.  To test the hypothesis that the mechanism of action of LSD and phenylisopropylamine hallucinogens is through stimulation of a specific brain serotonin receptor subtype, the affinities of these compds. for radiolabeled 5-HT2, 5-HT1A, 5-HT1B, and 5-HT1C receptors were detd. using a recently developed in vitro radioligand binding method.  The 5-HT2 receptor was labeled with the agonist/hallucinogen radioligand [3H]DOB.  The 5-HT1A, 5-HT1B, and 5-HT1C receptors were labeled with [3H]OH-DPAT, [3H]5-HT, and [3H]mesulergine, resp.  In general, the phenylisopropylamines displayed 10-100-fold higher affinities for the 5-HT2 receptor than for the 5-HT1C receptor and 100-1000-fold higher affinities for the 5-HT2 receptor than for the 5-HT1A or 5-HT1B receptor.  There was a strong correlation between hallucinogenic potencies and 5-HT2 receptor affinities of the phenylisopropylamines (r = 0.90); the correlation coeffs. for the 5-HT1A, 5-HT1B, and 5-HT1C were 0.73, 0.85, and 0.78, resp.  Because there is no evidence that 5-HT1A-selective or 5-HT1B-selective agonists are hallucinogenic and because the phenylisopropylamines are potent hallucinogens, a 5-HT2 receptor interaction is implicated and supports previous suggestions to this effect.  A secondary role for 5-HT1C receptors cannot be discounted at this time.  Thus, an important component of the mechanism of action of LSD and the phenylisopropylamine hallucinogens is through stimulation of brain 5-HT2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYMK5sDlN217Vg90H21EOLACvtfcHk0lhY7f9mpdNZxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhs1Whtbs%253D&md5=8eaca0cc14d55dd8309911efa62497d6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF00176847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00176847%26sid%3Dliteratum%253Aachs%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DRadioligand%2520binding%2520evidence%2520implicates%2520the%2520brain%25205-HT2%2520receptor%2520as%2520a%2520site%2520of%2520action%2520for%2520LSD%2520and%2520phenylisopropylamine%2520hallucinogens%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1988%26volume%3D94%26spage%3D213%26epage%3D216%26doi%3D10.1007%2FBF00176847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seggel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soine, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span> </span><span class="NLM_article-title">[<sup>125</sup>I]-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane: An iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT<sub>2</sub> serotonin receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1021/jm00396a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00396a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=5-7&author=R.+A.+Glennonauthor=M.+R.+Seggelauthor=W.+H.+Soineauthor=K.+Herrick-Davisauthor=R.+A.+Lyonauthor=M.+Titeler&title=%5B125I%5D-1-%282%2C5-Dimethoxy-4-iodophenyl%29-2-aminopropane%3A+An+iodinated+radioligand+that+specifically+labels+the+agonist+high-affinity+state+of+5-HT2+serotonin+receptors&doi=10.1021%2Fjm00396a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm00396a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00396a003%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DSeggel%26aufirst%3DM.%2BR.%26aulast%3DSoine%26aufirst%3DW.%2BH.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26atitle%3D%255B125I%255D-1-%25282%252C5-Dimethoxy-4-iodophenyl%2529-2-aminopropane%253A%2520An%2520iodinated%2520radioligand%2520that%2520specifically%2520labels%2520the%2520agonist%2520high-affinity%2520state%2520of%25205-HT2%2520serotonin%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D5%26epage%3D7%26doi%3D10.1021%2Fjm00396a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Rangisetty, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowd, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuPre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharif, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">1-[2-Methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT<sub>2A</sub> serotonin receptor affinity and antagonist character</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3283</span><span class="NLM_x">–</span> <span class="NLM_lpage">3291</span><span class="refDoi"> DOI: 10.1021/jm0100739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3283-3291&author=J.+B.+Rangisettyauthor=M.+Dukatauthor=C.+S.+Dowdauthor=K.+Herrick-Davisauthor=A.+DuPreauthor=S.+Gadepalliauthor=M.+Teitlerauthor=C.+R.+Kelleyauthor=N.+A.+Sharifauthor=R.+A.+Glennon&title=1-%5B2-Methoxy-5-%283-phenylpropyl%29%5D-2-aminopropane+unexpectedly+shows+5-HT2A+serotonin+receptor+affinity+and+antagonist+character&doi=10.1021%2Fjm0100739"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm0100739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100739%26sid%3Dliteratum%253Aachs%26aulast%3DRangisetty%26aufirst%3DJ.%2BB.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DDowd%26aufirst%3DC.%2BS.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DDuPre%26aufirst%3DA.%26aulast%3DGadepalli%26aufirst%3DS.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DKelley%26aufirst%3DC.%2BR.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D1-%255B2-Methoxy-5-%25283-phenylpropyl%2529%255D-2-aminopropane%2520unexpectedly%2520shows%25205-HT2A%2520serotonin%2520receptor%2520affinity%2520and%2520antagonist%2520character%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3283%26epage%3D3291%26doi%3D10.1021%2Fjm0100739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dowd, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuPre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT<sub>2A</sub> partial agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3074</span><span class="NLM_x">–</span> <span class="NLM_lpage">3084</span><span class="refDoi"> DOI: 10.1021/jm9906062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9906062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3074-3084&author=C.+S.+Dowdauthor=K.+Herrick-Davisauthor=C.+Eganauthor=A.+DuPreauthor=C.+Smithauthor=M.+Teitlerauthor=R.+A.+Glennon&title=1-%5B4-%283-Phenylalkyl%29phenyl%5D-2-aminopropanes+as+5-HT2A+partial+agonists&doi=10.1021%2Fjm9906062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm9906062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9906062%26sid%3Dliteratum%253Aachs%26aulast%3DDowd%26aufirst%3DC.%2BS.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DEgan%26aufirst%3DC.%26aulast%3DDuPre%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D1-%255B4-%25283-Phenylalkyl%2529phenyl%255D-2-aminopropanes%2520as%25205-HT2A%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3074%26epage%3D3084%26doi%3D10.1021%2Fjm9906062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seggel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span> </span><span class="NLM_article-title">N-Methyl derivatives of the 5-HT<sub>2</sub> agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1021/jm00388a032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00388a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2sXhsFGqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=930-932&author=R.+A.+Glennonauthor=M.+Titelerauthor=M.+R.+Seggelauthor=R.+A.+Lyon&title=N-Methyl+derivatives+of+the+5-HT2+agonist+1-%284-bromo-2%2C5-dimethoxyphenyl%29-2-aminopropane&doi=10.1021%2Fjm00388a032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane</span></div><div class="casAuthors">Glennon, Richard A.; Titeler, Milt; Seggel, Mark; Lyon, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">930-2</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">An enantiomeric potency comparison was made for the optical isomers of title compd. I (R = NH2), and the activities of I (R = NHMe, NMe2, N+Me3I-) were examd.  (R)-(-)-I (R = NH2) (Ki = 0.39 nM) had 6 times greater affinity than (S)-(+)-I (R = NH2) at tritiated I (R = NH2)-labeled (rat cortical homogenates) 5-HT2 sites; N-methylation of racemic I (R = NH2) decreased the affinity by at least 1 order of magnitude per Me group.  Similar results were obtained in an in vivo drug discrimination paradigm with rats as subjects and (R)-(-)-I (R = NH2) (0.2 mg/kg) as the training drug.  Thus, (R)-(-)-I (R = NH2) is more active than (S)-(+)-I (R = NH2) or any of the possible N-Me derivs. of I (R = NH2), both with respect to affinity at central 5-HT2 binding sites and with respect to potency in the behavioral (i.e., stimulus generalization) studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqno3zVIo2JSLVg90H21EOLACvtfcHk0lgpuIl3CAI8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsFGqtL8%253D&md5=1356b891209f5b155505ac8021157033</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00388a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00388a032%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DSeggel%26aufirst%3DM.%2BR.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26atitle%3DN-Methyl%2520derivatives%2520of%2520the%25205-HT2%2520agonist%25201-%25284-bromo-2%252C5-dimethoxyphenyl%2529-2-aminopropane%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D930%26epage%3D932%26doi%3D10.1021%2Fjm00388a032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Eckler, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang-Fong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J. C.</span><span> </span><span class="NLM_article-title">Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span><span class="refDoi"> DOI: 10.1016/S0091-3057(03)00159-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2803%2900159-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2003&pages=845-852&author=J.+R.+Ecklerauthor=J.+Chang-Fongauthor=R.+A.+Rabinauthor=C.+Smithauthor=M.+Teitlerauthor=R.+A.+Glennonauthor=J.+C.+Winter&title=Behavioral+characterization+of+2-O-desmethyl+and+5-O-desmethyl+metabolites+of+the+phenylethylamine+hallucinogen+DOM&doi=10.1016%2FS0091-3057%2803%2900159-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2803%2900159-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252803%252900159-X%26sid%3Dliteratum%253Aachs%26aulast%3DEckler%26aufirst%3DJ.%2BR.%26aulast%3DChang-Fong%26aufirst%3DJ.%26aulast%3DRabin%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DWinter%26aufirst%3DJ.%2BC.%26atitle%3DBehavioral%2520characterization%2520of%25202-O-desmethyl%2520and%25205-O-desmethyl%2520metabolites%2520of%2520the%2520phenylethylamine%2520hallucinogen%2520DOM%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2003%26volume%3D75%26spage%3D845%26epage%3D852%26doi%3D10.1016%2FS0091-3057%2803%2900159-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Jacob, P.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span> </span><span class="NLM_article-title">Chemical and biological studies of 1-(2,5-dihydroxy-4-methylphenyl)-2-aminopropane, an analogue of 6-hydroxydopamine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1021/jm00192a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00192a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=662-671&author=P.+Jacobauthor=T.+Klineauthor=N.+Castagnoli&title=Chemical+and+biological+studies+of+1-%282%2C5-dihydroxy-4-methylphenyl%29-2-aminopropane%2C+an+analogue+of+6-hydroxydopamine&doi=10.1021%2Fjm00192a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00192a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00192a011%26sid%3Dliteratum%253Aachs%26aulast%3DJacob%26aufirst%3DP.%26aulast%3DKline%26aufirst%3DT.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DChemical%2520and%2520biological%2520studies%2520of%25201-%25282%252C5-dihydroxy-4-methylphenyl%2529-2-aminopropane%252C%2520an%2520analogue%2520of%25206-hydroxydopamine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26spage%3D662%26epage%3D671%26doi%3D10.1021%2Fjm00192a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khorana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharif, N. A.</span><span> </span><span class="NLM_article-title">β-Oxygenated analogues of the 5-HT<sub>2A</sub> serotonin agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6034</span><span class="NLM_x">–</span> <span class="NLM_lpage">6041</span><span class="refDoi"> DOI: 10.1021/jm040082s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040082s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6034-6041&author=R.+A.+Glennonauthor=M.+L.+Bondarevauthor=N.+Khoranaauthor=R.+Youngauthor=J.+A.+Mayauthor=M.+R.+Hellbergauthor=M.+A.+McLaughlinauthor=N.+A.+Sharif&title=%CE%B2-Oxygenated+analogues+of+the+5-HT2A+serotonin+agonist+1-%284-bromo-2%2C5-dimethoxyphenyl%29-2-aminopropane&doi=10.1021%2Fjm040082s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm040082s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040082s%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DKhorana%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DMay%26aufirst%3DJ.%2BA.%26aulast%3DHellberg%26aufirst%3DM.%2BR.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BA.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26atitle%3D%25CE%25B2-Oxygenated%2520analogues%2520of%2520the%25205-HT2A%2520serotonin%2520agonist%25201-%25284-bromo-2%252C5-dimethoxyphenyl%2529-2-aminopropane%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6034%26epage%3D6041%26doi%3D10.1021%2Fjm040082s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">May, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharif, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, C. P.</span><span> </span><span class="NLM_article-title">Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT<sub>2</sub> receptor agonist AL-38022A [(<i>S</i>)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine]</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1016/j.pbb.2008.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2008.07.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2009&pages=307-314&author=J.+A.+Mayauthor=N.+A.+Sharifauthor=H.-H.+Chenauthor=J.+C.+Liaoauthor=C.+R.+Kellyauthor=R.+A.+Glennonauthor=R.+Youngauthor=J.-X.+Liauthor=K.+C.+Riceauthor=C.+P.+France&title=Pharmacological+properties+and+discriminative+stimulus+effects+of+a+novel+and+selective+5-HT2+receptor+agonist+AL-38022A+%5B%28S%29-2-%288%2C9-dihydro-7H-pyrano%5B2%2C3-g%5Dindazol-1-yl%29-1-methylethylamine%5D&doi=10.1016%2Fj.pbb.2008.07.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DJ.%2BA.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26aulast%3DChen%26aufirst%3DH.-H.%26aulast%3DLiao%26aufirst%3DJ.%2BC.%26aulast%3DKelly%26aufirst%3DC.%2BR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DJ.-X.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DFrance%26aufirst%3DC.%2BP.%26atitle%3DPharmacological%2520properties%2520and%2520discriminative%2520stimulus%2520effects%2520of%2520a%2520novel%2520and%2520selective%25205-HT2%2520receptor%2520agonist%2520AL-38022A%2520%255B%2528S%2529-2-%25288%252C9-dihydro-7H-pyrano%255B2%252C3-g%255Dindazol-1-yl%2529-1-methylethylamine%255D%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2009%26volume%3D91%26spage%3D307%26epage%3D314%26doi%3D10.1016%2Fj.pbb.2008.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">May, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharif, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severns, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, T. R.</span><span> </span><span class="NLM_article-title">Ocular hypotensive response in nonhuman primates of (8<i>R</i>)-1-[(2<i>S</i>)-2-aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol, a selective 5-HT<sub>2</sub> receptor agonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8818</span><span class="NLM_x">–</span> <span class="NLM_lpage">8833</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00857</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00857" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8818-8833&author=J.+A.+Mayauthor=N.+A.+Sharifauthor=M.+A.+McLaughlinauthor=H.+H.+Chenauthor=B.+S.+Severnsauthor=C.+R.+Kellyauthor=W.+F.+Holtauthor=R.+Youngauthor=R.+A.+Glennonauthor=M.+R.+Hellbergauthor=T.+R.+Dean&title=Ocular+hypotensive+response+in+nonhuman+primates+of+%288R%29-1-%5B%282S%29-2-aminopropyl%5D-8%2C9-dihydro-7H-pyrano%5B2%2C3-g%5Dindazol-8-ol%2C+a+selective+5-HT2+receptor+agonist&doi=10.1021%2Facs.jmedchem.5b00857"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00857%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DJ.%2BA.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DH.%2BH.%26aulast%3DSeverns%26aufirst%3DB.%2BS.%26aulast%3DKelly%26aufirst%3DC.%2BR.%26aulast%3DHolt%26aufirst%3DW.%2BF.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DHellberg%26aufirst%3DM.%2BR.%26aulast%3DDean%26aufirst%3DT.%2BR.%26atitle%3DOcular%2520hypotensive%2520response%2520in%2520nonhuman%2520primates%2520of%2520%25288R%2529-1-%255B%25282S%2529-2-aminopropyl%255D-8%252C9-dihydro-7H-pyrano%255B2%252C3-g%255Dindazol-8-ol%252C%2520a%2520selective%25205-HT2%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8818%26epage%3D8833%26doi%3D10.1021%2Facs.jmedchem.5b00857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">Further investigation of the discriminative stimulus properties of MDA</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span><span class="refDoi"> DOI: 10.1016/0091-3057(84)90295-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2884%2990295-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1984&pages=501-505&author=R.+A.+Glennonauthor=R.+Young&title=Further+investigation+of+the+discriminative+stimulus+properties+of+MDA&doi=10.1016%2F0091-3057%2884%2990295-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2884%2990295-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252884%252990295-8%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DFurther%2520investigation%2520of%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520MDA%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1984%26volume%3D20%26spage%3D501%26epage%3D505%26doi%3D10.1016%2F0091-3057%2884%2990295-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">MDA: An agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1016/0014-2999(84)90250-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0014-2999%2884%2990250-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=6145599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2cXitVent7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1984&pages=249-250&author=R.+A.+Glennonauthor=R.+Young&title=MDA%3A+An+agent+that+produces+stimulus+effects+similar+to+those+of+3%2C4-DMA%2C+LSD+and+cocaine&doi=10.1016%2F0014-2999%2884%2990250-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">MDA:  an agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine</span></div><div class="casAuthors">Glennon, Richard A.; Young, Richard</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">249-50</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">In rats trained to discriminate 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA)(I)  [4764-17-4] from saline, generalization to I stimulus occurred with 1-(3,4-dimethoxyphenyl)-2-aminopropane (3,4-DMA)  [120-26-3], (+)-LSD tartrate  [15232-63-0] and cocaine  [50-36-2].  All the drugs were administered i.p. at various doses; generalization to I stimulus occurred in all doses tested.  The similarity between the stimulus effects of I and those of central stimulants (amphetamine, cocaine) and hallucinogens (LSD, DOM) may account for its abuse potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhvWGzEWxwxLVg90H21EOLACvtfcHk0lhTMBFLPxv2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXitVent7g%253D&md5=7e511faf0913bd42dbd051387d82a075</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2884%2990250-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252884%252990250-4%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DMDA%253A%2520An%2520agent%2520that%2520produces%2520stimulus%2520effects%2520similar%2520to%2520those%2520of%25203%252C4-DMA%252C%2520LSD%2520and%2520cocaine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1984%26volume%3D99%26spage%3D249%26epage%3D250%26doi%3D10.1016%2F0014-2999%2884%2990250-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">A three-lever operant procedure differentiates the stimulus effects of <i>R</i>(−)-MDA from <i>S</i>(+)-MDA</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">594</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=8632326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK28XhtFaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1996&pages=594-601&author=R.+Youngauthor=R.+A.+Glennon&title=A+three-lever+operant+procedure+differentiates+the+stimulus+effects+of+R%28%E2%88%92%29-MDA+from+S%28%2B%29-MDA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A three-level operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA</span></div><div class="casAuthors">Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">594-601</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">1-(3,4-Methylenedioxyphenyl)-2-aminopropane (MDA) produces an effect in humans that is somewhat similar to both a hallucinogen and a central stimulant.  We have previously shown that R(-)-MDA but not S(+)-MDA produces a stimulus effect in animals similar to that of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), whereas S(+)-MDA but not R(-)-MDA produces a stimulus effect similar to that of the stimulant amphetamine.  Others have suggested that the stimulus effects of the two MDA isomers may be much more similar than our results would indicate.  To help clarify this issue, we have shown that rats can be trained to discriminate 1.25 mg/kg of R(-)-MDA (ED50 = 0.99 mg/kg) from 1.25 mg/kg of S(+)-MDA (ED50 = 0.80 mg/kg) vs. 0.9% saline with use of a three-level operant procedure.  To accomplish this task it was necessary to institute a sepn. of 4 days between injections of the isomers.  In tests of stimulus substitution, the administration of various doses of DOM (ED50 = 0.47 mg/kg), S(+)-DOM (Ed50 = 2.23 mg/kg) and mescaline (ED50 = 16.04 mg/kg) produced dose-related responding on the R(-)-MDA-appropriate lever.  In contrast, the injection of various doses of S(+)-amphetamine (ED50 = 0.46 mg/kg) and cocaine (ED50 = 6.40 mg/kg) produced dose-related responding on the S(+)-MDA-appropriate level.  The administration of racemic MDA, at twice the isomer training dose, resulted in the animals dividing their responses closely between the R(-)-MDA- and S(+)-MDA-designated levels.  In antagonism tests, the serotonin-2 antagonist pirenperone blocked the stimulus effect of 1.25 mg/kg of R(-)-MDA but had no effect on the stimulus effect of 1.25 mg/kg of S(+)-MDA.  Taken together these data support the contention that each optical isomer of MDA can produce a markedly different stimulus effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBr6Jl-Kp7JbVg90H21EOLACvtfcHk0lhTMBFLPxv2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFaktrg%253D&md5=1aa3eb39bb6f3371c1cf77aa491c6ca4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DA%2520three-lever%2520operant%2520procedure%2520differentiates%2520the%2520stimulus%2520effects%2520of%2520R%2528%25E2%2588%2592%2529-MDA%2520from%2520S%2528%252B%2529-MDA%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D276%26spage%3D594%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kamilar-Britt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, G.</span><span> </span><span class="NLM_article-title">The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2015.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.neubiorev.2015.08.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2015&pages=433-446&author=P.+Kamilar-Brittauthor=G.+Bedi&title=The+prosocial+effects+of+3%2C4-methylenedioxymethamphetamine+%28MDMA%29%3A+Controlled+studies+in+humans+and+laboratory+animals&doi=10.1016%2Fj.neubiorev.2015.08.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2015.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2015.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DKamilar-Britt%26aufirst%3DP.%26aulast%3DBedi%26aufirst%3DG.%26atitle%3DThe%2520prosocial%2520effects%2520of%25203%252C4-methylenedioxymethamphetamine%2520%2528MDMA%2529%253A%2520Controlled%2520studies%2520in%2520humans%2520and%2520laboratory%2520animals%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2015%26volume%3D57%26spage%3D433%26epage%3D446%26doi%3D10.1016%2Fj.neubiorev.2015.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span> </span><span class="NLM_article-title">3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at brain 5-HT<sub>1</sub> and 5-HT<sub>2</sub> receptors</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span><span class="refDoi"> DOI: 10.1007/BF00178519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FBF00178519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2871581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL28XltVygs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1986&pages=525-526&author=R.+A.+Lyonauthor=R.+A.+Glennonauthor=M.+Titeler&title=3%2C4-Methylenedioxymethamphetamine+%28MDMA%29%3A+Stereoselective+interactions+at+brain+5-HT1+and+5-HT2+receptors&doi=10.1007%2FBF00178519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Methylenedioxymethamphetamine (MDMA):  stereoselective interactions at brain 5-HT1 and 5-HT2 receptors</span></div><div class="casAuthors">Lyon, Robert A.; Glennon, Richard A.; Titeler, Milt</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">525-6</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">(±)-3,4-Methylenedioxymethamphetamine (MDMA)  [42542-10-9], (±)-3,4-methylenedioxyamphetamine (MDA)  [4764-17-4], and their optical isomers, were assayed for their affinities at radiolabeled brain serotonin (5-HT1, 5-HT2) and dopamine (D2) binding sites.  R(-)-MDA  [61614-60-6] and R(-)-MDMA  [81262-70-6] displayed moderate affinities for [3H]ketanserin-labeled 5-HT2 sites (Ki = 3425 and 3310 nm, resp.) whereas the affinities for S(+)-MDA  [65620-66-8] and S(+)-MDMA  [66142-89-0] were lower (Ki = 13,000 and 15,800 nM, resp.).  Similar abs. and relative affinities were obtained at [3H]serotinin-labeled 5-HT1 sites; binding at D2 sites was very low (Ki > 25,000 nM in each case).  The (-) > (+) order of potency at 5-HT2 sites is consistent with the observation that R(-)-MDA is a more potent psychoactive agent than its S(+)-enantiomer, but contrasts with the reported finding that S(+)-MDMA is more potent than R(-)-MDMA in humans.  These results suggest that MDMA, unlike MDA and other hallucinogenic phenylisopropylamines, does not work primarily through a direct interaction at 5-HT sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJEljWTnnov7Vg90H21EOLACvtfcHk0lisbjH0rCO6Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XltVygs70%253D&md5=923e15de8d7014b48e377ddcbdf629cd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2FBF00178519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00178519%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26atitle%3D3%252C4-Methylenedioxymethamphetamine%2520%2528MDMA%2529%253A%2520Stereoselective%2520interactions%2520at%2520brain%25205-HT1%2520and%25205-HT2%2520receptors%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D1986%26volume%3D88%26spage%3D525%26epage%3D526%26doi%3D10.1007%2FBF00178519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberlender, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of MDMA-like substances</span> <span class="citation_source-journal">NIDA Res. Monogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2575223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK3cXktlCht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1989&pages=1-29&author=D.+E.+Nicholsauthor=R.+Oberlender&title=Structure-activity+relationships+of+MDMA-like+substances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of MDMA-like substances</span></div><div class="casAuthors">Nichols, David E.; Oberlender, Robert</div><div class="citationInfo"><span class="NLM_cas:title">NIDA Research Monograph</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">Pharmacol. Toxicol. Amphetamine Relat. Des. Drugs</span>),
    <span class="NLM_cas:pages">1-29</span>CODEN:
                <span class="NLM_cas:coden">MIDAD4</span>;
        ISSN:<span class="NLM_cas:issn">0361-8595</span>.
    </div><div class="casAbstract">A review with 50 refs. discussing hallucinogenic effects of 3,4-methylenedioxymethamphetamine (MDMA)-like compds. in relation to their structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRtEc67nuxmLVg90H21EOLACvtfcHk0lisbjH0rCO6Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlCht7g%253D&md5=c9006717377d70b4b7d6f3f0f5800f07</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DOberlender%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationships%2520of%2520MDMA-like%2520substances%26jtitle%3DNIDA%2520Res.%2520Monogr.%26date%3D1989%26volume%3D94%26spage%3D1%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Stimulus properties of hallucinogenic phenylalkylamines and related designer drugs: Formulation of structure-activity relationships</span> <span class="citation_source-journal">NIDA Res. Monogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2575229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK3cXktFOgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1989&pages=43-67&author=R.+A.+Glennon&title=Stimulus+properties+of+hallucinogenic+phenylalkylamines+and+related+designer+drugs%3A+Formulation+of+structure-activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulus properties of hallucinogenic phenalkylamines and related designer drugs:  formulation of structure-activity relationships</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">NIDA Research Monograph</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">Pharmacol. Toxicol. Amphetamine Relat. Des. Drugs</span>),
    <span class="NLM_cas:pages">43-67</span>CODEN:
                <span class="NLM_cas:coden">MIDAD4</span>;
        ISSN:<span class="NLM_cas:issn">0361-8595</span>.
    </div><div class="casAbstract">A review with 32 refs. discussing drug discrimination studies in respect to structure-activity relationships of the title compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuHy8_VtPO-rVg90H21EOLACvtfcHk0lht4qhHWBS3yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktFOgtr4%253D&md5=194799f99707fc04e4bf463624dae663</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DStimulus%2520properties%2520of%2520hallucinogenic%2520phenylalkylamines%2520and%2520related%2520designer%2520drugs%253A%2520Formulation%2520of%2520structure-activity%2520relationships%26jtitle%3DNIDA%2520Res.%2520Monogr.%26date%3D1989%26volume%3D94%26spage%3D43%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Bondareva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title"><i>S</i>(+)- and <i>R</i>(−)<i>N</i>-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: Effect of cocaine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span><span class="refDoi"> DOI: 10.1016/j.pbb.2005.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2005.10.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2005&pages=531-538&author=T.+Bondarevaauthor=A.+Weso%C5%82owskaauthor=M.+Dukatauthor=M.+Leeauthor=R.+Youngauthor=R.+A.+Glennon&title=S%28%2B%29-+and+R%28%E2%88%92%29N-Methyl-1-%283%2C4-methylenedioxyphenyl%29-2-aminopropane+%28MDMA%29+as+discriminative+stimuli%3A+Effect+of+cocaine&doi=10.1016%2Fj.pbb.2005.10.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2005.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2005.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DBondareva%26aufirst%3DT.%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DS%2528%252B%2529-%2520and%2520R%2528%25E2%2588%2592%2529N-Methyl-1-%25283%252C4-methylenedioxyphenyl%2529-2-aminopropane%2520%2528MDMA%2529%2520as%2520discriminative%2520stimuli%253A%2520Effect%2520of%2520cocaine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2005%26volume%3D82%26spage%3D531%26epage%3D538%26doi%3D10.1016%2Fj.pbb.2005.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Broadbent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, J. B.</span><span> </span><span class="NLM_article-title">Generalization of cocaine to the isomers of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine: Effects of training dose</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1002/ddr.430160238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1002%2Fddr.430160238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1989&pages=443-450&author=J.+Broadbentauthor=E.+K.+Michaelauthor=J.+B.+Appel&title=Generalization+of+cocaine+to+the+isomers+of+3%2C4-methylenedioxyamphetamine+and+3%2C4-methylenedioxymethamphetamine%3A+Effects+of+training+dose&doi=10.1002%2Fddr.430160238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fddr.430160238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.430160238%26sid%3Dliteratum%253Aachs%26aulast%3DBroadbent%26aufirst%3DJ.%26aulast%3DMichael%26aufirst%3DE.%2BK.%26aulast%3DAppel%26aufirst%3DJ.%2BB.%26atitle%3DGeneralization%2520of%2520cocaine%2520to%2520the%2520isomers%2520of%25203%252C4-methylenedioxyamphetamine%2520and%25203%252C4-methylenedioxymethamphetamine%253A%2520Effects%2520of%2520training%2520dose%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1989%26volume%3D16%26spage%3D443%26epage%3D450%26doi%3D10.1002%2Fddr.430160238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Baker, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadbent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metosh, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, J. B.</span><span> </span><span class="NLM_article-title">Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxy-methamphetamine; MDMA)</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1097/00008877-199504000-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1097%2F00008877-199504000-00007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=263-275&author=L.+E.+Bakerauthor=J.+Broadbentauthor=E.+K.+Michaelauthor=P.+K.+Matthewsauthor=C.+A.+Metoshauthor=R.+B.+Saundersauthor=W.+B.+Westauthor=J.+B.+Appel&title=Assessment+of+the+discriminative+stimulus+effects+of+the+optical+isomers+of+ecstasy+%283%2C4-methylenedioxy-methamphetamine%3B+MDMA%29&doi=10.1097%2F00008877-199504000-00007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1097%2F00008877-199504000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008877-199504000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DL.%2BE.%26aulast%3DBroadbent%26aufirst%3DJ.%26aulast%3DMichael%26aufirst%3DE.%2BK.%26aulast%3DMatthews%26aufirst%3DP.%2BK.%26aulast%3DMetosh%26aufirst%3DC.%2BA.%26aulast%3DSaunders%26aufirst%3DR.%2BB.%26aulast%3DWest%26aufirst%3DW.%2BB.%26aulast%3DAppel%26aufirst%3DJ.%2BB.%26atitle%3DAssessment%2520of%2520the%2520discriminative%2520stimulus%2520effects%2520of%2520the%2520optical%2520isomers%2520of%2520ecstasy%2520%25283%252C4-methylenedioxy-methamphetamine%253B%2520MDMA%2529%26jtitle%3DBehav.%2520Pharmacol.%26date%3D1995%26volume%3D6%26spage%3D263%26epage%3D275%26doi%3D10.1097%2F00008877-199504000-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">MDMA (N-methyl-3,4-methylenedioxyamphetamine) and Its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span><span class="refDoi"> DOI: 10.1016/j.pbb.2007.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2007.09.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2008&pages=318-331&author=R.+Youngauthor=R.+A.+Glennon&title=MDMA+%28N-methyl-3%2C4-methylenedioxyamphetamine%29+and+Its+stereoisomers%3A+Similarities+and+differences+in+behavioral+effects+in+an+automated+activity+apparatus+in+mice&doi=10.1016%2Fj.pbb.2007.09.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2007.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2007.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DMDMA%2520%2528N-methyl-3%252C4-methylenedioxyamphetamine%2529%2520and%2520Its%2520stereoisomers%253A%2520Similarities%2520and%2520differences%2520in%2520behavioral%2520effects%2520in%2520an%2520automated%2520activity%2520apparatus%2520in%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2008%26volume%3D88%26spage%3D318%26epage%3D331%26doi%3D10.1016%2Fj.pbb.2007.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande-Allen, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesely, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1223</span><span class="NLM_x">–</span> <span class="NLM_lpage">1229</span><span class="refDoi"> DOI: 10.1124/mol.63.6.1223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1124%2Fmol.63.6.1223" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1223-1229&author=V.+Setolaauthor=S.+J.+Hufeisenauthor=K.+J.+Grande-Allenauthor=I.+Veselyauthor=R.+A.+Glennonauthor=B.+Bloughauthor=R.+B.+Rothmanauthor=B.+L.+Roth&title=3%2C4-Methylenedioxymethamphetamine+%28MDMA%2C+%22Ecstasy%22%29+induces+fenfluramine-like+proliferative+actions+on+human+cardiac+valvular+interstitial+cells+in+vitro&doi=10.1124%2Fmol.63.6.1223"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1223%26sid%3Dliteratum%253Aachs%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DGrande-Allen%26aufirst%3DK.%2BJ.%26aulast%3DVesely%26aufirst%3DI.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DBlough%26aufirst%3DB.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3D3%252C4-Methylenedioxymethamphetamine%2520%2528MDMA%252C%2520%2522Ecstasy%2522%2529%2520induces%2520fenfluramine-like%2520proliferative%2520actions%2520on%2520human%2520cardiac%2520valvular%2520interstitial%2520cells%2520in%2520vitro%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26spage%3D1223%26epage%3D1229%26doi%3D10.1124%2Fmol.63.6.1223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span> </span><span class="NLM_article-title">Therapeutic potential of monoamine transporter substrates</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1845</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span><span class="refDoi"> DOI: 10.2174/156802606778249766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.2174%2F156802606778249766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=17017961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVClurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1845-1859&author=R.+B.+Rothmanauthor=M.+H.+Baumann&title=Therapeutic+potential+of+monoamine+transporter+substrates&doi=10.2174%2F156802606778249766"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of monoamine transporter substrates</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1845-1859</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Monoamine transporter proteins are targets for many psychoactive compds., including therapeutic and abused stimulant drugs.  This paper reviews recent work from our lab. investigating the interaction of stimulants with transporters in brain tissue.  We illustrate how detg. the precise mechanism of stimulant drug action (uptake inhibitor vs. substrate) can provide unique opportunities for medication discovery.  An important lesson learned from this work is that drugs which display equipotent substrate activity at dopamine (DA) and serotonin (5-HT) transporters have minimal abuse liability and few stimulant side-effects, yet are able to suppress ongoing drug-seeking behavior.  As a specific example, we describe the development of PAL-287 (α-methylnaphthylethylamine), a dual DA/5-HT releasing agent that suppresses cocaine self-administration in rhesus monkeys, without the adverse effects assocd. with older phenylethylamine 5-HT releasers (e.g., fenfluramine) and DA releasers (e.g., amphetamine).  Our findings demonstrate the feasibility of developing non-amphetamine releasing agents as potential treatments for substance abuse disorders and other psychiatric conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE0sdYUhKT37Vg90H21EOLACvtfcHk0lhhqO3Cfkvnyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVClurjF&md5=a3d7c68c250eb00ad13ed00993f1db80</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F156802606778249766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778249766%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3DTherapeutic%2520potential%2520of%2520monoamine%2520transporter%2520substrates%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1845%26epage%3D1859%26doi%3D10.2174%2F156802606778249766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span> </span><span class="NLM_article-title">Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1074</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1196/annals.1369.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1196%2Fannals.1369.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1074&publication_year=2006&pages=245-260&author=R.+B.+Rothmanauthor=M.+H.+Baumann&title=Balance+between+dopamine+and+serotonin+release+modulates+behavioral+effects+of+amphetamine-type+drugs&doi=10.1196%2Fannals.1369.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1196%2Fannals.1369.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1369.064%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3DBalance%2520between%2520dopamine%2520and%2520serotonin%2520release%2520modulates%2520behavioral%2520effects%2520of%2520amphetamine-type%2520drugs%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1074%26spage%3D245%26epage%3D260%26doi%3D10.1196%2Fannals.1369.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">An examination of isomeric phenylpropanolamines in (−)ephedrine-trained rats</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1016/S0376-8716(99)00052-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0376-8716%2899%2900052-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10617308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVWlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=1-6&author=R.+Youngauthor=M.+Bondarevauthor=R.+A.+Glennon&title=An+examination+of+isomeric+phenylpropanolamines+in+%28%E2%88%92%29ephedrine-trained+rats&doi=10.1016%2FS0376-8716%2899%2900052-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">An examination of isomeric phenylpropanolamines in (-)ephedrine-trained rats</span></div><div class="casAuthors">Young, R.; Bondarev, M.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A total of eight isomeric phenylpropanolamines are possible when the terminal amine is either an N-monomethylamine or a primary amine: (-)ephedrine, (+)ephedrine, (+)pseudoephedrine, (-)pseudoephedrine, (-)norephedrine, (+)norephedrine, (+)cathine, and (-)cathine.  Few previous studies have examd. the individual optical isomers of these phenylpropanolamines and, with the exception of one report on locomotor effects, no comparative behavioral data have been published on this series of agents.  Using rats trained to discriminate 4 mg/kg of (-)ephedrine (i.p.) from saline vehicle using std. operant conditioning with a VI 15-s schedule of reinforcement, all eight agents were examd. in tests of stimulus generalization.  The (-)ephedrine stimulus (ED50=0.90 mg/kg) generalized to (+)ephedrine (ED50=2.64 mg/kg), (+)pseudoephedrine (ED50=6.58 mg/kg), (-)norephedrine (ED50=1.86 mg/kg), (+)norephedrine (ED50=5.75 mg/kg), and (+)cathine (ED50=4.87 mg/kg).  The (-)ephedrine stimulus failed to generalize to either (-)pseudoephedrine or (-)cathine; the latter agents produced a max. of 29 and 31% (-)ephedrine-appropriate responding, resp.  Thus, (a) six of the eight phenylpropanolamines produced ephedrine-like stimulus effects, (b) (-)ephedrine was the most potent of the examd. agents, and (c) where stimulus generalization occurred, ED50 values spanned less than a tenfold range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczQVGVd86DbVg90H21EOLACvtfcHk0ljD7TZjslsobw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVWlsb8%253D&md5=bfe5c3a71b0397be3a93cab552ae15d8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2899%2900052-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252899%252900052-6%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DBondarev%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DAn%2520examination%2520of%2520isomeric%2520phenylpropanolamines%2520in%2520%2528%25E2%2588%2592%2529ephedrine-trained%2520rats%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D1999%26volume%3D57%26spage%3D1%26epage%3D6%26doi%3D10.1016%2FS0376-8716%2899%2900052-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Bondareva, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Central stimulants as discriminative stimuli. Asymmetric generalization between (−)ephedrine and <i>S</i>(+)methamphetamine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/S0091-3057(02)00963-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2802%2900963-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2002&pages=157-162&author=T.+S.+Bondarevaauthor=R.+Youngauthor=R.+A.+Glennon&title=Central+stimulants+as+discriminative+stimuli.+Asymmetric+generalization+between+%28%E2%88%92%29ephedrine+and+S%28%2B%29methamphetamine&doi=10.1016%2FS0091-3057%2802%2900963-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2802%2900963-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252802%252900963-2%26sid%3Dliteratum%253Aachs%26aulast%3DBondareva%26aufirst%3DT.%2BS.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DCentral%2520stimulants%2520as%2520discriminative%2520stimuli.%2520Asymmetric%2520generalization%2520between%2520%2528%25E2%2588%2592%2529ephedrine%2520and%2520S%2528%252B%2529methamphetamine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D74%26spage%3D157%26epage%3D162%26doi%3D10.1016%2FS0091-3057%2802%2900963-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton-Toth, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1124/jpet.103.053975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1124%2Fjpet.103.053975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=12954796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslGktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=138-145&author=R.+B.+Rothmanauthor=N.+Vuauthor=J.+S.+Partillaauthor=B.+L.+Rothauthor=S.+J.+Hufeisenauthor=B.+A.+Compton-Tothauthor=J.+Birkesauthor=R.+Youngauthor=R.+A.+Glennon&title=In+vitro+characterization+of+ephedrine-related+stereoisomers+at+biogenic+amine+transporters+and+the+receptorome+reveals+selective+actions+as+norepinephrine+transporter+substrates&doi=10.1124%2Fjpet.103.053975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates</span></div><div class="casAuthors">Rothman, Richard B.; Vu, Nga; Partilla, John S.; Roth, Bryan L.; Hufeisen, Sandra J.; Compton-Toth, Beth A.; Birkes, Jon; Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">138-145</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Ephedrine is a long-studied stimulant available both as a prescription and over-the-counter medication, as well as an ingredient in widely marketed herbal prepns., and is also used as a precursor for the illicit synthesis of methamphetamine.  Ephedrine is related to phenylpropanolamine, a decongestant removed from the market place due to concerns that its use increased the risk of hemorrhagic stroke.  Std. pharmacol. texts emphasize that ephedrine is both a direct and indirect adrenergic agonist, activating adrenergic receptors both by direct agonist activity as well as by releasing norepinephrine via a carrier-mediated exchange mechanism.  Chem., ephedrine possesses two chiral centers.  In the present study, we characterized the stereoisomers of ephedrine and the closely related compds. pseudoephedrine, norephedrine, pseudonorephedrine (cathine), methcathinone, and cathinone at biogenic amine transporters and a large battery of cloned human receptors (e.g., "receptorome").  The most potent actions of ephedrine-type compds. were as substrates of the norepinephrine transporter (EC50 values of about 50 nM) followed by substrate activity at the dopamine transporter.  Screening the receptorome demonstrated weak affinity at α2-adrenergic and 5-hydroxytryptamine7 receptors (Ki values 1-10 μM) and no significant activity at β-adrenergic or α1-adrenergic receptors.  Viewed collectively, these data indicate that the pharmacol. effects of ephedrine-like phenylpropanolamines are likely mediated by norepinephrine release, and although sharing mechanistic similarities with, they differ in important respects from those of the phenylpropanonamines methcathinone and cathinone and the phenyisopropylamines methamphetamine and amphetamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3iuXuw5nBCrVg90H21EOLACvtfcHk0liXXpJghalNOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslGktb0%253D&md5=fdc393937c271d2cba5da078f30315c0</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.053975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.053975%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DVu%26aufirst%3DN.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DCompton-Toth%26aufirst%3DB.%2BA.%26aulast%3DBirkes%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520ephedrine-related%2520stereoisomers%2520at%2520biogenic%2520amine%2520transporters%2520and%2520the%2520receptorome%2520reveals%2520selective%2520actions%2520as%2520norepinephrine%2520transporter%2520substrates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D307%26spage%3D138%26epage%3D145%26doi%3D10.1124%2Fjpet.103.053975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Dulloo, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seydoux, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girardier, L.</span><span> </span><span class="NLM_article-title">Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: Adenosine antagonism or phosphodiesterase inhibition?</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1233</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span><span class="refDoi"> DOI: 10.1016/0026-0495(92)90015-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0026-0495%2892%2990015-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1435297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A280%3ADyaK3s%252Fmt1Wnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1992&pages=1233-1241&author=A.+G.+Dullooauthor=J.+Seydouxauthor=L.+Girardier&title=Potentiation+of+the+thermogenic+antiobesity+effects+of+ephedrine+by+dietary+methylxanthines%3A+Adenosine+antagonism+or+phosphodiesterase+inhibition%3F&doi=10.1016%2F0026-0495%2892%2990015-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition?</span></div><div class="casAuthors">Dulloo A G; Seydoux J; Girardier L</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism: clinical and experimental</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1233-41</span>
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    </div><div class="casAbstract">Current concepts about the mechanisms underlying the therapeutic effects of dietary methylxanthines (caffeine, theophylline, and theobromine) favor their actions as antagonists of adenosine receptors, and attribute their other possible modes of action, namely those associated with translocation of intracellular calcium, inhibition of phosphodiesterase enzyme (PDE) activity, or the release of catecholamines, to high (near-toxic) doses.  From studies measuring the respiration rate of brown adipose tissue (BAT), evidence is provided here that at concentrations compatible with therapeutic doses, the ability of methylxanthines (25 to 50 mumol/L) to potentiate the thermogenic effect of the sympathomimetic drug, ephedrine (0.25 mumol/L), particularly under conditions of caloric restriction, involves a minor contribution of adenosine antagonism, but could mainly be explained by the inhibition of PDE activity.  In view of current interest in the pharmacological stimulation of metabolic rate to assist the management of obesity with low-calorie regimens, the targeting of PDE activity is therefore a rational approach in the search for drugs that could potentiate sympathomimetic stimulation of metabolic rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSI095mVM4Nz0SWnHPWbmmfW6udTcc2ebwhXRzKE3SOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252Fmt1Wnsw%253D%253D&md5=57769406522028c061a05e0fe3376805</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0026-0495%2892%2990015-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0026-0495%252892%252990015-3%26sid%3Dliteratum%253Aachs%26aulast%3DDulloo%26aufirst%3DA.%2BG.%26aulast%3DSeydoux%26aufirst%3DJ.%26aulast%3DGirardier%26aufirst%3DL.%26atitle%3DPotentiation%2520of%2520the%2520thermogenic%2520antiobesity%2520effects%2520of%2520ephedrine%2520by%2520dietary%2520methylxanthines%253A%2520Adenosine%2520antagonism%2520or%2520phosphodiesterase%2520inhibition%253F%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D1992%26volume%3D41%26spage%3D1233%26epage%3D1241%26doi%3D10.1016%2F0026-0495%2892%2990015-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryszuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">-)Ephedrine and caffeine mutually potentiate one another’s amphetamine-like stimulus effects</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/S0091-3057(98)00044-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2898%2900044-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1998&pages=169-173&author=R.+Youngauthor=M.+Gabryszukauthor=R.+A.+Glennon&title=-%29Ephedrine+and+caffeine+mutually+potentiate+one+another%E2%80%99s+amphetamine-like+stimulus+effects&doi=10.1016%2FS0091-3057%2898%2900044-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2898%2900044-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252898%252900044-6%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGabryszuk%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D-%2529Ephedrine%2520and%2520caffeine%2520mutually%2520potentiate%2520one%2520another%25E2%2580%2599s%2520amphetamine-like%2520stimulus%2520effects%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1998%26volume%3D61%26spage%3D169%26epage%3D173%26doi%3D10.1016%2FS0091-3057%2898%2900044-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Holloway, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelis, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huerta, P. L.</span><span> </span><span class="NLM_article-title">Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1016/0024-3205(85)90191-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0024-3205%2885%2990191-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1985&pages=723-730&author=F.+A.+Hollowayauthor=R.+C.+Michaelisauthor=P.+L.+Huerta&title=Caffeine-phenylethylamine+combinations+mimic+the+amphetamine+discriminative+cue&doi=10.1016%2F0024-3205%2885%2990191-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2885%2990191-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252885%252990191-2%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DF.%2BA.%26aulast%3DMichaelis%26aufirst%3DR.%2BC.%26aulast%3DHuerta%26aufirst%3DP.%2BL.%26atitle%3DCaffeine-phenylethylamine%2520combinations%2520mimic%2520the%2520amphetamine%2520discriminative%2520cue%26jtitle%3DLife%2520Sci.%26date%3D1985%26volume%3D36%26spage%3D723%26epage%3D730%26doi%3D10.1016%2F0024-3205%2885%2990191-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Gauvin, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harland, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelis, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, F. A.</span><span> </span><span class="NLM_article-title">Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1016/0024-3205(89)90219-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0024-3205%2889%2990219-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1989&pages=67-73&author=D.+V.+Gauvinauthor=R.+D.+Harlandauthor=R.+C.+Michaelisauthor=F.+A.+Holloway&title=Caffeine-phenylethylamine+combinations+mimic+the+cocaine+discriminative+cue&doi=10.1016%2F0024-3205%2889%2990219-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2889%2990219-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252889%252990219-1%26sid%3Dliteratum%253Aachs%26aulast%3DGauvin%26aufirst%3DD.%2BV.%26aulast%3DHarland%26aufirst%3DR.%2BD.%26aulast%3DMichaelis%26aufirst%3DR.%2BC.%26aulast%3DHolloway%26aufirst%3DF.%2BA.%26atitle%3DCaffeine-phenylethylamine%2520combinations%2520mimic%2520the%2520cocaine%2520discriminative%2520cue%26jtitle%3DLife%2520Sci.%26date%3D1989%26volume%3D44%26spage%3D67%26epage%3D73%26doi%3D10.1016%2F0024-3205%2889%2990219-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Harland, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauvin, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelis, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seale, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, F. A.</span><span> </span><span class="NLM_article-title">Behavioral interaction between cocaine and caffeine: A drug discrimination analysis in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span><span class="refDoi"> DOI: 10.1016/0091-3057(89)90075-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2889%2990075-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1017-1023&author=R.+D.+Harlandauthor=D.+V.+Gauvinauthor=R.+C.+Michaelisauthor=J.+M.+Carneyauthor=T.+W.+Sealeauthor=F.+A.+Holloway&title=Behavioral+interaction+between+cocaine+and+caffeine%3A+A+drug+discrimination+analysis+in+rats&doi=10.1016%2F0091-3057%2889%2990075-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2889%2990075-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252889%252990075-0%26sid%3Dliteratum%253Aachs%26aulast%3DHarland%26aufirst%3DR.%2BD.%26aulast%3DGauvin%26aufirst%3DD.%2BV.%26aulast%3DMichaelis%26aufirst%3DR.%2BC.%26aulast%3DCarney%26aufirst%3DJ.%2BM.%26aulast%3DSeale%26aufirst%3DT.%2BW.%26aulast%3DHolloway%26aufirst%3DF.%2BA.%26atitle%3DBehavioral%2520interaction%2520between%2520cocaine%2520and%2520caffeine%253A%2520A%2520drug%2520discrimination%2520analysis%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1989%26volume%3D32%26spage%3D1017%26epage%3D1023%26doi%3D10.1016%2F0091-3057%2889%2990075-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Reid, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudie, A. J.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of β-phenylethylamine, deuterated β-phenylethylamine, phenylethanolamine and some metabolites of phenylethylamine in rodents</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1547</span><span class="NLM_x">–</span> <span class="NLM_lpage">1553</span><span class="refDoi"> DOI: 10.1016/0091-3057(86)90483-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2886%2990483-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1986&pages=1547-1553&author=D.+Reidauthor=A.+J.+Goudie&title=Discriminative+stimulus+properties+of+%CE%B2-phenylethylamine%2C+deuterated+%CE%B2-phenylethylamine%2C+phenylethanolamine+and+some+metabolites+of+phenylethylamine+in+rodents&doi=10.1016%2F0091-3057%2886%2990483-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2886%2990483-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252886%252990483-1%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DD.%26aulast%3DGoudie%26aufirst%3DA.%2BJ.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520%25CE%25B2-phenylethylamine%252C%2520deuterated%2520%25CE%25B2-phenylethylamine%252C%2520phenylethanolamine%2520and%2520some%2520metabolites%2520of%2520phenylethylamine%2520in%2520rodents%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1986%26volume%3D24%26spage%3D1547%26epage%3D1553%26doi%3D10.1016%2F0091-3057%2886%2990483-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span>PEA forum Web site. <a href="https://drugs-forum.com/forum/showthread.php?t=60910" class="extLink">https://drugs-forum.com/forum/showthread.php?t=60910</a> (accessed December 4,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PEA+forum+Web+site.+https%3A%2F%2Fdrugs-forum.com%2Fforum%2Fshowthread.php%3Ft%3D60910+%28accessed+December+4%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Ziegleder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojacic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpf, B.</span><span> </span><span class="NLM_article-title">Vorkommen von beta-phenylethylamin und seinen Derivaten in Kakao und Kakaoerzeugnissen</span> <span class="citation_source-journal">Z. Lebensm.-Unters. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span><span class="refDoi"> DOI: 10.1007/BF01202801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2FBF01202801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1413998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK3sXjslyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=1992&pages=235-238&author=G.+Zieglederauthor=E.+Stojacicauthor=B.+Stumpf&title=Vorkommen+von+beta-phenylethylamin+und+seinen+Derivaten+in+Kakao+und+Kakaoerzeugnissen&doi=10.1007%2FBF01202801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Occurrence of 2-phenylethylamine and its derivatives in cocoas and chocolates</span></div><div class="casAuthors">Ziegleder, Gottfried; Stojacic, Eva; Stumpf, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Zeitschrift fuer Lebensmittel-Untersuchung und -Forschung</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-8</span>CODEN:
                <span class="NLM_cas:coden">ZLUFAR</span>;
        ISSN:<span class="NLM_cas:issn">0044-3026</span>.
    </div><div class="casAbstract">Studies of β-phenylethylamine (I) levels in cocoa beans and powder and in chocolate by gas chromatog.-mass spectroscopy revealed av. levels to increase from 0.5 mg/kg in lightly fermented, unroasted beans to 1.8 mg/kg following normal fermn., and to decrease to 1.4 mg/kg after roasting.  Alkalized cocoa powder and bitter chocolate had concns. of 1.4 and 1.1 mg/kg, resp.  Concns. in bitter chocolate depended on the content of nonfat cocoa powder.  Six aldimines were detected in cocoa powder, formed from the condensation of I with aldehydes.  The major compd., the N-benzylidene deriv., was present at ≤4 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe9VcVSNOo6LVg90H21EOLACvtfcHk0li_qjQ2cLNGtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXjslyqsg%253D%253D&md5=2511b1a6ef018676d7eccc256906c699</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2FBF01202801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01202801%26sid%3Dliteratum%253Aachs%26aulast%3DZiegleder%26aufirst%3DG.%26aulast%3DStojacic%26aufirst%3DE.%26aulast%3DStumpf%26aufirst%3DB.%26atitle%3DVorkommen%2520von%2520beta-phenylethylamin%2520und%2520seinen%2520Derivaten%2520in%2520Kakao%2520und%2520Kakaoerzeugnissen%26jtitle%3DZ.%2520Lebensm.-Unters.%2520Forsch.%26date%3D1992%26volume%3D195%26spage%3D235%26epage%3D238%26doi%3D10.1007%2FBF01202801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">(+)Amphetamine-stimulus generalization to an herbal ephedrine product</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span><span class="refDoi"> DOI: 10.1016/S0091-3057(99)00238-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2899%2900238-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=655-658&author=R.+A.+Glennonauthor=R.+Young&title=%28%2B%29Amphetamine-stimulus+generalization+to+an+herbal+ephedrine+product&doi=10.1016%2FS0091-3057%2899%2900238-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2899%2900238-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252899%252900238-5%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3D%2528%252B%2529Amphetamine-stimulus%2520generalization%2520to%2520an%2520herbal%2520ephedrine%2520product%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2000%26volume%3D65%26spage%3D655%26epage%3D658%26doi%3D10.1016%2FS0091-3057%2899%2900238-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span><span class="refDoi"> DOI: 10.1016/B978-0-12-420118-7.00015-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FB978-0-12-420118-7.00015-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=24484988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFCitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=581-620&author=R.+A.+Glennon&title=Bath+salts%2C+mephedrone%2C+and+methylenedioxypyrovalerone+as+emerging+illicit+drugs+that+will+need+targeted+therapeutic+intervention&doi=10.1016%2FB978-0-12-420118-7.00015-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse</span>),
    <span class="NLM_cas:pages">581-620</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The term "synthetic cathinones" is fairly new, but, although the abuse of synthetic cathinones is a recent problem, research on cathinone analogs dates back >100 years.  One structural element cathinone analogs have in common is an α-aminophenone moiety.  Introduction of amine and/or aryl substituents affords a large no. of agents.  Today, >40 synthetic cathinones have been identified on the clandestine market and many have multiple "street names.  " Many cathinone analogs, although not referred to as such until the late 1970s, were initially prepd. as intermediates in the synthesis of ephedrine analogs.  The cathinones do not represent a pharmacol. or mechanistically homogeneous class of agents.  Currently abused synthetic cathinones are derived from earlier agents and seem to produce their actions primarily via the dopamine, norepinephrine, and/or serotonin transporter; i.e., they either release and/or inhibit the reuptake of one or more of these neurotransmitters.  The actions of these agents can resemble those of central stimulants such as methamphetamine, cocaine, and/or empathogens such as 1-(3,4-methylenedioxyphenyl)-2-aminopropane (Ecstasy) and/or produce other effects.  Side effects are primarily of a neurol. and/or cardiovascular nature.  The use of the "and/or" term is emphasized because synthetic cathinones represent a broad class of agents that produce a variety of actions; the agents cannot be viewed as being pharmacol. equiv.  Until valid structure-activity relationships are formulated for each behavioral/mechanistic action, individual synthetic cathinones remain to be evaluated on a case-by-case basis.  Treatment of synthetic cathinone intoxication requires more "basic science" research.  At this time, treatment is mostly palliative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZeLnZPeubvLVg90H21EOLACvtfcHk0lisOvrxXhtUGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFCitbc%253D&md5=a4f1c1877f906d352de4792d9598e971</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420118-7.00015-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420118-7.00015-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBath%2520salts%252C%2520mephedrone%252C%2520and%2520methylenedioxypyrovalerone%2520as%2520emerging%2520illicit%2520drugs%2520that%2520will%2520need%2520targeted%2520therapeutic%2520intervention%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D581%26epage%3D620%26doi%3D10.1016%2FB978-0-12-420118-7.00015-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Glennon, R. A.; Dukat, M.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of synthetic cathinones</span>. In  <span class="citation_source-book">New Psychoactive Substances</span>; <span class="NLM_contrib-group">Baumann, M. H.; Glennon, R. A.; Wiley, J.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>; in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glennon%2C+R.+A.%3B+Dukat%2C+M.+Structure-activity+relationships+of+synthetic+cathinones.+In+New+Psychoactive+Substances%3B+Baumann%2C+M.+H.%3B+Glennon%2C+R.+A.%3B+Wiley%2C+J.%2C+Eds.%3B+Springer%3B+in+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DStructure-activity%2520relationships%2520of%2520synthetic%2520cathinones%26btitle%3DNew%2520Psychoactive%2520Substances%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26pub%3DSpringer" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, D.</span><span> </span><span class="NLM_article-title">The effect of cathinone and several related derivatives on locomotor activity</span> <span class="citation_source-journal">Res. Commun. Subst. Abuse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL3MXktFyjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1981&pages=186-192&author=R.+A.+Glennonauthor=D.+Showalter&title=The+effect+of+cathinone+and+several+related+derivatives+on+locomotor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of cathinone and several related derivatives on locomotor activity</span></div><div class="casAuthors">Glennon, Richard A.; Showalter, Debra</div><div class="citationInfo"><span class="NLM_cas:title">Research Communications in Substances of Abuse</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-92</span>CODEN:
                <span class="NLM_cas:coden">RCSADO</span>;
        ISSN:<span class="NLM_cas:issn">0193-0818</span>.
    </div><div class="casAbstract">The effects of cathinone and several substituted derivs. on the locomotor activity of mice were compared with the effects produced by (+)-amphetamine.  (-)-Cathinone-HCl  [72739-14-1] was more active than its (+)-enantiomer  [76333-53-4], twice as active as (±)-cathinone-HCl  [16735-19-6], but only about one-seventh as active as (+)-amphetamine.  Removal of the α-Me group or substitution on the arom. ring abolished the stimulant effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg7LUPAayhGbVg90H21EOLACvtfcHk0lgYuL-1GH55Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXktFyjsrw%253D&md5=e5a463d8f7dae27eba6316dddc4086bb</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DShowalter%26aufirst%3DD.%26atitle%3DThe%2520effect%2520of%2520cathinone%2520and%2520several%2520related%2520derivatives%2520on%2520locomotor%2520activity%26jtitle%3DRes.%2520Commun.%2520Subst.%2520Abuse%26date%3D1981%26volume%3D2%26spage%3D186%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of phenylisopropylamine derivatives</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span><span class="refDoi"> DOI: 10.1016/0376-8716(86)90003-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0376-8716%2886%2990003-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=2874967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL28XltVOktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1986&pages=119-134&author=R.+A.+Glennon&title=Discriminative+stimulus+properties+of+phenylisopropylamine+derivatives&doi=10.1016%2F0376-8716%2886%2990003-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus properties of phenylisopropylamine derivatives</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">119-34</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    </div><div class="casAbstract">A review with 16 refs. of drug discrimination studies by the author to det. whether substituted and (or) structurally-modified phenylisopropylamines produce effects similar to (+)-amphetamine  [51-64-9] or (±)-2,5-dimethoxy-4-methylamphetamine  [15588-95-1].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARg8vf5mMIbVg90H21EOLACvtfcHk0lgYuL-1GH55Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XltVOktrs%253D&md5=7683c36d59249156eb75c90711d233fe</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2F0376-8716%2886%2990003-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0376-8716%252886%252990003-7%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520phenylisopropylamine%2520derivatives%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D1986%26volume%3D17%26spage%3D119%26epage%3D134%26doi%3D10.1016%2F0376-8716%2886%2990003-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousif, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalix, P.</span><span> </span><span class="NLM_article-title">Methcathinone: A new and potent amphetamine-like agent</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1016/0091-3057(87)90164-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2887%2990164-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3575369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL2sXktlaqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1987&pages=547-551&author=R.+A.+Glennonauthor=M.+Yousifauthor=N.+Naimanauthor=P.+Kalix&title=Methcathinone%3A+A+new+and+potent+amphetamine-like+agent&doi=10.1016%2F0091-3057%2887%2990164-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Methcathinone:  a new and potent amphetamine-like agent</span></div><div class="casAuthors">Glennon, Richard A.; Yousif, Mamoun; Naiman, Noreen; Kalix, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">547-51</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    </div><div class="casAbstract">The effect of N-monomethylation of phenylisopropylamine derivs. on amphetamine-like activity was examd.  With the exception of methcathinone, all of the new N-methyl derivs. were prepd. by acylation of the corresponding primary amine with ethyl chloroformate, followed by redn. of the resulting carbamate esters with lithium aluminum hydride.  In tests of stimulus generalization using rats trained to discriminate 1.0 mg/kg of (+)-amphetamine from saline, the N-monomethyl derivs. of 1-(X-phenyl)-2-aminopropane, where X = 2,4-dimethoxy-, 3,4-dimethoxy-, 2,4,5-trimethoxy-, and 2-methoxy-4,5-methylenedioxy-, did not produce amphetamine-appropriate responding at the doses evaluated.  However, the racemic N-monomethyl deriv. of cathinone (racemic methcathinone), like racemic cathinone, resulted in stimulus generalization.  Further studies with this agent revealed that (a) in the amphetamine-trained animals, methcathinone is more potent than racemic cathinone or racemic amphetamine; (b) methcathinone is capable of inducing release of radioactivity from 3H-labeled dopamine-prelabeled tissue of rat caudate nucleus in a manner similar to that obsd. with cathinone, amphetamine, and (+)-methamphetamine; and (c) methcathinone is more potent than cathinone as a locomotor stimulant in mice as detd. by their effect on spontaneous activity.  The results of the present study provide evidence for a structural analogy between the prototypic psychostimulants amphetamine/methamphetamine and cathinone/methcathinone, and lend further support to the concept that amphetamine and cathinone correspond in their pharmacol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMSeWNBePw87Vg90H21EOLACvtfcHk0lgYuL-1GH55Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktlaqurc%253D&md5=f1b2b1f805811dd496f6b8ca593cb29f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2887%2990164-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252887%252990164-X%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYousif%26aufirst%3DM.%26aulast%3DNaiman%26aufirst%3DN.%26aulast%3DKalix%26aufirst%3DP.%26atitle%3DMethcathinone%253A%2520A%2520new%2520and%2520potent%2520amphetamine-like%2520agent%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1987%26volume%3D26%26spage%3D547%26epage%3D551%26doi%3D10.1016%2F0091-3057%2887%2990164-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus effects of S(−)-methcathinone (MCAT): A potent stimulant drug of abuse</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1007/s002130050765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2Fs002130050765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=9877004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaK1MXitVOksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1998&pages=250-256&author=R.+Youngauthor=R.+A.+Glennon&title=Discriminative+stimulus+effects+of+S%28%E2%88%92%29-methcathinone+%28MCAT%29%3A+A+potent+stimulant+drug+of+abuse&doi=10.1007%2Fs002130050765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse</span></div><div class="casAuthors">Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">250-256</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Methcathinone ("CAT") is a CNS stimulant that is a very significant drug of abuse in the former Soviet Union.  It has also appeared on the clandestine market in the United States and has been recently classified as a Schedule I substance.  In the present study, S(-)-methcathinone [S(-)-CAT, 0.50 mg/kg, i.p.] was employed as the training drug in a two-lever drug discrimination task in rats.  Once established, the S(-)-CAT stimulus was shown to have a rapid onset to action (within 5 min) and a duration of effect of approx. 60-90 min.  In tests of stimulus generalization (substitution), the S(-)-CAT (ED50 = 0.11 mg/kg) stimulus generalized to S(+)-methamphetamine (ED50 = 0.17 mg/kg), S(-)-cathinone (ED50 = 0.19 mg/kg), S(+)-amphetamine (ED50 = 0.23 mg/kg), aminorex (ED50 = 0.27 mg/kg), (±)-CAT (ED50 = 0.25 mg/kg), (±)-cathinone (ED50 = 0.41 mg/kg), R(+)-CAT (ED50 = 0.43 mg/kg), cis-4-methylaminorex (ED50 = 0.49 mg/kg), methylphenidate (ED50 = 0.83 mg/kg), and cocaine (ED50 = 1.47 mg/kg).  S(-)-CAT-stimulus generalization did not occur to fenfluramine, a structurally related nonstimulant anorectic.  Lastly, haloperidol (AD50 = 0.18 mg/kg), a dopamine receptor antagonist, potently antagonized the S(-)-CAT stimulus.  It is concluded that S(-)-methcathinone is a very potent CNS stimulant, which appears to produce its stimulus effect, at least in part, via a dopaminergic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_83iSDXoKyLVg90H21EOLACvtfcHk0lhAYflfDYXKYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitVOksQ%253D%253D&md5=f1cc8ea2d737d474b9a5092eb420d643</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2Fs002130050765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002130050765%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520effects%2520of%2520S%2528%25E2%2588%2592%2529-methcathinone%2520%2528MCAT%2529%253A%2520A%2520potent%2520stimulant%2520drug%2520of%2520abuse%26jtitle%3DPsychopharmacology%26date%3D1998%26volume%3D140%26spage%3D250%26epage%3D256%26doi%3D10.1007%2Fs002130050765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Iversen, L. E.</span><span> </span><span class="NLM_article-title">Consideration of the cathinones. Advisory Council on the Misuse of Drugs</span>. A report submitted to the Home Secretary of the U.K. (March 31,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+E.+Iversen&title=Consideration+of+the+cathinones.+Advisory+Council+on+the+Misuse+of+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DL.%2BE.%26atitle%3DConsideration%2520of%2520the%2520cathinones.%2520Advisory%2520Council%2520on%2520the%2520Misuse%2520of%2520Drugs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Sakloth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonano, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negus, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">2210</span><span class="NLM_x">–</span> <span class="NLM_lpage">2218</span><span class="refDoi"> DOI: 10.1111/bph.13043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1111%2Fbph.13043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=25522019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVentrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=2210-2218&author=F.+Saklothauthor=R.+Kolanosauthor=P.+D.+Mosierauthor=J.+S.+Bonanoauthor=M.+L.+Banksauthor=J.+S.+Partillaauthor=M.+H.+Baumannauthor=S.+S.+Negusauthor=R.+A.+Glennon&title=Steric+parameters%2C+molecular+modeling+and+hydropathic+interaction+analysis+of+the+pharmacology+of+para-substituted+methcathinone+analogues&doi=10.1111%2Fbph.13043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues</span></div><div class="casAuthors">Sakloth, F.; Kolanos, R.; Mosier, P. D.; Bonano, J. S.; Banks, M. L.; Partilla, J. S.; Baumann, M. H.; Negus, S. S.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2210-2218</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : There is growing concern over the abuse of certain psychostimulant methcathinone (MCAT) analogs.  This study extends an initial quant. structure-activity relationship (QSAR) investigation that demonstrated important steric considerations of seven 4- (or para-)substituted analogs of MCAT.  Specifically, the steric character (Taft's steric ES) of the 4-position substituent affected in vitro potency to induce monoamine release via dopamine and 5-HT transporters (DAT and SERT) and in vivo modulation of intracranial self-stimulation (ICSS).  Here, we have assessed the effects of other steric properties of the 4-position substituents.  Exptl. Approach : Definitive steric parameters that more explicitly focus on the vol., width and length of the MCAT 4-position substituents were assessed.  In addn., homol. models of human DAT and human SERT based upon the crystd. Drosophila DAT were constructed and docking studies were performed, followed by hydropathic interaction (HINT) anal. of the docking results.  Key Results : The potency of seven MCAT analogs at DAT was neg. correlated with the vol. and maximal width of their 4-position substituents, whereas potency at SERT increased as substituent vol. and length increased.  SERT/DAT selectivity, as well as abuse-related drug effects in the ICSS procedure, also correlated with the same parameters.  Docking solns. offered a means of visualizing these findings.  Conclusions and Implications : These results suggest that steric aspects of the 4-position substituents of MCAT analogs are key determinants of their action and selectivity, and that the hydrophobic nature of these substituents is involved in their potency at SERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre4XEAp6rxMbVg90H21EOLACvtfcHk0lhAYflfDYXKYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVentrbM&md5=8bcbd5708f72e4583518c29e28a59705</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1111%2Fbph.13043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13043%26sid%3Dliteratum%253Aachs%26aulast%3DSakloth%26aufirst%3DF.%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DMosier%26aufirst%3DP.%2BD.%26aulast%3DBonano%26aufirst%3DJ.%2BS.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DSteric%2520parameters%252C%2520molecular%2520modeling%2520and%2520hydropathic%2520interaction%2520analysis%2520of%2520the%2520pharmacology%2520of%2520para-substituted%2520methcathinone%2520analogues%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D2210%26epage%3D2218%26doi%3D10.1111%2Fbph.13043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakloth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Felice, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">“Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1524</span><span class="NLM_x">–</span> <span class="NLM_lpage">1529</span><span class="refDoi"> DOI: 10.1021/cn4001236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn4001236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SgsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1524-1529&author=R.+Kolanosauthor=E.+Solisauthor=F.+Saklothauthor=L.+J.+De+Feliceauthor=R.+A.+Glennon&title=%E2%80%9CDeconstruction%22+of+the+abused+synthetic+cathinone+methylenedioxypyrovalerone+%28MDPV%29+and+an+examination+of+effects+at+the+human+dopamine+transporter&doi=10.1021%2Fcn4001236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Deconstruction of the Abused Synthetic Cathinone Methylenedioxypyrovalerone (MDPV) and an Examination of Effects at the Human Dopamine Transporter</span></div><div class="casAuthors">Kolanos, Renata; Solis, Ernesto; Sakloth, Farhana; De Felice, Louis J.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1524-1529</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthetic cathinones, β-keto analogs of amphetamine (or, more correctly, of phenylalkylamines), represent a new and growing class of abused substances.  Several such analogs have been demonstrated to act as dopamine (DA) releasing agents.  Methylenedioxypyrovalerone (MDPV) was the first synthetic cathinone shown to act as a cocaine-like DA reuptake inhibitor.  MDPV and seven deconstructed analogs were examd. to det. which of MDPV's structural features account(s) for uptake inhibition.  In voltage-clamped (-60 mV) Xenopus oocytes transfected with the human DA transporter (hDAT), all analogs elicited inhibitor-like behavior shown as hDAT-mediated outward currents.  Using hDAT-expressing mammalian cells the authors detd. the affinities of MDPV and its analogs to inhibit uptake of [3H]-DA by hDAT that varied over a broad range (IC50 values ∼135 to >25,000 nM).  The methylenedioxy group of MDPV made a minimal contribution to affinity, the carbonyl group and a tertiary amine are more important, and the extended α-alkyl group seems most important.  Either a tertiary amine, or the extended α-alkyl group (but not both), are required for the potent nature of MDPV as an hDAT inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfwvQn5iY92LVg90H21EOLACvtfcHk0lgISKoEScgk8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SgsLjJ&md5=916dc6e16c83e9617a157b378f3f2f73</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fcn4001236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn4001236%26sid%3Dliteratum%253Aachs%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DSolis%26aufirst%3DE.%26aulast%3DSakloth%26aufirst%3DF.%26aulast%3DDe%2BFelice%26aufirst%3DL.%2BJ.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D%25E2%2580%259CDeconstruction%2522%2520of%2520the%2520abused%2520synthetic%2520cathinone%2520methylenedioxypyrovalerone%2520%2528MDPV%2529%2520and%2520an%2520examination%2520of%2520effects%2520at%2520the%2520human%2520dopamine%2520transporter%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1524%26epage%3D1529%26doi%3D10.1021%2Fcn4001236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP)</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.brainresbull.2016.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.brainresbull.2016.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=27142261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsV2ntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=111-126&author=R.+A.+Glennonauthor=R.+Young&title=Neurobiology+of+3%2C4-methylenedioxypyrovalerone+%28MDPV%29+and+%CE%B1-pyrrolidinovalerophenone+%28%CE%B1-PVP%29&doi=10.1016%2Fj.brainresbull.2016.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP)</span></div><div class="casAuthors">Glennon, Richard A.; Young, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">Part_1</span>),
    <span class="NLM_cas:pages">111-126</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Synthetic cathinones are analogs of cathinone or β-ketoamphetamine - the major psychostimulant component of the shrub Catha edulis or khat.  Cathinone analogs - though not termed as such - have been known for >100 years, but confusing chem. nomenclature often made the topic difficult to appreciate.  In addn., many of the early analogs were prepd. as synthetic precursors for the development of various other agents, and relatively few were pharmacol. evaluated.  Cathinone is a close structural relative of amphetamine.  Today, certain cathinone derivs., synthetic cathinones, are known to produce central stimulant actions and represent a "new" class of drugs of abuse.  Depending upon the nature of their terminal amine, α substituent, and aryl substituents, they seem to produce their effects via release or reuptake of various neurotansmitters including dopamine norepinephreine and/or serotonin.  Two of the newest and most prominent members of the class are MDPV and its parent α-PVP ("flakka").  Both have been encountered on their own and in what might be constituents of what has been termed by a variety of names including psychoactive "bath salts".  Here, we describe the nomenclature of synthetic cathinones, the mechanism(s) of action of MDPV and α-PVP, and their structure-activity relationships.  In order to assist in forensic studies, and to identify novel substances requiring future pharmacol. evaluation, the metab. of these agents is also described.  Finally, the preclin. behavioral actions of these two agents in a variety of behavioral assays, including rodent locomotor assays, self-administration studies, intracranial self-stimulation, conditioned place preference, and drug discrimination, is summarized.  The results of these studies with MDPV and α-PVP are consistent with their acting as potent cocaine-like central stimulants with abuse liability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAsLTRQFk2wrVg90H21EOLACvtfcHk0lgISKoEScgk8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsV2ntLg%253D&md5=21eac8b7500d48fe780ff37f37391716</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2016.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2016.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DNeurobiology%2520of%25203%252C4-methylenedioxypyrovalerone%2520%2528MDPV%2529%2520and%2520%25CE%25B1-pyrrolidinovalerophenone%2520%2528%25CE%25B1-PVP%2529%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2016%26volume%3D126%26spage%3D111%26epage%3D126%26doi%3D10.1016%2Fj.brainresbull.2016.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakloth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Structural modification of the designer stimulant α-pyrrolidinovalerophenone (α-PVP) influences potency at dopamine transporters</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1726</span><span class="NLM_x">–</span> <span class="NLM_lpage">1731</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00160</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00160" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1CitL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1726-1731&author=R.+Kolanosauthor=F.+Saklothauthor=A.+D.+Jainauthor=J.+S.+Partillaauthor=M.+H.+Baumannauthor=R.+A.+Glennon&title=Structural+modification+of+the+designer+stimulant+%CE%B1-pyrrolidinovalerophenone+%28%CE%B1-PVP%29+influences+potency+at+dopamine+transporters&doi=10.1021%2Facschemneuro.5b00160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters</span></div><div class="casAuthors">Kolanos, R.; Sakloth, F.; Jain, A. D.; Partilla, J. S.; Baumann, M. H.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1726-1731</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">α-Pyrrolidinovalerophenone (α-PVP, 7) is an illegal synthetic stimulant that is being sold on the clandestine market as "flakka" and "gravel".  The potent pharmacol. effects of α-PVP are presumably mediated by inhibition of dopamine uptake at the dopamine transporter (DAT).  However, little is known about how structural modification of α-PVP influences activity at DAT.  Eleven analogs of α-PVP were synthesized and examd. for their ability to inhibit uptake of [3H]dopamine and [3H]serotonin in rat brain synaptosomes.  None of the analogs significantly inhibited [3H]serotonin uptake when tested at 10 μM at the serotonin transporter (SERT).  All of the analogs behaved as DAT reuptake inhibitors, but potencies varied over a >1500-fold range.  Potency was primarily assocd. with the nature of the α-substituent, with the more bulky substituents imparting the highest potency.  Expansion of the pyrrolidine ring to a piperidine reduced potency up to 10-fold, whereas conformational constraint in the form of an aminotetralone resulted in the least potent compd.  Our study provides the first systematic and comparative structure-activity investigation on the ability of α-PVP analogs to act as inhibitors of DAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobeMNshDnZ-LVg90H21EOLACvtfcHk0liH6lIq-HH7hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1CitL7J&md5=e952abc13123688c8993bcb055c30554</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00160%26sid%3Dliteratum%253Aachs%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DSakloth%26aufirst%3DF.%26aulast%3DJain%26aufirst%3DA.%2BD.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DStructural%2520modification%2520of%2520the%2520designer%2520stimulant%2520%25CE%25B1-pyrrolidinovalerophenone%2520%2528%25CE%25B1-PVP%2529%2520influences%2520potency%2520at%2520dopamine%2520transporters%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1726%26epage%3D1731%26doi%3D10.1021%2Facschemneuro.5b00160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutsell, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negus, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Stereoselective actions of methylenedioxypyrovalerone (MDPV) to inhibit dopamine and norepinephrine transporters and facilitate intracranial self-stimulation in rats</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisl2nsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=771-777&author=R.+Kolanosauthor=J.+S.+Partillaauthor=M.+H.+Baumannauthor=B.+A.+Hutsellauthor=M.+L.+Banksauthor=S.+S.+Negusauthor=R.+A.+Glennon&title=Stereoselective+actions+of+methylenedioxypyrovalerone+%28MDPV%29+to+inhibit+dopamine+and+norepinephrine+transporters+and+facilitate+intracranial+self-stimulation+in+rats&doi=10.1021%2Facschemneuro.5b00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats</span></div><div class="casAuthors">Kolanos, R.; Partilla, J. S.; Baumann, M. H.; Hutsell, B. A.; Banks, M. L.; Negus, S. S.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">771-777</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The designer stimulant methylenedioxypyrovalerone (MDPV) is a potent reuptake inhibitor at transporters for dopamine (DAT) and norepinephrine (NET) that produces a constellation of abuse-related behavioral effects.  MDPV possesses a chiral center, and the abused formulation of the drug is a racemic mixt., but no data are available on the pharmacol. of its isomers.  Here, the individual optical isomers of MDPV were prepd. and examd. with respect to their neurochem. actions on neurotransmitter reuptake and behavioral effects in an assay of intracranial self-stimulation (ICSS) in rats.  In assays of DAT uptake inhibition, S(+)MDPV (EC50 = 2.13 nM) was more potent than either (±)MDPV (EC50 = 4.85 nM) or R(-)MDPV (EC50 = 382.80 nM); the three drugs were less potent at NET uptake inhibition, with the same rank order of potency.  Neither racemic MDPV nor its optical isomers inhibited the reuptake of serotonin at concns. up to 10 μM.  S(+)MDPV produced an abuse-related and dose-dependent facilitation of ICSS, and the potency of S(+)MDPV (significant facilitation at doses ≥ 0.1 mg/kg) was greater than that of the racemate (significant facilitation at doses ≥ 0.32 mg/kg).  R(-)MDPV failed to alter ICSS at doses up to 100 times greater than the lowest ED of S(+)MDPV.  The results indicate that abuse-related neurochem. and behavioral effects of racemic MDPV reside primarily with its S(+) isomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEYqB2-T_luLVg90H21EOLACvtfcHk0liH6lIq-HH7hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisl2nsLs%253D&md5=1dc2fc5c94ce8e4f8a5e58fb0e676652</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00006%26sid%3Dliteratum%253Aachs%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DHutsell%26aufirst%3DB.%2BA.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DStereoselective%2520actions%2520of%2520methylenedioxypyrovalerone%2520%2528MDPV%2529%2520to%2520inhibit%2520dopamine%2520and%2520norepinephrine%2520transporters%2520and%2520facilitate%2520intracranial%2520self-stimulation%2520in%2520rats%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D771%26epage%3D777%26doi%3D10.1021%2Facschemneuro.5b00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1016/S0091-3057(01)00666-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2801%2900666-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=205-213&author=R.+Youngauthor=R.+A.+Glennon&title=The+stimulus+effect+of+5%2C6%2C7%2C8-tetrahydro-1%2C3-dioxolo%5B4%2C5-g%5Disoquinoline+is+similar+to+that+of+cocaine+but+different+from+that+of+amphetamine&doi=10.1016%2FS0091-3057%2801%2900666-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2801%2900666-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252801%252900666-9%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DThe%2520stimulus%2520effect%2520of%25205%252C6%252C7%252C8-tetrahydro-1%252C3-dioxolo%255B4%252C5-g%255Disoquinoline%2520is%2520similar%2520to%2520that%2520of%2520cocaine%2520but%2520different%2520from%2520that%2520of%2520amphetamine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D71%26spage%3D205%26epage%3D213%26doi%3D10.1016%2FS0091-3057%2801%2900666-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangisetty, J. B.</span><span> </span><span class="NLM_article-title">Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1016/S0091-3057(01)00768-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2801%2900768-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2002&pages=379-387&author=R.+A.+Glennonauthor=R.+Youngauthor=J.+B.+Rangisetty&title=Further+characterization+of+the+stimulus+properties+of+5%2C6%2C7%2C8-tetrahydro-1%2C3-dioxolo%5B4%2C5-g%5Disoquinoline&doi=10.1016%2FS0091-3057%2801%2900768-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2801%2900768-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252801%252900768-7%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DRangisetty%26aufirst%3DJ.%2BB.%26atitle%3DFurther%2520characterization%2520of%2520the%2520stimulus%2520properties%2520of%25205%252C6%252C7%252C8-tetrahydro-1%252C3-dioxolo%255B4%252C5-g%255Disoquinoline%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D72%26spage%3D379%26epage%3D387%26doi%3D10.1016%2FS0091-3057%2801%2900768-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1016/j.pbb.2006.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2006.04.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=62-73&author=R.+Youngauthor=S.+Batkaiauthor=M.+Dukatauthor=R.+A.+Glennon&title=TDIQ+%285%2C6%2C7%2C8-tetrahydro-1%2C3-dioxolo%5B4%2C5-g%5Disoquinoline%29+exhibits+anxiolytic-like+activity+in+a+marble-burying+assay+in+mice&doi=10.1016%2Fj.pbb.2006.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2006.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2006.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DBatkai%26aufirst%3DS.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DTDIQ%2520%25285%252C6%252C7%252C8-tetrahydro-1%252C3-dioxolo%255B4%252C5-g%255Disoquinoline%2529%2520exhibits%2520anxiolytic-like%2520activity%2520in%2520a%2520marble-burying%2520assay%2520in%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2006%26volume%3D84%26spage%3D62%26epage%3D73%26doi%3D10.1016%2Fj.pbb.2006.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of the 5-HT<sub>1A</sub> agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin (8-OH DPAT)</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1016/0091-3057(86)90243-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2886%2990243-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=135-139&author=R.+A.+Glennon&title=Discriminative+stimulus+properties+of+the+5-HT1A+agonist+8-hydroxy-2-%28di-n-propylamino%29tetralin+%288-OH+DPAT%29&doi=10.1016%2F0091-3057%2886%2990243-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2886%2990243-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252886%252990243-1%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520the%25205-HT1A%2520agonist%25208-hydroxy-2-%2528di-n-propylamino%2529tetralin%2520%25288-OH%2520DPAT%2529%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1986%26volume%3D25%26spage%3D135%26epage%3D139%26doi%3D10.1016%2F0091-3057%2886%2990243-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Björk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höök, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andén, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span> </span><span class="NLM_article-title">Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: Stereoselective interactions with 5-HT<sub>1A</sub> receptors in the brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1021/jm00124a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00124a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=779-783&author=L.+Bj%C3%B6rkauthor=B.+B.+H%C3%B6%C3%B6kauthor=D.+L.+Nelsonauthor=N.+E.+And%C3%A9nauthor=U.+Hacksell&title=Resolved+N%2CN-dialkylated+2-amino-8-hydroxytetralins%3A+Stereoselective+interactions+with+5-HT1A+receptors+in+the+brain&doi=10.1021%2Fjm00124a009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm00124a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00124a009%26sid%3Dliteratum%253Aachs%26aulast%3DBj%25C3%25B6rk%26aufirst%3DL.%26aulast%3DH%25C3%25B6%25C3%25B6k%26aufirst%3DB.%2BB.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DAnd%25C3%25A9n%26aufirst%3DN.%2BE.%26aulast%3DHacksell%26aufirst%3DU.%26atitle%3DResolved%2520N%252CN-dialkylated%25202-amino-8-hydroxytetralins%253A%2520Stereoselective%2520interactions%2520with%25205-HT1A%2520receptors%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D779%26epage%3D783%26doi%3D10.1021%2Fjm00124a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Naiman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydelek, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">2-(Alkylamino)tetralin derivatives: interaction with 5-HT<sub>1A</sub> serotonin binding sites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1021/jm00121a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00121a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=253-256&author=N.+Naimanauthor=R.+A.+Lyonauthor=A.+E.+Bullockauthor=L.+T.+Rydelekauthor=M.+Titelerauthor=R.+A.+Glennon&title=2-%28Alkylamino%29tetralin+derivatives%3A+interaction+with+5-HT1A+serotonin+binding+sites&doi=10.1021%2Fjm00121a045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm00121a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00121a045%26sid%3Dliteratum%253Aachs%26aulast%3DNaiman%26aufirst%3DN.%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DBullock%26aufirst%3DA.%2BE.%26aulast%3DRydelek%26aufirst%3DL.%2BT.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3D2-%2528Alkylamino%2529tetralin%2520derivatives%253A%2520interaction%2520with%25205-HT1A%2520serotonin%2520binding%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D253%26epage%3D256%26doi%3D10.1021%2Fjm00121a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Ariens, E. J.</span><span> </span><span class="NLM_article-title">Agonists and antagonists—Their structural relationship</span>. In  <span class="citation_source-book">Drug Design</span>; <span class="NLM_contrib-group">Ariens, E. J.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1971</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">I</span>, pp  <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1971&pages=162-193&author=E.+J.+Ariensauthor=E.+J.+Ariens&title=Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAriens%26aufirst%3DE.%2BJ.%26atitle%3DAgonists%2520and%2520antagonists%25E2%2580%2594Their%2520structural%2520relationship%26btitle%3DDrug%2520Design%26aulast%3DAriens%26aufirst%3DE.%2BJ.%26pub%3DAcademic%2520Press%26date%3D1971%26volume%3DI%26spage%3D162%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Hauck, A. E.</span><span> </span><span class="NLM_article-title">CNS stimulants and serotonergic properties of phenylalkylamines</span>. Doctoral Dissertation, Virginia Commonwealth University, Richmond, VA, May<span class="NLM_x"> </span><span class="NLM_year">1985</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&author=A.+E.+Hauck&title=CNS+stimulants+and+serotonergic+properties+of+phenylalkylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauck%26aufirst%3DA.%2BE.%26atitle%3DCNS%2520stimulants%2520and%2520serotonergic%2520properties%2520of%2520phenylalkylamines%26date%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">MDMA stimulus generalization to the 5-HT<sub>1A</sub> serotonin agonist 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1016/S0091-3057(00)00174-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2800%2900174-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2000&pages=483-488&author=R.+A.+Glennonauthor=R.+Young&title=MDMA+stimulus+generalization+to+the+5-HT1A+serotonin+agonist+8-hydroxy-2-%28di-n-propylamino%29tetralin&doi=10.1016%2FS0091-3057%2800%2900174-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2800%2900174-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252800%252900174-X%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DMDMA%2520stimulus%2520generalization%2520to%2520the%25205-HT1A%2520serotonin%2520agonist%25208-hydroxy-2-%2528di-n-propylamino%2529tetralin%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2000%26volume%3D66%26spage%3D483%26epage%3D488%26doi%3D10.1016%2FS0091-3057%2800%2900174-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Khorana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Effect of 8-hydroxy-2-(N,N-di-<i>n</i>-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1016/j.pbb.2008.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2008.08.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2009&pages=385-392&author=N.+Khoranaauthor=R.+Youngauthor=R.+A.+Glennon&title=Effect+of+8-hydroxy-2-%28N%2CN-di-n-propylamino%29tetralin+and+MDMA+on+the+discriminative+stimulus+effects+of+the+classical+hallucinogen+DOM+in+rats&doi=10.1016%2Fj.pbb.2008.08.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DKhorana%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DEffect%2520of%25208-hydroxy-2-%2528N%252CN-di-n-propylamino%2529tetralin%2520and%2520MDMA%2520on%2520the%2520discriminative%2520stimulus%2520effects%2520of%2520the%2520classical%2520hallucinogen%2520DOM%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2009%26volume%3D91%26spage%3D385%26epage%3D392%26doi%3D10.1016%2Fj.pbb.2008.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Walker, J. M.; Martin, W. J.; Hohmann, A. G.; Hemstreet, M. K.; Roth, J. S.; Leitner, M. L.; Weiser, S. D.; Patrick, S. L.; Patrick, R. L.; Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">Role of sigma receptors in brain mechanisms of movement</span>. In  <span class="citation_source-book">Sigma Receptors</span>; <span class="NLM_contrib-group">Itzhak, Y.</span> Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">1994</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=205-224&author=J.+M.+Walker&author=W.+J.+Martin&author=A.+G.+Hohmann&author=M.+K.+Hemstreet&author=J.+S.+Roth&author=M.+L.+Leitner&author=S.+D.+Weiser&author=S.+L.+Patrick&author=R.+L.+Patrick&author=R.+R.+Matsumotoauthor=Y.+Itzhak&title=Sigma+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520sigma%2520receptors%2520in%2520brain%2520mechanisms%2520of%2520movement%26btitle%3DSigma%2520Receptors%26aulast%3DItzhak%26aufirst%3DY.%26pub%3DAcademic%2520Press%26date%3D1994%26spage%3D205%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Liu, Y.; Yu, Y.; Shaikh, J.; Pouw, B.; Daniels, A.; Chen, Q.-D.; Matsumoto, R. R.</span><span> </span><span class="NLM_article-title">σ receptors and drug abuse</span>. In  <span class="citation_source-book">Sigma Receptors, Chemistry, Cell Biology and Clinical Implications</span>; <span class="NLM_contrib-group">Matsumoto, R. R.; Bowen, W. D.; Su, T.-P.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2F978-0-387-36514-5_15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=315-336&author=Y.+Liu&author=Y.+Yu&author=J.+Shaikh&author=B.+Pouw&author=A.+Daniels&author=Q.-D.+Chen&author=R.+R.+Matsumotoauthor=R.+R.+Matsumoto&author=W.+D.+Bowen&author=T.-P.+Su&title=Sigma+Receptors%2C+Chemistry%2C+Cell+Biology+and+Clinical+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-36514-5_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-36514-5_15%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26atitle%3D%25CF%2583%2520receptors%2520and%2520drug%2520abuse%26btitle%3DSigma%2520Receptors%252C%2520Chemistry%252C%2520Cell%2520Biology%2520and%2520Clinical%2520Implications%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26pub%3DSpringer%26date%3D2007%26spage%3D315%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Ablordeppey, S. Y.; Glennon, R. A.</span><span> </span><span class="NLM_article-title">Pharmacophore models for sigma1 receptor binding</span>. In  <span class="citation_source-book">Sigma Receptors, Chemistry, Cell Biology and Clinical Implications</span>; <span class="NLM_contrib-group">Matsumoto, R. R.; Bowen, W. D.; Su, T.-P.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=71-98&author=S.+Y.+Ablordeppey&author=R.+A.+Glennonauthor=R.+R.+Matsumoto&author=W.+D.+Bowen&author=T.-P.+Su&title=Sigma+Receptors%2C+Chemistry%2C+Cell+Biology+and+Clinical+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26atitle%3DPharmacophore%2520models%2520for%2520sigma1%2520receptor%2520binding%26btitle%3DSigma%2520Receptors%252C%2520Chemistry%252C%2520Cell%2520Biology%2520and%2520Clinical%2520Implications%26aulast%3DMatsumoto%26aufirst%3DR.%2BR.%26pub%3DSpringer%26date%3D2007%26spage%3D71%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Pharmacophore identification for sigma-1 (σ<sub>1</sub>) receptor binding: Application of the “Deconstruction-Reconstruction-Elaboration” approach</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.2174/138955705774329519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.2174%2F138955705774329519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=16250835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=927-940&author=R.+A.+Glennon&title=Pharmacophore+identification+for+sigma-1+%28%CF%831%29+receptor+binding%3A+Application+of+the+%E2%80%9CDeconstruction-Reconstruction-Elaboration%E2%80%9D+approach&doi=10.2174%2F138955705774329519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore identification for sigma-1 (σ1) receptor binding: Application of the deconstruction - reconstruction - elaboration approach</span></div><div class="casAuthors">Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">927-940</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  At least two different types of sigma σ (σ1 and σ2) receptors have been identified.  A structural feature common to high-affinity (Ki <10 nM) σ1 ligands is: C-N(R)-X-Ph; both C and Ph are assocd. with regions of bulk tolerance.  Numerous other ligands bind, but typically do so with lower affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot_9JlDBLhrbVg90H21EOLACvtfcHk0liCkAPg1rBsBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWku7rM&md5=66ae2e51d57fa97cd3954ae90e7e3167</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.2174%2F138955705774329519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955705774329519%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DPharmacophore%2520identification%2520for%2520sigma-1%2520%2528%25CF%25831%2529%2520receptor%2520binding%253A%2520Application%2520of%2520the%2520%25E2%2580%259CDeconstruction-Reconstruction-Elaboration%25E2%2580%259D%2520approach%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D927%26epage%3D940%26doi%3D10.2174%2F138955705774329519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J. L.</span><span> </span><span class="NLM_article-title">Antagonism of a (+)<i>N</i>-allylnormetazocine stimulus by (−)PPAP and several structurally related analogs</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span><span class="refDoi"> DOI: 10.1016/0091-3057(93)90133-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2893%2990133-E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=865-869&author=R.+A.+Glennonauthor=R.+Youngauthor=J.+L.+Herndon&title=Antagonism+of+a+%28%2B%29N-allylnormetazocine+stimulus+by+%28%E2%88%92%29PPAP+and+several+structurally+related+analogs&doi=10.1016%2F0091-3057%2893%2990133-E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2893%2990133-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252893%252990133-E%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DHerndon%26aufirst%3DJ.%2BL.%26atitle%3DAntagonism%2520of%2520a%2520%2528%252B%2529N-allylnormetazocine%2520stimulus%2520by%2520%2528%25E2%2588%2592%2529PPAP%2520and%2520several%2520structurally%2520related%2520analogs%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1993%26volume%3D45%26spage%3D865%26epage%3D869%26doi%3D10.1016%2F0091-3057%2893%2990133-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Ablordeppey, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Probing the proposed phenyl-A region of the sigma-1 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2765</span><span class="refDoi"> DOI: 10.1016/S0968-0896(02)00096-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0968-0896%2802%2900096-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2759-2765&author=S.+Y.+Ablordeppeyauthor=J.+B.+Fischerauthor=H.+Lawauthor=R.+A.+Glennon&title=Probing+the+proposed+phenyl-A+region+of+the+sigma-1+receptor&doi=10.1016%2FS0968-0896%2802%2900096-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900096-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900096-2%26sid%3Dliteratum%253Aachs%26aulast%3DAblordeppey%26aufirst%3DS.%2BY.%26aulast%3DFischer%26aufirst%3DJ.%2BB.%26aulast%3DLaw%26aufirst%3DH.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DProbing%2520the%2520proposed%2520phenyl-A%2520region%2520of%2520the%2520sigma-1%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2759%26epage%3D2765%26doi%3D10.1016%2FS0968-0896%2802%2900096-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Binding characteristics of σ<sub>2</sub> receptor ligands</span> <span class="citation_source-journal">Brazil. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1590/S1516-93322005000100002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1590%2FS1516-93322005000100002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFCksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=1-12&author=R.+A.+Glennon&title=Binding+characteristics+of+%CF%832+receptor+ligands&doi=10.1590%2FS1516-93322005000100002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102aR"><div class="casContent"><span class="casTitleNuber">102a</span><div class="casTitle"><span class="NLM_cas:atitle">Binding characteristics of σ2 receptor ligands</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Revista Brasileira de Ciencias Farmaceuticas</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">RBCFFM</span>;
        ISSN:<span class="NLM_cas:issn">1516-9332</span>.
    
            (<span class="NLM_cas:orgname">Universidade de Sao Paulo, Faculdade de Ciencias Farmaceuticas</span>)
        </div><div class="casAbstract">A review.  Sigma (σ) receptors, once considered a type of opioid receptor are now recognized as representing a unique receptive entity and at least two different types of σ receptors have been identified σ1 and σ2 receptors.  Evidence suggests that these receptors might be targeted and exploited for the development of agents potentially useful for the treatment of several central disorders.  This review primarily describes some of our efforts to understand those structural features that contribute to σ2 receptor binding, and some recent work by other investigators is also included.  Despite an inability to formulate a unified pharmacophore model for α2 binding due to the diversity of structure-types that bind at the receptor, and to the conformational flexibility of these ligands, significant progress has been made to ward the development od some very high affinity agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQAG2gQdALrVg90H21EOLACvtfcHk0lgaR8ElMjo3qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFCksLg%253D&md5=863bf7ddc28bafbe45a21d852d85954f</span></div><a href="/servlet/linkout?suffix=cit102a&amp;dbid=16384&amp;doi=10.1590%2FS1516-93322005000100002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS1516-93322005000100002%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520characteristics%2520of%2520%25CF%25832%2520receptor%2520ligands%26jtitle%3DBrazil.%2520J.%2520Pharm.%2520Sci.%26date%3D2005%26volume%3D41%26spage%3D1%26epage%3D12%26doi%3D10.1590%2FS1516-93322005000100002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit102b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Abate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">A structure-affinity and comparative molecular field analysis of sigma-2 (σ<sub>2</sub>) receptor ligands</span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.2174/1871524910909030246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.2174%2F1871524910909030246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=20021358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=246-257&author=C.+Abateauthor=P.+Mosierauthor=F.+Berardiauthor=R.+A.+Glennon&title=A+structure-affinity+and+comparative+molecular+field+analysis+of+sigma-2+%28%CF%832%29+receptor+ligands&doi=10.2174%2F1871524910909030246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102bR"><div class="casContent"><span class="casTitleNuber">102b</span><div class="casTitle"><span class="NLM_cas:atitle">A structure-affinity and comparative molecular field analysis of sigma-2 (σ2) receptor ligands</span></div><div class="casAuthors">Abate, Carmen; Mosier, Philip Daniel; Berardi, Francesco; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">246-257</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Several σ1 receptor ligands with sub-nanomolar affinity and excellent selectivity have been reported, but relatively few σ2-selective ligands are known.  1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl] piperazine (PB28; 1) has been reported by us as a high-affinity σ2 receptor ligand with significant σ2 selectivity, and several analogs of (1) now have been developed.  Among these are the class of cyclohexylpiperazines that display a good compromise between affinity/activity and selectivity for σ2 receptors.  Very little is currently known about the nature of σ2 receptors.  In the absence of structure-based receptor information, we applied a comparative mol. field anal. (CoMFA) - a three-dimensional structure-activity relationship (3D-QSAR) method - to a set of cyclohexylpiperazine σ2 ligands to develop a predictive model that might provide information about the stereoelectronic nature of the receptor binding site.  Two CoMFA models were generated from two different alignments: the first used an automated FlexS algorithm, and the second used a rationally-driven manual alignment.  Significantly better predictivity was obtained with the manual alignment (TSET: q2 = 0.73, r2 = 0.95; PSET: r2 = 0.55/0.73) than from the automated alignment (TSET: q2 = 0.69, r2 = 0.98; PSET: r2 = 0.13/0.16).  The resulting CoMFA maps account for obsd. structure-affinity relationships and suggest a possible anatomy for the σ2 receptor/cyclohexylpiperazine binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNSRDXO2Ws7bVg90H21EOLACvtfcHk0lgaR8ElMjo3qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rK&md5=b1203a3a8343205b4439481c0ece5a8e</span></div><a href="/servlet/linkout?suffix=cit102b&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030246%26sid%3Dliteratum%253Aachs%26aulast%3DAbate%26aufirst%3DC.%26aulast%3DMosier%26aufirst%3DP.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DA%2520structure-affinity%2520and%2520comparative%2520molecular%2520field%2520analysis%2520of%2520sigma-2%2520%2528%25CF%25832%2529%2520receptor%2520ligands%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D246%26epage%3D257%26doi%3D10.2174%2F1871524910909030246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siripurapu, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikazwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span> </span><span class="NLM_article-title">The medicinal chemistry of 5-HT<sub>6</sub> receptor ligands with a focus on arylsulfonyltryptamine analogs</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span><span class="refDoi"> DOI: 10.2174/156802610791111542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.2174%2F156802610791111542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=20166945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFKnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=579-595&author=R.+A.+Glennonauthor=U.+Siripurapuauthor=B.+L.+Rothauthor=R.+Kolanosauthor=M.+L.+Bondarevauthor=D.+Sikazweauthor=M.+Leeauthor=M.+Dukat&title=The+medicinal+chemistry+of+5-HT6+receptor+ligands+with+a+focus+on+arylsulfonyltryptamine+analogs&doi=10.2174%2F156802610791111542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs</span></div><div class="casAuthors">Glennon, Richard A.; Siripurapu, Uma; Roth, Bryan L.; Kolanos, Renata; Bondarev, Mikhail L.; Sikazwe, Donald; Lee, Mase; Dukat, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Arylsulfonyl analogs of aminopyrimidines (e.g. Ro 04-6790; 2), aminopyridines (e.g. Ro 63-0563; 3), 1-phenylpiperazines (e.g. SB-271046; 4), and tryptamines (e.g. MS-245; 5) were described as the first examples of selective 5-HT6 receptor antagonists only ten years ago.  Today, hundreds of compds. of seemingly diverse structure have been reported.  The early antagonists featured an arylsulfonyl group leading to the widespread assumption that an arylsulfonyl moiety might be crit. for binding and antagonist action.  With respect to the arylsulfonyltryptamines, it seems that neither the "arylsulfonyl" nor the "tryptamine" portion of these compds. is essential for binding or for antagonist action, and some such derivs. even display agonist action.  The present review describes many of the currently available 5-HT6 receptor ligands and, unlike prior reviews, provides a narrative of the thinking (where possible) that led to their design, synthesis, and evaluation.  The arylsulfonyltryptamines are also used as the structural basis of attempts to relate various structure-types to one another to afford a better understanding of the overall structural requirements for 5-HT6 receptor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlcIaCOtbRK7Vg90H21EOLACvtfcHk0ljgCLtBWEPxDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFKnur8%253D&md5=c9aac49fd24a4bc84f478db4217073d4</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.2174%2F156802610791111542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791111542%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DSiripurapu%26aufirst%3DU.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DSikazwe%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3DThe%2520medicinal%2520chemistry%2520of%25205-HT6%2520receptor%2520ligands%2520with%2520a%2520focus%2520on%2520arylsulfonyltryptamine%2520analogs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D579%26epage%3D595%26doi%3D10.2174%2F156802610791111542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Frantz, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouffer, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span><span class="refDoi"> DOI: 10.1016/S0028-3908(01)00165-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0028-3908%2801%2900165-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=170-180&author=K.+J.+Frantzauthor=D.+G.+Hanssonauthor=L.+H.+Stoufferauthor=A.+Parsons&title=5-HT6+receptor+antagonism+potentiates+the+behavioral+and+neurochemical+effects+of+amphetamine+but+not+cocaine&doi=10.1016%2FS0028-3908%2801%2900165-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2801%2900165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252801%252900165-4%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DK.%2BJ.%26aulast%3DHansson%26aufirst%3DD.%2BG.%26aulast%3DStouffer%26aufirst%3DL.%2BH.%26aulast%3DParsons%26aufirst%3DA.%26atitle%3D5-HT6%2520receptor%2520antagonism%2520potentiates%2520the%2520behavioral%2520and%2520neurochemical%2520effects%2520of%2520amphetamine%2520but%2520not%2520cocaine%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D42%26spage%3D170%26epage%3D180%26doi%3D10.1016%2FS0028-3908%2801%2900165-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Pullagurla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondareva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Modulation of the stimulus effects of (+)amphetamine by the 5-HT<sub>6</sub> antagonist MS-245</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span><span class="refDoi"> DOI: 10.1016/j.pbb.2004.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2004.03.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2004&pages=263-268&author=M.+Pullagurlaauthor=T.+Bondarevaauthor=R.+Youngauthor=R.+A.+Glennon&title=Modulation+of+the+stimulus+effects+of+%28%2B%29amphetamine+by+the+5-HT6+antagonist+MS-245&doi=10.1016%2Fj.pbb.2004.03.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2004.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2004.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DPullagurla%26aufirst%3DM.%26aulast%3DBondareva%26aufirst%3DT.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DModulation%2520of%2520the%2520stimulus%2520effects%2520of%2520%2528%252B%2529amphetamine%2520by%2520the%25205-HT6%2520antagonist%2520MS-245%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2004%26volume%3D78%26spage%3D263%26epage%3D268%26doi%3D10.1016%2Fj.pbb.2004.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondareva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Effect of the 5-HT<sub>6</sub> serotonin antagonist MS-245 on the actions of (−)nicotine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1016/j.pbb.2006.07.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2006.07.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=170-177&author=R.+Youngauthor=T.+Bondarevaauthor=A.+Wesolowskaauthor=S.+Youngauthor=R.+A.+Glennon&title=Effect+of+the+5-HT6+serotonin+antagonist+MS-245+on+the+actions+of+%28%E2%88%92%29nicotine&doi=10.1016%2Fj.pbb.2006.07.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2006.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2006.07.029%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DBondareva%26aufirst%3DT.%26aulast%3DWesolowska%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DEffect%2520of%2520the%25205-HT6%2520serotonin%2520antagonist%2520MS-245%2520on%2520the%2520actions%2520of%2520%2528%25E2%2588%2592%2529nicotine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2006%26volume%3D85%26spage%3D170%26epage%3D177%26doi%3D10.1016%2Fj.pbb.2006.07.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacyno, J. M.</span><span> </span><span class="NLM_article-title">Indolealkylamine and phenalkylamine hallucinogens: Effect of α-methyl and N-methyl substituents on behavioral activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1267</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span><span class="refDoi"> DOI: 10.1016/0006-2952(83)90281-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0006-2952%2883%2990281-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1983&pages=1267-1273&author=R.+A.+Glennonauthor=R.+Youngauthor=J.+M.+Jacyno&title=Indolealkylamine+and+phenalkylamine+hallucinogens%3A+Effect+of+%CE%B1-methyl+and+N-methyl+substituents+on+behavioral+activity&doi=10.1016%2F0006-2952%2883%2990281-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2883%2990281-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252883%252990281-2%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DJacyno%26aufirst%3DJ.%2BM.%26atitle%3DIndolealkylamine%2520and%2520phenalkylamine%2520hallucinogens%253A%2520Effect%2520of%2520%25CE%25B1-methyl%2520and%2520N-methyl%2520substituents%2520on%2520behavioral%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1983%26volume%3D32%26spage%3D1267%26epage%3D1273%26doi%3D10.1016%2F0006-2952%2883%2990281-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Lyon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seggel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Indolealkylamine analogs share 5-HT<sub>2</sub> binding characteristics with phenalkylamine hallucinogens</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.1016/0014-2999(88)90432-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0014-2999%2888%2990432-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=3350047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADyaL1cXksVOrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1988&pages=291-297&author=R.+A.+Lyonauthor=M.+Titelerauthor=M.+R.+Seggelauthor=R.+A.+Glennon&title=Indolealkylamine+analogs+share+5-HT2+binding+characteristics+with+phenalkylamine+hallucinogens&doi=10.1016%2F0014-2999%2888%2990432-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens</span></div><div class="casAuthors">Lyon, Robert A.; Titeler, Milt; Seggel, Mark R.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-7</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">A group of 25 substituted indolealkylamines I; R = H, Me, Et; R2, R3 = H, Me; R4 = H, OMe; R5 = H, OH, OMe, benzyloxy; R6 = H, Me, OMe; R7 = H, OH, Me, OMe, Br) and related compds. some of which are known to be psychoactive in man, were examd. for their binding interactions with rat brain cortical 5-HT2 receptors labeled with the antagonist radioligand [3H]ketanserin in order to develop structure-activity relationships for binding at these sites.  Features investigated included arom., α-Me, and terminal amine substituents.  4-Methoxy and 5-methoxy substitution impart a higher affinity than 6- or 7-methoxy substitution; a 7-hydroxyl group essentially abolishes affinity whereas a 7-Me or 7-bromo group enhances affinity.  α-Methylation has little effect on affinity and, in the one case examd., the S(+) isomer of α-methyltryptamine was essentially equipotent with its racemate and twice as potent as its R(-) enantiomer.  Terminal amine methylation results in a small but progressive decrease in affinity in the order: primary amine > dimethylamine > diethylamine.  Similarities were noted between these structural requirements for binding and those of the phenalkylamines.  Selected compds. (5-methoxytryptamine, N,N-dimethyltryptamine, 5-methoxy-N,N-diethyltryptamine and 5-methoxy-N,N-dimethyltryptamine) were further examd. by 2-site anal. of displacement studies for [3H]ketanserin specific binding.  Hill coeffs. were less than 1 and computer-assisted anal. indicated that a 2-site model better fit the data than a 1-site model.  In displacement studies using the putative agonist radioligand [3H]DOB to label 5-HT2 receptors affinities were 10-100-fold higher than those using [3H]ketanserin.  These results are also consistent with earlier findings using psychoactive phenalkylamines in competition studies for radiolabeled 5-HT2 receptors.  The interactions of indolealkylamines and phenalkylamines with 5-HT2 receptors have many characteristics in common, supporting the hypothesis that 5-HT2 receptors may mediate the psychoactive properties of indolealkylamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRNq0psu7f-rVg90H21EOLACvtfcHk0lisYuzp5ibpCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXksVOrtr0%253D&md5=1085e511e975b40cb19036a2240036e4</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990432-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990432-3%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DR.%2BA.%26aulast%3DTiteler%26aufirst%3DM.%26aulast%3DSeggel%26aufirst%3DM.%2BR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DIndolealkylamine%2520analogs%2520share%25205-HT2%2520binding%2520characteristics%2520with%2520phenalkylamine%2520hallucinogens%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D145%26spage%3D291%26epage%3D297%26doi%3D10.1016%2F0014-2999%2888%2990432-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of site-selective serotonin agonists</span>. In  <span class="citation_source-book">Transduction Mechanisms of Drug Stimuli</span>; <span class="NLM_contrib-group">Colpaert, F. C.; Balster, R. L.</span>, Eds.; <span class="NLM_publisher-name">Springer Verlag</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">1988</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1007%2F978-3-642-73223-2_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=15-31&author=R.+A.+Glennonauthor=F.+C.+Colpaert&author=R.+L.+Balster&title=Transduction+Mechanisms+of+Drug+Stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-73223-2_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-73223-2_2%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520site-selective%2520serotonin%2520agonists%26btitle%3DTransduction%2520Mechanisms%2520of%2520Drug%2520Stimuli%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26pub%3DSpringer%2520Verlag%26date%3D1988%26spage%3D15%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Hong, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Discriminative stimulus properties of α-ethyltryptamine optical isomers</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span><span class="refDoi"> DOI: 10.1016/S0091-3057(01)00605-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2FS0091-3057%2801%2900605-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=311-316&author=S.-S.+Hongauthor=R.+Youngauthor=R.+A.+Glennon&title=Discriminative+stimulus+properties+of+%CE%B1-ethyltryptamine+optical+isomers&doi=10.1016%2FS0091-3057%2801%2900605-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2801%2900605-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252801%252900605-0%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520%25CE%25B1-ethyltryptamine%2520optical%2520isomers%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2001%26volume%3D70%26spage%3D311%26epage%3D316%26doi%3D10.1016%2FS0091-3057%2801%2900605-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misenheimer, B. R.</span><span> </span><span class="NLM_article-title">Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span><span class="refDoi"> DOI: 10.1016/0091-3057(89)90491-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2889%2990491-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1989&pages=909-912&author=R.+A.+Glennonauthor=B.+R.+Misenheimer&title=Stimulus+effects+of+N-monoethyl-1-%283%2C4-methylenedioxyphenyl%29-2-aminopropane+%28MDE%29+and+N-hydroxy-1-%283%2C4-methylenedioxyphenyl%29-2-aminopropane+%28N-OH+MDA%29+in+rats+trained+to+discriminate+MDMA+from+saline&doi=10.1016%2F0091-3057%2889%2990491-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2889%2990491-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252889%252990491-7%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DMisenheimer%26aufirst%3DB.%2BR.%26atitle%3DStimulus%2520effects%2520of%2520N-monoethyl-1-%25283%252C4-methylenedioxyphenyl%2529-2-aminopropane%2520%2528MDE%2529%2520and%2520N-hydroxy-1-%25283%252C4-methylenedioxyphenyl%2529-2-aminopropane%2520%2528N-OH%2520MDA%2529%2520in%2520rats%2520trained%2520to%2520discriminate%2520MDMA%2520from%2520saline%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1989%26volume%3D33%26spage%3D909%26epage%3D912%26doi%3D10.1016%2F0091-3057%2889%2990491-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">MDMA-Like stimulus effects of α-ethyltryptamine and the α-ethyl homolog of DOM</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span><span class="refDoi"> DOI: 10.1016/0091-3057(93)90379-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2F0091-3057%2893%2990379-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=459-462&author=R.+A.+Glennon&title=MDMA-Like+stimulus+effects+of+%CE%B1-ethyltryptamine+and+the+%CE%B1-ethyl+homolog+of+DOM&doi=10.1016%2F0091-3057%2893%2990379-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2893%2990379-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252893%252990379-8%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DMDMA-Like%2520stimulus%2520effects%2520of%2520%25CE%25B1-ethyltryptamine%2520and%2520the%2520%25CE%25B1-ethyl%2520homolog%2520of%2520DOM%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1993%26volume%3D46%26spage%3D459%26epage%3D462%26doi%3D10.1016%2F0091-3057%2893%2990379-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondareva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span> </span><span class="NLM_article-title">α-Ethyltryptamine (α-ET) as a discriminative stimulus in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span><span class="refDoi"> DOI: 10.1016/j.pbb.2006.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.pbb.2006.09.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=448-453&author=R.+A.+Glennonauthor=T.+Bondarevaauthor=R.+Young&title=%CE%B1-Ethyltryptamine+%28%CE%B1-ET%29+as+a+discriminative+stimulus+in+rats&doi=10.1016%2Fj.pbb.2006.09.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2006.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2006.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DBondareva%26aufirst%3DT.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3D%25CE%25B1-Ethyltryptamine%2520%2528%25CE%25B1-ET%2529%2520as%2520a%2520discriminative%2520stimulus%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2006%26volume%3D85%26spage%3D448%26epage%3D453%26doi%3D10.1016%2Fj.pbb.2006.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landavazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span> </span><span class="NLM_article-title">α-Ethyltryptamines as dual dopamine-serotonin releasers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4754</span><span class="NLM_x">–</span> <span class="NLM_lpage">4758</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.07.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1016%2Fj.bmcl.2014.07.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4754-4758&author=B.+E.+Bloughauthor=A.+Landavazoauthor=J.+S.+Partillaauthor=A.+M.+Deckerauthor=K.+M.+Pageauthor=M.+H.+Baumannauthor=R.+B.+Rothman&title=%CE%B1-Ethyltryptamines+as+dual+dopamine-serotonin+releasers&doi=10.1016%2Fj.bmcl.2014.07.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.07.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.07.062%26sid%3Dliteratum%253Aachs%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DLandavazo%26aufirst%3DA.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DPage%26aufirst%3DK.%2BM.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26atitle%3D%25CE%25B1-Ethyltryptamines%2520as%2520dual%2520dopamine-serotonin%2520releasers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4754%26epage%3D4758%26doi%3D10.1016%2Fj.bmcl.2014.07.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Evidence for possible involvement of 5-HT<sub>2B</sub> receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2836</span><span class="NLM_x">–</span> <span class="NLM_lpage">2841</span><span class="refDoi"> DOI: 10.1161/01.CIR.102.23.2836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=10.1161%2F01.CIR.102.23.2836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=11104741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=2836-2841&author=R.+B.+Rothmanauthor=M.+H.+Baumannauthor=J.+E.+Savageauthor=L.+Rauserauthor=A.+McBrideauthor=S.+J.+Hufeisenauthor=B.+L.+Roth&title=Evidence+for+possible+involvement+of+5-HT2B+receptors+in+the+cardiac+valvulopathy+associated+with+fenfluramine+and+other+serotonergic+medications&doi=10.1161%2F01.CIR.102.23.2836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.; Savage, Jason E.; Rauser, Laura; McBride, Ace; Hufeisen, Sandra J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2836-2841</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Serotonergic medications with various mechanisms of action are used to treat psychiatric disorders and are being investigated as treatments for drug dependence.  The occurrence of fenfluramine-assocd. valvular heart disease (VHD) has raised concerns that other serotonergic medications might also increase the risk of developing VHD.  We hypothesized that fenfluramine or its metabolite norfenfluramine and other medications known to produce VHD have preferentially high affinities for a particular serotonin receptor subtype capable of stimulating mitogenesis.  Medications known or suspected to cause VHD (pos. controls) and medications not assocd. with VHD (neg. controls) were screened for activity at 11 cloned serotonin receptor subtypes by use of ligand-binding methods and functional assays.  The pos. control drugs were (±)-fenfluramine; (+)-fenfluramine; (-)-fenfluramine; its metabolites (±)-norfenfluramine, (+)-norfenfluramine, and (-)-norfenfluramine; ergotamine; and methysergide and its metabolite methylergonovine.  The neg. control drugs were phentermine, fluoxetine, its metabolite norfluoxetine, and trazodone and its active metabolite m-chlorophenylpiperazine.  (±)-, (+)-, And (-)-Norfenfluramine, ergotamine, and methylergonovine all had preferentially high affinities for the cloned human serotonin 5-HT2B receptor and were partial to full agonists at the 5-HT2B receptor.  Our data imply that activation of 5-HT2B receptors is necessary to produce VHD and that serotonergic medications that do not activate 5-HT2B receptors are unlikely to produce VHD.  We suggest that all clin. available medications with serotonergic activity and their active metabolites be screened for agonist activity at 5-HT2B receptors and that clinicians should consider suspending their use of medications with significant activity at 5-HT2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6spUXOCLtLrVg90H21EOLACvtfcHk0lg3GGCezd1glQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D&md5=6b8c6059885dd9b058859089914c61b3</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.102.23.2836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.102.23.2836%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DSavage%26aufirst%3DJ.%2BE.%26aulast%3DRauser%26aufirst%3DL.%26aulast%3DMcBride%26aufirst%3DA.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DEvidence%2520for%2520possible%2520involvement%2520of%25205-HT2B%2520receptors%2520in%2520the%2520cardiac%2520valvulopathy%2520associated%2520with%2520fenfluramine%2520and%2520other%2520serotonergic%2520medications%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D2836%26epage%3D2841%26doi%3D10.1161%2F01.CIR.102.23.2836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00085&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00085%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-7" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00085" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991df31f9a3bfe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
